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Abstract
The primary protein recovery process of an industrial E.coli fermentation at large scale was cha-
racterized and optimized based on the total protein, total interferon-α-2b and interferon-isoform
concentrations. Mass balances for total protein and interferon-α-2b were set up for each centrifu-
gation step throughout the primary recovery process to identify critical process steps. With the
characterization of the recovery process a loss of 90% of the total protein and a loss of 80% in
total interferon-α-2b was observed, occurring at two main critical process steps (CPS). The ma-
jority loss of proteins was identified during critical process step one, due to insufficient solubility
and low protein saturation levels in water.
Following the characterization, CPS-1 was optimized by the addition of detergents. Two dif-
ferent detergents, Sarkosyl and Zwittergent 3-14 were tested and their impacts on the following
recovery steps as well as on the first down-stream step were studied. A new purification method
was developed in order to remove one of the detergent (Sarkosyl) from process samples prior
to the down-stream process With the addition of Zwittergent 3-14 during CPS-1 the recovery of
interferon-α-2b at the end of the protein recovery process was successfully increased 4-fold com-
pared to the previous protein recovery and no negative impact on the first down-stream step was
observed.
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Chapter 1
Introduction
1.1 Thesis aims and scopes
The primary recovery of proteins at the end of a fermentation process can be considered as a
keystone for the overall protein loss during purification. Recombinant proteins are often produced
in batch and fed-batch fermentations at industrial scale since the early 1980s using Escherichia
coli (E.coli) or other microbial cells. The main challenge remains in the isolation and recovery
of the protein from the fermentation broth at the end of the fermentation. The primary recovery
of proteins after a microbial fermentation is usually composed of several centrifugation steps to
separate the protein from the fermentation broth and to reduce the volume before starting the final
purification steps during downstream processing. During the centrifugation steps different set-
points of pH, conductivity and volume will be adjusted which can affect the product quality and
quantity. Therefore the characterization of the primary protein recovery process is indispensable
to maintain product quality and quantity, especially at industrial scale.
The recombinant protein interferon-α-2b is produced at manufacturing scale at 40’000L in an
E.coli batch fermentation since the early 1980s. The fermentation is followed by a primary protein
recovery process in order to harvest the recombinant protein and separate it from the fermentation
broth prior to the final purification steps. This recovery process was identified as the primary
source of the overall protein loss during the production of the drug substance interferon-α-2b.
In order to optimize this primary recovery process a research collaboration was formed in 2011
between the industrial partner and NIBRT/ DCU with the aim to enhance the overall process
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yield.
The primary focus of this project is to characterize the protein recovery process and to identify
critical process parameters in order to optimize and minimize the protein loss during the recovery
process. In a first step protein mass balances for total protein and total interferon-α-2b need to be
set up throughout the recovery process to identify the critical process steps (CPS). Following the
characterization, identified CPS can be investigated and optimized in order to increase the overall
process yield.
In a second step, identified critical process steps will be optimized using design of experiment
and optimized conditions will be applied to the protein recovery process in a small scale study.
Following the optimization, the impact of the optimized process on the first down-stream step will
be investigated.
This project is done in a research collaboration between an industrial partner and NIBRT/DCU,
therefore all information given in this manuscript is confidential!
1.2 Thesis outline
This thesis is divided into twelve chapters, whose structure is described in the following para-
graphs:
Chapter 2 - Project Outline
The first part, chapter 2, provides information about the project outline itself. It contains detailed
plans about the manufacturing process, as well as sampling systems that were put in place through
the manufacturing process.
Chapter 3 - Simulation of the protein recovery process
Chapter 3 describes the development of a protein assay using a small scale model of the manufac-
turing recovery process. Since different media components do interfere with some protein assays
it is important to develop a robust method with a minimum of interference from media or cell
components.
Beside this, chapter 3 also provides information about some characteristics of the recovery process
itself as well as the application of the small scale model of the recovery process at lab scale.
PhD-Thesis from Tanja Buch 2
CHAPTER 1. INTRODUCTION
Chapter 4 - Process Characterization - total protein mass balances
Chapter 4 is the first of three parts about the characterization of the protein recovery process. Total
protein mass balances are set up throughout the entire RP in order to identify critical process steps
for protein recovery.
Chapter 5 - Process Characterization - total Interferon mass balances
This chapter is the second part about process characterization. After setting up mass balances
for total protein in chapter 4, chapter 5 contains mass balances for total interferon-α-2b. Critical
process steps are identified for IFN losses throughout the recovery process and compared to the
CPS’s identified for total protein.
Chapter 6 - Process Characterization - Isoform mass balances
Chapter 6 is the last part about the characterization of the protein recovery process and can be
divided into three sections. The first section focuses on the development and optimization of a
HPLC method for the quantification of interferon-isoforms. The second section discusses the de-
velopment of a purification and concentration technique for the recovery process samples in order
to purify interferon-α-2b and its isoforms from host cell proteins prior to analysis. The last section
of this chapter covers the setting up of mass balances for the interferon-isoforms. Identified critical
process steps are compared with the findings from chapter 4 and 5.
Chapter 7 - Process Optimization - protein dilution study
Chapter 7 is the first of two chapters focussing on the optimization of the identified critical process
step 1. A dilution study is performed around cycle 1 of the protein recovery process to increase
protein solubility. The optimal dilution factor is applied to the protein recovery process in a small
scale study and the impact of the optimized recovery process on the first down-stream step is in-
vestigated.
Chapter 8 - Process Optimization - Solubility study with detergents
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This chapter is the second part focussing on the optimization of the critical process step 1. Differ-
ent detergents are tested for their potential to improve the interferon-α-2b solubility during CPS-1.
Two detergents are selected and implemented in the protein recovery process in a small scale study.
The impact of the presence of the detergents on the following recovery process steps is studied.
Chapter 9 - Detergent Removal from the Recovery Process
Chapter 9 focuses on the removal of the two detergents from process samples. First, two analytic
methods are developed for the quantification of the two detergents selected in chapter 8. Fol-
lowing, different techniques are studied for their potential to remove the detergents from process
samples while keeping interferon-α-2b in solution.
Chapter 10 - Impact of optimized recovery process on Down Stream Process
This chapter studies the impact of the presence of detergents on the first down-stream step, an
ion-exchange chromatography method. First, the ion-exchange method is characterized and mass
balances for interferon-α-2b and total protein are being set-up throughout the chromatographic
procedure. The second part studies the impact of the two detergents on the interferon-α-2b purifi-
cation with the ion-exchange method.
Chapter 11 - Summary chapter - Optimized Protein Recovery Process
Chapter 11 is summarizing the findings of chapter 7, 8, 9 and 10 and proposed three new optimized
protein recovery processes with an enhanced interferon-α-2b recovery. Following, advantages and
disadvantages of each optimized process are discussed and the most efficient and applicable opti-
mized recovery process is presented, considering interferon recovery and process time and cost.
Chapter 12 - Conclusion and Outlook
This chapter gives a conclusion of the achieved results of all ten chapters, focusing on the char-
acterization of the primary protein recovery process, the optimization of identified critical process
steps and the impact of the optimized processes on the first down-stream step. Chapter 12 also con-
tains an outlook of potential following steps in order to increase the interferon-α-2b productivity
and to enhance the overall process yield.
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Chapter 2
Project Outline
2.1 Introduction
Interferon-α-2b is produced at manufacturing scale since 1983. The industrial partner is a leader
in the pharmaceutical industry in developing and producing therapeutic proteins. Their facility in
Ireland includes large-scale fermentation, purification, sterile manufacturing and quality control
operations.
On site analysis in the years up to 2011 showed an overall yield of only 5% of the interferon-α-2b
production process. The main loss of interferon of around 75% was detected in the primary pro-
tein recovery process prior to the purification process. These findings made the recovery process
priority number 1 for the research collaboration between the industrial partner, NIBRT and DCU.
The collaboration started in summer 2011 with the aim to characterize and optimize the primary
recovery process for interferon-α-2b to enhance the overall process yield.
This chapter will provide more detailed information about the structure and outline of this research
collaboration and gives a guidance on the different steps of this project.
2.2 Interferon-α-2b drug substance production
Interferon and cytokines are an important part of our immune system to protect it from pathogens
such as viruses, bacteria, parasites or tumour cells [17]. Therefore they are nowadays often used
in cancer treatment or for immune diseases. Interferon can be divided into two main categories:
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type I and type II. Type I interferon (IFN-α, -β and -ω) are important in the anti-viral response and
activity against tumours [18, 19]. Type II interferon (IFN-γ) is active against bacterial infection as
well as in tumour control [20].
Interferon-α-2b is an important drug for the treatment of viral diseases, especially Hepatitis C
[21, 22]. Up until today there are three companies who are producing IFN-α-2 at manufacturing
scale [23, 24]. Figure 2.1 shows the molecular structure of the recombinant protein interferon-α-
2b.
Fig. 2.1: Molecular structure of interferon-α-2b [1]
Interferon-α belongs to the large class of glycoproteins but studies have shown that the glycan-
profiles are not mandatory to achieve biological activity of IFN-α in cancer and Hepatitis-C treat-
ment [25]. Hence, interferon-α is produced by bacterial fermentation to avoid glycan variability,
that can occur during production by mammalian cells.
At manufacturing scale interferon-α-2b is produced by a modified E.coli strain in a batch fermen-
tation. Escherichia coli K-12/P1 strain using a EK1 E.coli host, bears the plasmid KMAC-43 to
produce interferon-α-2b. The plasmid itself contains of 7882 bp including the human interferon-α-
2b gene, a tetracycline resistance region and a temperature-inducible runaway origin of replication,
which allows the plasmid to accumulate to a high copy number following a temperature up-shift
during fermentation. The production occurs at a 32000L working volume, at 70 rpm and pH 7.0.
The pH is maintained by the addition of NaOH. Two temperature shifts are necessary during the
production. The first one is from 30 to 37◦C and the second one is from 37 down to 25◦C. In the
first phase of the fermentation at 30◦C cell growth of the E.coli cells occurs. The short second
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phase at 37◦C is the induction phase for interferon-α-2b, whose genome sequence is located on
a temperature controlled vector. The last phase at 25◦C is for protein/interferon production and
maintenance of cell viability.
Producing recombinant proteins in bacterial cells has the advantage of no glycosylation of the
protein of interest. However, there is also a large disadvantage, proteins are generally not secreted
into the medium but remain within the cytoplasm or periplasmic space of the bacterial cell. Hence,
cells need to be lysed in order to release the protein of interest and to harvest it. This happens in
the primary protein recovery process which will be described in more detail in the next section.
After the recovery process the actual purification steps follow. The first step for interferon-α-2b is
an ion-exchange chromatography using a cation-exchange column. This step is followed by sev-
eral chromatographic and filtration steps until the pure active drug substance of interferon-α-2b
remains.
The overall process yield is around 5%, with the major loss during the primary recovery process.
Therefore this part was chosen to be the most important process to be characterized and optimized
to enhance the overall process yield.
2.3 Recovery Process for Interferon-α-2b
The primary recovery process post fermentation has two main purposes. First, break up the bacte-
rial cells to release the proteins and secondly to separate the proteins from the fermentation broth.
For the recovery of interferon-α-2b the recovery process is comprised of four steps, each separated
by a centrifugation step. An overview of all four steps can be seen in figure 2.2.
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Fig. 2.2: Overview of the primary protein recovery process for interferon-α-2b
Step 1 is called the "acid kill", which happens in the production fermenter. At the end of the
fermentation 50% TCA is added to the fermentation broth to a final concentration of 1.5% to
break up the cells. The pH is lowered to 2.0 by the addition of 75% Phosphoric Acid. After 30
minutes agitation all cells are lysed, proteins released and due to low pH environment proteins
precipitated. The pellet of the following centrifugation step continues in cycle 1, the second step
of the recovery process.
In this cycle the pellet is redissolved in water and the pH is set to 7.0 due to the addition of
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NaOH. Agitation for four hours under these conditions re-suspends the precipitants. After the
2nd centrifugation step the supernatant is recovered which enters cycle 2, step number 3 of the
recovery process. This cycle is also called the "Salting-Out" step with the purpose to salt-out host
cell proteins and to keep interferon in solution. This is achieved by adjusting conductivity and pH
due to the addition of NaCl and HCl.
Again the supernatant is recovered during the centrifugation step 3 entering the last cycle 3. In
this step 50% TCA is added to a final concentration of 3% in order to precipitate all proteins
again. After a holding time of 10 - 24 hours to flocculate precipitants, a final centrifugation step is
performed where the sludge is collected in the TCA-pellet.
In previous studies a loss of up to 70% of the interferon was discovered during this process making
the recovery process the main important part for characterization and optimization.
2.4 Project set-up
The whole project was divided into three main work packages. The first one is defined as the setup
of the analytical toolkit in which different analytical methods, needed for the characterization of
the primary recovery process, were included. The second work package contains the character-
ization of the primary recovery process on the basis of mass balances. The third and last work
package includes the optimization of the recovery process, starting from the critical process steps
identified during the characterization. Table 2.1 gives a more detailed plan about different steps of
this project.
Chapter 3 discusses the set up and the selection of analytical methods in order to follow the protein
amount throughout the recovery process using a small scale model of this process. Chapter 4, 5 and
6 dispute the characterization of the primary protein recovery process using mass balances for total
protein, total interferon-α-2b and interferon-isoforms to identify critical process steps. Chapter 7
and 8 focus on the optimization of the identified critical process steps of the recovery process using
a dilution study and the application of different detergents to increase protein solubility. Chapter
9 discusses several techniques to remove the detergents from process samples at the end of the
protein recovery process prior to the down-stream process. And finally in chapter 10 the impact
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Tab. 2.1: Project-outline and objectives
Work package description of the objectives
Analytical Toolkit total protein protein-assays
total interferon SDS-PAGE
Western Blot
Biacore, BLItz
Isoforms RP-HPLC
sample purification & concentration
Process Characterization total protein mass balances
identification of CPS
total interferon mass balances
identification of CPS
Isoforms mass balances
Process Optimization Solubility study Dilution experiment
detergents addition
Detergent removal Sarkosyl
Zwittergent 3-14
impact on DSP Sarkosyl
Zwittergent 3-14
of different detergents on the first down-stream step, an ion-exchange method, is investigated.
2.5 Implementation of sampling system
In order to characterize the primary protein recovery process a sampling system was put in place
for the manufacturing process by the industrial partner. Samples were taken at different time-
points throughout the process in order to analyse these sample for total protein and total interferon-
α-2b and to set-up protein mass balances. Figure 2.3 shows the sampling plan, indicating all
sample time points that were implemented by the industrial partner.
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Fig. 2.3: Overview of all sample time points throughout the whole primary recovery process
Each red dot symbolizes a sample taken at this stage of the recovery process. Later on in chapter
4 and 5 all samples are only named after their number, related to the sample time point taken from
the process. Samples 14a and 14b are both from the supernatant of Routing 4 that goes into the
waste stream. For this last routing two separate runs are required in order to process all material
from cycle 3. Hence, sample 14a is the supernatant from the first run and sample 14b the one from
the second run. Sample 15 contains a mixed sample of both pellets received from run 1 and 2 of
routing 4 together.
Samples 4a, 7a, 11a and 11b were added to the sampling plan at later stage. Accordingly the first
two batches 1-AVAF-211 and 1-AVAF-212 do not contain these samples and the whole sampling
system consists only of 16 samples. From batch 2-AVAF-201 all samples were included into the
sampling and one batch consists of 20 samples. Table 2.2 gives an overview about the different
batches performed on sight by the industrial partner during this project and indicates which of
these batches was analysed.
Batches 2-AVAF-202, -203 and -205 were not analysed, since problems occurred during the ship-
ment from the manufacturing site to the university. Samples taken at the manufacturing site were
stored at -80◦C immediately after sampling and shipped on dry ice to the university, where they
were stored again at -80◦C prior to analysis.
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Tab. 2.2: Different batches of the primary protein recovery process for interferon-α-2b
batch-number year no. of samples taken missing samples analysed
1-AVAF-211 2011 16 4a, 7a, 11a & b yes
1-AVAF-212 2011 16 4a, 7a, 11a & b yes
2-AVAF-201 2012 19 2 yes
2-AVAF-202 2012 20 none no
2-AVAF-203 2012 20 none no
2-AVAF-204 2012 0 all no
2-AVAF-205 2012 18 2 &8 no
2-AVAF-206 2012 20 none yes
2-AVAF-207 2012 20 none yes
2-AVAF-208 2012 20 none yes
2-AVAF-209 2012 18 5 & 6 yes
2-AVAF-210 2012 20 none yes
2-AVAF-211 2012 20 none yes
2-AVAF-212 2012 20 none yes
2.6 Conclusion
This PhD-thesis focuses on the optimization of the primary protein recovery process for interferon-
α-2b to increase the IFN recovery and the overall process yield. The work is divided into three
work packages, whereas package one and two covers the setup of several analytical techniques
in order to characterize the primary protein recovery process of the manufacturing site from the
industrial partner (compare chapter 3). Process samples taken from the manufacturing process
(see section 2.5) are analysed for total protein, total interferon-α-2b and interferon-isoforms in
order to set up mass balances and to identify critical process steps (compare chapter 4, chapter 5
and chapter 6).
Work package three focuses on the optimization of the identified critical process steps. A dilution
study is performed to enhance protein solubility (chapter 7) and different detergents are tested
for their potential to increase interferon-α-2b solubility (chapter 8). In a last step, methods are
developed to remove detergents from process samples (chapter 9) and the impact of remaining
detergents on the first down-stream step is investigated (chapter 10).
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Chapter 3
Simulation of the Protein Recovery
Process in a Small Scale Model
3.1 Introduction
A priority step for process optimization is the understanding of each step during the process.
Therefore it is necessary to characterize the process with respect to proteins and the effect of each
process step on the different proteins, i.e. host cell protein and drug substance.
To detect the total amount of protein throughout the protein recovery process, it is necessary to
find a protein assay that is able to quantitatively measure proteins at all stages of the recovery
process without interference by the fermentation broth components.
The industrial protein recovery process from the industrial partner will be analysed and charac-
terized during this study. During this process strong acids, bases and salts are added, which can
interfere with any protein assay and falsify the results. Therefore it is necessary to examine the in-
fluence of these components during the process on the selected protein methods to find the method
which shows the least interference.
To examine the influence of different components on several protein assays, a simulation of a
small-scale model of the protein recovery process is performed. For the simulation of the reco-
very process two proteins with known concentration dissolved in water or fermentation medium
are used to perform the protein recovery process instead of using the end of fermentation broth
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(EOF).
Besides the selection of an adequate protein assay, the simulation of the recovery process will
also provide information about the characteristics of the process itself. Due to changes of certain
parameters during the recovery process simulation (protein, medium, volume) several different
informations should be gained during this simulation study.
3.1.1 Characteristics of BSA and IFN
Bovine Serum Albumin (BSA) is a commonly studied protein and is widely used as a reference
standard in several protein assays. It has a molecular weight of 66.5kDa and consists of 607
amino acids [26]. The secondary structure of BSA is composed of 67% α-helix, but it can un-
dergo modifications dependent on pH, temperature and various kinds of denaturants [27]. BSA
is an universally accepted reference protein for total protein quantification, since its amino acid
composition represents an average over most host cell proteins [10]. Table 3.1 gives an overview
of the amino acid composition of Bovine Serum Albumin.
Tab. 3.1: Amino Acid Composition of BSA [10]
Ala 48 Cys 35 Asp 41 Glu 58
Phe 30 Gly 17 His 16 Ile 15
Lys 60 Leu 65 Met 5 Asn 14
Pro 28 Gln 21 Arg 26 Ser 32
Thr 34 Val 38 Trp 3 Tyr 21
Arginine (Arg) is one of the amino acids that is detected during the Bradford protein assay, in order
to quantify the total amount of protein. Since BSA has a total of 607 amino acids, the fraction of
arginine represents 4.28%.
Interferon-α-2b on the other hand is a much smaller protein with only 165 amino acids and a
molecular weight of 19.265kDa [6]. Its amino acid composition is shown in table 3.2.
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Tab. 3.2: Amino Acid Composition of IFN-α-2b [6]
Ala 8 Cys 4 Asp 8 Glu 14
Phe 10 Gly 5 His 3 Ile 8
Lys 10 Leu 21 Met 5 Asn 4
Pro 5 Gln 12 Arg 10 Ser 14
Thr 10 Val 7 Trp 2 Tyr 5
The fraction of arginine present in interferon-α-2b equals to 6.06%. Hence, the arginine fraction
is 1.78% higher in IFN-α-2b than it is in BSA which can have a significant impact during the total
protein quantification using protein assays as the Bradford method.
3.1.2 Small-scale models
Small scale models are commonly used in biotechnology to simulate a culture process at smaller
scale [28]. Process characterization studies are mainly performed with small scale models, espe-
cially during cell culture to understand culture performance for culture growth and productivity
and final product quality [29].
The most common scaling criteria for small-scale models of fermentations is a constant specific
power input (P/V) [30] and a constant VVM [31]. But also other scale down strategies are de-
scribed in literature for example impeller tip speed (Vtip), shear rate (γ) and specific impeller
pumping rate (QS) [32].
In this study a small scale model is used to simulate the protein recovery process which includes
4 centrifugation steps. Between the centrifugation steps different acids, bases and salts are added
at certain flow-rates to the process in order to set the pH or conductivity. The amount of the acids,
bases or salts were either scaled-down in a linear relation to the working volume or they were
dependant on the pH/ conductivity setting.
The biggest challenge in the scale-down model of the protein recovery process is the simulation
of the four centrifugation steps which will be discussed in the following section.
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Centrifugation
The centrifugation step is the most challenging part during the scale-up or scale-down of a recovery
process. At manufacturing scale continuous centrifuges are used to separate cells and particles
from the fermentation broth. For the performance of a continuous centrifuge several litres of
fermentation broth are required. At lab-scale the fermentation broth volume is often less than
a litre and therefore discontinuous centrifuges are used. The efficiency of clarification is highly
dependent on the capacity of the separator or centrifuge [33]. The smaller the capacity of the
centrifuge the higher is the efficiency. Hence, separation of precipitants from the supernatant
performed with small volumes in a discontinuous centrifuge is more efficient than at a large scale
in a continuous centrifuges. The next paragraphs explains the differences in performance between
continuous and discontinuous centrifuges.
Most continuous centrifuges at large scale are either separator or decanter. Both systems function
according to a similar mechanism. Figure 3.1 shows the mechanism from the inside of a separator.
Fig. 3.1: Mechanism of continuous centrifuge; Separator from Westfalia: 1: Product feed, 2: Centripetal
pump, 3: Distributor, 4: Disc stack, 5: Solids holding space, 6: Sliding piston, 7: Closing
chamber, 8: Spindle, drive, 9: Solids ejection port, 10: Discharge, clarified phase [2]
The fermentation broth enters through the product feed (1). In the rising channel the product is
split up over a large number of disk inter-spaces (4). Due to higher density the solids stream
against the conical discs and slide to the solid holding space (5). The sliding piston (6) opens
and closes hydraulically and provides a gap for discharging the accumulated solids. The clarified
liquid streams to a central discharged channel towards the centripetal pump (2) and is discharged
under pressure through the discharged line (10). A large clarification area compared to sedimen-
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tation by gravity is realized by the conical discs and high g-forces and allows to process large
amount of volumes [2].
Discontinuous centrifuges are used on a daily basis in laboratories as bench-top or floor-centrifuges.
The separation occurs through sedimentation by gravity and centrifugal force (g-force) and is
based upon behaviour of particles in the applied centrifugal field. Discontinuous centrifugation
can be separated into two main types: differential centrifugation and density gradient centrifuga-
tion. Density gradient separation can either separate per size (rate zonal separation) or per density
(Isopycnic separation). Differential centrifugation is based on the size and mass of particles and
separates a solution into pellet and supernatant [34].
All centrifugation steps performed during the small scale model of the primary recovery process
used differential centrifugation.
3.1.3 Goals/Aims
The simulation of the protein recovery process in a small scale model is set up and performed in
order to achieve the following aims:
• selection of protein assay to determine total protein amount in recovery process samples
throughout the entire process
• impact of reduced process volume and variable protein concentration on the recovery pro-
cess
• specificity of the recovery process for certain proteins
In order to characterize the primary recovery process a protein assay needs to be put in place
that allows the determination of total protein in process samples without interfering with different
components added throughout the fermentation and recovery process. Using samples from the
small scale model of the recovery process, the protein assay with the best criteria can be selected.
The other information regarding protein specificity or impact of variable protein concentration will
provide fundamental information in order to proceed with process characterization at manufactur-
ing scale.
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3.2 Materials and Methods
3.2.1 List of Materials
Tab. 3.3: Materials and suppliers
materials supplier
Total protein kit, Micro Lowry Sigma Aldrich
Pierce R© BCA Protein Assay Kit Thermo Scientific
Bradford Reagent Sigma Aldrich
Bovine serum albumin (BSA) Sigma Aldrich
interferon-α-2b drug substance industrial partner
fermentation medium industrial partner
Trichloroacetic acid solution (TCA) Sigma Aldrich
Phosphoric Acid (H3PO4) Sigma Aldrich
NaOH Merck KGaA
Sodium Chloride (NaCl) VWR
HCl Fisher Scientific
3.2.2 Protein assays
Protein assays are used to determine the amount of protein in fermentation or culture samples and
to follow protein production throughout a process. The most sensitive and accurate method would
be to perform acid hydrolysis followed by amino acid analysis. Since this method is very time
consuming and challenging to perform, several other protein assays are available which are easier
and faster in performance.
Lowry-method
The Lowry method is a protein assay based on the Biuret reaction and the Folin - Ciocalteau
reaction. In the Biuret reaction the peptide bonds of the protein react with copper under alkaline
conditions to produce Cu2+. This reacts in the second reaction with the Folin reagent to oxidize
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aromatic amino acids [35]. Therefor the sensitivity of the Lowry method is dependent on the amino
acid composition of the protein, especially the aromatic amino acids tryptophan and tyrosine. The
reaction results in a strong blue or purple colour and can be detected at a suitable wavelength
between 500 and 800 nm [11].
For the performance of the Lowry assay the different steps listed in table 3.4 have to be followed.
Tab. 3.4: Performance of Lowry method [11]
component required volume [mL]
standard/ sample 0.500
Lowry reagent 0.500
(Na2CO3, CuSO4, NaOH and
KNaC4H4O6−4H2O)
incubate for 20 min at RT
Folin Reagent 0.250
(C10H5NaO5S)
incubate for 30 min at RT
measure absorbance between 550 and 750 nm
BCA-method
The BCA method is as well as the Lowry method based on the Biuret reaction followed by the
detection of the formed cuprous cations (Cu1+). The colorimetric detection of Cu1+ uses bicin-
choninic acid (BCA). Two molecules of BCA chelate with one molecule of Cu1+ to form a water
soluble complex with an absorbance maximum at 562nm [12].
As well as the Lowry method, the BCA method is sensitive to the amino acid composition of the
protein. The BCA method detects the presence of the amino acids Tyrosine and Tryptophan, as
well as Lowry, but it is also depending on the macromolecular structure of the protein and the
number of peptide bonds.
For the performance of the BCA assay the different steps listed in table 3.5 have to be followed.
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Tab. 3.5: Performance of the BCA method [12]
component required volume [mL]
standard/ sample 0.050
BCA reagent 1.000
(Na2CO3, NaHCO3, BCA,
Na2C4H4O6 and CuCO4)
incubate for 30 min at 37◦C
cool down to RT
measure absorbance at 562nm within 10 min
Bradford-method
The Bradford method is the most popular dye-based protein assay to quantify proteins in solution.
It is based on the formation of a complex between the dye, Brilliant Blue G, and proteins in
solution with an absorbance maxima at 595nm [35]. The anionic blue dye binds most readily to
the amino acids Arginine, Histidine and Lysine. This leads to variances in the response of the
assay to different proteins which have different amino acid distributions [35]. This has to be kept
in mind by selecting an adequate protein standard.
The advantage of the Bradford method compared to Lowry and BCA assay is that it is simpler,
faster and more sensitive. The Bradford method shows also less interference with common reagent
and non-protein components of biological samples [35].
For the performance of the Bradford assay the different steps listed in table 3.6 have to be followed.
Tab. 3.6: Performance of the Bradford method [13]
component required volume [mL]
standard/ sample 0.050
Bradford reagent 1.500
(Brilliant Blue G,
Phosphoric Acid
and Methanol)
incubate for 10 min at RT
measure absorbance at 595nm within 20 min
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3.2.3 Simulation of Protein Recovery Process
The protein recovery process is based on the primary recovery process from the industrial part-
ner to recover proteins, especially interferon, from the fermentation broth. The simulation was
performed with a small scale model of the original process. The goal of this simulation is to
identify the most suitable protein assay to detect the amount of protein throughout the whole
process and to identify first characteristics of this primary recovery, to get a better understanding
of the whole process.
3.2.3.1 Down-Scale model
The primary recovery process performed at manufacturing scale has the aim to recover interferon-
α-2b and its isoforms (-2, 3 and 4) from the fermentation broth. Another aim is to reduce the
volume and to remove cell compartments as well as nucleic acids from the fermentation broth
before it goes into the purification process.
The elementary recovery process starts with a volume of up to 40’000L which is reduced to
8’000L. These volumes were scaled down to a starting volume of 40mL and 500mL which were
reduced to 20mL and 150mL during the process.
To work as closely as possible to the original recovery process most of the parameters were kept
the same, only some concentrations of added base or acids had to be reduced at small scale. Be-
sides reduced acid and base concentrations the biggest difference between the original process and
the small scale model are the centrifugation steps. At large scale a continuous centrifuge has been
used, whereas in the small scale model a discontinuous centrifuge was used to separate the precip-
itations from the supernatant. The separation of a discontinuous centrifuge works more efficiently
than a continuous one which makes it challenging to achieve similar process conditions in these
steps (compare section 3.1.2).
The different volumes and acid/ base concentrations used for the elementary process, as well as
for the small scale models are listed in table 3.7.
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At large scale a continuous centrifuge from Westfalia CRA-160 at 5,800 rpm with a flow rate
of 0.9 - 5.4 m3/h was used during centrifugation step 1,2 and 3. Step 4 involves a continuous
separator from Westfalia BKB-45, which is run at 5’800 rpm, inflow rate of 0.9 - 5.4m3/h and
a back-pressure of 3 bar. For the down scale models a discontinuous bench-top centrifuge was
used with the following parameters: 40ml volume was centrifuged at 7500rpm (8175 g) in a fixed
bucket, at 4◦C for 30 minutes, and 500mL volume was centrifuged at 3500 rpm (1780 g) in a
swing out rotor, at 4◦C for 30 minutes.
To identify different characteristics of the protein recovery process, certain parameters were changed
in the scale-down models. First of all different starting volumes of the scale-down model were
used to identify the effect of reduced volume to the process, 40mL versus 500mL (see also table
3.1.2). Secondly different protein concentrations were tested at the beginning of the small scale
model, to identify the impact of variances of protein production during fermentation on the reco-
very process. The protein concentration at the beginning of the small scale model varied between
0.07 g/L to 2.0 g/L. The third characteristic to be analysed with these small scale models was the
protein specificity of the recovery process. Therefore different proteins were used to perform the
down-scale model, BSA, IFN and BSA + IFN together.
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3.3 Results and Discussion
3.3.1 Protein assays
Three different protein assays were performed and analysed after the following criteria: sensitivity,
accuracy, pH-dependency, interference of media components, time factor and the handling. All
experiments were performed using BSA (Bovine serum albumin) as the reference standard.
The different advantages and disadvantages of each method are listed in the table 3.8 below.
Tab. 3.8: Advantages and disadvantages of three protein assays
detection range
method sample min max standard pH- ferm. media process
volume [µL] mg/mL mg/mL deviation dependency dependency time [h]
Lowry 500 0.05 0.4 ±2.4% - - 2h00
BCA 50 0.03 0.5 ±0.5% none yes 1h30
Bradford 50 0.05 1.0 ±0.4% none none 1h00
The Lowry assay was performed following the instructions listed in table 3.4 and described in
section 3.2.2. All experiments were performed in DI-water and BSA was used as the reference
standard.
Looking at the different criteria for the Lowry assay, it can be seen that this assay is not favourable
compared to other assays. The required sample amount is with 500 µL very high, which means
that a lot of standard material would be required to measure a reference standard in triplicate with
each set of samples to be analysed. Although the detection range of 0.05 - 0.4mg/mL would be
sufficient, BCA and Bradford do provide an even bigger detection range, with a lower standard
deviation than the Lowry-assay. The last disadvantage of Lowry over the other assays is the long
process time, see table 3.8. The average required time for Lowry is twice as long as for Bradford.
Since the Lowry method showed already disadvantages in the first 4 criteria compared to BCA
and Bradford, the last two criteria were not studied for Lowry.
The BCA-assay was performed following the instructions listed in table 3.5 and described in sec-
tion 3.2.2. All experiments were performed in DI-water besides the study on interferences with
fermentation media. These experiments were performed in fermentation media.
In some of the studied criteria the BCA-assay showed advantages over the other tested assays.
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Hence, the BCA assay required only a tenth of sample volume than the Lowry assay (50 µL). The
biggest advantage of the BCA-assay is the accurate detection of very low protein concentration,
down to 0.03mg/mL with a standard deviation of only 0.5%, see table 3.8. There was no pH
dependency detectable, which is important for analysing samples throughout a recovery process
where different pH-conditions are present. Unfortunately the BCA-assay showed a high interfer-
ence with the pure fermentation media. To avoid these interferences high dilutions of the media
and samples would be necessary, which would interfere with the accuracy of this assay and the
limit of detection. Another big disadvantage of the BCA-assay is the required process time and
the handling of the assay performance itself. With a process time of 1.5 hours the BCA assay is
in the middle of the three tested assays, but during the performance an incubation time at 37◦C is
necessary. This gives an additional factor in which variations can occur during assay performance
and increases the risk of appearance of handling mistakes.
The Bradford-assay was performed following the instructions listed in table 3.6 and described in
section 3.2.2. All experiments were performed in DI-water besides the study on interferences with
fermentation media. These experiments were performed in fermentation media.
The Bradford assay shows, in most of the tested criteria, advantages over the other two protein
assays, see table 3.8. It requires only a small amount of sample which is important when the
available amount of standard material is limited. The working range, in which an accurate linear
relation exists between the detected absorbance and the protein amount, is very wide. This is
especially an advantage when the analysed samples have big variations in their protein amount.
The Bradford assay showed also no pH dependency over the whole range from pH 1.0 to pH 12
and the interference of media components was very low. A more detailed discussion about the pH
dependency can be found at later stage of this section.
A big advantage of the Bradford method over the other two protein assays is the short process time.
The whole assay can be performed in less than an hour and it is easy to handle. No preparation
of reagents is required, the Bradford-reagent can be bought as a ready to use reagent without any
further preparations required.
Three protein assays listed in table 3.8 were compared regarding the aim to find an assay which
gives accurate protein predictions over a wide range, shows no interference with different pH-
values and media components and has a short process time with easy handling. The comparison
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showed that the Bradford assay is the most suitable method to perform accurate protein measure-
ments in solution over a wide range with a minimum expenditure of time.
To determine the pH dependency of the Bradford-assay two BSA stock solutions at 0.3mg/mL
were prepared, one diluted with DI-water and the other one diluted with PBS-buffer (1X). Both
BSA stock solutions were divided into 9 fractions. Each fraction was set to a certain pH-unit
between 1.0 - 12.0 using either NaOH or HCl. The Bradford-assay was performed and the ab-
sorbance values at 595nm were detected and plotted versus the pH values as shown in figure 3.2.
For the BSA-sample in DI-water, DI -water was used to deduct the background noise from the
measurements. On the other hand PBS-buffer was used to deduct the background noise from the
BSA-samples diluted in PBS-buffer.
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Fig. 3.2: pH dependency of BSA standards during Bradford assay
Looking at the absorbance values at 595nm for 0.3mg/mL BSA in DI-water compared to the one
in PBS-buffer, no significant difference can be detected between both buffers. This shows that
PBS-buffer does not interfere with the Bradford-assay.
Some slight variations can be detected between the absorbance of 0.3mg/mL BSA-sample at dif-
ferent pH-values. These small variations can be explained by dilutions, which occurred during the
addition of NaOH or HCl while setting the pH.
Overall no significant pH-dependency on the Bradford assay was detectable. This is an important
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result, since the pH varies a lot during the recovery process. Knowing that the pH does not have
any impact on the assay avoids further sample preparations for pH-adjustment, before analysing
recovery process samples from different stages of the process.
3.3.1.1 Protein Reference Standards
Protein assays do not detect the whole protein, but they detect certain amino acids or peptide bonds
between the amino acids as described in section 3.2.2. Therefore it can be expected that proteins
with different size and different amino acid distributions will have differences in their limit of de-
tection as well as in the absorbance rate.
Two proteins were tested in the following experiment in two different buffers to study the im-
pact of their size and amino acid distribution on the Bradford assay. Interferon-α-2b and BSA
were analysed with the Bradford assay at different concentrations in DI-water and in fermentation
media.
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Fig. 3.3: The significance of using the correct protein standard for each Bradford-assay
The graph on the left of figure 3.3 shows the absorbance at 595nm of IFN-α-2b and BSA in
DI-water and fermentation media over the amount of protein. No significant difference can be
seen between the absorbance of IFN-α-2b in DI-water and fermentation media nor for BSA in
DI-water and fermentation media. In all four cases the appropriate blank was used to subtract
the background noise. This shows that the influence of media components on the detection of
BSA and IFN-α-2b with the Bradford assay is not significant and can be negligible. However,
comparing pure fermentation media with DI-water showed, that the fermentation medium already
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contains 0.06g/L of total protein due to the presence of yeast extracts in the media. This shows the
importance of selecting the correct blank value to deduct the present background noise.
A distinct difference can be seen in the absorbance at 595nm between IFN-α-2b and BSA for the
same protein concentrations. The absorbance of IFN-α-2b is always higher compared to BSA.
Looking at the right graph of figure 3.3 shows that the detection range of the Bradford assay
differs for IFN-α-2b and BSA. BSA can be detected in an accurate linear range between 0.0 -
50.0µg (0.05 - 1.0g/L) with a R2=0.9968. On the other hand IFN-α-2b can only be detected in an
accurate linear range between 0.0 - 10.0 µg (0.05 - 0.20g/L) with a R2=0.9996. Therefore the limit
of detection is five times higher for BSA than for IFN-α-2b and IFN-α-2b has a higher absorbance
than BSA. As mentioned in the paragraph above the differences in the absorbance and the limit
of detection can have two reasons. First, the size of the proteins. BSA is composed of 607 amino
acids, whereas IFN-α-2b comprises only 165 amino acids (see section 3.1.1). Therefore BSA is
3.6-fold bigger than IFN-α-2b, meaning for each single protein there are more peptide bonds and
amino acids present to react with the Bradford reagent. Hence, BSA needs to be more concentrated
to reach a saturation point with the Bradford reagent compared to a smaller protein. The second
reason is the distribution of the amino acids in the protein. Arginine is the primary reactant of
the Bradford reagent (compare section 3.2.2). The percental amount of Arginine in IFN-α-2b is
1.78% higher than in BSA (see 3.1.1), meaning one single protein of IFN-α-2b can interact with
more Bradford reagent than one BSA-protein. Summarizing, IFN-α-2b is 3.6-fold smaller than
BSA but contains 1.42x more Arginine, hence, the limit of detection of IFN-α-2b for Bradford
assay is 5-fold lower than of BSA. It needs to be kept in mind that this calculation only looks at
the naked amino acid chain. However, it does not take the tertiary structure of both proteins into
account where some of the Arginine aminoc acids might be hidden in the inside of the protein.
Hence, the right graph in figure 3.3 gives an example that illustrate the importance of selecting the
correct reference standard. Having an unknown process sample with the measured absorbance at
595nm of 0.30 abs: using BSA as the reference standard but IFN-α-2b is present in the process
sample would result in an overestimation of the protein concentration. However, using IFN as the
reference standard when BSA is present in the process sample would result in an underestimation
of the protein.
After showing the importance of selecting the correct reference standard to determine the protein
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amount in an unknown sample, the next question would be which standard to choose if you have a
mixture of proteins in your process sample. Therefore BSA and IFN-α-2b were analysed together
in a mixture with different portions of IFN-α-2b, see table 3.9 below.
Tab. 3.9: Analysing a mixed protein sample using Bradford assay
Experiment theoretical protein IFN fraction analysed protein
concentration [g/L] [%] concentration [g/L] ]
1 total: 0.60 total: 0.791
IFN: 0.30 50.0 IFN: 0.373
2 total: 0.60 total: 0.738
IFN: 0.20 33.3 IFN: 0.348
3 total: 0.60 total: 0.681
IFN: 0.10 16.7 IFN: 0.322
The second column of table 3.9 shows the theoretical concentration of total protein (BSA + IFN-
α-2b) and pure IFN-α-2b for each experiment. The fourth column lists the detected protein con-
centrations using the Bradford assay. For total protein determination, BSA was used as a reference
standard and for IFN-α-2b determination, IFN-α-2b was used as the reference standard.
Table 3.9 shows, that using IFN-α-2b as the reference standard to determine the total protein con-
centration in a mixture of proteins results in underestimation of the concentration. This confirms
the observations in the section above. However, IFN-α-2b can be used as a reference standard to
determine the IFN-α-2b concentration in a protein mixture, as long as the IFNα-2b portion repre-
sent more than 50% of total protein mixture.
Using BSA as a reference standard to determine the total protein concentration in a mixture of
proteins, the total protein amount will be overestimated, especially if non-host cell proteins are
present in the mixture. IFN-α-2b does not belong to host cell proteins of E.coli and is different
in its amino acid distribution. However, if the IFN-α-2b portion is below 17% of the mixture, the
prediction of total protein concentration becomes accurate using BSA as the reference standard.
Concluding, for a heterogeneous sample containing different kinds of protein it is more accurate to
use BSA as the reference standard, as long as proteins with high Arginine levels, such as IFN, are
below 20%. If the IFN-α-2b fraction represents more than half of the total amount of protein, it is
more precise to use IFN-α-2b as reference to determine the IFN-α-2b concentration in a mixture
but not for total protein determination.
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3.3.2 Simulation of Recovery Process
3.3.2.1 Recovery Process buffer
Simulation of the recovery process was performed in a small scale model as listed in table (3.7).
The total protein of 2.0 g/L at the beginning, was determined at different stages throughout the
process using the Bradford-assay and BSA as a reference standard.
The impact of different components added during the recovery process (TCA, NaOH, NaCl or
HCl) on the Bradford assay was studied. It showed that the addition of these components does not
have a significant impact on the Bradford assay, as long as the simulation is performed in DI-water.
The Blank-values vary between 0.424 - 0.458. These variations (∆ 0.034) are acceptable, since
similar variations were observed due to small differences in the DI-water itself and due to different
batches of Bradford reagent.
Performing the simulation in fermentation media showed that the blank value of pure fermenta-
tion media does change significantly throughout the process. The Blank values of fermentation
media varied between 0.534 - 0.468 through the recovery process simulation. These variations (∆
0.066) are twice as high as observed with DI-water and need to be considered for protein analysis.
Therefore a negative control of pure fermentation media but without any additional protein was
performed for the whole process simulation with all experiments using fermentation media (data
not shown).
Figure 3.4 shows the recovered total protein amount in % throughout the recovery process simula-
tion using BSA at 2.0g/L in DI-water and fermentation media at 40mL. All protein concentrations
were detected via Bradford assay using BSA as a reference standard and DI-water or fermentation
media as blank.
Figure 3.4 shows no significant difference between the simulated recovery of BSA in DI-water and
fermentation media. The main difference between both simulations were the necessary addition
of H3PO4 during the acid kill using fermentation media to set the pH down to 2.0. This addition
was not necessary using DI-water as a buffer, since the pH was already below 2.0 after adding
TCA. This indicates that the fermentation media gives a higher buffered environment compared to
DI-water. However, the overall recovery of BSA throughout the recovery process was identical in
DI-water and fermentation media, with up to 80%. The biggest loss of BSA was observed between
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Fig. 3.4: Buffer dependency on protein recovery throughout recovery process
cycle 1 and 2 of around 18%, compare figure 3.4. The detected reduction in total protein in step
3 of the recovery process could not be confirmed with the protein mass balances. The protein
amount lost during step 3 could not be detected in the sludge recovered from centrifugation step 3.
This indicated that the protein either degrades due to the addition of NaCl or HCL or this reduction
is due to handling errors.
No loss of total protein was detected between step 1 and 2 neither in DI-water nor in fermentation
media. Addition of TCA and NaOH do not have an impact on the protein recovery. It has to be
pointed out that the concentration of NaOH used in this small scale process is much lower than the
one used at production scale (0.1M versus 19.4M). The much higher NaOH concentration can have
a different impact on the protein recovery especially in the protein conformation and function.
Concluding, performing the recovery process simulation with BSA in DI-water or fermentation
media does not show any significant differences. Both simulations showed the main reduction
of BSA during step 3 while adding NaCl and HCl. The loss of BSA could not be confirmed by
mass balances. The reduced amount of BSA was not found in the sludge recovered at this step.
This indicated either protein degradation, meaning the protein was not lost but not detectable via
Bradford assay. Alternatively there may be handling mistakes, to reach the conductivity set point
of 20mS/cm a high amount of NaCl-solution was necessary to add. The increment of the volume
could falsify the results.
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3.3.2.2 Volume effect
The simulation of the recovery process at 40mL and 500mL in DI-water was performed as listed
in the table 3.7 with a starting concentration of 2.0g/L for both conditions. For both simulations
the total protein amounts were analysed via Bradford assay using BSA as a reference standard and
DI-water as the blank.
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Fig. 3.5: Volume dependency on protein recovery throughout recovery process
Figure 3.5 shows the simulation of the recovery process at 40mL compared to the simulation at
500mL. It can be seen that the recovery is dependent on the volume. The protein loss of around
20% detected with the small scale model at 40mL could not be confirmed with the small scale
model at 500mL. This indicates that the detected protein loss at 40mL was only due to handling
errors or imprecise determinations of the volume in cycle 2, which led to the reduced protein
amount. Performing the simulation at a larger scale of 500mL showed, that no significant protein
loss occurred during the simulation. The overall loss of BSA during the whole recovery process
was less than 10%. Due to changes in the blank-value, Bradford reagent and dilution errors the
overall acceptable deviation of this assay is ±5.0%. This means that the detected protein loss of
10% is in between the acceptance criteria of variations and is therefore not significant.
Concluding, simulation at higher scale showed that the detected loss of total protein in the previous
section was due to handling mistakes and imprecise determinations of the volume. At higher
volume no significant protein loss was detectable throughout the whole process for BSA.
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3.3.2.3 Protein starting concentration
Simulation of the recovery process was performed with different protein starting concentrations
(2.0g/L versus 1.07g/L) to study the impact of the starting concentration on the recovery process.
Similar changes could occur due to different protein production amounts during the fermentation
process.
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Fig. 3.6: Protein starting concentration dependency on protein recovery throughout recovery process
The results above in figure 3.6 show that different protein starting concentrations at the beginning
of the recovery process have no significant impact on the protein recovery throughout the process.
The slight changes between the simulation at 2.0g/L compared with the simulation containing only
1.07g/L at different steps of the process are less than 5% and therefore in between the acceptable
deviations of the Bradford assay. Therefore it can be said that the protein starting concentration
has no influence on the efficiency of the protein recovery process.
3.3.2.4 Protein specificity
For this experiment three different pools of proteins were prepared to perform the simulation of
the recovery process. The first one contained 2.0 mg/mL of BSA diluted in DI-water. The second
pool consisted of 1.0mg/mL BSA + 0.07mg/mL IFN-α-2b. A similar proportion can be expected
at the end of the fermentation process before it enters the recovery process. The last pool only
consists of 0.07mg/mL IFN-α-2b diluted in DI-water.
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All samples were analysed with the Bradford assay using DI-water as a blank throughout the
recovery process. For pool 1 and 2 BSA was used as a reference standard, since in pool 2 IFN-
α-2b represents less than 16.7%. For pool 3 IFN-α-2b was used as a reference standard, since no
other protein was present.
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Fig. 3.7: Different protein dependency on protein recovery throughout recovery process
Comparing only the first two pools with each other in figure 3.7 it can be seen that there are no sig-
nificant differences between the recovery of BSA at 2.0mg/mL and BSA+IFN at 1.07mg/mL, as
already discussed in the previous section. Comparing these results with the recovery of pure IFN
at 0.07mg/mL significant changes in the protein recovery can be observed in the first three steps,
leading to the conclusion that the protein itself and its concentration do have an impact on the pro-
tein recovery. However, looking more closely into these results it can be seen that the reduction in
the amount of IFN-α-2b between the acid kill and cycle 1 is only 7.55mg and between cycle 1 and
2 only 4.55mg. Due to previous experiments, variations of ±5.0mg of proteins are very likely due
to changes in the blank values as well as dilution errors. This means that the obviously significant
reduction in IFN-α-2b during the first three steps of the recovery process is not significant but is
caused by variations in the Bradford assay. This would also explain why the IFN-α-2b amount in
cycle 3 increased again to a final protein recovery of 90%. All observations lead to the conclusion
that the IFN-α-2b remained constant throughout the recovery process and that the reduced IFN
amounts in cycle 1 and 2 were due to errors and imprecise measurements in the Bradford assay.
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Comparing all three simulations with each other it can be said that the recovery process is not
specific for any particular protein. For all three combinations the process showed the same ef-
ficiency. It can also been said that the protein concentration has no impact on the efficiency of
the process. Between 0.07mg/mL and 2.0mg/mL the recovery of proteins resulted in comparable
results. However, it can be said that at small volumes and low protein concentrations the accuracy
of the small scale model is reduced and can lead to incorrect results.
PhD-Thesis from Tanja Buch 35
CHAPTER 3. SIMULATION OF THE PROTEIN RECOVERY PROCESS IN A SMALL
SCALE MODEL
3.4 Conclusion
The performance of the simulation of the primary protein recovery process had several aims to
accomplish. First goal was the selection of a protein assay to follow the amount of total protein
throughout the recovery process. The Bradford assay showed the highest potential for the quan-
tification of total protein in process samples. It is the most accurate assay which shows no or only
low interference to different media components and no pH dependency. Therefore the Bradford
assay was chosen to quantify total protein in recovery process samples.
In order for the selection of the most suitable reference standard for the Bradford assay, BSA was
selected as long as the other proteins with a high Arginine level, as interferon-α-2b, are less than
20% of the protein mixture. If these proteins with high Arginine levels represents more than 50%
of the protein mixture one of those proteins need to be selected as the reference standard, in order
to quantify the correct total protein amount.
A second aim of this chapter was the analysis of certain parameters on the protein recovery. The
results show that neither different buffers, as media or water, nor the protein starting concentration
have an impact on the protein recovery during this process. However, it could be seen that the
reduction of the process volume in a small scale model does influence the accuracy of the perfor-
mance. Hence, results achieved with the small scale model at 500mL give a more representative
picture of the manufacturing process than the 40mL small scale model.
The last aim of the recovery process simulation was to research if the process is specific for any
particular protein. It was shown that different types of proteins as BSA or interferon behaved sim-
ilar throughout the entire process. However, both proteins showed no significant loss during the
entire process simulation. Due to previous studies performed on sight of the manufacturing recov-
ery process, a loss of at least 50% was expected in the interferon-α-2b at the end of the process.
A reason why this protein loss was detected on sight at the manufacturing scale but not during the
simulation in DCU could be as follows. First, the loss was only detected in interferon amount and
not in total protein. Hence, it is possible that the loss only appears in IFN, however, other studies
of this chapter indicate that the process is not protein specific. Second, the simulation of the recov-
ery process differs to the one from the industrial partner in the concentrations of NaOH, NaCl and
HCl. More concentrated bases and acids can have a stronger impact on the protein stability and
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recovery than less concentrated form. The biggest differences between the small scale model and
the manufacturing process are the centrifugation steps. The industrial partner is using continuous
centrifuges which are less effective in separation than discontinuous centrifuges used in DCU for
the small scale model.
In summary, these results provide already considerable information about the characteristics of the
primary recovery process, although the simulation of the recovery process in a small scale model
has its limits. To obtain further characteristics about total protein and interferon throughout the
process, process samples need to be analysed and protein mass balances need to be set up. These
results can be found in the following chapter 4, 5 and 6.
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Chapter 4
Process Characterization - Total Protein
Mass Balances
4.1 Introduction
The characterization of the primary recovery process is indispensable to maintain product quality
and quantity, and to gain better understanding of single process steps. The primary recovery of
proteins after a microbial fermentation is usually composed of several centrifugation steps to sep-
arate the protein from the fermentation broth and to reduce the volume before starting the final
purification steps during down-stream processing. In order to characterize the process, mass bal-
ances of total protein have been set up for different centrifugation steps. Using the mass balances,
critical process steps can be identified and selected for further studies or optimization.
In this chapter samples derived from the manufacturing primary recovery process were analysed
for their total protein quantities and mass balances were set up for all four centrifugation steps
performed during the primary recovery. A detailed plan of the sampling points throughout the
process has been discussed in chapter 2 and can be seen in figure 2.3. In order to set up full mass
balances, samples from the waste-stream were also required. These sample points were only put in
place and included into the sampling plan from batch 2-AVAF-201. For two batches, 1-AVAF-211
and 1-AVAF-212, these samples were not available and therefore the setup of a complete mass
balance was not possible for these batches.
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4.1.1 Cell lysis
The majority of microbial produced products are of intracellular type and retained within the cells,
like interferon-α-2b. In order to isolate and harvest intracellular products, microbial cells must be
disintegrated by physical, chemical or mechanical means [36]. At small or lab scale this step can
easily be achieved by mechanical cell disruption using liquid shear methods such as ultrasonic
or high-pressure homogenization [37]. However, at large or manufacturing scale this step can be
more challenging. The choice of cell disruption method is often dependent on the type of product
to recover. To receive high throughput of large volumes, the cell disruption method is either a
high-pressure homogenizer, solid shear using a bead mill or non-mechanical but chemical disrup-
tion with acids or alkalis [37].
For harvesting sensitive proteins, as enzymes, cell disruption is often achieved using bead mills or
high-pressure homogenization since the addition of strong acids or alkalis could lead to damage
of the protein. For more robust proteins, chemical cell lysis can be used to achieve product release
but also cell inactivation. Due to low pH by acid addition, proteins precipitate within this step
[37].
During the primary protein recovery process for interferon-α-2b, cell lysis is performed by chem-
ical cell disruption due to the addition of trichloroacetic acid (TCA) and phosphoric acid. This
step therefore called acid kill. Under low pH conditions the cell wall and membrane breaks up and
released proteins precipitate. On the other hand, for analysis of proteins in the end of fermentation
sample, sonication is used to disrupt the cells. The ultrasound of a sonicator with frequency higher
than 15 - 20 kHz causes disruption of microbial cells in suspension [37].
4.1.2 Flow Cytometry
Flow Cytometry (FCM) is a method of enumerating and analysing cells which has been utilized
since the 1970’s [38]. In conjunction with the use of fluorescent dyes, flow cytometry has become
an increasingly important tool in the screening of cells of all kinds [39]. The basic idea of the
method is that cells will pass in single file through the measuring device of the system in a fluid
stream [40]. With the use of fluorescence dyes it is not only possible to distinguish between living
and dead microorganism but also to differentiate between intermediate physiological states of the
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cells. For example, a cell may be metabolically active but may or may not have the capability
to replicate itself [41]. With the selection of different dyes certain different extrinsic parameters
of the cells can be analysed, for example: DNA, chromatin structure, RNA and total and basic
proteins [40].
4.1.3 Protein stability
Protein stability and solubility is highly important during preparation, sterilization, shipping and
storage of pharmaceutical proteins. Therefore a lot of studies focus on the understanding of protein
stability and solubility and the parameters interfering with it [42]. The following two sections
describe the dependency of protein stability and how to increase the protein solubility in solutions.
Protein stability can be described by the energy change involved in unfolding the three dimensional
structure of a protein to the polypeptide chains. This energy change is called the standard Gibbs
energy ∆GD [3] and can be described by the following formula 4.1.
∆GD = GU −GN (4.1)
∆GD is the free energy of the protein stability, GU stands for the free energy of the unfolded state
and GN for the energy of the folded, native state [43].
The free energy levels of folded and unfolded proteins can be seen in figure 4.1.
Fig. 4.1: Kinetic stability of a protein that folds to a stable native state through a free-energy barrier [3]
The larger and more positive the free Gibbs energy ∆GD of a protein, the more stable the protein
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is to denaturation. ∆GD is highly dependent on temperature as well as on the pH of the protein
solution. It is well known that changes in the pH and salt concentration interfere with the unfol-
ding free energy of proteins [44]. Far from their pI, proteins accumulate large net charges which
increase their free energy, thus lower ∆GD and the protein stability. Studies have shown that
proteins at low pH of 4.0 have higher risks for degradation compared to proteins at a pH around
6.0 or higher [45]. The impact of salt on protein stability and solubility will be discussed in the
following section.
Besides pH and salt concentration, also other parameters affect protein stability and can lead to
protein degradation like temperature or oxygen radicals. Most proteins are highly instable at
high temperatures and lead more easily to degradation at temperatures over 37◦C [45]. Also the
presence of oxygen radicals can modify proteins in their tertiary and secondary structure [46].
For drug delivery, protein stability plays also an important role. Some protein-drugs have a fast
metabolic degradation activity. To reduce this metabolic degradation in the human body the protein
is PEGylated at the end of the purification process. PEGylation reduces the metabolic degradation
and improves the drug delivery in the human body [47].
4.1.4 Protein solubility and Salting-out of proteins
Protein solubility is dependent on various interactions as protein-protein, protein-water, protein-
ions and ion-water. Besides these interactions other factors such as ionic strength, solution com-
position, pH and temperature interfere with the protein solubility as well [42]. In this section we
will focus on the impact of salt on protein solubility in water.
Salt can either stabilize or destabilize proteins dependent on their concentration and the type of
salt. Salt ions affect the protein stability by changing the hydrogen-bonding properties of water.
Known as the Hofmeister Series, the preferential hydrations of salt anions increase in the follow-
ing order: Cl− < CH−3 < COO
− < SO2−4 whereas cations following a different order: Ni
2+ < Ca2+
< Ba2+ < Mg2+ < Na+ [48].
Two terms are used when talking about protein solubility and the impact of salt: salting-in and
salting-out. Salting-in describes the stabilization of proteins in water due to low salt concentra-
tions. Salt is increasing the surface tension of a medium and hence increases non-specific elec-
trostatic interactions by new formations of protein - salt ion pairs. These new ion pairs enhance
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the water binding ability of the protein surface. Salt concentrations used for salting-in are usually
between 0-0.3M [42]. Table 4.1 gives some examples for salts commonly used for salting-in and
salting-out of proteins.
Tab. 4.1: Salts commonly used for Salting-In and Salting-Out of proteins [14]
Salting-In Salting-Out
BaCl2 MgSO4
CaCl2 NaCl
MgCl2 Na2SO4
MnCl2 Mg(OAc)2
Ca(OAc)2
Salting-out on the other hand describes the destabilization and precipitation of proteins in solu-
tion. At high salt concentrations proteins are less soluble in water [14]. Salt ions, especially
sodium ions, lead to preferential hydrations, meaning water molecules are attracted by salt ions.
Hence, the number of water molecules available to interact with the protein surface decreases and
leads to protein precipitation formations [14]. Different proteins need different amount of salts to
precipitate. Therefore the protein solubility in the salting-out state can be described as in equation
4.2:
logS = β −KsCs (4.2)
S stands for the solubility of the protein, β is the theoretical solubility of the protein with zero
salt, Ks is the salting-out constant and Cs is the molar salt concentration [42]. With this equation
it is possible to calculate the required concentration from a particular salt in order to precipitate a
certain type of protein.
The salting-out characteristics of proteins is often used for concentrating and purifying proteins
selectively from solution [49]. A comparable approach is used during the primary protein recovery
process characterized in this chapter. Sodium chloride and hydrochloric acid are added during the
process with the aim to salt-out different proteins.
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4.1.5 Goals and Aims
The aim of this chapter is to characterize the primary protein recovery process performed by the
industrial partner on the basis of total protein amount throughout the process. Samples taken from
the manufacturing process at different time-points of the process are analysed for their total protein
amount via Bradford assay. Using these results, mass balances for total protein are set up for each
step throughout the recovery process and critical process steps can be identified.
Hence, the three main aims of this chapter are as follow:
• characterize primary protein recovery process
• set up of mass balances for total protein throughout recovery process
• identification of critical process steps
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4.2 Materials and Methods
4.2.1 List of Materials
Tab. 4.2: Materials and suppliers
materials supplier
Recovery Process samples industrial partner
Trizma Base Sigma Aldrich
EDTA tetrasodium salt VWR
Bradford Reagent Sigma Aldrich
Bovine serum albumin (BSA) Sigma Aldrich
Acetic Acid (glacial) 100% VWR
BD FACScalibur flow cytometer Teagasc
5(6)-carboxyfluprescein diacetate Sigma Aldrich
Ethanol Sigma Aldrich
4.2.2 Sample preparation
Different sample preparations need to be performed on samples received from the manufacturing
protein recovery process, see sampling plan in figure 2.3.
End of fermentation sample
This sample preparation is only necessary for the EOF-sample (End of fermentation sample), since
all E.coli cells are still intact and most proteins are kept inside the cell. To analyse total protein
produced by E.coli, cell lysis needs to be performed. This is established by using a sonicator UO-
100H (Hielscher, Teltow, Germany).
The received EOF-pellet is redissolved in 200mL 20mM Tris, 1mM EDTA buffer and stirred for
30min until homogeneity is achieved. 5mL of this solution are taken for sonification. The sonica-
tor UO-100H is set to the following parameters: cycle = 1 and amplitude = 90%. The sonotrode
is inserted into 5mL EOF solution and the sonicator is switched on for 60sec followed by a 20sec
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break. This cycle needs to be repeated 18 times. Keep EOF solution on ice during the whole
sonification process.
The 20mM Tris, 1mM EDTA buffer will be used as the blank-solution for total protein determi-
nation of the EOF sample, diluted with DI-water with the same dilution factor that is used for the
EOF-sample itself.
Samples containing precipitations
This sample preparation is necessary for all recovery process samples containing protein precipi-
tations. This applies for all samples between S-2 and S-13, see sampling plan in figure 2.3.
Samples were thawed in a water-bath at 37◦C for 2 hours until the whole sample volume was
thawed. Samples were mixed well before transferring the whole volume into 50mL centrifuge
tubes.
5mL of each sample will be centrifuged at 4000rpm at 4◦C for 30min in a discontinuous centrifuge
FL40R (Thermo Scientific, Dublin, Ireland). The volume of the supernatant is been collected and
samples are stored at 4◦C until proceeding with protein determination. The unused sample volume
was stored back at -80◦C after sample preparation was finished.
The sludge is redissolved in 5mL of 20mM Tris, 1mM EDTA buffer (pH 8.0) on an orbital shaker
at 600rpm for 2.0 hours. After redissolving, the pH is set to 7.5±0.5 with either 1M tris or 4M
acetic acid. After collecting the final pH and volume of the redissolved sludge the samples are
mixed one more hour on the orbital shaker at 600rpm before storing them at 4◦C until proceeding
with protein determination.
For all supernatants the blank solution, to be used for total protein determination, will be pure
fermentation medium, diluted with DI-water with the same dilution factor that is used for the
supernatant samples themselves. For all redissolved sludge samples, 20mM Tris, 1mM EDTA
buffer (pH 8.0) will be used as the blank solution for total protein determination, also diluted with
DI-water with the same dilution factor that was used for the sludge samples themselves.
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TCA-pellet
This sample preparation is only necessary for the TCA-pellet, S-15, since this is the only sample
that comes in a pellet form.
Approximately 10g of TCA-pellet are redissolved in 100mL of chilled 10mM acetic acid and
stirred for 10min until solution is homogenized. The redissolved pellet is centrifuged in the FL40R
centrifuge (Thermo Scientific, Dublin, Ireland) at 4000rpm for 60min at 4◦C. After centrifugation
the supernatant is discard and the pellet is redissolved in 500mL chilled 20mM tris, 1mM EDTA
buffer (pH 8.0) for 20min. After redissolving the pH is set to 8.0±0.1 with either 4M acetic acid or
1M tris, followed by 2 hours of gently mixing. At the end the pH is set to 5.5±0.05 with 4M acetic
acid followed by a last centrifugation at 3500rpm for 20min at 4◦C. The volume of the collected
supernatant is recorded and stored at 4◦C until proceeding with protein determination. The sludge
can be discard.
The 20mM tris, 1mM EDTA buffer (pH 8.0) is used as the blank-solution for total protein deter-
mination of the TCA-pellet, diluted with DI-water with the same dilution factor that is used for
the TCA-pellet itself.
4.2.3 Total protein determination
After different sample preparations are performed all samples are analysed for total protein with
the Bradford assay, see section 3.2.2 and table 3.6. The reference standard is BSA in DI-water,
since the expected IFN-α-2b portions of total protein concentration is weigh below 16.7% (com-
pare section 3.3.1.1 and table 3.9).
The blank value for the reference standard is always DI-water. However, the blank value for the
recovery process samples differ from sample to sample. More information is given in each sample
preparation section.
4.2.4 Flow Cytometry analysis
Protein recovery process samples S-1 to S-4 are analysed for their vital physiological cell state with
a BD FACScalibur flow cytometer (Teagasc, Carlow, Ireland) which is equipped with a 15-mW
488nm argon laser and a 635nm diode laser. Samples S-1 to S-4 derived from the manufacturing
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recovery process are diluted with phosphate-buffered salin to an OD600 of 0.100 and stained with
5(6)-carboxyfluorescein diacetate (cFDA) to a concentration of 5mg/l. The sample is incubated at
37◦C for 10 minutes followed by an incubation on ice for 10 minutes.
After injecting the sample containing fluorescence dye onto the flow cytometer, the fluorescence
signal emitted is collected in four optical channels, FL1 (515 to 545nm), FL2 (564 to 606nm),
FL3 (>650nm) and FL4 (>670nm). The BD software (BD Biosciences) is used in the cytometer
to complete the data analysis.
Sample-1 untreated and sample-1 treated with 90% ethanol are used as a positive and negative
control to find the best discrimination between the subpopulations of active and dead cells.
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4.3 Results and Discussion
All samples analysed in this section were taken from the manufacturing protein recovery process
according to the sampling plan in section 2.5. Samples were taken from four different batches.
Two of them performed in 2011 (1-AVAF-211 and 1-AVAF-212) and the other batches from 2012
(2-AVAF-201 and 2-AVAF-206). The samples were frozen at -80◦C immediately after sampling
and shipped on dry ice from the industrial partner to DCU, where they were stored at -80◦C until
analysis was performed.
4.3.1 Characterization of 4 Recovery Process Cycles
Batch 2-AVAF-206 was selected as an example of all 4 analysed batches of the protein recovery
process in this section. Figure 4.2 shows the detected total protein amount throughout the protein
recovery process, after different sample preparations were performed (see section 4.2.2). The
four red arrows indicate four centrifugation cycles which separated the four different cycles of the
recovery process from each other. S-1 to S-4 represent the acid kill cycle, S-5 to S-7 are in cycle-
1, S-8 to S-11 are part of cycle-2 , S-11b to S-13 represent cycle-4 and S-15 stands for the final
TCA-pellet. All samples indicated with a red ’W’, are samples collected from the waste stream
for the particular centrifugation cycle.
Bars in blue represent the protein fractions analysed in the sludge, meaning these proteins were
in precipitated form at this stage during the recovery process. Bars in green, on the other hand,
represent the protein fractions analysed in the collected supernatant, meaning these proteins were
in solution at the particular stage.
Figure 4.2 represents the total protein amount throughout the protein recovery process of batch
2-AVAF-206. During the acid kill cycle, E.coli cells are disrupted to release the proteins due to the
addition of TCA and H3PO4. The addition of acid also leads to the precipitation of the proteins,
therefore the main protein fraction of S-2 to S-4 can be find in precipitated form. S-1 represent
the EOF (end of fermentation) sample in which all proteins are still in solution. The total protein
amount at the end of the fermentation was expected to be similar to sample S-4. The difference
between S-1 and S-4 can be explained due to the lack of analysing the supernatant of the fermen-
tation broth. S-1 represents only the spun down cell pellet at the end of the fermentation. Proteins
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Fig. 4.2: Total protein amount throughout recovery process of batch 2-AVAF-206
released to the supernatant during fermentation are not included in this analysis. Due to analysis
of batches 1-AVAF-211 and 1-AVAF-212, where both, supernatant and cell pellet, were available,
the total protein amount released to the supernatant corresponds to 20.0 - 23.0kg (data not shown).
This corresponds to the detected difference in total protein between S-1 and S-4 of this batch.
Since S-1, where cell lysis was performed using a physical disruption, does not show significantly
higher protein levels than S-4, where cell lysis was achieved using chemical disruption (see sec-
tion 4.1.1), the acid kill step results in an efficient disruption of E.coli cells and release of proteins
in precipitated form, a more detailed discussion about the characterization of the acid kill step can
be found in section 4.3.1.1.
During cycle-1 of the recovery process (S-5 to S-7), the recovered protein pellet needs to be resolu-
bilised. This should be achieved due to the addition of UP-water and pH setting to 7.0 by addition
of NaOH. Figure 4.2 shows that only a small protein percentage (≈18%) gets resolubilised under
these conditions and the majority of total protein remains in precipitated form.
Cycle-2 (S-8 to S-11) is a ’salting out step’ to selective recovery the protein of interest (compare
section 4.1.4). For this purpose the conductivity is set to 20mS/cm by the addition of NaCl, fol-
lowed by pH setting to 4.5 due to the addition of HCl. With the reduction of the pH in sample 10
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more than 80% of total protein precipitate and only half of the total protein amount gets recovered
during the following centrifugation step. It needs to be investigated if this ’salting out step’ is pro-
tein specific and only E.coli host cell proteins are salted-out and IFN-α-2b is recovered (compare
chapter 5). Due to previous results of the small scale model of the recovery process (compare
chapter 3), no major specificity in the recovery of different proteins is expected. It is more likely
that the protein of interest IFN-α-2b shows similar characteristics during the recovery process and
the ’salting-out step’ to the host cell proteins.
The last cycle, cycle-3 (S-11b to S-15), ends with the formation of the TCA-pellet. Due to the
addition of TCA the remaining proteins precipitate and the precipitants are recovered in the TCA-
pellet. The protein precipitation works efficient, since only small amounts of total protein were
detected in solution in sample 13 (see figure 4.2).
Summarizing, the characteristics of the recovery process cycles are as follow: the acid kill effi-
ciently disrupts E.coli cells to release and precipitate total proteins. Solubilisation of the protein
precipitants should take place during cycle-1, but as seen in figure 4.2 the yield of solubilisation
is only 20% of total protein. During cycle-2 proteins are efficiently salted-out, with a yield of
50%. It still needs to be characterized if this salting-out is protein specific and is not affecting IFN
recovery. Finally in cycle-3 the recovered proteins precipitate with a yield of more than 95% and
are recovered in the TCA-pellet.
4.3.1.1 Characterization of the Acid Kill step with flow cytometry
The previous section of this chapter discussed already the protein recovery of the E.coli cells
throughout the acid kill step. The protein recovery from the end of fermentation sample with
physical cell disruption using a sonicator was compared to sample 4 from the recovery process
where cell lysis was achieved by chemical disruption with acid addition. The following graph
shows more detailed information about the physical cell disruption of the E.coli cells using a
sonicator.
Figure 4.3 shows the protein recovery from E.coli cells of the EOF sample in dependency on
different sonification cycles. It can be seen that the recovery of total protein is increasing with
an increase in sonification cycles. This is as expected. However, after 16 cycles the product
recovery stagnates and no significant increase can be seen compared to 18 cycles. These results
PhD-Thesis from Tanja Buch 50
CHAPTER 4. PROCESS CHARACTERIZATION - TOTAL PROTEIN MASS BALANCES
10 - cycles 12 - cycles 14 - cycles 16 - cycles 18 - cycles
0
20
40
60
80
100
120
140
Fig. 4.3: Total protein recovery from E.coli cells of the EOF sample after physical cell disruption with a
sonicator
show that with 16-18 sonification cycles the cell lysis of E.coli cells is complete and all proteins
are recovered.
In order to analyse the acid kill step at the beginning of the primary protein recovery process for
its capability for complete cell lysis flow cytometry was used. During the acid kill, cell lysis of
E.coli cells should take place and proteins are released into the supernatant. In order to ensure a
complete disruption of all cells at the end of the acid kill step, samples were analysed for their
physiological state using the flow cytometer. During sample treatment, cells were stained with a
fluorescence dye which stains the cells depending on the condition of the cell membranes. With
the flow cytometer each individual cell can be detected by a laser at a different wavelength at
which the UV reading is dependent on the staining of the cell (see section 4.1.2). In this way
the flow cytometer can distinguish between living cells with intact membranes, injured cells with
partly intact membranes and dead cells with complete disrupted membranes. In order to have a
complete cell lysis and to recover all proteins from the E.coli cells, all cells need to be ’dead’ with
completely disrupted membranes.
Recovery process samples S-1 to S-4 were analysed with the flow cytometer as described in section
4.2.4. The results obtained for sample-1, the end of fermentation sample, is depicted in figure 4.4.
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Fig. 4.4: Results of flow cytometric analysis of the end of fermentation sample (before acid kill) of the
recovery process of batch 2-AVAF-206
This figure shows the results of the flow cytometry analysis of the end of fermentation sample (be-
fore the acid kill). It can be seen that over 96% of the cells are in an active and viable physiological
state, which is to be expected at the end of the fermentation. No cells (< 1.0%) were identified as
injured or dead.
Analysing samples 2 and 3 of the recovery process, which were taken during the acid kill step
after the addition of TCA and phosphoric acid, showed an increase in injured and dead cells (data
not shown). Sample 2 had 40% dead cells and 10% injured and sample 3 showed 80% dead and
5% injured cells. This observation indicates that the addition of acid and lowering the pH to 2.0
results in disruption of the E.coli cells.
Sample 4 of the recovery process is the last sample taken during the acid kill, after 30 minutes of
agitation at pH 2.0. The flow cytometer results of this process time point are shown in figure 4.5.
It can be seen that over 98% of cells were detected as dead cells with completely disrupted mem-
branes at sample time point 4. This observation indicates that the acid kill step works efficiently in
lysing and disrupting the E.coli cells to release all proteins into the supernatant. These data con-
firm the findings observed during the total protein quantification of samples 1 to 4 of the previous
section 4.3.1.
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Fig. 4.5: Results of flow cytometric analysis of sample 4 (end of acid kill) of the recovery process of batch
2-AVAF-206
4.3.2 Protein Mass Balances throughout the Recovery Process
To gain further information about the characteristics of the recovery process and to identify critical
process steps, mass balances were set up for each of the four centrifugation cycles.
Acid Kill→ Cycle 1
The first mass balance is between the acid kill and cycle-1. The formula 4.3 illustrates the samples
of the recovery process that have been used for this balance.
S − 4 =⇒ S − 5 + waste (4.3)
Inserting the analysed total protein quantities for each sample results in mass balance 4.4.
185.5kg ± 5.41kg =⇒ 146.9kg ± 3.97kg + not measured (38.6kg) (4.4)
Since a sample of the waste stream of the first centrifugation cycle is not available, it is not possible
to set up a complete protein mass balance for this step. However, due to the analysed protein
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amount in S-5 and S-4, theoretically around 38kg of total protein end up in the waste stream
during this centrifugation. This corresponds to 80% recovery of total protein and 20% loss in total
protein. Since the yield of the protein precipitation during the acid kill is over 95%, the protein
loss during this centrifugation can be explained by the inefficiency of the centrifugation process
itself. As described in chapter 3 the efficiency of a continuous centrifuge is not comparable to
a discontinuous centrifuge. Hence, the separation of precipitations from the supernatant is only
around 80%.
Cycle 1→ Cycle 2
The next mass balance needs to be set up between cycle 1 and 2. Formula 4.5 gives information
about the recovery process samples that are needed for this balance.
S − 7 =⇒ S − 8 + waste (S − 7a) (4.5)
Inserting the analysed total protein quantities for each sample results in mass balance 4.6.
145.4kg ± 2.04kg =⇒ 29.6kg ± 0.75kg + 110.7kg ± 2.1kg (4.6)
The mass balance 4.6 between cycle 1 and 2 results in an even balance for total protein. The 5.1kg
(3.1%) that are missing from a complete mass balance are in between the standard deviations of
the sample analysis. Hence, more than 75% of total protein can be found in the waste stream and
only 20% of total protein is recovered during this centrifugation cycle. The reason therefore can be
found in the insufficient resolubilisation of protein precipitations during cycle 1. Only 18% of total
protein is resolubilised during cycle 1 which is recovered in the supernatant after centrifugation
cycle 2. Most proteins that remain in precipitations are not recovered (80%) and can be found in
the waste stream of this centrifugation.
PhD-Thesis from Tanja Buch 54
CHAPTER 4. PROCESS CHARACTERIZATION - TOTAL PROTEIN MASS BALANCES
Cycle 2→ Cycle 3
The third mass balance is between cycle 2 and 3. The formula 4.7 illustrates the samples of the
recovery process that are been used for this balance.
S − 11 =⇒ S − 11b + waste (S − 11a) (4.7)
Inserting the analysed total protein quantities for each sample results in mass balance 4.8.
28.1kg ± 0.74kg =⇒ 13.7kg ± 0.39kg + 5.5kg ± 0.12kg (4.8)
The mass balance 4.8 between cycle 2 and 3 does not result in a complete mass balance, 8.9kg of
total protein (31.7%) were neither detected in the recovered supernatant nor in the waste stream.
The reason therefore could lie in the imprecise determination of the process volume for the dif-
ferent steps through the volumetric flow rate. Since the waste stream is very concentrated with
respect to total protein (up to 25.0g/L), small changes in the volume can lead to significant changes
in the determination of total protein.
Another explanation for an incomplete mass balance is protein degradation. Protein degradation
can lead to modifications in the chemical structure (amino acids chain) or shape (disulphide bonds)
of the protein (compare section 4.1.3). The change of the chemical structure can lead to changes
in the detection of the total protein amount, as described in chapter 3. Hence, the undetected total
protein amount of ≈9.0kg can be due to modification of the protein structure which falsifies the
protein measurements.
However, even with the incomplete mass balance it can been seen that only 50.0 - 60.0% of
proteins are recovered in this centrifugation cycle. This is due to the salting-out of protein in cycle
2. It still needs to be investigated if the salting-out of proteins only affects E.coli host cell proteins
or interferon-α-2b as well (see chapter 5).
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Cycle 3→ TCA-pellet
The last mass balance needs to be set up between cycle 3 and the TCA-pellet. Formula 4.9 gives
information about the recovery process samples that are needed for this balance.
S − 13 =⇒ S − 15 + waste (S − 14a/b) (4.9)
Inserting the analysed total protein quantities for each sample results in mass balance 4.10.
12.6kg ± 0.38kg =⇒ 13.6kg ± 0.12kg + 0.3kg ± 0.03kg (4.10)
The mass balance 4.10 between cycle 3 and the TCA-pellet results in a complete balance for total
protein. Only ∆1.3kg (10.3%) are exceeding the complete even mass balance which is in between
the standard deviations of the sample analysis. Hence, a complete recovery of total protein is
achieved during the last centrifugation cycle.
Summarizing all four mass balances throughout the recover process, the centrifugation between
cycle 1 and 2 can be identified as the main critical process step with a loss of more than 75% in
total protein. The centrifugation between cycle 2 and 3 is another critical step, with only 50%
recovery of total protein.
4.3.3 Comparison between 4 batches of the Recovery Process
An important factor for industrial processes and process characterization is the robustness and
reproducibility of a process. For this reason four different batches of the recovery process were
analysed for their total protein behaviour throughout the process.
Figure 4.6 shows the analysed total protein quantity for different time points throughout 4 different
batches of the protein recovery process. To prepare the fermentation media different lots of raw
material were used for the different batches. Batch 1-AVAF-211 and 1-AVAF-212 had similar lots
of raw material to produce the fermentation media. However, batch 2-AVAF-201 and 2-AVAF-206
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used different lots of raw-material for their fermentation media preparation.
Sample S-7a, S-11a and S-11b were only available for batches 2-AVAF-201 and 2-AVAF-206 but
not for batches 1-AVAF-211 and 1-AVAF-212.
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Fig. 4.6: Total protein amount throughout recovery process of 4 batches: 1-AVAF-211, 1-AVAF-212,
2-AVAF-201 and 2-AVAF-206
It can be seen in figure 4.6 that the produced amount of total protein at the end of the fermentation
differs between the 4 analysed batches dependent on the raw material that was used for the media
preparation. Batch 1-AVAF-211 and 1-AVAF-212 which had the same raw material for media
preparation show no significant difference in their total protein production at end of the fermenta-
tion (compare S-1 in figure 4.6).
It has to be kept in mind that sample 1 represents different protein pools for the different batches.
For batch 1-AVAF-211 and 1-AVAF-212 S-1 represent the total produced protein amount, mean-
ing protein kept in the intracellular compartments of the E.coli cells, as well as the protein fraction
that was released into the supernatant. However, for batch 2-AVAF-201 and 2-AVAF-206 S-1 rep-
resents only the protein pool that was kept in the intracellular compartments of the E.coli cells.
Meaning the total produced protein amount during fermentation is precisely represented by S-4
for these batches. Hence, comparing S-4 from batch 2-AVAF-201 with S-1 from batches 1-AVAF-
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211/212 it can be seen that the total protein production during the fermentation is more than 40%
higher. Also for batch 2-AVAF-206, the total protein production is up to 20% higher than in
batches 1-AVAF-211/212. Since the focus in this chapter is on the protein recovery process and
not on the fermentation or raw-material side this observation will not be discussed any further at
this stage.
Besides the difference in the total produced protein amount between the different batches, the
characteristics of the 4 cycles of the recovery process are very alike between all batches. For all
4 batches the acid kill cycle resulted in efficient cell disruption to release all total protein (refer
to section 4.3.1), followed by a 10 - 17% loss in total protein due to insufficient centrifugation
cycle (refer to section 4.3.2). During cycle 2 the solubilisation of total protein is a key factor in
all four batches. Independent of the total protein amount at the beginning of this cycle (S-5), the
amount of resolubilised protein and therefore recovered protein in cycle 3 (S-8) is very similar in
all four batches. The variations between batch 2-AVAF-201 and 1-AVAF-211 in S-5 corresponds
to ∆80kg, but in S-8 this variation is reduced to ∆14kg. This indicates that the insufficient protein
solubilisation in cycle 1 is due to a protein saturation in S-7. Independent of the protein amount
entering cycle 1, if the protein saturation level of water is reached no more protein can be solu-
bilised. This observation in cycle 1 corresponds with the total protein amounts detected for the
following cycles in all four batches. The big variations in total protein amount observed in the
acid kill and cycle 1 due to different produced amount of total protein during fermentation, cannot
be observed in cycle 2 and 3. The total protein amount detected in samples of cycle 2 and 3 are
comparable between all four batches.
Since the total recovered protein amount at the end of the recovery process is independent of the
total protein amount at the end of the fermentation, this recovery process is the key factor in op-
timizing and enhancing the overall process yield. An increase in protein production during the
fermentation would not lead to an enhanced protein amount at the end of the recovery process due
to the limited saturation level of protein solubilisation in cycle 1.
4.3.4 Critical process steps & protein mass balances
To identify the overall critical process steps of the protein recovery process, the average of the
percental total protein amount of all four analysed recovery process batches was determined and is
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shown in figure 4.7. The total protein amount quantified in S-4 was set to 100% since this sample
represents the total protein amount for all four batches (compare section 4.3.3). The percentages
of all other samples were calculated on the basis of sample 4.
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Fig. 4.7: Total protein amount throughout recovery process of 4 batches in percentage; S-4 was set to
100%
Figure 4.7 shows the characteristics of the total protein quantity throughout the recovery process
in percentage of four analysed batches. Two critical process steps can be identified, between cycle
1 and 2 (S-7 to S-8) and between cycle 2 and 3 (S-11 to S-11b). The mass balances for these two
critical process steps are listed below in formula 4.11 and 4.12.
Critical Process Step 1: Cycle 1→ Cycle 2
80.7%± 5.7% =⇒ 14.9%± 1.3% + 63.8%± 5.8% (4.11)
In the critical process step 1 more than 80% of total protein ends up in the waste stream and only
20% is recovered. The reason for this significant protein loss is insufficient protein solubilisation
in cycle 1 due to low saturation levels (compare section 4.3.2 and 4.3.3).
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Critical Process Step 2: Cycle 1→ Cycle 2
17.5%± 7.1% =⇒ 10.9%± 4.0% + 3.0%± 3.5% (4.12)
The second critical process step shows a protein decrease of more than 40% and only 60% of total
protein is recovered. This loss in total protein occurs during the salting-out step of proteins in
cycle 2. At this stage it is not identified yet, if this loss occurs only in host cell proteins or as well
in the protein of interest interferon-α-2b (4.3.2). Further studies in the characteristics of IFN-α-2b
itself during this recovery process are necessary, which will be discussed in chapter 5.
Summarizing these results, two critical process steps were identified in the protein recovery pro-
cess. The first step showed a total protein loss of up to 80% and the second one showed a protein
loss of up to 40%. Overall, the total protein loss during the whole recovery process is up to 90%,
meaning that the process yield is only 10% for total protein.
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4.4 Conclusion
In this chapter process characterization of the primary protein recovery using total protein mass
balances were performed. An overall loss in total protein of more than 90% was identified through-
out the recovery process. The loss occurs due to several reasons. First, insufficient separation of
precipitations from supernatant using continuous centrifuges. Second, insufficient resuspension
of precipitated proteins during cycle 1 due to low saturation levels of proteins in water. And third,
salting-out of proteins during cycle 2. Hence, two main critical process steps were identified: be-
tween cycle 1 and 2 and cycle 2 and 3.
An open question at this stage is: does interferon-α-2b behave in a similar way to total protein
throughout the recovery process? In particular, for the second identified critical process step, the
salting-out step, it is of high interest whether interferon-α-2b is salting-out as well or is this step
protein specific and only affects host cell proteins. Due to previous results discussed in chapter 3,
it can be assumed that interferon-α-2b behaves in a similar way to total protein. The characteristics
of total interferon-α-2b will be discussed in the following chapter 5.
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Chapter 5
Process Characterization - Total
Interferon Mass Balances
5.1 Introduction
In chapter 4 the primary protein recovery process was characterized using total protein mass bal-
ances. As mentioned in section 4.4 a next step is to verify the characteristics of total protein for
the protein of interest interferon-α-2b.
This chapter now will focus on the characterization of the primary protein recovery process on the
basis of total interferon-α-2b amount throughout the process. The same set of samples derived
from the manufacturing process as described in section 4.1 are analysed for their total interferon-
α-2b amount using SDS-PAGE.
After identifying critical process steps for the loss of total protein it is indispensable to investigate
if the protein of interest follows the same characteristics. Especially for the salting-out step, whose
purpose it is to salt-out host cell proteins but not the recombinant protein.
5.1.1 SDS-PAGE
Polyacrylamide-Gel Electrophoresis (PAGE) is an important tool in protein characterization for
more than forty years [50]. There are four different forms of PAGE: Native-PAGE, SDS-PAGE,
1D-PAGE and 2D-PAGE. Native-PAGE detects native, non-denatured proteins and separates a
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protein mixture depending on their charge and mobility in the gel [35]. SDS-PAGE on the other
hand analyses denatured proteins and separates them as a function of molecular weight. Due to the
addition of sodium dodecyl sulphate (SDS) the denatured protein is negatively charged and thus
the original charge has no impact on the separation [35]. 1D-PAGE is the performance of just a
native or SDS-PAGE. 2D-PAGE on the other hand has an IEF-separation prior to the SDS-PAGE.
IEF, iso-electric focusing, separates the protein mixture after their pI. In this way a protein mixture
can be separated as a function of pI and molecular weight and provides much more information
about single proteins [51]. In this section we will focus only on the procedure of a SDS-PAGE.
A SDS-PAGE consists of six major steps: sample preparation, polyacrylamide gel, buffer sys-
tem, electrophoresis, staining and analysis which will be described in more details in the next
paragraphs.
Sample preparation
The sample preparation is very dependent on the type of PAGE that needs to be applied. For a
SDS-PAGE the important ingredients are SDS and a reducing agent like β-Mercaptoethanol or
Dithiothreitol (DTT). Due to the application of heat (70◦C) for 10 minutes the reducing agent
reduces disulphide bonds of the native protein. SDS coats the polypeptides chain of the protein
with a negative charge [52].
Polyacrylamide Gel
The gel is made out of acrylamide, whose concentration is highly important for a successful se-
paration of a protein mixture. Using a high concentration of acrylamide results in a gel with very
small pores, hence only small proteins can be separated and large proteins remain in the upper part
of the gel during electrophoresis. Low concentrations of acrylamide on the other hand result in
gels with large pores and only large proteins can be separated [4]. Figure 5.1 gives an example of
the same sample analysed with different gels of different concentration of acrylamide.
Besides different acrylamide concentration, many gels consist of a stacking and a running gel. The
stacking gel is usually made of a different buffer and a much lower concentration of acrylamide
than the running gel. In this way protein can get stacked according to their size before entering the
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Fig. 5.1: Dependency of acrylamide concentration on successful separation of different protein mixtures
[4]
running gel. More information can be found in the following section buffer system.
Nowadays most gels are gradient gels. They consist of different concentrations of acrylamide and
allow to separate proteins with a wider molecular weight range [53]. These gels can be purchased
commercially to increase reproducibility.
Buffer System
There exist two different systems to run a SDS-PAGE. The first and older one is the continuous
system. The same running buffer is used for the inner and outer chamber of the PAGE-unit. This
system is easy to perform but it is low in protein separation and resolution [52].
The newer system is the discontinuous system also called Laemmli-system [54]. Different buffers
are used for the inner and outer chamber with different pHs. Due to the presence of different ions
and the different pHs, an ion gradient is formed in the stacking gel. This ion gradient is forming
a successive front that runs towards the sample molecules, which become stacked between the ion
gradient according to their electrophoretic mobility. Hence, small molecules at the bottom and
larger on the top. As soon as this front is entering the running gel, the pH changes and the ion
gradient is eliminated. Due to the pre-selective ordering of the proteins according to their size,
separation and resolution is increased [55].
A known problem nowadays with this Laemmli-system is the working pH. At pH 8-9 disulphide
bonds start to form again between cysteine due to their pKa of 8-9. Therefore an optimized discon-
tinuous buffer system is used with a Bis-Tris running buffer operating at pH 6.8. A reducing agent,
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sodium bisulfide, is also added to the inner chamber that moves into the gel ahead to maintain a
reducing environment for the proteins [56]. Especially for small proteins this system can provide
an improvement in resolution [57].
Electrophoresis
There are three modes of operation of the electrophoresis: constant voltage, constant current or
constant power input. In most cases a constant voltage is used to run electrophoresis. Usually
the voltage is set at the beginning to provide a current of 50-60mAm per gel, which is around
112-120V. If the voltage is set higher the electrophoresis will be shorter but the gels can get too
hot during the run, which can destroy the gels. The same can happen if the voltage is set too low
and the run time is increased too much [57].
Staining
There are two widely-used techniques available for staining gels: coomassie-blue or silver stain-
ing. Coomassie blue staining is the more practical version of the two, since it involves only
two steps. The gels are incubated in coomassie blue stain for one hour and then de-stained in
a methanol/ acetic acid solution overnight. Nowadays there are even commercialized coomassie
blue stains available that allow detaining with pure DI-water [58].
Silver staining is more difficult because it requires additional steps and some experience to per-
form successfully. However, it is more sensitive and detects also smaller bands with low protein
concentrations [58].
Analysis
To receive information about the molecular weight of an unknown protein, gels can be scanned
to obtain pictures. After that the molecular weight can be determined using the molecular weight
marker as a reference [50].
To determine the protein quantity of single bands, densitometry is needed. The density analysis
of bands of a reference standard can be correlated to the density of unknown bands in the gel.
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However, it needs to be kept in mind that the SDS-PAGE is not a very accurate quantitative method
and is more used in protein characterization.
In this chapter pre-cast gradient gels are used with an acrylamide concentration from 4-12% and a
stacking gel. The used buffer system is the new Laemmli-buffer system with a Bis-Tris buffer at pH
7.0, since the protein of interested has a low molecular weight of 19kDa. After electrophoresis with
constant voltage supply, gels are stained using coomassie blue staining, followed by quantification
via densitometry. More details about the procedure can be found in the material and method
section of this chapter.
5.1.2 Western Blot
Western blotting (WB), was developed in the early 1970 and describes the transfer of proteins
from polyacrylamide gel onto a membrane. The Western Blot, also called protein blotting or im-
munoblotting, consists of several different steps which need to be considered in assay development
or optimization. The most important parameters to be considered throughout western blotting are:
selection of membrane, transfer technique, blocking agent, antibody concentrations and the anti-
gen detection [59]. Nitrocellulose and PVDF (polyvinylidene difluoride) are the most common
membranes used in western blotting. PVDF membranes have the advantage of high protein bind-
ing capacity, physical strength and chemical stability. Nitrocellulose membranes, on the other
hand are more widely used although they are poor in binding small proteins and an additional
membrane incubation step needs to be performed. Both membranes bind the proteins through
primarily hydrophobic interactions [60].
Three different techniques can be used to transfer the proteins onto the membrane: simple dif-
fusion, vacuum blotting and electro-blotting. Electro-blotting is the most common technique in
protein blotting due to its advantages in speed and completeness of transfer. Two different electro-
blotting techniques are available: wet transfer and semi-dry transfer. In a wet transfer, the sand-
wich of gel, membrane and filter paper is placed vertical in a buffer tank with platinum wire
electrodes. The semi-dry transfer on the other hand, places the sandwich horizontal between two
stainless steel or graphite-carbon plate electrodes which are clamped together. Each layer of the
sandwich is well soaked in the transfer buffer which provides the connection for the electrophoretic
transfer. The semi-dry transfer has the advantage of blotting several membranes simultaneously,
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cheaper equipment and less required power input [60].
The following step after the transfer of the proteins onto the membrane is the blocking of the
membrane. This is necessary to mask any potential non-specific binding sites on the membrane
itself and to promote renaturation of antigen sites on the proteins. The blocking agent is usually
5% BSA or 5% non-fat milk powder in a Tris buffered saline containing 0.1% Tween-20 (TBST).
After blocking the membrane, primary and secondary antibodies needs to be selected and their
concentration optimized. Optimization of the correct antibody concentration should be utilized to
ultimately provide the best signal to noise ratio and can be achieved conducting a dot blot analysis.
Besides the concentration of the antibody a decision between polyclonal and monoclonal antibod-
ies need to made. Polyclonal antibodies have the advantages of having many antibody molecules
that bind the target protein antigen and hence resulting in stronger signals. On the other hand this
can lead to protein binding which are unrelated to the protein of interest. In this case monoclonal
antibodies are favourable, since they are more sensitive and specific for the protein antigen of in-
terest. However, a disadvantage of monoclonal antibodies can be that the specific antigenic site is
affected (denatured) by the electrophoresis and no or less antibody binding can occur [60].
The last step in western blotting is the detection of the antigen, mainly using a secondary anti-
body. This detection can be over immunodetection as chemiluminescent detection or fluoresces
labelling. Chemiluminescense detection usually contains an enzyme linked reagent using alkaline
phosphatase (AP) or horseradish peroxidase (HRP). The enzyme is coupled with the secondary an-
tibody and catalyses the reaction with a substrate (HRP catalysis the oxidation of luminol), which
light output can then be detected on film or by a camera equipped documentation system [61]. If
the signal is detected by film no quantitative information can be gained. However, chemilumi-
nescense detection is usually the most sensitive detection technique in western blotting. Another
common method is the labelling of secondary antibodies with fluorescence molecules. These tech-
niques have the advantage of being faster and more robust since they eliminate the steps associated
with substrate incubation, washing and film exposure [60].
5.1.3 Biacore and BLItz
The Biacore bio-sensor instruments were launched in the 1990 and with a label-free surface plas-
mon resonance (SPR) technology [62]. The SPR-technology is an optical method, measuring the
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refractive index near a sensor surface. The detector measures the changes in the refractive index
that occur due to mass variations at the sensor surface when molecular complexes form or break.
One binding partner of the molecular complex is bound to the sensor surface, the other one is
flowing in a flow cell over this surface to allow binding [62][63]. Figure 5.2 shows a basic set-up
of the surface plasmon resonance technology of a Biacore system.
Fig. 5.2: Basic set-up of the surface plasmon resonance technology of a Biacore system. Changes of the
refractive index are symbolized with little arrows and indicated with the numbers one and two.
These changes are than displayed by the computer software as a change in resonance over time
[5].
As it can be seen in figure 5.2, the SPR-technology in the Biacore system is based on a sensor chip
which are immobilized with a ligand specific to the target analyte which flows through the flow
channel. Several different pre-immobilized chips are available from Biacore, the most common
ones are CM4 and CM5 sensor chips. These chips are pre-immobilized with carboxylmethylated
dextran on their gold surface. These dextran groups can be attached to different ligands, such
as antibodies, protein A or others. In order to immobilize these ligands onto the sensor surface,
the dextran groups need to be activated by the addition of N-hydroxysuccinimide (NHS) and N-
ethyl-N-(3-dimethylaminopropyl)carbodiimde hydrochloride (EDC). Following the activation, the
specific ligand can be immobilized onto the chip surface and remaining binding sites are blocked
with ethanolamine [5]. Due to its flexibility in the chip-surface, the Biacore can be used for several
application: analysis of kinetic constants, measurement of analytes’ concentration, protein-protein
interaction and the affinity of an interaction [62].
The BLItzTM system is based on the biosensor technology, similar to the Biacore. Instead of us-
ing surface plasmon resonance technology the BLItz system uses label-free bio-layer interfrometry
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technology (BLI). Different analyte-specific ’Dip and Read’ bio-sensors are pre-immobilized avail-
able with different capture molecules, such as Protein A, Anit-Mouse-Capture (AMC) and several
more. The biosensor is selected after the affinity to the recombinant protein to be analysed, for
example Protein A to determine IgG [64].
A label-free BLI technique is used to measure protein interactions in real time. White light is
emitted down the biosensor which is reflected back from the tip surface to the BLItz instrument.
The reflected wavelengths are dependent on the coating of the biosensor, resulting in a shift in
the wavelength if the target protein is bound to the sensor surface. The wavelength shift, due to
the binding of proteins, is collected over a certain amount of time between 30 - 120 seconds and
re-calculated in a binding rate in nm/sec. The binding rate can be correlated directly to the specific
protein concentration present in the sample [65].
5.1.4 Interferon and its isoforms
This chapter focuses on the characterization of total interferon-α-2b. As mentioned in chapter 2
interferon-α-2b has four known isoforms which are Iso-2, Iso-3, Iso-4-P and Iso-4-R. The total
interferon-α-2b amount in process samples includes all fours isoforms and the active drug sub-
stance altogether.
A more detailed description of the chemical structure of the different isoforms can be found in the
following chapter 6.
5.1.5 Goals and Aims
The aim of this chapter is to characterize the primary protein recovery process on the basis of
total interferon amount throughout the process. Samples taken from the manufacturing process
at different time-points of the process are analysed for their total IFN amount using SDS-PAGE.
Using these results, mass balances for total interferon are set up for each step throughout the
recovery process and critical process steps can be identified. The identified critical process steps
can then be compared with the findings of chapter 4 to see, if total protein and total interferon
behave in a similar way throughout the recovery process.
Hence, the three main aims of this chapter are as follow:
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• set up of mass balances for total interferon throughout recovery process
• identification of critical process steps
• comparison between total protein and total interferon characteristics throughout the process
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5.2 Materials and Methods
5.2.1 List of Materials
Tab. 5.1: Materials and suppliers
materials supplier
Recovery Process samples industrial partner
Trizma Base Sigma Aldrich
EDTA tetrasodium salt VWR
Acetic Acid (glacial) 100% VWR
Methanol Sigma Aldrich
interferon-α-2b drug substance industrial partner
NuPAGE R© Novex Bis-Tris Gel 4-12% Invitrogen
NuPAGE R© LDS Sample Buffer (4x) Invitrogen
NuPAGE R© Reducing Agent (10x) Invitrogen
NuPAGE R© MES SDS Running Buffer (20x) Invitrogen
NuPAGE R© Antioxidant Invitrogen
prestained protein ladder, 10-170kDa Fisher BioReagent
EZ-Run Protein Gel Staining Solution Fisher
Fast semi dry transfer buffer (10x) Invitrogen
2.5mm thick blotting paper Whatman
Nitrocellulose Blotting membrane NOVEX Invitrogen
TBST-buffer (1X TBS + 0.05% Tween-20) Sigma Aldrich
anti-IFN-α-2b, mouse monoclonal Santa-Cruz
anti-IFN-α-2b [9D3], mouse monoclonal abcam
IRDye 800CW goat anti-mouse IgG (H+L) LI-COR Biosciences
CM-5 chips GE Healthcare
Amine Coupling Kit GE Healthcare
HBS-EP+-buffer 10x GE Healthcare
Anti-mIgG Fc Capture (AMC) sensors forte BIO (PALL Life Sciences)
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5.2.2 Sample preparation
All sample preparations are performed as described in chapter 4 in section 4.2.2. Only the EOF-
sample was analysed in two different forms. First, after sonification to perform cell lysis before
starting SDS-PAGE method (followed protocol in section 4.2.2). And second, without performing
any cell lysis prior to SDS-PAGE method. In this case, cell lysis was only achieved due to heating
and the addition of SDS during performance of SDS-PAGE method (compare following section).
5.2.3 SDS-PAGE method
SDS-PAGE stands for Sodium Dodecyl Sulphate Polyacryl Amide Gel Electrophoresis and se-
parates proteins by size (refer to section 5.1.1). In this experiment pre-cast gels from NuPAGE
(Invitrogen by life technologies, Dublin, Ireland) are used to increase reproducibility. Novex R©
Bis-Tris gels (Invitrogen by life technologies, Dublin, Ireland) are used with a polyacrylamide gra-
dient of 4-12% for optimal separation of small and medium sized proteins (compare section 5.1.1).
The SDS-PAGE method follows mainly the suggested protocol steps from Life Technology-NuPAGE,
[15], using a discontinuous buffer system (compare section 5.1.1). The SDS-PAGE protocol fol-
lowed in these experiments is listed in table 5.2.
Tab. 5.2: Performance of sample preparation for SDS-PAGE with NuPAGE Novex Bis Tris gels 4-12%
[15]
component required volume [µL]
standard/ sample 5.0
NuPAGE R© LDS Sample Buffer (4x) 5.0
NuPAGE R© Reducing Agent (10x) 2.4
Deionized water 7.6
• vortex samples and incubate at 70◦C for 10min (do not boil)
After sample preparation for SDS-PAGE the following steps are required:
• load 10µL of each standard/ sample to one well of NuPAGE R© Novex R© Bis Tris gels
• fill inner buffer chamber with 200mL 1X NuPAGE R© MES SDS Running Buffer
containing 500µL NuPAGE R© Antioxidant
• fill outer buffer chamber with 800mL 1X NuPAGE R© MES SDS Running Buffer
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• run 2 gels at constant voltage, 110V (current ≈ 130mA) for 90 minutes
Each gel contains one well loaded with a molecular weight marker, pre-stained protein ladder for
10-170kDa (Fisher BioReagents, Dublin, Ireland), as well as 3 to 4 IFN-α-2b reference standards.
The reference standards were diluted with DI-water to concentrations between 1.0 to 0.05g/L.
After the electrophoresis run, four more steps need to be followed:
• place gels in fixing solution (7% acetic acid in 40% (v/v) methanol) for 1h at RT
• stain gels in Coomassie staining solution (EZ-Run Protein Gel Staining Solution,
Fisher Scientific, Dublin, Ireland)
• incubate at RT for 45-60min
• destain gels in DI-water over night at RT
• scan and analyse gels, using LI-COR scanner (LI-COR Biosciences, Nebraska, USA)
5.2.4 SDS-PAGE-quantification
After destaining gels in DI-water over night, gels need to be scanned using a LI-COR scanner (LI-
COR Biosciences, Nebraska, USA). With the software Odyssey 3.0 scanned gels can be analysed
for their densitometry of different protein bands (compare section 5.1.1).
The analysed density of the IFN-α-2b reference standards (in K-points) are used to perform a
linear standard curve in the range of 0.05 - 1.0g/L of IFN-α-2b. The determined slope of this
standard curve is used to calculate IFN-α-2b amounts of the recovery process samples using their
analysed density of the IFN-α-2b band at 19kDa.
5.2.5 Western Blot method
The Western Blot is performed following the electrophoresis run, before fixing and staining of
the gels (compare previous section). In this experiment a semi-dry transfer is performed using a
nitrocellulose membrane (Invitrogen by life technologies, Dublin, Ireland).
After the completion of the electrophoresis run the gel needs to equilibrate in 1X fast semi dry
transfer buffer (Invitrogen by life technologies, Dublin, Ireland) for 10 min, followed by the trans-
fer onto the membrane. Therefore a blotting sandwich needs to be put together following the order
displayed in figure 5.3:
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Fig. 5.3: Order of blotting sandwich for semi-dry transfer
The transfer runs at constant voltage (9.0V) for 17min (expected current: 400mA).
After the transfer following steps need to be performed:
• blocking of unspecific binding sites in 5% BSA in TBST (3h at RT)
• 3 washes with TBST for each 10min
• incubation in primary antibody (1/5000 in TBST) over night at 4◦C
use: anti-IFN-α-2b, mouse monoclonal (Santa-Cruz, Texas, USA)
or: anti-IFN-α-2b [9D3], mouse monoclonal (abcam, Cambridge, England)
• 4 washes with TBST for each 10min
• incubation in secondary antibody (1/10000 in TBST) for 2h at RT
use: IRDye 800CW goat anti-mouse IgG (H+L) (LI-COR Biosciences, Nebraska, USA)
• 6 washes with TBST for each 10min
• scan membrane, using LI-COR scanner (LI-COR Biosciences, Nebraska, USA)
Western Blot-quantification
After scanning the membranes with the LI-COR scanner (LI-COR Biosciences, Nebraska, USA)
and optimization of the intensity levels of the 700 and 800 channels, the software Odyssey 3.0 (LI-
COR Biosciences, Nebraska, USA) is used to measure the fluorescence signal of each band. The
analysed fluorescence signal of the IFN-α-2b reference standards (in K-points) is used to perform
a linear standard curve in the range of 0.05 - 0.5g/L of IFN-α-2b. The determined slope of this
standard curve is used to calculate IFN-α-2b amounts of the recovery process samples using their
analysed fluorescence signal of the IFN-α-2b bands.
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5.2.6 Biacore and BLItz method
Biacore system
The Biacore T100 (GE Healthcare, Buckinghamshire, England) is used for all analysis. The sur-
face of a CM-5 chip (GE Healthcare, Buckinghamshire, England) is activated with an amine cou-
pling kit (GE Healthcare, Buckinghamshire, England) and Protein A is immobilized onto the chip
surface. Following the immobilization, the sample analysis is performed is the following order:
• capture IFN-antibody (abcam, Cambridge, England) at 10mg/ml
flow-rate: 10µL/min, contact time: 120sec
• inject interferon-α-2b reference standard or process sample
concentration: 0.05-1.0mg/ml, at 10µL/min and 120sec contact time
• regenerate chip with 10mM glycine at pH 2.0 for 120 seconds
The analysed RU signals of the IFN-α-2b reference standards are used to perform a linear standard
curve in the range of 0.05 - 1.0g/L of IFN-α-2b. The determined slope of this standard curve is
used to calculate IFN-α-2b amounts of the recovery process samples using their analysed RU
signals.
BLItz system
The BLItz system (forte BIO, Portsmouth, UK) is used with anti-mIgG Fc Capture (AMC) sensors
to quantify interferon-α-2b reference standards. In a first step the anti-IFN antibody (abcam,
Cambridge, England) at 0.2mg/ml is immobilized onto the sensor surface with a contact time
of 120 seconds. In a second step the interferon-α-2b reference standards are captured by the
immobilized antibody at concentration from 0.075 - 0.1mg/ml and a contact time of 120 seconds.
The difference between the binding signal of the antibody and the IFN reference standard can be
correlated to the interferon-α-2b concentration.
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5.3 Results and Discussion
5.3.1 Interferon characteristics throughout Recovery Process
The total interferon-α-2b (total IFN) amount, including IFN-α-2b and all isoforms, was quantified
in recovery process samples via SDS-PAGE as described in sections 5.2.3. Figure 5.4 shows the
total IFN-α-2b in soluble (green) and in insoluble (blue) fractions throughout the whole primary
recovery process. All samples indicated with a red ’W’ are samples collected from the waste
stream for the particular centrifugation step, which are indicated through an arrow. Standard
deviations are calculated from an average error of reference standards that were performed in
triplicates and applied for the process samples.
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Fig. 5.4: Interferon-α-2b amount in soluble and insoluble fractions throughout the recovery process
Samples S-1 to S-4, representing the acid kill step of the recovery process, illustrate that the
functions of the acid kill, to disrupt cells and release whole proteins, are fulfilled. Since the end
of fermentation sample S-1 shows similar total IFN amount than the last sample of the acid kill
step (S-4), all IFN was released from the cells during the acid kill. Another purpose of the acid
kill is to precipitate all proteins, which also worked efficiently since more than 97% of total IFN
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in S-4 was found in the insoluble fraction in precipitations. Sample 2 and 3 show lower total IFN
amounts compared to S-1 and S-4, which is not as expected. Usually a lower protein amount
in these samples indicates that the disruption of the cells and the release of proteins is not fully
completed at this stage. Due to the sample preparation for SDS-PAGE, complete cell lysis should
occur during the addition of SDS and incubation at 70◦C, meaning that similar amounts in total
IFN were expected for S-1, S-2, S-3 and S-4. A reason for the lower total IFN amounts in S-2 and
S-3 can be found in the imprecise quantification method of densitometry. Keeping in mind that
the standard deviation for interferon reference standards is in average 10%, the total IFN amounts
of S-1 - S-4 are within this variation.
Looking at the total IFN amount in cycle-1 (S-5 - S-7) similar unexpected variations between the
samples can be seen. Due to inefficient continuous centrifugation a decrease of around 15-20%
between S-4 to S-5 in total IFN amount was expected (compare chapter 4, section 4.3.1), which
remained constant in samples 6 and 7. However, including the 10% variations into the calculations
all three samples result in a constant total IFN amount with around 15% decrease compared to
sample 4. The distribution of soluble and insoluble fractions in total IFN in sample 6 and 7 are as
expected. Only up to 35% of total IFN gets resolubilised during cycle-1, leaving 65% of total IFN
remaining in precipitated form.
The insufficient solubilisation of total IFN in cycle-1 explains the low amount of recovered total
IFN in cycle-2, which represents only 40% (compare S-8 in figure 5.4). This indicates that only
the total IFN in the soluble fractions was recovered during the centrifugation cycle. The total IFN
in the insoluble fractions was detected in the waste stream in S-7a. During cycle-2 the salting-out
of E.coli host cell proteins should take place. However, as it can be seen in S-10 and S-11 in figure
5.4, precipitation also occurs in total IFN of up to 50%. This indicates that the salting-out step is
not protein specific for interferon-α-2b.
In cycle-3 a reduction of around 30% in total IFN is detected compared to the end of cycle-2. The
reduction can be explained due to the precipitates of total IFN formed in cycle-2. The majority of
the precipitates of total IFN end-up in the waste stream during the centrifugation cycles and were
partly detected in S-11a. During cycle-3 a precipitation of all proteins should occur due to the
addition of TCA. This process is efficient, since all detected total IFN was in precipitated form in
sample 13. Due to the efficient precipitation of total IFN in cycle-3 the majority is being recovered
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in the TCA-pellet at the end of the recovery process.
5.3.2 IFN mass balances throughout the Recovery Process
All mass balances of total IFN throughout the recovery process were performed using the results of
batch 2-AVAF-206 shown in figure 5.4. Since the analysis was performed only once, no standard
deviations are available.
Acid Kill→ Cycle 1
The first mass balance is between the acid kill and cycle-1. The formula 5.1 illustrates the samples
of the recovery process that have been used for this balance.
S − 4 =⇒ S − 5 + waste (5.1)
Inserting the analysed total interferon-α-2b quantities for each sample results in mass balance 5.2.
7 086.6g =⇒ 5 614.4g + not measured (1 472.2g) (5.2)
Only 80% of total IFN was recovered during centrifugation cycle-1, indicating that around 20%
ends up in the waste stream. Unfortunately no sample is available from this waste stream to proof
this assumption. However, as already mentioned in the previous sections a reduction in protein of
15-20% was expected due to insufficient separation of particles and supernatant in a continuous
centrifuge as it has been used during this centrifugation cycle.
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Cycle-1→ Cycle-2
The next mass balance needs to be set up between cycle 1 and 2. Formula 5.3 gives information
about the recovery process samples that are needed for this balance.
S − 7 =⇒ S − 8 + S − 7a (5.3)
Inserting the analysed total interferon-α-2b quantities for each sample results in mass balance 5.4.
7 037.38g =⇒ 2 453.2g + 2 780.6g (5.4)
In formula 5.4 35% of total IFN was recovered after centrifugation cycle 2 but only 40% of total
IFN was detected in the waste stream. Leaving an uneven mass balance with 25% of total IFN
undetected. As described in the section above, the quantification via SDS-PAGE has a mean
standard deviation of 10%. Due to variations in total IFN amount in the three samples of cycle-1
(compare figure 5.4) it is likely that S-7 contains only 6000g of total IFN instead of 7000g. This
would lead to a 40% recovery of IFN in S-8 and up to 48% of IFN in the waste stream (S-7a). The
difference of 12% to an even mass balance is within the standard deviation of the method.
Cycle-2→ Cycle-3
The third mass balance is between the cycle 2 and cycle-3. The formula 5.5 illustrates the samples
of the recovery process that are been used for this balance.
S − 11 =⇒ S11b + S − 11a (5.5)
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Inserting the analysed total interferon-α-2b quantities for each sample results in mass balance 5.6.
2 444.6g =⇒ 1 695.4g + 91.8 g (5.6)
The mass balance 5.6 indicates that only 70% of total IFN is recovered during centrifugation
cycle 3. Hence, 30% of total IFN is lost in this step but only 4% could be detected in the waste
stream. This shows that only 74% of total IFN was detected after the centrifugation cycle 3. The
missing difference of 24% to a complete mass balance can be explained by the significant standard
deviations of the quantitative method.
Cycle-3→ TCA-pellet
The last mass balance needs to be set up between cycle 3 and the TCA-pellet. Formula 5.7 gives
information about the recovery process samples that are needed for this balance.
S − 13 =⇒ S − 15 + S − 14a/b (5.7)
Inserting the analysed total interferon-α-2b quantities for each sample results in mass balance 5.8.
1 539.9g =⇒ 1 382.3g + 0 g (5.8)
The last balance for total IFN of the recovery process results in an even mass balance, since 90%
of total IFN was recovered in the TCA-pellet. Including the significant standard deviations of
the SDS-PAGE method of 10%, this recovery can be add up to a 100%. This would also explain
that no IFN was detected in the waste stream of this centrifugation cycle. Besides a complete
recovery of total IFN in the TCA-pellet, the untraceable IFN in the waste stream can be below the
detection limit of this method. Ten percent of total IFN corresponds to 160g of IFN resulting in a
concentration 0.02g/L at this stage of the process. The limit of detection of IFN using SDS-PAGE
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is 0.05g/L.
5.3.3 Comparison of IFN-amount between 4 batches
To study the reproducibility of interferon-α-2b recovery throughout the recovery process, four
different batches of recovery process samples were analysed via SDS-PAGE for their total IFN
amount and the average in percentage was calculated for each sample. The average total IFN
amount of four batches for each sample of the recovery process can be seen in figure 5.5.
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Fig. 5.5: Average of interferon-α-2b amount of 4 different batches throughout the recovery process
Figure 5.5 indicates that the characteristics of total IFN throughout the recovery process is consis-
tent. Two critical process steps (CPS) can be identified. The critical process step one is between
cycle 1 and 2 where more than 60% of total IFN is lost in the waste stream (S-7a) and only 40%
is recovered (S-8). The second critical process step is between cycle 2 and 3. After this centrifu-
gation cycle 70% of total IFN is recovered (S-11b) and up to 30% ends up in the waste-stream
(S-11a). As it can be seen in figure 5.5 this IFN reduction in CPS-2 is indeed in between the stan-
dard deviations of sample 11 and 11b, meaning the detected changes are not significant. However,
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since samples 8, 9 and 10 result in comparable results to S-11 and on the other hand samples 13
and 15 result in comparable IFN amounts to S11b, the reduction in total IFN between these two
sample sets can be seen as significant.
The significant big standard deviations of these results do not necessarily indicate big variations in
total IFN between the different analysed batches. It is more likely that these deviations are due to
an imprecise quantitative method. Besides the common errors that affect the standard deviation,
such as dilution errors and performance errors of the method, the SDS-PAGE method also has an
important error due to the quantification via densitometry (compare section 5.2.4). After scanning
the gels, every single band appearing at 19kDa needs to be marked with a square border, before
the band density is determined. Besides execution errors during this analysis, two other factors
can falsify the analysis at this stage.
The IFN-samples with known concentration that are used as a reference standard contain only
purified IFN material, meaning the detected density of the band is only due to interferon. How-
ever, the recovery process samples contain less than 4% IFN and over 96% of the total amount
of proteins are host cell proteins (HCP) from E.coli. Hence, marking the band at 19kDa with a
square border can lead to the contaminent of other proteins into the analysis of the band-density.
Figure 5.1.1 shows the scanned-image of a SDS-PAGE with a molecular weight marker in lane
1, the purified interferon standard material at two concentrations in lane 2 and 3, and 9 different
recovery process samples.
In order to reduce the influence of host cell proteins on the interferon quantification, sample di-
lutions are necessary. However, since the IFN amount is less than 4% of the overall total protein
amount, high dilutions would lead to very low IFN concentrations. Due to repeated analysis of
purified interferon material, standard deviations of 8.5% were detected for IFN concentrations be-
tween 0.5 - 1.0g/L and up to 20% deviation for IFN concentrations between 0.05 - 0.1g/L. This
indicates that the selected dilution of each sample needs to be balanced to minimize the influence
of host cell proteins on the analysis but also to maximize the IFN-concentration in the assay.
On the other hand, since more than 96% of total protein represent host cell proteins from E.coli,
it is possible that there are other proteins beside interferon with a molecular weight of 19kDa. As
described in section 5.6, SDS-PAGE separates proteins based on molecular weight. If a protein
mixture contains more than one protein with the same or similar molecular weight, no differences
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Fig. 5.6: Scanned SDS-PAGE image of purified interferon standard material and different recovery
process samples
can be detected between these proteins. Meaning all proteins with the same molecular weight
appear only in one band on the SDS-PAGE. In our case it would lead to an overestimation of the
total interferon in the recovery process samples.
To confirm the detected total IFN amounts throughout the recovery process a more specific ana-
lytical method needs to be performed, for example Western Blot or HPLC/ UPLC.
5.3.4 Comparison of total protein and total Interferon characteristics
The detected amount of total protein throughout the recovery process discussed in chapter 4 is
compared to the analysed amount of total IFN in the recovery process samples. Figure 5.7 shows
the comparison between total protein and total IFN in percentage throughout the whole recovery
process, whereas sample 4 was set to 100%.
Both, total protein and total IFN, follow a similar characteristic throughout the recovery process
with two major critical process steps. The first critical process step was identified between cycle
1 and 2 for total protein as well as for total interferon and also the second critical process step is
identical for total protein and total IFN between cycle 2 and 3.
The loss in interferon in both critical process steps is not as distinctive as it is in total protein.
Table 5.3 lists the average losses in total protein and total IFN during the two identified critical
process steps as well as the overall loss throughout the recovery process.
The overall loss throughout the recovery process of 90% in total protein and 80% in total IFN
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Fig. 5.7: Total interferon-α-2b characteristics compared to total protein amount throughout the recovery
process
indicate that this primary recovery process is not protein specific for interferon-α-2b. Two critical
process steps were identified throughout the primary protein recovery process for total protein
(compare chapter 4) and total interferon-α-2b (compare section 5.3.3).
5.3.5 Alternative methods for total Interferon-α-2b quantification
Until now, all results for total interferon-α-2b have been quantified using SDS-PAGE. As ex-
plained before in section 5.1.1, SDS-PAGE does not specifically detect interferon but distinguishes
between proteins only by size. It is possible that several proteins with the same or similar molec-
ular weight than interferon are present in the recovery process samples. Accordingly, the SDS-
PAGE detects only the mixture of proteins with the same molecular weight and thus, it may over-
estimate the amount of interferon in the recovery process samples.
In order to obtain more precise information of the actual quantity of interferon-α-2b in recovery
process samples several different techniques were tested for potential to quantify total interferon.
These techniques are: Western Blot, Biacore and BLItz and their results are discussed in this sec-
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Tab. 5.3: Summarising total protein loss and total interferon loss throughout the entire recovery process
critical process total protein total IFN
step (CPS) loss [%] loss [%]
CPS-1 (Cycle-1) 80.0% 60.0%
CPS-2 (Cycle-2) 40.0% 30.0%
overall loss in PRP 90.0% 80.0%
tion.
The first method used for a more specific quantification of interferon-α-2b in recovery process
samples is the Western Blot. The Western Blot separates the protein mixture by size, followed by
a protein-specific quantification using an antibody specific for interferon-α-2b (compare section
5.1.2).
All Western Blot quantifications were performed as described in section 5.2.5. Figure 5.8 shows
the linear relationship between interferon-α-2b and the densitometric area of the fluorescence sig-
nal analysed using Western Blot between 0.5 and 4.0µg interferon.
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Fig. 5.8: Linear regression of total interferon-α-2b reference standards analysed with Western Blot
Figure 5.8 shows a linear relationship between interferon and fluorescence intensity with a R2-
value of 0.9849. The slope of the linear regression is 6.195 [K-count/µg], which can be used to
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determine interferon in process samples over the measured fluorescence intensity. Results also
indicate an increase in the variation of the interferon quantification for higher protein amounts.
Hence, this quantification method is more precise for IFN below 2.0µg which corresponds to an
IFN concentration of 0.2mg/ml. If required, process samples should be diluted to a final interferon
concentration below 0.2mg/ml with DI-water.
Observations throughout the method development showed that the measured fluorescence intensi-
ties are highly dependent on the incubation time of the IFN-antibody and on the protein transfer
from gel to membrane. Hence, it is important to run 3 to 4 IFN reference standards with each
membrane and perform a new linear regression for each run to quantify IFN in process samples
more accurately.
Overall, this Western Blot can be used to quantify total interferon-α-2b in process samples, how-
ever, the method is not very accurate. It shows high variations with errors of up to 15%, espe-
cially at higher interferon concentrations (>2µg). Consequently, 5 samples of the recovery pro-
cess batch 2-AVAF-206 were analysed for their total amount of interferon-α-2b with this Western
Blot method. Each sample was run in quadruplicates on the same membrane with 4 IFN reference
standards that were used for the IFN quantification.
Figure 5.9 shows the results of total interferon-α-2b for the 5 five samples of the recovery process
batch 2-AVAF-206 quantified by Western Blot and by SDS-PAGE.
The interferon-α-2b results quantified with the Western Blot show significantly lower values of
IFN compared with the SDS-PAGE method throughout the recovery process. In the end of fer-
mentation sample 3’200g of total interferon-α-2b were quantified, which is reduced throughout
the primary recovery to yield 800g of interferon. The majority of this loss occurs during cycle-1
(between S-7 and S-8), where 65% of the initial IFN is lost. This process step was identified as
critical process step 1 from previous results for total protein and total interferon. Between S-11
and the final TCA-pellet (S-15), an additional 30% loss in interferon-α-2b was detected with the
Western Blot results, which is the critical process step 2. Overall, a 75% loss in interferon-α-2b
was detected with the Western Blot results throughout the primary protein recovery process.
These findings are consistent with the SDS-PAGE results for interferon-α-2b. However, compar-
ing the interferon results quantified with SDS-PAGE with the results quantified with Western Blot
(figure 5.9), it can be seen that the SDS-PAGE overestimates the amount of interferon in recovery
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Fig. 5.9: Total interferon-α-2b quantified with Western Blot and SDS-PAGE in recovery process samples
of batch 2-AVAF-206
process samples. The SDS-PAGE consistently quantifies twice as much interferon-α-2b compared
to the Western Blot. These findings were not unexpected, since SDS-PAGE only distinguishes
proteins by size such that host cell proteins with a similar molecular weight than interferon would
falsify the SDS-PAGE results. The Western Blot results should only detect the interferon which
interact with the specific antibody for interferon-α-2b. Accordingly, these results should be more
precise and should give more reliable information about the actual quantity of interferon-α-2b in
recovery process samples. However, it is not clear if all isoforms of interferon-α-2b bind to the
specific antibody. If some isoforms do not bind to the antibody for interferon-α-2b, Western Blot
results would underestimate the total interferon amount in recovery process samples.
In summary it was seen, that the SDS-PAGE results did overestimate the amount of interferon-α-
2b in recovery process samples. Western Blot results for interferon were generally only half the
amount of the SDS-PAGE quantities. However, the percentage reduction of interferon throughout
the recovery process remained the same. During the critical process step 1 in cycle 1, over 65%
of the initial interferon-α-2b is lost and an overall loss of 75% in interferon-α-2b was detected
throughout the whole protein recovery process.
Besides Western Blot, two other techniques were tested for their potential to quantify total interferon-
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α-2b in recovery process samples. These techniques are the Biacore and the BLItz system. Both
techniques are based on the interaction of a specific interferon antibody to interferon-α-2b. The
IgG-antibody itself is immobilized on the chip or sensor surface where it interacts with Protein
A or an anti-mouse Fc-capture-ligand (compare section 5.1.3). Experiments with the Biacore and
BLItz system were carried out as described in section 5.2.6 with the interferon-α-2b drug sub-
stance as the reference standard.
During the method development for both techniques, Biacore and BLItz, an unstable baseline of
the antibody - interferon complex was observed. This indicates that the affinity between the an-
tibody and interferon-α-2b is not sufficient and the binding-interaction is very weak. Due to this
observation four different commercialised antibodies for interferon-α-2b from different suppliers
were tested (Santa-Cruz, Sigma and Abcam). The antibody, which showed the highest binding
affinity towards the interferon-α-2b drug substance was used for further experiments (interferon-
α-2 antibody [4E10] from Abcam).
Another observation made during the method development is the poor resolution of both methods.
Both methods quantify the proteins over a shift in the refractive index (Biacore) or wavelength
(BLItz) due to the binding of molecules on the chip/ sensor surface. The immobilization of the
specific IgG-antibody results in a significant shift in the refractive index or wavelength of the Bi-
acore/ BLItz system, due the molecular weight of the IgG-AB of ≈150kDa. Unfortunately the
binding of interferon-α-2b, which is only 19kDa, does not result in a significant shift in the refrac-
tive index/ wavelength, especially at lower IFN concentrations. Hence, the limit of detection for
the Biacore is 0.3g/l which is higher than the average concentration of interferon-α-2b in recovery
process samples. The BLItz system showed a limit of detection of 0.08g/l but the upper limit of
detection was identified at 0.1g/l due to saturation of the sensor surface. This results in only a
small detection range, which makes it challenging for protein quantification of process samples.
Due to the two observations made during method development, no increase in accuracy and res-
olution for total interferon-α-2b quantification in recovery process samples was expected with
the Biacore or BLItz system compared to the existing results with SDS-PAGE and Western Blot.
Hence, no further analysis was carried out with the Biacore and neither the BLItz system.
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5.4 Conclusion
This chapter studied the characteristics of total interferon-α-2b throughout the primary recovery
process. An overall loss of up to 80% was detected, which is 10% less than detected for total
protein (see chapter 4). Two main critical process steps (CPS) were identified throughout the
process which confirm the findings of total protein mass balances. CPS-1 is between cycle 1 and
2 due to insufficient protein resuspension. Critical process step 2 is between cycle 2 and 3 where
salting-out of protein occurs not only in host cell proteins but also in interferon-α-2b. Since total
protein and total interferon-α-2b show very similar characteristics throughout the entire primary
recovery process, it can be concluded that the process is not protein specific.
Since the method used for interferon quantification is known not to be very accurate for specific
protein quantification, some samples of the recovery process were quantified with an alternative
method, the Western Blot. Results showed that the SDS-PAGE method indeed overestimated
the IFN amounts in recovery process samples of about 50%. However, the characteristics of
interferon-α-2b throughout the recovery process were similar to the findings with SDS-PAGE.
The overall loss in interferon quantified with the Western Blot method was 75% with the majority
loss occurring during cycle 1, which was identified as critical process step 1.
The SDS-PAGE and Western Blot methods only quantify the total interferon-α-2b amounts but do
not distinguish between the different isoforms of interferon that are present in recovery process
samples. Hence, in a next step the characteristics of the four different IFN isoforms throughout
the protein recovery process need to be investigated. These results can be found in the following
chapter 6.
Beside the characteristics of the IFN isoforms, a next step is the optimization of identified critical
process steps of the primary protein recovery process. Since CPS-1 was shown to have a bigger
impact on the overall loss of interferon, this steps needs to be investigated and optimized first. The
main problem in cycle 1 in an insufficient resuspension of interferon in water. Hence, a solubility
study should be performed to ascertain the potential to increase interferon solubility during this
cycle. The results of the solubility study and other optimization steps of the protein recovery
process can be found in chapters 7 and 8.
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Chapter 6
Process Characterization -
Interferon-Isoform Mass Balances
6.1 Introduction
This chapter focuses on the characterization of the primary protein recovery process of interferon-
α-2b looking at the different interferon isoforms present. Mass balances throughout the entire
recovery process need to be set up to investigate critical process steps for different interferon iso-
forms, as well as transformations from one isoform to the other.
The first part of this chapter focuses on the development and optimization of quantification meth-
ods to distinguish between the different interferon isoforms. Quantification of low protein con-
centrations in the presence of host cell proteins can be challenging and often requires purification
and concentration steps prior to the analysis. Hence, the second part of this chapter focuses on the
development of a purification and concentrating step for interferon isoforms in recovery process
samples prior to the protein quantification. The last part discusses the obtained characteristics of
interferon isoforms throughout the primary protein recovery process.
6.1.1 Interferon-α-2b and its isoforms
As mentioned in chapter 2, during the E.coli fermentation at manufacturing scale, not only the
active drug substance interferon-α-2b is produced, but also 4 different isoforms. These isoforms
CHAPTER 6. PROCESS CHARACTERIZATION - INTERFERON-ISOFORM MASS
BALANCES
are called Iso-2, Iso-3, Iso-4-P and Iso-4-R. Isoform 4 can be divided into Iso-4-R and Iso-4-P with
Iso-4-P as the pyruvated form of isoform 4 and Iso-4-R as the non-pyruvated form. The chemical
structure of isoforms 2, 3 and 4 can be seen in figure 6.1.
Fig. 6.1: Interferon-α-2b and three of its four Isoforms [6]
The differences between the isoforms and the active drug substance are in their number of disul-
phide bonds and post-translational modifications (PTM) in the characteristic groups. The PTMs
for Iso-2 are an acetylation and oxidation at the N-terminal of Cys1, for Iso-3 and Iso-4 the disul-
phide bridge between Cys29 and Cys138 is partial reduced and the disulphide bridge between Cys1
and Cys98 is fully reduced. The N-terminal of Cys1 is bonded to a pyruvic acid. Iso-3 also has a
Glutathione attached at Cys98.
Due to previous studies it is known that during the fermentation the isoforms are produced rather
than the active drug substance. Isoforms such as Iso-4 can be transformed into the active drug
substance at a later stage of the down-stream process. This conversion can be seen in figure 6.2.
Therefore it is of high interest to follow the isoform distribution throughout the production and
recovery process prior to down-stream processing.
This chapter focuses on the characteristics of the different interferon isoforms throughout the
primary protein recovery process. Mass balances on each isoform should be set-up throughout the
recovery process to identify transformations of one isoform to the other or increased protein loss
of one particular isoform at different steps of the process.
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Fig. 6.2: Conversion of Iso-4-P and Iso-4-R into the active drug substance interferon-α-2b [6]
6.1.2 Reverse phase high pressure liquid chromatography
High performance liquid chromatography, or HPLC, is an analytical technique widely used in
chemistry, biology and numerous other research fields. It is a major tool for analyses of biomolecules
and it can be used for a wide range of protein types and sizes [66]. Its principle lies in liquid solid
interactions where the molecules of interest interact with the solvent and the solid phase of a co-
lumn. Depending on the affinity of the molecules towards the mobile phase or the column, the
compound will pass through the column slower or faster. In the end, separated compounds reach
the end of the column where they are detected at different time points [66][67].
A wide variety of columns exists to exploit different physical and chemical properties. The most
popular one for protein separation and quantification is reverse phase HPLC (RP-HPLC). This
technique separates molecules by polarity using a stationary phase covered with hydrocarbon
chains (typically C-8 or C-18) [68]. Affinity with the mobile phase is set using a mix between
water and on organic solvent (typically methanol or acetonitrile). Compounds are thus separated
according to their hydrophobicity [69]. Reverse phase HPLC is also known to distinguish between
closely related molecules with similar chemical structures as protein isoforms [70].
The resolution, sensitivity and reproducibility of a reverse phase HPLC run is dependent on se-
veral different factors, such as mobile phase, flow rate, column temperature, injection volume and
protein load [70].
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The mobile phase is composed of water and organic solvents. During isocratic elution mode, the
composition of the mobile phase is constant. An alternative is gradient elution with varying mo-
bile phase composition throughout the elution. Ion pairing agents such as TFA (trifluoroacetic
acid) are commonly added to the mobile phase in order to improve the separation and to buffer the
mobile phase [71].
The flow rate is defined as the linear velocity of the mobile phase through the column. The increase
of flow rate is limited by the maximal pressure capacity supported by the column. An increase in
the flow rate has a significant impact on the retention time of an analyte, since it increases the
dynamics and kinetics of the interaction between the analytes and the mobile phase [72].
Column temperature modifies the chemical kinetics, therefore affects sample affinity to the col-
umn and to the mobile phase [73]. An increase in the column temperature also decreases the
mobile phase viscosity and therefore facilitates the movement of samples through the column.
High column temperature can also cause protein denaturation, modification or degradation and
thus modifies its behaviour in the column [70].
The injection volume and the protein load determine the actual protein amount injected onto the
column for analysis. If the column load exceeds the limits of the dynamic capacity of the column,
this leads to local saturation of the column. Hence, the protein load and injection volume need to
be adjusted to each other to avoid overloading of the column [67].
6.1.3 Design of Experiments - MODDE software
With the still increasing effort but the limiting factor of time and supplies, it is getting more impor-
tant to have an established plan and a structured analysis of different experiments. It is important
to receive the maximum information out of the experiments about a system with a minimal labour
input. In this case it is helpful to use the Design of Experiment (DoE). One example is the op-
timization of analytical methods such as HPLC methods, where several different factors have to
be considered on the same time. The Design of Experiments is used to plan the amount of ex-
periments and to analyse them afterwards in an appropriate way. Depending on the amount of
input variables (factors) and the amount of different levels of the input variables the DoE arranges
different experimental designs. The goal of the DoE is to determine the significant input variables
and their interactions and to describe the process output with a mathematical equation depending
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on the significant input variables. With the received information out of the DoE-analysis the de-
pendency of the inputs and outputs are statistically evaluated and the effect of the input variables
and their interactions to the output are quantifiable.
6.1.3.1 Different experimental designs
The basic design of experiments is simple and straightforward in that the effects of multiple input
factors are varied and investigated in relation to response variables. The basic designs are called
full factorial designs. A full design applies a lot of experiments in order to cover every possibility.
To reduce the number of experiments a fractional factorial design can be performed first, which
provides sufficient information about which factor is significant or insignificant. In order to use
design of experiments as an optimization tool, more information about the different interactions
between the input variables and the output are required. In this case a central composite factorial
design (CCF-design) can be used. For this design different experiments will be added at a third
level (the center level). Figure 6.3 shows an example of a face centred central composite factorial
design of three factors [7].
Fig. 6.3: A central composite factorial design for three factors [7]
Depending on the amount of input variables and their interactions to the output the Design of
Experiment supports to plan the experiments and to analyse the results in an appropriate way to
receive as many information as possible.
6.1.3.2 Linear regression models
The concept of linear regression or regression analysis deals with finding the best possible re-
lationship between a response and the independent variables of a system. This type of analysis
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also aims to determine the strength of this relationship and allows for greater predictions of re-
sponses. Simple linear regression predicts the best fitting line between response data and a single
independent variable [74]. The use of more than one independent variable is called multiple linear
regression, however, this section will focus on simple linear regression.
In the age of powerful computing a regression line between data points is usually done using a
software. Simple linear regression is a method of determining the best possible fit of the data in
relation to the desired response [75].
Evaluation of the model quality can be made using several factors. R2, Q2, model validity and
reproducibility are given by the ’summary of fit’. These values can determine if the model is valid
and can also explain some variations between the different models and the actual defined working
parameters after optimization.
R2 and Q2
R2, the least square coefficient, is one of the most common ways to evaluate a model. It is the
fraction of the variations of actual values from predicted values.
It is given by:
R2 = SS−SSeSS (6.1)
With:
SS =
∑
i Y
2
i or the sum of the square of the values for the model
(sum of squares).
SSe =
∑
i
(
Yi − Yˆi
)2
or the sum of the square of the difference between real
and predicted values (sum of squares of residuals).
Thus, R2 corresponds to the difference between the values given for the creation of the model and
the model itself. A perfect model gives no difference between predicted and actual values, thus
SSe = 0, and R2 = 1 [74].
Q2, or cross-validation, defines the prediction ability of a model. It is a fraction of an actual value
of the prediction value, but the value itself is not part of the values used to create the model [75].
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It is given by:
Q2 = SS−PRESSSS (6.2)
with PRESS as the prediction residual sum of squares. As for R2, it is a value ≤1, with 1 as the
best value [76].
Comparison of these coefficients gives an excellent indication on the quality of a model. Since R2
usually overestimates the fitting, and is well complemented with Q2. Thus, a good model implies
close R2 and Q2, with a generally admitted difference of less than 0.2-0.3 [76].
Model validity
This value based on the F-test of MSmodel error/MSpure error indicates the validity of the model,
if the model error is in the same range as the variations of the values [76]. A value over 0.25
indicates no lack of fit. It needs replicates to be calculated, and in the case where replicates are not
in a sufficient number and/or show a lot of variation, this value can be less considered than R2 and
Q2 [75]. It can be noticed that the F-test, which is based on the model validity, is dependent on the
degrees of freedom (DF), itself related to the number of runs and replicates. It is also related to the
number of independent variables of the model: for instance, 2 parameters A and B in a quadratic
model, lead to the independent variables A, B, AB, A2 and B2. However, during the creation of
the model, some of these variables are not significant and are excluded. Although this can improve
the quality of the model, this costs degrees of freedom (DF) [74]. Negative values can appear with
an insufficient number of runs, replicates and/or degrees of freedom. These can also appear if the
replicates are too close to each other. Indeed, this causes a lack of fit of 0, and is reflected in the
model validity calculation by a negative value.
Reproducibility
Reproducibility is given by:
reproducibility = 1− MSpure errorMStotal corrected (6.3)
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With: MS = 1N
∑
i
(
Yˆ − Y
)2
, the mean square [74]. This value assesses the variation of points at
the same conditions, replicates or center points, compared to the general variation of the model. A
value below 0.5 indicates the pure error is important and the control on the procedure is poor [76].
6.1.3.3 ANOVA, F-Test and Lack of Fit
Analysis of variance (ANOVA) is a statistical technique used to examine and model the relation-
ship between a response variable and one or more independent variables. ANOVA can also be
used to compare two alternative models (one of which may have been refined) to evaluate the per-
formance [76]. One way to calculate the analysis of variances is the F-test.
The F-test compares the model variance with the residual variance and calculates if the model-
coefficients are adequate and significant. If the variances are similar (close to one) it is less likely
that any of the variables have a significant effect on the response [75].
Usually the calculated F-value will be compared with a theoretical value of the F-distribution
which is listed in statistic tables. To avoid this step, there is the possibility to calculate a p-value.
This p-value calculates the proportion of the area under the curve of the F-distribution that lies
beyond the observed F-value. The p-value has to be smaller than 0.05 (with a 95% confidence
interval) to assure the model-coefficients have a significant effect on the response and the model
or the coefficient is significant. If the model is not significant there is the possibility to perform
some replication measurements to improve the model. If any model-coefficients are not significant
these variables can be removed from the model [74].
The next important statistic parameter is the Lack of Fit (LOF). The LOF is the variation of the data
around the fitted model. Meaning the variation of the replicates about their mean values should be
less than the variation of the design points about their predicted values. If this statement applies
the LOF is greater than 5.0 % and the Lack of Fit is not significant. A significant Lack of Fit does
not mean that the whole model does not fit well to the model. It is always important to check
the experimental conditions. Were the replicates performed independently? If they were just re-
peated measurements it is likely that the error has been underestimated and the LOF is artificially
small. In this case the LOF is no longer a valid test. It is also important to look at the Degrees of
Freedoms which are left over to calculate the LOF. As more leftover degrees of freedom exist to
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calculate the Lack of Fit as more precise will be the result of the LOF. There are so many Degrees
of Freedom as experiments were performed. The calculation of every model-coefficient needs one
DF and two for the calculation of the total error [75][74].
For this work all design and experiments and statistical analysis were carried with the support of
the software MODDE 10.0 from Umetrics.
6.1.4 Purification and concentrating techniques for protein mixtures
Production of recombinant proteins with bacterial cells result in the presence of a large fraction
of host cell proteins at the end of the fermentation and the beginning of the down-stream process.
This can lead to a decrease of the detection sensitivity of the analytical method. Furthermore the
concentration of recombinant proteins are very low at this stage of the process and are often at
the limit of quantification. For that reason certain purification and concentrating techniques for
protein mixtures are available in order to separate the recombinant protein from host cell proteins
to increase the sensitivity level of the analytical methods.
The following sections describe some potential purification and concentrating techniques for the
separation of the recombinant protein from host cell proteins.
6.1.4.1 Ion-exchange chromatography
Ion-exchange chromatography, or IEC, is a type of separation based on the charges of a molecule.
In other terms, the separation occurs thanks to the electrostatic interactions between a charged
molecule and an immobilized material of the opposite charge, the ion-exchanger [77]. A cation-
exchanger binds positively charged molecules and an anion-exchanger binds negatively charged
molecules [78]. For protein separation using IEC, pH is extremely important. Depending on the
pH of its environment and its pI, a protein will have a positive or negative net charge. At a specific
pH, name the isoelectric point (pI), the net charge is zero, meaning that all positive charges of
the various amino acids compensate the negative charges [79]. This point is very important when
working with proteins (or any other zwitterions). The pI generally corresponds to the minimum of
solubility of zwitterions, and precipitation often occurs at this pH. Moreover, if the pH is below the
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pI net charge of the molecule is positive, and negative if the pH is above the pI. With knowledge
of this point, it is possible to estimate if a molecule carries a positive or a negative net charge at a
given pH [78].
The conductivity of the medium, closely related to the salt concentration, also plays an important
role in ion-exchange chromatography. The strength of the binding of the surface will depend on
the charges present. A high conductivity implies that more charges of the surface of the exchanger
are involved with ions in the medium. It is then generally advised to have low conductivity in the
medium in order to improve the binding of the analytes on the column [80].
The isoelectric point of interferon-α-2b is at 6.2, thus depending on the sample pH its net charge
can be positive or negative. For this reason different resins were tested for their potential to bind
interferon-α-2b, which are described in the following sections.
SP Sepharose
SP Sepharose is a strong cation-exchange resin on highly cross-linked 34µm agarose beads, which
allows high resolution and high-capacity separations of protein mixtures. This resin is available
in prepacked columns, such as HiPrepTM and HiTrapTM columns (GE Healthcare, Bucking-
hamshire, UK), and laboratory packs up to 10.0l. The resin matrix is composed of 6% spherical,
cross-linked agarose with sulphopropyl (SP) as the functional groups. It has a binding capacity of
55mg ribonuclease A/ml medium, which results in a total binding capacity of 275mg ribonuclease
A for 5ml columns [81].
Dowex
Dowex ion exchange resin, produced by Dow water Solutions, are a leader in separation tech-
nologies. It was the first manufacture for ion-exchange resins in 1983 and is still today one of
the most common resin producer in the world [82]. Dow offers a wide range of different resins
for chemical and pharmaceutical column separations from weak anion-exchanger to strong cation-
exchanger [83].
Dowex R© 1x4 chloride form (20-50 mesh) is a strong anion-exchanger, which is composed of
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styrene divinylbenzene and a particle size of 20 - 50 mesh. Its binding capacity is roughly 35mg
protein/ml and it meets the FDA food additive regulations. The Dowex R© 50Wx4 hydrogen form
(50-100 mesh) is a strong cation-exchanger with sulfonic acid as the active group and a particle
size of 50 - 100 mesh. Its binding capacity is roughly 20mg protein/ml and it meets the FDA food
additive regulations [83].
6.1.4.2 Hydroxyapatite
Mixed-mode chromatography combines at least two modes of interactions simultaneously. The
use of multiple mechanisms of interactions on one stationary phase allows a much wider range of
application. Mixed-mode chromatography has its benefits in analysing complex mixtures of pro-
teins due to the 2D selectivity on a single run [84]. One example for mixed-mode chromatography
is the application of hydroxyapatite resin.
Hydroxyapatite resin is considered to be a ’pseudo-affinity’ chromatography or ’mixed-mode’ ion-
exchange. The functional groups consists of positively charged pairs of calcium ions and clusters
of six negatively charged oxygen atoms associated with phosphates. Hence, it is a combination
of cation-exchanger and metal affinity chromatography. Protein amino groups interact with the
negatively charged phosphates and get repelled by positively charged calcium groups. Both inter-
actions affect the protein binding and can be disrupted by the addition of salt or increasing pH. The
carboxyl clusters and/ or phosphoryl groups on proteins interact with the hydroxyapatite through
calcium affinity which is 15 to 60 times stronger than the ionic interaction alone. This metal affin-
ity is not affected by ionic strength. However, it can be dissociated by the addition of phosphate
[85].
The hydroxyapatite resin used for the experiments included in this study has a binding capacity of
25mg lysine/g CHT and a nominal pore size of 600-800 A˚ [86].
6.1.4.3 Ultrafiltration spin tubes
Another technique used for protein purification and concentration is ultrafiltration. Process sam-
ples from fermentation broth or the primary protein recovery often require sample purification
prior to protein quantification due to the presence of large numbers of impurities [87]. Ultrafil-
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tration techniques are successfully applied in large-scale processes as well as in laboratories for
protein purification. Especially the purification of low concentrated proteins in protein mixtures is
challenging with chromatographic techniques, and ultrafiltration is certainly beneficial. The im-
pact of pH and salt concentrations on the purification of proteins with ultrafiltration was studied
by Ehsani et al. 1996 [88]. Salt concentration and pH showed an impact on the hydrodynamic
radius of the proteins and thus interfere with the purification by size.
Ultrafiltration at laboratory scale is performed with ultrafiltration spin tubes, which can be used
for purification and concentration. The separation technique is controlled by the selection of the
membrane and its pore size. A membrane pore size that retains the product while passing low
molecular weight contaminants result in a concentration step, whereas membrane pore size that
passes the product but retains any larger molecular weight contaminants results in a purifying step.
The molecular weight cut-off of the membrane in protein purification should be three to six times
smaller or larger than the molecular weight of the product [89].
Besides the pore size of the membrane, the membrane material is another important factor which
needs to be considered during ultrafiltration. Different membrane materials, such as polyethersul-
fone, nylon or polypropylene, have different key characteristics, for example: low DNA or protein
binding, antifoam resistance or specific chemical and physical properties. For the separation of
protein mixtures in the fermentation broth a membrane with low protein binding and high flow
rates and throughputs is beneficial. Hence, a hydrophilic polyethersolfone membrane is com-
monly used to separate such process samples [89].
A disadvantage of the purification of protein mixtures using ultrafiltration is the risk of membrane
fouling by larger proteins than the protein to purify or by protein adsorption to the membrane [89].
In this case protein recovery is reduced due to the fouling of the membrane pores by larger pro-
teins. Size exclusion chromatography can be an alternative method for the separation of protein
mixtures and is described in the following section.
6.1.4.4 Size exclusion chromatography
Size exclusion chromatography (SEC), or gel filtration, separates a mixture of molecules by their
molecular weight and the shape of the molecules. Molecules diffuse through the SEC matrix,
which consists of a range of beads with slightly different pore sizes. The separation of the protein
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mixture depends on the ability of different proteins to enter all or some of the channels inside the
beads. Hence, smaller proteins have more potential channels to access and diffuse slower through
the column, whereas larger proteins are excluded from the channels and pass quickly through the
column [90]. In ’ideal’ size exclusion chromatography, the separation of the protein mixtures is
only dependent on the hydrodynamic volume of the protein, which is dependent on the molecular
weight and the shape of the protein. Unfortunately, ’ideal’ SEC is only achieved when the station-
ary phase of the column is neutral and the protein polarity similar to the mobile phase [91].
Previous studies showed that a decrease in the pH of the mobile phase results in an increase in the
retention volume of the target protein, whereas a decrease in the ionic strength of the mobile phase
results in a decrease of the retention volume. Several different reasons have been suggested for
this observation, which are changes in the protein conformation, alteration of the pore size of the
resin, protein adsorption or protein exclusion due to intermolecular electrostatic interactions [92].
In order to run the size-exclusion chromatography under ’ideal’ conditions the mobile phase
should be at neutral pH and contain an ionic strength of 0.15M salt to avoid pH dependent non-
ionic interactions with the stationary phase.
6.1.4.5 Controlled protein precipitation
Precipitation methods are cheap and simple methods that are commonly used in purification pro-
cesses. They are generally easily scalable and comprise a variety of techniques that can suit
depending on the protein, media and conditions involved. The general idea of protein precipita-
tion consists in the aggregation of proteins into clusters that can be separated from the rest of the
solution by centrifugation. Proteins can then be resuspended into smaller volumes. This can be
for instance a common and easy way to separate proteins from their media after production [93].
As already explained in section 4.1.4 proteins are soluble in water because of their electrostatic
interactions with water. Since the electrostatic interaction of a protein is dependent on the pH, its
solubility is therefore also dependent on the pH. This explains also why their lowest solubility oc-
curs when the pH equals the pI, where their net charge is 0 and therefore their activity with water
is the weakest. Studying the influence of pH will be therefore a major point of all investigations
[94].
One typical method is called ’salting-out’, which acts on the free water of the solution. It is one of
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most commonly used methods, especially in early stages of purification processes [93]. In order
to be soluble in water, a molecule has to be in electrostatic interaction with a certain number of
water molecules. If salt is added, it will interact with water molecules. If enough salt is added,
water molecules will no longer interact with the protein but with the salt with which it has a higher
affinity. Eventually, free water molecules will not be in sufficient number to keep the protein in
solution, in other terms, protein will precipitate [95]. Detailed information about the salting out of
proteins can be find in section 4.1.4.
Precipitation with water-miscible organic solvents, like ethanol, or for this work acetone, is another
commonly used protein precipitation technique. These solvents will interact with water molecules,
which will group themselves around solvent molecules. This results in a decrease of water activity.
Non-polar proteins can become more soluble, where water-soluble proteins solubility decreases.
They tend then to aggregate together due to an energetically more favourable situation. In other
terms, they will precipitate [96].
6.1.5 Goals and Aims
The overall goal of this chapter is the set-up of mass balances of each interferon isoform through-
out the entire primary protein recovery process. In order to achieve this aim, an analytical method
for interferon isoform quantification needs to be developed.
Existing quantification methods for interferon isoforms will be optimized for their resolution and
sensitivity followed by the development of a purification and concentrating step of the recovery
process samples prior to interferon isoform quantification. Hence, the three main goals for this
chapter are as follow:
• Optimization of RP-HPLC methods for interferon isoform quantification
• Development of purification and concentration methods prior to isoform quantification
• Set up of mass balances of interferon isoforms through the primary protein recovery process
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6.2 Material and Methods
Tab. 6.1: Materials and suppliers
materials supplier
Recovery Process samples industrial partner
interferon-α-2b drug substance industrial partner
interferon-isoforms reference standard industrial partner
Sodium phosphate monobasic Merck
Sodium phosphate dibasic Merck
Sodium chloride Merck
YMC ODS-A 5t¸m 4.6x100mm Column 300A˚ Waters
Zorbax 300SB C18 rapid res HPLC column Agilent
Aeris WIDEPORE 3.6u XB-C18 New column 150 x 4.6mm Phenomenex
Acetonitrile Fisher Scientific
Trifluoroacteic acid (TFA) Fisher Scientific
Ultrafiltration spin tubes Sartorius
Zwittergent 3-14 Sigma Aldrich
Sarkosyl (30%) Sigma Aldrich
Dowex R© 1x4 chloride form (20-50 mesh) Sigma Aldrich
Dowex R© 50Wx4 hydrogen form (50-100 mesh) Sigma Aldrich
hydroxyapatite with < 200 nm particle size (measured by BET) Sigma Aldrich
Acetone Sigma Aldrich
Ammonium sulphate Sigma Aldrich
Trizma Base Sigma Aldrich
EDTA tetrasodium salt VWR
HiPrep 16/60 Sephacryl S-100 HR column GE Healthcare
Bradford Reagent Sigma Aldrich
Pierce R© BCA Protein Assay Kit Thermo Scientific
Bovine serum albumin (BSA) Sigma Aldrich
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6.2.1 Interferon-α-2b Isoform detection with RP-HPLC
Interferon-α-2b and its isoforms are quantified by three different RP-HPLC methods. All three
methods have a reversed phase C-18 column but differ in the pore size and technology. The
columns are used on an Agilent HPLC system 1100 with UV detector (Agilent, Cork, Ireland).
Two of the three methods, Bakerbond and Zorbax, originate from the industrial partner and the
existing SOPs were transferred to the lab in DCU.
For all methods, the drug substance of interferon-α-2b, provided by the industrial partner was
used as the reference standard for all quantifications. In order to examine the retention times for
the different isoforms, the DEAE feed-sample provided by the industrial partner was used, which
derives from the industrial downstream process for interferon-α-2b production.
All samples and standards were diluted, if required, with a phosphate buffer (0.02M phosphate
buffer, 0.22M NaCl, pH 8.0) to the appropriate concentration and filtered through a 0.45µm PVDF
filter (Millipore, Billerica, USA).
6.2.1.1 RP-HPLC with Bakerbond column
The Bakerbond method uses a C-18 column, 5µm particles, 300 A˚ pore size and 4.6 x 100mm
column size (Waters, Massachusetts, USA). Two different mobile phases were used: mobile phase
A with 0.1% (v/v) trifluoroacteic acid (TFA) aqueous solution filtered through Whatman 0.45µm
cellulose nitrate membrane filter (Whatman/GE Healthcare, Buckinghamshire, UK) and mobile
phase B with acetonitrile / 1.0% aqueous TFA (90:10, v/v) filtered through Millipore 0.45µm
Durapore membrane filter (Millipore, Billerica, USA). The gradient method started at 53% mobile
phase A to 47% mobile phase B and ran over 52 minutes with an increase in mobile phase B. Flow
rate was constant at 3.2ml/min and column temperature was controlled at 35◦C. Standard injection
volume was 20µl with interferon-α-2b concentrations of 0.05 - 4.0mg/ml.
6.2.1.2 RP-HPLC with Zorbax column
The Zorbax method uses a C-18 column, 3.5µm particles, 80 A˚ pore size and 4.6 x 150mm col-
umn size (Agilent, Cork, Ireland). Two different mobile phases were used: mobile phase A with
0.2% (v/v) trifluoroacteic acid (TFA) aqueous solution filtered through Whatman 0.45µm cellu-
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lose nitrate membrane filter (Whatman/GE Healthcare, Buckinghamshire, UK) and mobile phase
B with acetonitrile / 2.0% aqueous TFA (90:10, v/v) filtered through Millipore 0.45µm Durapore
membrane filter (Millipore, Billerica, USA). The gradient method started at 50.5% mobile phase
A to 49.5% mobile phase B and ran over 72 minutes with an increase in mobile phase B. Flow
rate was constant at 1.0ml/min and column temperature was controlled at 35◦C. Standard injection
volume was 20µl with interferon-α-2b concentrations of 0.05 - 4.0mg/ml.
6.2.1.3 RP-HPLC with Aeris column
The Aeris method, developed in the lab at DCU, uses a C-18 Aeris widepore core-shell col-
umn, 3.6µm particles, 100 A˚ pore size and 4.6 x 150mm column size (Phenomenex, Cheshire,
UK). Two different mobile phases were used: mobile phase A with 0.1% (v/v) trifluoroacteic
acid (TFA) aqueous solution filtered through Whatman 0.45µm cellulose nitrate membrane filter
(Whatman/GE Healthcare, Buckinghamshire, UK) and mobile phase B with acetonitrile / 1.0%
aqueous TFA (90:10, v/v) filtered through Millipore 0.45µm Durapore membrane filter (Millipore,
Billerica, USA). The gradient method started at 53% mobile phase A to 47% mobile phase B and
ran over 35 minutes with an increase in mobile phase B. Flow rate was constant at 1.0ml/min and
column temperature was controlled at 45◦C. Standard injection volume was 20µl with interferon-
α-2b concentrations of 0.05 - 4.0mg/ml.
6.2.2 Design of Experiment study
For the optimization of RP-HPLC methods, design of experiment (DoE) was used. Four factors,
column temperature, flow rate, injection volume and interferon load, were analysed for two res-
ponses, peak width and retention time. A CCF design was used at two levels and 3 center points
giving 27 experiments per method. The full list of experiments and factor levels can be found in
the appendix A.
For the design and statistical analysis the software MODDE 10.0 from Umetrics was used.
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6.2.3 Purification and Concentration of Interferon-α-2b
6.2.3.1 Ultrafiltration spin tubes
Ultrafiltration spin tubes (Sartorius, Goettingen, Germany) were used for concentrating or purify-
ing samples, dependent on the molecular weight cut-off of the polyethersulfone membrane (PES).
A molecular weight cut-off (MWCO) of 5kDa was used for concentrating samples, whereas 50kDa
and 100kDa cut-offs were used for sample purification.
The upper chamber of the spin tube was filled with 5mL of the process sample, in the presence or
absence of a detergent (1.0% Zwittergent 3-14 or 3.0% Sarkosyl).
For concentrating samples, tubes were centrifuged at 7500rpm at room temperature for 30 min-
utes, until approximately 1.0ml was left in the upper chamber. The recovered volume of process
samples in the upper and lower chamber were recorded and a sample taken from both compart-
ments and stored at 4◦C for further analysis. The aim of this concentrating step was to recover all
proteins in the upper chamber at a higher concentration than the untreated samples. No proteins
were expected to be found in the lower chamber.
For purification of process samples, tubes were centrifuged at 7000rpm (7122g) at room tempera-
ture for 40 minutes, until three quarters of the volume had passed through the membrane into the
lower chamber. The volume of recovered process sample in the upper and lower chambers were
recorded and samples from both chambers were taken for mass balances and stored at 4◦C for fur-
ther analysis. The aim of the purification step was to recover all interferon in the lower chamber,
whereas the larger host cell proteins should remain in the upper chamber.
6.2.3.2 Ion-exchange methods
Four different ion-exchange materials were tested to purify recovery process samples. The first
one, using Sepharoses derived from the industrial partner. The other three with Dowex and hy-
droxyapatite were developed as part of this work.
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SP Sepharose in HiTrap column
The purification method for recovery process samples is the same method used during the indus-
trial downstream processing and more detailed information on sample preparations and the method
can be found in chapter 10 section 10.2.2.
This purification was carried out with 5ml HiTrap SP HP columns (GE Healthcare, Bucking-
hamshire, UK) controlled on an AKTA Explorer (GE Healthcare, Buckinghamshire, UK). All
samples taken throughout the method are stored at 4◦C for further analysis.
Dowex and Hydroxyapatite
To perform ion-exchange chromatography in order to separate interferon from host cell proteins,
the chromatographic procedure was simulated in a small 2.0mL Eppendorf tube, instead of using a
column. Between 100 - 200mg of the specific resin was added to the eppendorf tube, followed by
the addition of 1.0mL of the process sample containing interferon and host cell proteins. After 2.0
hours of continuously mixing, the samples were centrifuged at 10’000rpm (12’200g) for 15min
at room temperature (Eppendorf centrifuge, Hamburg, Germany). The supernatant (0.8mL) was
recovered and stored at 4◦C for further analysis.
The resins to be investigated for this study were: Dowex R© 1x4 chloride form (20-50 mesh),
Dowex R© 50Wx4 hydrogen form (50-100 mesh) and hydroxyapatite with < 200 nm particle size
(measured by BET).
6.2.3.3 Controlled protein precipitation with acetone or ammonium sulphate
For controlled protein precipitation, 2mL of the recovery process sample was poured into a 50mL
centrifuge tube. With continuous stirring of the sample, 2mL of acetone or ammonium sulphate
was gently added with a pipette. Samples were then centrifuged for 30 minutes at 7500rpm
(FL40R centrifuge, Thermo Scientific, Dublin, Ireland). After having collected the supernatant,
pellets were re-suspended in 2mL of extraction buffer (20mM Tris, 1mM EDTA buffer, pH 8.0).
Samples were taken before precipitation (starting samples), after centrifugation (supernatant) and
after resuspension of the pellets and stored at 4◦C for further analysis.
PhD-Thesis from Tanja Buch 108
CHAPTER 6. PROCESS CHARACTERIZATION - INTERFERON-ISOFORM MASS
BALANCES
6.2.3.4 Size-Exclusion Chromatography
For sample purification with size-exclusion chromatography a HiPrep 16/60 Sephacryl S-100 High
Resolution column (GE Healthcare, Buckinghamshire, UK) was used. Column flow rate was
controlled constantly at 1.0ml/min with an AKTA Explorer (GE Healthcare, Buckinghamshire,
UK). All solutions were filtered through 0.21µm filter (Millipore, Billerica, USA) prior to injection
onto the column. Equilibration was performed with 0.05M Na2HPO4, 0.15M NaCl at pH 7.20
for two column volumes. The recovery process sample of 1.0ml was directly injected onto the
column with a separate pump at 1.0ml/min. Elution of the sample was performed for 160 minutes
at 1.0ml/min with the equilibration buffer.
Different fractions throughout the elution were collected to concentrate the recovered protein in
this fraction with ultrafiltration spin tubes as described in the method above.
The column was washed with deionized water for 1 column volume prior to equilibration and new
sample injection.
6.2.4 Total protein quantification
Total amounts of protein were quantified using the BCA assay as described in section 3.2.2 and
table 3.5 or Bradford assay as described in section 3.2.2 and table 3.6. Samples without a detergent
present were analysed using the Bradford assay, whereas samples with a detergent present were
analysed using the BCA-assay. Sample pellets were dissolved in EDTA-Tris buffer (20mM Tris,
1mM EDTA, pH 8.0) prior to protein analysis. BSA dissolved in water was used as a reference
standard for all total protein quantifications. The blank was chosen according to the sample to be
analysed, from water, EDTA-Tris buffer or detergents.
6.2.5 Total Interferon-α-2b quantification
Total interferon-α-2b amounts were quantified with SDS-PAGE as described in chapter 5.2.3 and
5.2.4. Sample pellets were dissolved in EDTA-Tris buffer (20mM Tris, 1mM EDTA, pH 8.0) prior
to analysis as mentioned in the section above. No further sample treatment was required. The drug
substance of interferon-α-2b was used as a reference standard for all quantifications.
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6.3 Results and Discussion
This discussion section can be divided into three main parts. The first part focuses on the opti-
mization of quantification methods for interferon-α-2b and its isoforms. The second part discusses
possibilities to purify and concentrate process samples prior to quantification to enhance accuracy
and resolution of the quantitative methods. The last and third part looks into the mass balances of
interferon isoforms throughout the primary protein recovery process.
6.3.1 Quantification of Interferon-α-2b Isoforms
In order to quantify interferon and its isoforms in recovery process samples, analytical methods
are required. This section compares three available RP-HPLC methods with each other followed
by an optimization of the methods to increase their resolution and accuracy using a design of
experiment (DoE).
6.3.1.1 Comparison of different RP-HPLC methods
Three different RP-HPLC methods are compared for their resolution and accuracy to quantify
interferon and its isoforms. Two methods were developed by the industrial partner and existing
SOPs were transferred to the labs in DCU. The third method was developed as part of this work in
relation to the existing two methods. Retention times for all isoforms needed to be re-established
due to a change in the HPLC manufacturer. The new re-established retention times of all isoforms
for all three methods are shown in table 6.2.
Tab. 6.2: Retention times [min] of all 4 isoforms for all three RP-HPLC methods
methods IFN-α-2b Iso-2 Iso-3 Iso-4
Bakerbond 6.51 8.06 10.27 12.61
Zorbax 15.17 16.95 19.47 22.95
Aeris 12.67 14.58 16.99 18.89
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The Zorbax and Aeris method can also distinguish between two different forms of isoform 4, the
pyruvated form (Iso-4P) and the non-pyruvated form (Iso-4R). The pyruvated form elutes only a
few seconds after the non-pyruvated form, which leads to an overlap of both peaks. Complete
separation of both peaks could not be achieved with any of the three RP-HPLC methods. How-
ever, the utilization of UPLC methods might improve the resolution and lead to a complete peak
separation.
Figure 6.4 shows the UV-chromatogram of a DEAE-feed sample from the down-stream process
of interferon-α-2b for all three RP-HPLC methods. The DEAE-feed sample contains interferon-
α-2b and its three to four isoforms. The elution sequence of the isoforms as well as the chemical
structure of each isoform were published by Yan-Hui Lui 2010 [6].
A
B
C
Fig. 6.4: UV-chromatogram of RP-HPLC analysis of DEAE-feed sample, showing interferon-α-2b and its
3/4 isoforms: A) chromatogram of bakerbond column; B) chromatogram of zorbax column; C)
chromatogram of aeris column
Window A in figure 6.4 shows the chromatogram of the Bakerbond column with interferon-α-2b
at a retention time of 6.5 minutes. Limit of detection (LOD) for IFN-α-2b is 1.5µg and limit
of quantification (LOQ) is 10.0µg. Window B shows the chromatogram of the Zorbax column,
which is much more sensitive compared to the Bakerbond column. The LOD for IFN-α-2b is
0.2µg and the LOQ is 1.0µg. The disadvantage of the Zorbax method is the low resolution at low
concentrations due to large interferences of other proteins in the sample, which makes it difficult
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to distinguish between different peaks, especially for isoform-2 and -3. These isoforms are of-
ten at very low concentrations and therefore difficult to identify. Window C in figure 6.4 shows
the chromatogram of the Aeris column. The sensitivity is slightly lower compared to the Zorbax
method, with a LOD of 0.2µg and a LOQ of 2.0µg. However, the Aeris column provides the best
separation of the two forms of isoform-4.
Besides sensitivity, two other parameters have been investigated during the comparison study of
the three methods: the drift in retention time and the peak-width. The drift in retention time needs
to be as small as possible in order to detect and quantify interferon and its isoforms in unknown
process samples. The peak-width of a peak should be as thin as possible to avoid fronting and
tailing which can falsify the peak area and hence the protein quantity.
Table 6.3 shows the retention time drifts for interferon-α-2b and the peak-width for IFN-α-2b and
isoform-4 for all three methods. The drift in retention time is calculated from the analysed reten-
tion times of three runs of the interferon-α-2b drug substance with a constant IFN load.
Tab. 6.3: Retention time drift and peak width of all three RP-HPLC methods
RtT drift [min] Peak width [min]
method IFN-α-2b IFN-α-2b Isoform 4
Aeris 0.69 0.69 0.92
Bakerbond 1.35 0.48 0.57
Zorbax 0.27 0.23 0.60
It can be seen, that the Zorbax method has the lowest retention time drift and the smallest peak-
width for interferon-α-2b, followed by the Aeris method. The Bakerbond method has the smallest
peak-width for isoform-4 since this method cannot distinguish between the two forms of isoform-4
and both elute under the same peak. In order to optimize the retention time drift and the peak-
width of interferon-α-2b a design of experiment study was performed, the results of which are
shown and discussed in the following section.
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6.3.1.2 Optimization of RP-HPLC methods with Design of Experiment
To optimize the retention time drift and the peak-width of the three methods for interferon-α-2b a
CCF design (Central Composite Face centred design) for four factors was used, giving 27 expe-
riments for each method. The four factors investigated are flow rate, injection volume, IFN-load
and column temperature. The previous method conditions were generally set as the center points,
if this was applicable. The full design plan of all experiments with all factor values can be found
in the appendix A. The development of the models and the statistical analysis were done with the
software MODDE 10.0 from Umetrics.
Table 6.4 gives an overview of the different parameters that were investigated throughout the
design of experiments study to optimize the three HPLC methods.
Tab. 6.4: Design of Experiment parameters for the optimisation of all three HPLC methods
method injection volume IFN - load flow-rate temperature
[µL] [µg] [ml/min] [◦C]
Aeris 10 - 40 2 - 20 0.5 - 2.5 25 - 55
Bakerbond 10 - 40 2 - 20 1.0 - 3.2 35 - 55
Zorbax 10 - 40 2 - 20 0.5 - 2.0 25 - 55
Six different models were developed, for each response (retention time and peak-width) for each
of the three methods. The models for retention time gave good statistic results for all methods
with Q2 and R2 always above 0.97, which indicates a good correlation between the actual and
the predicted values (6.1.3.2). For all three models only three of the four factors are statistically
significant, which indicates their p-value of less than 0.05 (see appendix A). These three factors
are: column temperature, flow-rate and IFN-load. The impact of the injection volume is statisti-
cally insignificant for the retention time. However, most of the factor-factor interactions are not
significant either, with the exception of the interaction between flow-rate and temperature.
For all methods the injection volume, IFN-load and flow rate have a negative impact on the re-
tention time, meaning the larger these factors get the shorter the retention time will be. This
observation is as expected. More protein loaded onto the column results in lower binding affinity
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as described in section 6.1.2. And a higher flow rate results in a reduced binding time and a shorter
retention time of the protein. The column temperature has a positive impact on the retention time
which results in longer retention times at higher temperatures. This result indicates that the col-
umn temperature has a positive impact on the binding affinity of the protein to the column, which
increases with higher temperature.
The most significant impact on the retention time is the flow-rate which is indicated through the
highest factor value in all model equations. This impact can also be seen in figure 6.5 in the image
on the left, which shows a contour plot of the retention time of the Aeris method dependent on the
column temperature and the flow rate.
Fig. 6.5: Contour plot of the retention time and peak-width of Aeris method dependent on column
temperature and flow-rate. IFN-load is set constant to 11µg and injection volume is constant at
25µl. Left: retention time [min], right: peak width [min]
The image on the left in figure 6.5 shows the high dependency of the retention time on the flow-rate
for the Aeris method, especially at lower flow rates up to 1.2ml/min. The impact of the column-
temperature is less significant compared to the injection volume and the IFN-load.
The models for the peak-width were slightly less statistically quantitative compared to the models
for the retention time. The Q2 and R2 are between 0.86 and 0.97 for the Aeris and Zorbax meth-
ods respectively and even below 0.55 for the Bakerbond method. Values above 0.85 still indicate a
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good correlation between predicted and actual values but a Q2 of less than 0.55 should be handled
carefully. Similar to the retention time models, only the column temperature, flow rate and IFN
load have a significant impact on the peak-width but not the injection volume (see p-values in the
appendix A).
The injection volume, flow rate and column temperature have a negative impact on the peak width,
meaning with an increase in those factors, the peak width is decreasing. This observation is as ex-
pected. With an increased flow rate the elution of a protein is shorter compared to a lower flow-rate.
The IFN load is the only factor with a positive impact on the peak-width. Higher protein amounts
loaded onto the column results in wider peak-width which is as expected. The image on the right
in figure 6.5 shows the dependency of flow rate and column temperature on the peak-width of IFN
during the Aeris method. It can be seen that with an increase in flow rate and column temperature
the peak-width is decreasing. Contour plots for the Bakerbond and Zorbax method, as well as all
statistic parameters are shown in the appendix A.
To optimize the retention time drift and the peak-width of IFN-α-2b, the following criteria were
set: retention time (RtT) has to be within two minutes of the average RtT and the peak-width has
to be lower than a certain maximum value. The two criteria for all three methods can be seen in
table 6.5.
Tab. 6.5: Criteria for retention time and peak-width optimization for all three HPLC methods
method retention time Peak width [min]
[min] IFN-α-2b
Aeris 9 - 13 < 0.55
Bakerbond 9.5 - 12 < 0.64
Zorbax 15 - 19 < 0.25
With the two criteria for the retention time and the peak-width a sweet spot plot can be designed
which highlights the areas where both responses are within the specified ranges. Figure 6.6 shows
the sweet spot plot for the Aeris method. The green area indicates the sweet spot where both
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criteria meet, the blue area highlights the areas where only one criteria meets and the white areas
indicate that no criteria meets. On the inner axis are the injection volume and the IFN-load and on
the outer axis are the flow-rate and the column temperature.
Fig. 6.6: Sweet Spot plot from Aeris method: Green area meets both criteria, Retention time between 9-13
min and peak width less than 0.55min. Blue area meets only of those two criteria
As discussed earlier in this section, the flow rate and column temperature have the biggest impact
on the retention time and the peak-width. Both criteria, retention time between 9-13 minutes and
peak-width less than 0.55 minutes, are only fulfilled at a flow-rate higher than 1.5mL/min and a
column temperature of more than 40◦C. In order to receive the biggest possible sweet spot area but
keeping the column temperature as low as possible to avoid possible protein degradation, the flow
rate was set to 1.5ml/min and the column temperature to 40◦C. To be within the sweet spot area,
the IFN load onto the column has to be below 6µg. Since the injection volume has no significant
impact on either the retention time nor the peak-width, the volume of the injected sample can be
adjusted with respect to the protein concentration to keep the actual IFN load below 6µg.
Similar procedures were performed for the Zorbax and Bakerbond method and the new optimized
RP-HPLC method conditions are shown in table 6.6. The sweet spot plot for the Zorbax method
can be found in the appendix A.
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Tab. 6.6: Optimized RP-HPLC conditions for Aeris, Bakerbond and Zorbax method
method column temp. flow rate IFN load Inj. volume
[◦C] [ml/min] [µg] [µl]
Aeris 40 1.50 < 6.0 11 - 37
Bakerbond 35 2.05 < 18.0 11 - 37
Zorbax 40 1.25 < 8.0 11 - 37
The new optimized factor conditions for all RP-HPLC methods were validated with each six ex-
periments. Three interferon-α-2b concentrations between 0.1 and 0.5 mg/ml were selected and
the IFN load and injection volume were adjusted to be first within the new optimized criteria of
each method and in the second run to be outside the criteria. All six validation runs for each
method were performed in triplicate and each run fulfilled the criteria. These results validated
the optimized RP-HPLC methods which are improved in their accuracy of the retention time and
peak-resolution. A comparison between the retention time drifts and the peak-width before and
after the optimization study can be seen in table 6.7.
Tab. 6.7: Comparison of retention time drifts and peak widths before and after optimization
Retention time drift [min] Peak width [min]
Method before optim. after optim. before optim. after optim.
Aeris 0.69 0.19 0.69 0.53
Bakerbond 1.35 0.26 0.48 0.37
Zorbax 0.27 0.11 0.23 0.21
The retention time drift of the Aeris method decreased 3.6-fold and the peak-width reduced by
25%. The optimization of the Bakerbond method is even more drastic with a 5.2-fold reduction
in retention time drift as well as a 25% reduction in peak-width. The Zorbax method shows less
change with the optimized method. Only a 2.5-fold decrease was seen for the retention time drift
while the peak-width was reduced by 10%. Even though, Zorbax showed the smallest changes
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due to the optimization, this method is still the most accurate one with the highest resolution
followed by the Aeris method and the Bakerbond. Keeping in mind that only the Aeris method
was able to distinguish between the two forms of isoform-4, this method was selected as the best
method to quantify interferon-α-2b and its isoforms in process samples. Another advantage of the
Aeris method compared to the Zorbax and Bakerbond methods is the short run time of only 35
minutes and thus the smallest consumption of mobile phase with 52.5ml per run. Hence, all further
analysis for interferon-α-2b and its isoforms with RP-HPLC was performed with the optimized
Aeris method.
6.3.2 Purifying and concentrating of recovery process samples
One major problem with the quantification of interferon-α-2b and its isoforms in recovery process
samples is the presence of a large amount of host cell proteins. More than 95% of total proteins
are HCP and only 5% are interferon. The second problem is the low concentration of interferon
and its isoforms in process samples, which makes it difficult to quantify IFN accurately. To en-
hance the accuracy and resolution of the quantification of interferon and its isoforms in recovery
process samples, different purification and concentrating methods were tested to first purify IFN
from host cell proteins, followed by a concentrating step. The aim of each purification and con-
centrating method is to receive at least 95% recovery of interferon to avoid large errors within the
quantification results.
6.3.2.1 Ion-exchange purification with HiTrap columns
One purification and concentrating method was already put in place by the industrial partner, which
is the same ion-exchange method as the first step of the industrial down-stream process. This
method was transferred to the labs in DCU and adjusted to some samples throughout the recovery
process. Sample preparation and the ion-exchange chromatography were performed as described
in section 6.2.3.2. For quantification of IFN-isoforms the elution fractions 7-12 were selected
which are the fractions with the highest UV-280 values. The elution fractions were analysed for
interferon-α-2b and isoforms with the Aeris RP-HPLC method and SDS-PAGE as described in
sections 6.2.1.3 and 6.2.5. Further to these samples, the starting sample, flow-through and wash
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sample were also analysed for interferon with the SDS-PAGE.
SDS-PAGE results of the starting and flow through sample showed that 50% of loaded interferon
was found in the flow through and only 40-50% were recovered in the elution fractions which were
used for quantification. These findings indicate that interferon was underestimated in recovery
process samples on site with the industrial partner when using the HiTrap method as purification
and concentrating step prior to the quantification analysis.
To avoid this loss in interferon during the purification step, some samples were injected directly
onto the RP-HPLC column. Figure 6.7 shows the comparison between the quantified interferon-
α-2b and its isoforms in the elution fractions 7-12 after the HiTrap method and the quantified IFN
in samples directly injected onto the HPLC column without purification. The figure also shows the
comparison of IFN quantified with SDS-PAGE in the elution fractions and without purification.
HPLC-Fr. 7-12 HPLC-direct injection SDS-PAGE-Fr.7-12 SDS-PAGE-direct injection
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Fig. 6.7: Comparison between interferon and its isoforms quantification of HiTrap fractions 7-12 and after
direct injection without purification quantified with RP-HPLC and SDS-PAGE
The results for interferon and its isoforms quantified by HPLC and SDS-PAGE show both that
only 50% of the loaded interferon was detected in the elution fractions. The IFN in the samples
analysed without any purification step is for both methods, HPLC and SDS-PAGE, twice as much
as the interferon detected in the purified sample. These findings confirm the previously results
of IFN detected in the flow through of the ion-exchange method. A closer look to the isoforms
indicates, that the majority of this loss is in isoforms-4. Isoform-4 is the only isoform without any
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disulphide bonds, hence its tertiary structure will be different compared to the interferon-α-2b pro-
tein. A change in the tertiary structure can lead to a change in the net-charge of the protein. Since
ion-exchange chromatography purifies proteins as a result of charge it is possible that isoform-4
binds with a much lower affinity to the HiTrap column than IFN and the other two isoforms (sec-
tion 6.1.1 and 6.1.4.1).
Comparing the quantified total interferon-α-2b by RP-HPLC with the results obtained with SDS-
PAGE shows that the SDS-PAGE overestimates the IFN in recovery process samples. This result
confirms the findings from chapter 5, where the SDS-PAGE results were compared to Western
Blot results which is more protein specific. SDS-PAGE only distinguishes by molecular weight
and it is very likely that other host cell proteins with the same molecular weight than interferon
are present in the recovery process samples.
Hence, the most precise results for interferon-α-2b were quantified by RP-HPLC without any pu-
rification. However, the big disadvantage of this procedure is the low accuracy and low resolution
of the UV-280 chromatogram. Figure 6.8 shows such a chromatogram of a TCA-pellet directly
injected onto the Aeris column without any sample purification or concentration.
Fig. 6.8: UV-chromatogram of a direct injection of TCA-pellet onto the Aeris column without any sample
purification
The chromatogram shows that it is very difficult to distinguish between the different peaks and to
select the correct peak for each isoform. Especially isoform-2 and -3 are so low in concentration
that no peak is visible without amplification. Thus, analysing all recovery process samples with
this procedure can easily lead to false interferon quantities due to errors during peak selection
and imprecise peak-areas. Hence, a purification and concentrating method prior to the interferon
quantification with RP-HPLC would increase the accuracy and sensitivity.
The ion-exchange chromatography method with HiTrap column showed only a 50% recovery of
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purified interferon and its isoforms which makes it unfeasible for the purification of recovery
process samples prior to IFN quantification. However, another observation was made during the
comparison of purified and unpurified samples. Analysing the end of fermentation (EOF) at dif-
ferent pH for their isoform distribution showed a strong dependency of isoform-3 and -4 on the
pH value of process samples. Figure 6.9 shows the pH dependency of the isoform distribution in
EOF samples.
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Fig. 6.9: pH dependency on isoform distribution in end of fermentation sample
Three different pH values were tested: 5.50, 6.80 and 8.00. At the end of fermentation the pH of
the fermentation broth is around 7.0, for the purification with ion-exchange the pH was reduced to
5.50. As it can be seen in figure 6.9 the reduction of pH leads to a shift between isoform -3 and -4.
With a reduction in the pH, isoform-3 is converted to isoform-4. Interferon-α-2b and isoform-2
are less affected by the pH, which could be due to their disulphide bonds and thus stronger tertiary
structure. The pH dependency of the isoform distribution in recovery process samples indicates
the importance of purifying, concentrating and quantifying the process samples without changing
the pH of the sample. Hence, the ion-exchange method did not only underestimate the interferon-
α-2b and its isoforms, it also gave misleading results about the isoform distribution in the analysed
samples.
Summarizing the results of this section shows that the existing purification method followed by
RP-HPLC quantification of interferon, underestimated the total interferon-α-2b and falsifies the
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isoform distribution. Hence, a new purification and concentration method needs to be developed,
which recovers interferon to a minimum of 95% and requires no pH adjustment prior to the purifi-
cation, concentrating or quantification step.
6.3.3 Other purification methods
The previous section showed that the accurate quantification of interferon isoforms requires a pu-
rification and concentration step to separate interferon-α-2b from host cell proteins. The method
in place, an ion-exchange method, demonstrated to underestimate interferon-α-2b and falsifies the
results for the isoform distribution. Hence, this section focuses on the development of a new purifi-
cation and concentrating method. Seven different techniques have been tested to purify the recov-
ery process samples. All tested techniques were assessed on two criteria: first, an interferon-α-2b
recovery yield of at least 95% and second, no necessity for pH-adjustment during the purification.
6.3.3.1 Ultrafiltration with spin tubes
The ultrafiltration with spin tubes is the first technique used to purify and concentrate recovery
process samples. The principle of this method is to separate a mixture of molecules based on
molecular weight. Hence, no pH-adjustment seems to be required in order to purify or concentrate
the recovery process samples.
Concentrating
In a first step, the ultrafiltration spin tubes were used to concentrate interferon-α-2b in the recovery
process samples. IFN has a molecular weight of around 19kDa, hence a molecular weight cut-off
of 5kDa was selected to concentrate interferon.
The experiment was performed as described in section 6.2.3.1 and the agitation time was adjusted
to receive the desired concentration. For example reducing the volume from 5ml to 1ml leads
to a 5-fold concentration from a protein concentration at 1mg/ml to 5mg/ml. Figure 6.10 shows
the results for interferon before and after the concentrating step with ultrafiltration spin tubes at a
cut-off of 5kDa.
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Fig. 6.10: Concentrating of recovery process samples with ultrafiltration spin tubes and 5kDa cut-off.
Lower chamber gets discard and upper chamber is concentrated sample
The sample concentrated in this experiment was a TCA-pellet from the manufacturing process and
no additional sample treatment was performed prior to this method. Interferon-α-2b was quantified
by SDS-PAGE as described in section 6.2.5. It can be seen that all interferon was recovered in the
upper chamber of the spin tube and no IFN was found in the lower chamber. Since the volume
in the upper chamber reduced throughout the centrifugation and the interferon amount remained
constant, the protein concentration increased. In this example the IFN concentration increased
from 0.082g/l to 0.399g/l which is a concentration factor of 5.
These results indicate that interferon-α-2b can be successfully concentrated in recovery process
samples using ultrafiltration spin tubes with a cut-off of 5kDa. No pH setting is required for this
method and the interferon recovery was > 95%, hence both basic criteria are fulfilled.
Purification
In a second step, the ultrafiltration spin tubes were used to separate interferon-α-2b from host
cell proteins in recovery process samples. As mentioned before, IFN has a molecular weight
of 19kDa, hence molecular weight cut-off of 50 and 100kDa were selected for the purification.
Usually a cut-off of at least three times the molecular weight of the purified molecule is selected
(section 6.1.4.3).
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All experiments were performed as described in section 6.2.3.1 using a TCA-pellet from the manu-
facturing process. Figure 6.11 shows the results of the TCA-pellet purification with ultrafiltration
spin tubes and a 100kDa cut-off in the presence and absence of 3% Sarkosyl.
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Fig. 6.11: Purification of recovery process samples with ultrafiltration spin tubes and 100kDa cut off in the
presence and absence of 3% Sarkosyl. The image shows the starting sample and the recovery of
interferon-α-2b in the lower chamber of the ultrafiltration spin tubes.
The interferon-α-2b was quantified by SDS-PAGE as described in section 6.2.5. Figure 6.11
shows the recovery of purified interferon-α-2b in the lower chamber of the ultrafiltration spin
tubes. As it can be seen, in the absence of a detergent no IFN was detected in the purified fraction,
neither with 50kDa nor 100kDa cut off. This observations led to the conclusion, that interferon
interacts with other larger host cell proteins and the formed protein complex is too big to pass
through the ultrafiltration membrane. Accordingly, a detergent was added to the starting sample
in order to avoid protein-protein interactions. Two different detergents were tested, Sarkosyl at a
concentration of 3.0% and Zwittergent 3-14 at a concentration of 1.0%. The bar to the right in
figure 6.11 shows the recovery of interferon in the purified sample in the presence of 3% Sarkosyl.
It can be seen that the recovery of IFN in the purified fraction in the presence of 3% Sarkosyl
did improve compared to the experiment without a detergent. However, the interferon recovery
is less than 30%, meaning that 70% was lost during this purification, which is not acceptable for
a pre-treatment prior to a quantification. An explanation for the low IFN recovery could be that
larger host cell proteins foul the pores of the membrane and hinder the small interferon molecules
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passing through.
Using the addition of 1.0% Zwittergent 3-14 to the starting sample resulted in only 2% recovery
of the initial interferon in the purified sample (data not shown). This observation indicates that
Sarkosyl has a higher potential to break-up protein-protein interactions than Zwittergent 3-14.
In summary, the separation of interferon from host cell proteins in recovery process samples with
ultrafiltration spin tubes did not result in a sufficient recovery yield. The low interferon recovery
yield of less than 30% is probably due to larger host cell proteins fouling the membrane pores
and hindering the passage of smaller molecules. An inverted method might result in higher IFN
recovery yields, where larger molecules pass through first and the elution of smaller molecules is
delayed. An example of such a method would be size exclusion chromatography, the results of
which are discussed later in this section.
6.3.3.2 Ion-exchange and precipitation methods
Besides using ultrafiltration spin tubes for the purification of recovery process samples prior to
interferon quantification, several other techniques were also investigated. This section describes
briefly the application of three other techniques which are: cation- and anion-exchange resin,
mix-mode resin and controlled protein precipitation. For all experiments the TCA-pellet of the
manufacturing process was used.
Dowex resin
The hitherto existing method used for the purification of recovery process samples prior to isoform
quantification, is an ion-exchange method with cationic SP Sepharose resin. Due to the nature of
a cation-exchange method it requires a controlled pH environment below the pI of the protein to
be purified (section 6.1.4.1). Section 6.3.2.1 showed that the adjustment of the pH of the sample
influences the distribution of the interferon isoforms. Instead of setting the pH of the process
sample, an idea was to use a cationic resin for pH below 6.2 and an anionic resin for sample pH
above 6.2. The resins used for this experiment are Dowex R© 1x4 chloride form as the anionic
resin and Dowex R© 50Wx4 hydrogen form as the cationic resin. The experiments were performed
as described in section 6.2.3.2 and total protein and total interferon-α-2b were quantified in the
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supernatant using the BCA-assay and SDS-PAGE according to sections 6.2.4 and 6.2.5.
The results showed that, independent of the conductivity value of the sample and independent of
the presence or absence of a detergent, both resins have a stronger binding affinity at pH values
around 5.0. It was also observed that interferon and host cell proteins show similar binding affinity
towards both resins, which makes it impossible to separate one from the other. In summary, neither
of the Dowex resins showed potential to separate interferon from host cell proteins with or without
pH adjustment.
Hydroxyapatite
The second technique tested for the purification of interferon in recovery process samples is the
use of a mix-mode resin as hydroxyapatite. This type of resin involves non-specific interactions
between positively charged calcium ions and negatively charged phosphate ions, thus it should
bind positively charged molecules as well as negatively charged molecules (section 6.1.4.1). The
experiment was performed as described in section 6.2.3.2.
Unfortunately results showed that hydroxyapatite has a similar binding affinity towards interferon
and host cell proteins present in the recovery process samples. The impact of different pH, conduc-
tivity and the presence and absence of two detergents on the binding of hydroxyapatite to interferon
and host cell proteins were tested. None of these factors showed a significant improvement on the
separation of interferon from host cell proteins. Hence, the mix-mode resin hydroxyapatite cannot
be used to separate interferon-α-2b from host cell proteins in recovery process samples prior to
IFN quantification.
Protein precipitation
The last technique tested in this section is protein precipitation with ammonium sulphate and ace-
tone. The aim of this technique is to perform a selective protein precipitation by the controlled ad-
dition of either ammonium sulphate or acetone to the recovery process samples. Different proteins
have different precipitation points due to the addition of salt or organic solvents (section 6.1.4.5).
Accordingly, this phenomenon is also called salting-out of proteins. The idea is to salt-out host
cell proteins while maintaining interferon-α-2b in solution. The experiments were performed as
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described in section 6.2.3.3.
Similar to the results obtained with Dowex and hydroxyapatite, protein precipitation with am-
monium sulphate and acetone showed no significant difference between the precipitation point
of interferon and host cell proteins. Both groups of proteins precipitated at similar time points
throughout the addition of ammonium sulphate and acetone. This led to the conclusion that the
characteristics of both protein groups are too similar in order to separate them efficiently with
neither of the above methods.
In summary, all three different techniques tested for the purification of interferon from host cell
proteins showed that both protein groups have similar characteristics in their binding affinity to-
wards ion-exchange resins and mix-mode resins and in their precipitation points. The remaining
characteristic that differ between both protein groups is their molecular weight. Hence, the fol-
lowing section focuses on the IFN purification from process samples using size-exclusion chro-
matography.
6.3.3.3 Size-exclusion chromatography
As a last technique to purify interferon-α-2b from host cell proteins in recovery process samples,
size-exclusion chromatography was tested. Results of the previous section showed that many pro-
tein characteristics of interferon and host cell proteins are very similar and accordingly this makes
it challenging to separate one from the other efficiently. One characteristic that distinguishes
between interferon and host cell proteins is molecular weight. Interferon-α-2b has a molecular
weight of approximately 19kDa, whereas most host cell proteins have a molecular weight between
60 and 100kDa. Results with ultrafiltration spin tubes in section 6.3.3.1 showed, that a separation
of IFN and HCP by size is possible, but larger proteins tend to block the membrane pores and
interfered with this technique. With size-exclusion chromatography larger molecules should elute
first and the elution of smaller molecules is delayed due to partitioning with the stationary phase
of the column (section 6.1.4.4).
For the purification of interferon from host cell proteins in recovery process samples, a HiPrep
16/60 Sephacryl S-100 High Resolution column was used with a separation range of 1 - 100kDa
and 120ml column volume. The experiments were performed as described in section 6.2.3.4.
In order to identify the elution time of interferon, a sample of the pure drug substance of interferon-
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α-2b in phosphate buffer was injected onto the column. Figure 6.12 shows the elution chro-
matogram at UV-280 for interferon-α-2b in phosphate buffer at a concentration of 3.40g/l.
Fig. 6.12: UV chromatogram of size exclusion purification of interferon-α-2b drug substance in phosphate
buffer. Interferon elutes between 60 and 72ml at a flow rate of 1ml/min
Two elution peaks can be seen in the elution chromatogram, the first with an elution time of 60 -
72 minutes and the second at 115 - 125 minutes. The first peak is expected to be interferon with
an increase in the UV-280 reading of ∆2.50mAU. The second, smaller peak is probably due to
impurities in the phosphate buffer. Both peaks were collected as separate fractions, as well as the
eluate between and before the peaks. Thus, four different fractions were collected for different
protein analysis. These fractions were analysed for total protein using the Bradford assay and for
total interferon-α-2b using SDS-PAGE as described in sections 6.2.4 and 6.2.5.
No proteins, neither total protein nor interferon, were detectable in any of the collected fractions.
The reason therefore is probably the significant dilution performed throughout the size-exclusion
chromatography. One millilitre was injected onto the column and was recovered in fractions be-
tween 10 - 60ml. Hence, the collected fractions were concentrated prior to their analysis with
ultrafiltration spin tubes and a 5kDa cut-off as described in section 6.2.3.1 and discussed in sec-
tion 6.3.3.1. Unfortunately after the concentration only 15% of the initial interferon amount was
found in the fraction of peak 1 (60-72min). In all other fractions no protein was detected which
was as expected. It is inexplicable what happened to the remaining 80% of the initial interferon,
other than that dilution resulted in the concentration falling below the detection limit of the assay
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system. Results of section 6.3.3.1 showed that the concentrating step with ultrafiltration spin tubes
has a recovery yield for interferon of >95% and no protein was detected in the flow through of the
concentrating step.
Figure 6.13 shows another UV-280 chromatogram of a size-exclusion purification. The sample
injected onto the column contained 0.5g/l BSA and 0.6g/l IFN (drug substance) diluted with fer-
mentation media.
Fig. 6.13: UV chromatogram of size exclusion purification of a mixture of interferon-α-2b drug substance
and bovine serum albumin (BSA) in process media. Interferon elutes between 60 and 72ml at a
flow rate of 1ml/min
Two elution peaks can be seen in the first half of the chromatogram, the first peak between 43 to
50ml and the second peak between 60 to 72ml. The first peak is expected to be BSA, since this
protein is larger than interferon and should elute first and the second peak is expected to be inter-
feron with the same elution time than detected during the first experiment. The peaks eluted after
interferon are expected to be media components from the fermentation media and are collected in
one fraction.
The chromatogram shows a complete separation between both peaks which indicates a complete
separation of the protein mixture between BSA and IFN. However, concentrating and analysing
both fractions for total protein and interferon-α-2b again resulted in only 10 - 15% recovery of
the initial injected concentration of BSA and IFN. These results are unexpected. Theoretically, all
eluted proteins recovered in the different fractions should add up to the initial protein loaded onto
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the column. There is no reasonable explanation why more than 70 - 80% of the initial protein load
is not detectable in any of the collected fractions.
Since it is not explicitly possible to determine where the proteins were lost throughout this method
(either throughout the SEC or the concentrating step), no further optimization steps were per-
formed. In summary, the SEC showed potential to separate interferon-α-2b from other proteins by
size without any additional pH settings but the recovery yield was less than 20%. This yield is too
low and insufficient for a purification method prior to a quantification. Hence, the size-exclusion
chromatographic method cannot be used to separate interferon from host cell proteins in recovery
process samples prior to the IFN isoform quantification.
6.3.3.4 Summary of all purification and concentrating methods
Recovery process samples have two challenging characteristics for protein quantification, first the
interferon-α-2b is at a very low concentration of less than 0.3g/l and second interferon-α-2b re-
presents less than 5% of the total protein with 95% being host cell proteins. Quantifying these
recovery process samples directly with the RP-HPLC methods for their IFN isoforms result in low
resolution and poor accuracy. Accordingly, a purification and concentrating method was required
in order to receive higher resolutions and increase the accuracy of the RP-HPLC quantification.
First the existing ion-exchange HiTrap method was tested which showed an IFN recovery of only
50% and a falsified isoform distribution due to required pH settings. Next, ultrafiltration spin
tubes were tested for their potential to purify and concentrate interferon in recovery process sam-
ples. An efficient method was developed for concentrating interferon with ultrafiltration spin tubes
and 5kDa cut-off membranes with a IFN recovery yield of >95%. The purification with 100kDa
cut-off membrane resulted only in 30% interferon recovery, which is not sufficient. Furthermore,
three other techniques with ion-exchange resin, mix-mode resin and protein precipitation were
tested for their potential to separate interferon from host cell proteins. None of these methods
met the criterion of 95% recovery yield. At last a size-exclusion chromatographic method was
investigated. SEC uses the inverted technique compared to ultrafiltration spin tubes. Instead of the
filtration of smaller molecules through a membrane, larger molecules are eluting first followed by
the smaller ones. The SEC successfully separated interferon from other larger proteins but unfor-
tunately only with a recovery of <20%.
PhD-Thesis from Tanja Buch 130
CHAPTER 6. PROCESS CHARACTERIZATION - INTERFERON-ISOFORM MASS
BALANCES
Another possible method for the purification of interferon from host cell proteins would be im-
munoaffinity chromatography with specific interferon-α-2b antibodies on the stationary phase.
However, results with the Biacore and BLItz (compare section 5.3.5) showed a very low binding
affinity between interferon and commercialized antibodies. And it is not certain if all isoforms
bind to the same antibody for interferon-α-2b since there exists no pure reference standard or
specific antibody for each isoform. Hence, the immunoaffinity chromatographic method is not
expected to have any potential to purify interferon from process samples with a recovery yield of
>95%.
None of the tested purification methods were able to fulfil both criteria of an IFN recovery yield of
>95% and no requirement for pH adjustment. Hence, the only way to get an idea about the mass
balances of IFN isoforms throughout the recovery process is the direct sample injection onto the
RP-HPLC column and accept the low resolution and poor accuracy.
6.3.4 IFN isoforms distribution throughout the primary recovery process
This section focuses on the distribution of the different interferon isoforms throughout the reco-
very process. Unfortunately, no complete mass balances could be performed due to the lack of a
suitable purification method or more sensitive quantification methods for the isoforms.
As discussed in section 6.3.3.4, the only existing method to quantify IFN isoforms in recovery pro-
cess samples is the direct injection of the sample onto the RP-HPLC column. The Aeris column
was used for all quantifications, since this column is most sensitive and accurate in the quantifica-
tion of all isoforms as described in section 6.3.1.2.
Results of chapter 4 and 5 showed that total protein and total interferon-α-2b exist in precipitated
form and in solution throughout the recovery process. To avoid the necessity to separate precipi-
tants from isoforms in solution and hence reducing the interferon concentration in each fraction
even further, only samples of the recovery process were analysed that have simply proteins in so-
lution and no protein precipitant fractions. These samples are S-1 (EOF) and S-8 (compare figure
5.4) and S-15 (TCA-pellet), where all precipitants can easily be solubilized in extraction buffer
(20mM Tris, 1mM EDTA buffer, pH 8.0).
The isoform results of these three samples, quantified by Aeris RP-HPLC method as described in
section 6.2.1.3, are shown in figure 6.14
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Fig. 6.14: Interferon isoform distribution in the recovery process samples EOF, S-8 and TCA-pellet in
total grams quantified with RP-HPLC and Aeris column
It can be seen in figure 6.14 that the total amount of interferon-α-2b, including all isoforms, is
reducing throughout the recovery process. From the end of fermentation to S-8 (cycle-2) more
than 58% of total interferon is lost, which is consistent with the findings of total IFN quantified
by SDS-PAGE discussed in chapter 5. From sample 8 to the final TCA-pellet of the recovery
process further 40% in total interferon-α-2b is lost, which results in an overall loss of more than
75%. These findings are consistent with the mass balances set up in chapter 5. Comparing the
actual quantified interferon from the RP-HPLC analysis with the SDS-PAGE quantification of
chapter 5 it can be observed that with RP-HPLC only half the IFN is quantified compared with
SDS-PAGE. This observation is consistent with the findings of section 5.3.5. It was shown that
SDS-PAGE overestimates the total interferon-α-2b due to interferences of host cell proteins with
the same or similar molecular weight than interferon. However, the findings of figure 6.14 show
the total interferon-α-2b was overestimated but the percentage reduction and IFN loss throughout
the recovery process remains the same.
Looking at the distribution of the isoforms, figure 6.14 shows that the majority of interferon at the
end of fermentation is composed of the isoforms 2 and 3 and only smaller portions of isoform 4 and
interferon-α-2b. Throughout the recovery process interferon-α-2b and isoform 4 show only minor
reductions of less than 40% whereas isoform 2 and 3 are reduced by 75 - 95%. With the available
PhD-Thesis from Tanja Buch 132
CHAPTER 6. PROCESS CHARACTERIZATION - INTERFERON-ISOFORM MASS
BALANCES
information it is not clear whether isoform 2 and 3 were lost to higher fractions throughout the
recovery process or if some of these isoforms were converted to isoform 4 or interferon-α-2b. In
order to draw these conclusions a full mass balance of all isoforms throughout every step of the
recovery process would be required.
Results in figure 6.15 show the interferon isoform distribution as a percentage for each of the three
analysed recovery process samples.
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Fig. 6.15: Interferon isoform distribution in the recovery process samples EOF, S-9 and TCA-pellet in
total percentage quantified with RP-HPLC and Aeris column
As was already seen in figure 6.14, interferon-α-2b and isoform 4 increase throughout the recovery
process and isoform 2 and 3 decrease. In the end of fermentation the majority of total interferon is
isoform 2 and 3 with more than 40 and 32%. Interferon-α-2b and isoform 4 represent only 15 and
12%. This proportion changes throughout the recovery process and in the TCA-pellet interferon-
α-2b and isoform represent 36 and 25%. Isoform 2 and 3 on the other hand represent only 8 and
31%.
This observations is important, since only interferon-α-2b is the actual drug substance and isoform
4 can be converted to interferon-α-2b during the down-stream process. This means with 27% of
interferon-α-2b and isoform 4 in the EOF sample only 810g of the 3000g total interferon are
expedient for the drug substance. In the TCA-pellet interferon-α-2b and isoform 4 represent 61%
together which are 450g of the 750g total interferon. Hence, more than 50% of the expedient
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fraction of total interferon is recovered throughout the recovery process, which is twice as much
as the 25% recovery in total interferon.
In summary, the results for interferon isoforms quantified with RP-HPLC showed a loss of 75% in
total interferon-α-2b throughout the protein recovery process. Looking at the expedient fraction
of interferon-α-2b and isoform 4, only 50% reduction was observed throughout the process. The
major loss was detected between the EOF and sample 8, which confirms the findings with the
SDS-PAGE of chapter 5.
It has to be kept in mind to treat these results with caution. Quantification with RP-HPLC showed
very low resolution and poor accuracy due to low protein concentrations and interference from a
large number of host cell proteins present in the recovery process samples.
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6.4 Conclusion
Concluding the findings observed during this chapter, this section is divided into four parts. The
first part will summarize the results of the characterization and optimization of the three RP-
HPLC quantification methods for interferon isoforms, followed by the summary of the findings
for a purification and concentration method for recovery process samples prior to the RP-HPLC
quantification. The third part focusses on the conclusion of the isoform distribution throughout
the recovery process analysed with the RP-HPLC methods. The last part of this section gives an
overall conclusion for this chapter and an outlook for next possible steps.
6.4.1 Quantification of interferon isoforms
Three RP-HPLC methods for interferon isoform quantification were characterized and optimized
with design of experiments to receive higher accuracy and enhanced resolution. The Zorbax
method was identified to have the best accuracy and highest resolution for the quantification of
interferon-α-2b. However, the Aeris method showed the best accuracy and resolution in order to
quantify all interferon isoforms and interferon-α-2b. Hence, the Aeris method was selected as the
method of choice for further interferon isoform quantification.
6.4.2 Purification and concentrating recovery process samples
Since recovery process samples have very low concentrations of interferon and its isoforms, while
the presence of host cell proteins interferes with the RP-HPLC quantification, a purification and
concentrating step prior to quantification was required. The method currently used by the in-
dustrial partner, an ion-exchange method with HiTrap columns, showed only a 50% recovery in
interferon and the pH required adjustment during sample preparation resulted in changes in the
isoform distribution and hence falsified the results. Other techniques were tested for purifying
and concentrating recovery process samples to receive a recovery yield of at least 95% and no pH
adjustment is required during sample preparation.
Ultrafiltration spin tubes with a 5kDa cut-off showed good results to concentrate interferon in re-
covery process samples with an IFN recovery yield of over 95%.
For purifying recovery process samples, ultrafiltration spin tubes, different ion-exchange resins,
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mix-mode resins, protein precipitation and size-exclusion chromatography were tested. However,
none of these techniques resulted in a recovery yield of 95%. SEC showed the highest potential
and successfully separated interferon from host cell proteins. Unfortunately the recovery was only
20%.
6.4.3 Isoform distribution throughout the recovery process
Since no purification technique had a 95% recovery for interferon, selected samples of the recovery
process were analysed for their isoform distribution directly with the RP-HPLC method and Aeris
column without any pre-purification steps. Results confirmed the findings of the SDS-PAGE with
75% loss of total interferon throughout the recovery process. The main reduction occurred in
isoform 2 and 3, whereas isoform 4 and interferon-α-2b showed only a 50% reduction throughout
the process. To draw final conclusions as to whether the reduction in isoform 2 and 3 is due to
losses throughout the recovery process or due to conversions into isoform 4 and interferon-α-
2b, more recovery process samples need to be analysed for their isoform distribution with more
accurate quantification methods.
6.4.4 Overall conclusion and Outlook
The findings of this chapter showed that no method is in place to accurately quantify the interferon
isoforms throughout the entire recovery process. The existing RP-HPLC methods can distinguish
between the isoforms if the process samples reach a certain purity and concentration. Without
purification the existing quantification methods are not accurate enough and are too poor in reso-
lution in order to obtain reliable results. The purification of the recovery process sample showed to
be more challenging than expected. Several known techniques for protein purification were tested,
however none of them met the criteria to purify the recovery process samples successfully.
In order to set up an accurate and robust method for the quantification of interferon isoforms
throughout the recovery process a more sensitive quantification method needs to be developed.
Possible methods known from the literature could be an UPLC method or a LC-MS method.
However, the literature showed that the presence of large amounts of host cell proteins interferes
with these quantification methods. Hence, the development of a purification method prior to the
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interferon quantification seems to be indispensable. With the current protein purification tech-
niques available, it was not possible to find a method for interferon purification in the recovery
process samples.
Furthermore, recovery process samples directly analysed with the low accurate RP-HPLC quan-
tification methods showed a loss of more than 75% of the total interferon throughout the recovery
process with the main loss in interferon 2 and 3. The critical process point was identified be-
fore cycle-2 which confirms the findings of the two previous chapters. Hence, the next step is to
optimize the recovery process in order to minimize the loss of interferon-α-2b and its isoforms.
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Chapter 7
Process Optimization - Protein Dilution
Study
7.1 Introduction
Chapters 4, 5 and 6 have shown two critical process steps (CPS) throughout the primary protein
recovery process, with an overall loss of 80% in the total interferon-α-2b and 90% in total protein.
CPS-1 was identified during cycle-1 with an interferon loss of 60% due to insufficient protein
solubilization and results indicated a protein saturation problem.
This chapter will focus on the optimization of the primary critical process step by diluting the
protein concentration during cycle-1 of the protein recovery process in order to eliminate the
saturation problem and to increase the interferon-α-2b recovery.
7.1.1 Protein solubility levels
The solubility levels of proteins in water can vary from completetly insoluble to hundreds of
milligrams per milliliter, for example the protein crambin is completely insoluble in water [97]
whereas serum albumin has a solubility of more than 500mg/ml [98]. Protein solubility is a ther-
modynamic parameter which is influenced by a number of extrinsic and intrinsic factors. Most
important extrinsic factors are: pH, ionic strength, temperature and the presence of solvent addi-
tives such as detergents [99]. On the other hand intrinsic factors are mainly defined by the charged
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groups (side chains) on the protein surface, thus the folding and packing of the polypeptide chain.
The proportion of charged side chains on the protein surface is determined by 4 main physical
forces: conformational entropy, charge-charge interactions and salt bridges, hydrophobic interac-
tions and hydrogen bonding and polar group burial [100].
Free rotation of protein bonds provide strong entropic driving forces which can lead to unfold a
protein. However, protein charges on the surface are more attractive than repulsive interactions at
neutral pH. Hence, protein can be stabilized by reducing the surface charges due to the addition
of small salt concentrations (salting-in, see section 4.1.4). Salt ions reduce the electrostatic attrac-
tions between neighboring protein molecules. Hydrophobicity and hydrogen bonding as well as
van-der-Waals interactions are also important for the protein stability and solubility such as polar
group burial [100].
Proteins interact with water molecules in order to stay in solution. If too many proteins are present
for too few water molecules the solution is saturated and proteins start to aggregate and become
insoluble. Studies have shown that this precipitation can be partly reversed by the addition of
further buffer or water [99].
Protein solubility is a function of ionic strength. With the addition of salt at low ionic strength,
protein solubility can be increased; this is termed salting-in. However, the addition of salt at high
ionic strength leads to a decrease in protein solubility and protein precipitation; this is termed
salting-out. Protein stability is also dependent on the pH. The stability decreases at lower pH,
acidic environment, and at the pI of the protein [101].
7.1.2 Protein precipitation and salting-out
Protein precipitation or salting-out is one of the oldest techniques to separate proteins from a
solution mixture [101]. Precipitation of proteins due to the addition of salt was already briefly
described in section 4.1.4. This section will focus more on a macromolecular level during the
salting-out.
Grover et al. [102] describes salting-out as a precipitation of less soluble material and proteins,
from a solution such as water, in which it is mixed with other substances. As already mentioned
in section 4.1.4 and equation 7.1, the salting-out effect can be mathematically described by the
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Setschenow equation [102]:
logSo/S = k ∗ Cs (7.1)
With:
So = solubility of the protein in water
S = solubility of salt
Cs = salt concentration in mol/L
k = salting out constant (dependent on the salt)
If the salting-out constant is a positive value, it indicates salting-out (precipitation) and a negative
value indicates an increase in protein solubility. With a constant protein solubility value in wa-
ter (So) it follows from equation 7.1, that the added amount of salt is directly proportional to the
amount of protein precipitationed. The salting constant ’k’ is the sum of cationic and anionic salt
ions, and different salt ions have different salting constants. Hence, various combinations of salt
ions, such as different salts as NaCl and MgCl2, lead to different properties to cause salting-out.
The physical and thermodynamic reactions/ processes during salting-out is very complex and still
not completely understood. Several different types of intermolecluar interactions and forces occur
between protein and water, water and salt and protein and salt [102]. However, the salting-out
effect occurs mainly due to the electrostatic effects and the competing between proteins and salt
ions over water molecules. The electrostatic effects are dependent on the size, structure, charge
density and hydration of the protein and the salt ions itself.
In particular the size, structure and shape of the protein have an important role during salting-out,
as was shown by Chane et al. [101]. At low pH and ionic strength the proteins form derivates
from the sphericity which become more voluble and hence less stable and precipitation occurs.
Non-spherical proteins have a larger contact surface for interactions with salt ions or other pro-
teins, which leads to an increase in the formation of precipitants.
Protein-protein interactions in protein mixtures can also lead to co-precipitation of proteins [103].
Co-precipitation occurs due to isoelectric coagulation of proteins and sometimes even disulfide
bond formations between cystein groups [104]. Especially in the presence of calcium salts, co-
precipitation of proteins occurs. This can lead to a salting-out of proteins with high solubility
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levels at lower ionic strength or salt concentrations than usually required, due to protein-protein
interaction of a protein with a lower solubility level.
Grover and Ryall [101] also describe the salting-out effect by an internal pressure theory. Accord-
ing to this, the salting-out effect increases with a decrease in the compressibility of the solution.
This explains the low protein solubility levels in water, since water has a very low compressibility
factor. This study also shows that the salting-out effect of proteins is less effective in the presence
of low protein concentrations.
In summary, the salting-out of proteins depends on several factors such as, electrostatic effects,
protein shape, protein-protein interactions and protein concentration.
7.1.3 Goals and Aims
The aim of this chapter is the optimization of the critical process step one of the primary protein
recovery process by the implementation of a dilution step during cycle-1 to eliminate the protein
saturation problem and to enhance interferon-α-2b recovery.
First, a screening step of several different dilution factors is performed to identify the optimal
dilution condition for maximal interferon-α-2b recovery and minimal process volume. Secondly,
the optimal dilution factor is applied to the primary protein recovery process in a small scale study
to investigate the impact of increased protein solubilization in cycle-1 on the following recovery
process steps. Finally, the impact of the increased protein recovery during the recovery process on
the first step of the down-stream process, an ion-exchange method, is investigated.
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7.2 Material and Methods
7.2.1 List of Materials
Tab. 7.1: Materials and suppliers
materials supplier
Recovery process samples industrial partner
(EOF, and Sample-4)
interferon-α-2b - drug substance industrial partner
NaOH Sigma Aldrich
EDTA tetrasodium salt VWR
Trizma Base Sigma Aldrich
Bovine serum albumin (BSA) Sigma Aldrich
Bradford Reagent Sigma Aldrich
7.2.2 Dilution experiments
The dilution experiments were performed using recovery process samples from the manufacturing
process. Sample time point 4 was selected for this purpose (figure 2.3 in chapter 2.5). The sample
4 was thawed in a waterbath at 37◦C and centrifuged in a bench top centrifuge (FL40R centrifuge,
Thermo Scientific, Dublin, Ireland) at 7500rpm for 30 minutes at 4◦C. Supernatant was discharged
and the pellet was dissolved in water accordingly to the different dilution factors. Dilution factor
one correlates to the original volume of the small scale model (table 3.7). After setting the pH
to 7.0 with NaOH the sample was mixed for 4 hours constantly. To collect the resuspended pro-
teins, the sample was centrifuged again under the same conditions as mentioned earlier and both
fractions, supernatant and pellet, were recovered and stored for protein analysis at 4◦C. Collected
pellets were dissolved in EDTA-Tris extraction buffer (1mM EDTA, 20mM Tris, pH 8.0) prior to
analysis.
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7.2.3 Simulation of the Protein Recovery Process
The laboratory-scale simulation of the recovery process (RP) is based on the industrial-scale pri-
mary protein recovery process as described in chapter 3.2.3. The industrial process is performed
with a working volume of 32’500L which was scaled down to 0.04L and 0.5L for the laboratory
RP (table 3.7).
For the performance of the process simulation two types of samples are used. The first type is an
End of Fermentation (EOF) sample, orginated from a fermentation at manufacturing scale, which
was shipped on dry ice to DCU. The second type of sample is an End of Fermentation pellet,
originated from a small scale fermentation run performed from the industrial partner. This pellet
was resuspend in an EDTA-Tris-extraction buffer (1mM EDTA, 20mM Tris, pH 8.0) in the labs in
DCU to proceed with the simulation of the recovery process.
In order to determine the impact of a dilution-step on the recovery process and the recovery of
interferon at the end of the RP-process, the amount of water added to the process in cycle-1 after
the first centrifugation was adjusted according to the dilution factor. A two-fold dilution factor
correlates to a two-fold increment in the water-volume added to the process.
Throughout the simulation of the recovery process, samples were taken at several different time
points as implemented on site with the industrial partner for the manufacturing process (chapter
2.5 and figure 2.3). Samples taken from the simulation process were stored at 4◦C until protein
analysis was performed.
7.2.4 Simulation of Down Stream method - Ion Exchange Chromatography
The simulation of the first step of the down-stream process, an ion-exchange chromatography
method, was performed as described in chapter 10 in section 10.2.2.
7.2.5 Total protein quantification - Bradford
Total protein was quantified using the Bradford assay as described in chapter 3.2.2 and table 3.6.
Sample pellets were dissolved in EDTA-Tris buffer (1mM EDTA, 20mM Tris, pH 8.0) prior to
protein analysis. BSA dissolved in water was used as a reference standard for all total protein
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quantifications. The blank was chosen accordingly to the sample to be analysed, water, EDTA-
Tris buffer (1mM EDTA, 20mM Tris, pH 8.0) or diluted fermentation media.
7.2.6 Total Interferon-α-2b quantification
Total interferon-α-2b was quantified using SDS-PAGE as described in chapter 5.2.3 and 5.2.4.
Sample pellets were dissolved in EDTA-Tris buffer (1mM EDTA, 20mM Tris, pH 8.0) prior
to analysis as mentioned in the section above. No further sample treatment was required. The
interferon-α-2b drug substance was used as a reference standard for all quantifications.
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7.3 Results and Discussion
7.3.1 Dilution factor study
Chapter 4 and 5 discussed the characteristics of the primary protein recovery process performed
by the industrial partner. Two critical process steps (CPS) were discovered for total protein and
total interferon-α-2b recovery. CPS-1 was identified during cycle 1 of the recovery process and
is believed to be due to insufficient resuspension of precipitated proteins (HCP and IFN) due to
the low solubility of the proteins in water. CPS-2 was identified in cycle 2, where salting-out of
protein occurs not only in host cell proteins but also in interferon-α-2b. CPS-1 has been selected
as the more critical process step with a loss of 80% in total protein and 60% in interferon-α-2b.
Hence, a first step in the recovery process optimization is to look at the critical process step 1 and
to enhance the protein solubility in water.
Since the protein recovery process is performed at a manufacturing scale of 40,000L the optimiza-
tion steps need to be applicable to large scale and GMP production conditions. One relatively
straight forward method to increase the protein solubility is to dilute the samples by increasing
the volume. Accordingly, different dilution factors were tested to enhance the interferon-α-2b
solubility in water. Keeping the process volumes at manufacturing scale in mind, a two or three
fold dilution would be the highest realistic volume to be implemented on site with the industrial
partner.
Figure 7.1 shows the resuspended amounts of total protein and total interferon-α-2b in water du-
ring cycle-1 of the recovery process for different dilution factors. Dilution factor 1 represents the
actual conditions of the manufacturing process in cycle-1. Hence, a two-fold dilution correlates to
a doubling in volume.
The dilution experiment was performed as described in section 7.2.2. Each dilution factor was
performed in triplicate and figure 7.1 shows the average of these three runs for the collected super-
natant. The results show the protein fraction in % that was resolubilized during the experiment.
The total amount of interferon-α-2b (IFN), analysed with SDS-PAGE (section 7.2.6), shows an in-
crease from 32% at dilution factor of 1 up 50% for a dilution factor of 2. Thus the recovery of IFN
during CPS-1 can be improved from 32% up to 50% by simple dilution. However, it can be seen
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Fig. 7.1: Recovered amount of solubilized interferon-α-2b and total protein for different dilution factors
during Cycle 1 of the Recovery Process
that the increase in IFN-solubility is not linearly correlated with the dilution factor, as would have
been expected. The reason for the non-linear relationship may be due to protein-protein interac-
tions. Host cell proteins (HCP) represent a large fraction of total protein in the process samples and
therefore non-specific interactions with IFN proteins is likely. Some HCP have a lower solubility
limit in water compared to IFN, which might interfer with the solubilty of IFN, by co-precipitation
effects (section 7.1.2). This hypothesis is further supported by the detected IFN fraction at a 3-fold
dilution factor, where no increase in resolubilized IFN was observed even though the volume was
increased with corresponding decrease in concentration. This indicates that all ’free’ IFN-proteins
(those not interacting with HCP) are in solution at a 2-fold dilution factor, and the remaining IFN
protein interacts with HCP which have a much lower solubility limit in water. Hence these IFN
proteins remained in a precipitated form even though the volume was further increased.
The total amount of protein, analysed using the Bradford assay (section 7.2.5), remained constant
over the whole range of dilution factors at around 18 - 20%. This result is unexpected. From the
observations in chapter 4 and 5, it was expected that the solubility of total protein and interferon
would be similar, since they are following the similar concentration profiles throughout the re-
covery process. However, this is not the case, which supports the hypothesis, that some host cell
proteins have a much lower solubility limit in water. Host cell proteins with a high solubility limit
in water are resolubilized completely at a 1x dilution factor (section 7.1.1). The remaining 80%
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of HCP appears to have a much lower solubility limit in water and thus remained in precipitated
form even after the water level was increased.
One may wonder why the increment of interferon at different dilution factors cannot be seen in
the total protein results. The reason is probably due to the small amount of IFN compared to total
quantity of proteins, with interferon representing less than 5% of total protein. Hence, the small
changes in the amount of interferon would not be significant compared to the total protein concen-
tration.
Since the IFN solubility increases with a doubling of the dilution factor, whereas the total amount
of protein remained constant, the ratio of HCP to IFN is changing. At a dilution factor of 1-fold,
which represents the working conditions at manufacturing scale, interferon-α-2b represents only
8.5% of total protein. With an increment in IFN due to an increase in the dilution factor, this ratio
between HCP and IFN changes and interferon represents 13.4% of total protein at a 2-fold dilution
factor. This means that interferon represents a higher fraction of the total amount of protein and
it needs to be investigated how this interfers with the subsequent salting-out step of the recovery
process. This impact will be investigated in a simulation of the recovery process in a small scale
model in the following section.
7.3.2 Small scale recovery process model
In order to verify the observed results from the previous section, a simulation of the protein re-
covery process in a small scale model at 0.04L was performed as described in section 7.2.3. The
simulation was performed four-times and all samples taken throughout the recovery process were
analysed using SDS-PAGE for total interferon-α-2b (7.2.6) and Bradford assay for amount of total
protein (7.2.5). Cycle-1 to cycle-4 in the following figures represent the four different centrifu-
gation cycles throughout the recovery process (c.f. figure 2.2 of the primary protein recovery
process). The detected amount of protein at each cycle is the recovered protein fraction after the
centrifugation cycle.
Figure 7.2 shows the total amount of interferon-α-2b throughout the recovery process simulation
(steps cycle 1 to cycle 4) at small scale (0.04L) for the undiluted (1x dilution) and the twice diluted
samples (2x dilution).
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Fig. 7.2: The amount of total interferon-α-2b recovered throughout the simulated recovery process in a
small scale model at 0.04L-scale
The IFN results in figure 7.2 show an approximate 32% recovery after resolubilization in water
(cycle-2) for both, 2x and 1x diluted simulation runs. Hence, no improvement in protein solubility
could be observed due to increasing the volume. This result is not consistant with the observation
from section 7.3.1, where an increment of 18% in IFN recovery was observed due to dilution
of the sample two-fold. One reason for this inconsitency in the amount of IFN may be due to
the quantification method to determine total IFN using SDS-PAGE. The results in chapter 5 have
shown that the average error in quantifying IFN reference standards with SDS-PAGE can be up
to 10%. Consequently it is possible that in the case of the simulation of the recovery process, the
recovered amount of IFN after resolubilization actually increased in the 2x diluted run compared
to the 1x diluted run, however the error in quantitative estimation using the SDS-PAGE method
resulted in an apparent lack of improvement.
Following resolubilization is the salting-out step in which protein recovery is represented by cycle-
3, figure 7.2. The results indicate a reduced loss of IFN in this step in the 2x diluted simulation
run. Although the amount of interferon is the same in cycle 2, the volume is doubled, cosequently
the IFN concentration is only half of the concentration as in the 1x diluted run. A lower protein
concentration can have an impact on the salting-out of proteins, where proteins precipitate due to
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protein-protein interactions (section 7.1.2). A lower protein concentration results in fewer protein-
protein interactions and consequently reduced protein precipitation. The observed enhanced IFN
recovery in the 2x diluted run can also be seen at the end of the recovery process in the TCA-
pellet (cycle-4), where 17% of total IFN was recovered in the 2x diluted simulation compared to
only 10% recovery of IFN in the 1x diluted run. However, care should be taken in interepreting
this result, since the error bars, which result from the four performed iterations of the recovery
process simulation overlap each other. This indicates that the detected differences are probably
not significant. The challenge with the small scale model is the very small volume of 0.04L. At
this scale small errors can have a big impact on the results, as has been seen previously in chapter
3. Increasing the volume of the recovery process simulation, would be expected to increase the
precision of the results. To verify the significance of the findings of this section, the process
simulation needs to be performed at larger scale (see section 7.3.3).
Figure 7.3 shows the total amount of protein throughout the recovery process simulation at small
scale (0.04L) for the undiluted (1x dilution) and twice diluted samples (2x dilution).
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Fig. 7.3: Recovered amount of total protein throughout the simulated recovery process in a small scale
model at 0.04L scale
The recovered amount of total protein after the resolubilization step (in cycle-2) is 18 - 20%
PhD-Thesis from Tanja Buch 149
CHAPTER 7. PROCESS OPTIMIZATION - PROTEIN DILUTION STUDY
for both the 2x and 1x diluted simulation. These results are consistant with the findings of the
previous section 7.3.1. Consequently no significant improvement was observed in the recovery of
total protein due to the doubling of the volume, i.e. reducing the protein concentration to a value
potentially below the solubility limit. A similar result was observed for total protein results for the
salting-out step (cycle-3), where no significant differences were observed between the 2x and 1x
diluted runs. A similar amount of total protein precipitated during the salting-out step regardless
of the protein concentration. Overall, at the end of the recovery process simulation, the detected
total protein recovery is 7.3% in 2x diluted and 5.2% in 1x diluted run, which is not considered to
be significantly different.
Since the recovery process simulation at 0.04L scale demonstrateed an increase in total IFN reco-
very at the end of the process through a two-fold increase of the volume, a change in the HCP to
IFN ratio might be expected between the 2x and 1x diluted runs. However, the ratio of HCP to
IFN is in both cases comparable with a factor of 8.5 for 2x diluted simulation and a factor of 8.6
for the 1x diluted run. One reason for the similar ratio of HCP to IFN between both simulations,
is that the measured amount of total protein in 2x and 1x diluted run is similar. The amount of
interferon is only a small fraction of the total protein, hence the detected changes in IFN have no
significant impact on the HCP to IFN ratio.
Summarising the results of the recovery process simulation at 0.04L scale with a 2x and a 1x
dilution shows that while there is potential for an increase in IFN recovery through dilution in
cycle-1 no definite conclusion can be drawn, due to the large errors associated with the small scale
at which this simulation was performed. In order to further explore the potential to increase IFN
recovery through process sample dilution, a simulation at larger scale, with a working volume of
0.5L should provide more reliable and reproducible results.
7.3.3 Pilot Scale model at 500mL
Since the results of the recovery process simulation at 0.04L scale showed some inconsistencies,
the simulation with a 2x and 1x dilution was repeated at the larger scale of 0.5L in order to de-
termine wether more reliable and reproducible results could be determined. The recovery process
simulation was performed as described in section 7.2.3. Total interferon-α-2b was quantified u-
sing SDS-PAGE and total protein was quantified using the Bradford assay (see section 7.2.6 and
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7.2.5). The simulation was performed three times and the results shown in figures 7.4 and 7.5 are
the average values of these runs. As already described in section 7.3.2 above, in figure 7.4 and
7.5, cycle-1 to cycle-4 stand for the four different centrifugation cycles throughout the recovery
process (see figure 2.2 of the primary protein recovery process). The detected amount of protein
at each cycle represents the recovered protein fraction after the centrifugation.
Figure 7.4 shows the total amount of interferon-α-2b throughout the recovery process simulation
at 0.5L for the original volume ratio (1x dilution) and the double volume ratio (2x dilution).
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Fig. 7.4: Recovered total interferon-α-2b amount throughout the simulated recovery process in a small
scale model at 0.5L
The simulation at large scale (0.5L) shows an increase in IFN recovery after the second centrifu-
gation step due to a two-fold dilution of the process samples. After cycle-2, 60% of IFN was
recovered in the 2x dilution run compared with only 47% of IFN in the 1x dilution run. These
findings are consistant with the results from the dilution study (section 7.3.1), where a duplica-
tion of the volume resulted in an increase of IFN solubility of up to 15%, however, they are not
consistant with results received in the simulation runs at 0.04L scale. Since a large error (more
than±6%) is associated with the IFN recovery in the simulation at 0.04L scale, an increase in IFN
recovery of 15% at this point would be within the standard variations of the small scale simulation.
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Hence, the findings of the recovery process simulation at 0.5L are more reliable.
An unexpected result is the loss of interferon in the salting-out step for both dilution runs (1x and
2x), as seen for cycle-3 in figure 7.4. The loss of IFN in the 2x dilution run (50%) is even higher
than the IFN loss of the 1x dilution run (37%). Both runs had a similar salt concentration du-
ring the salting-out step at a conductivity of ≈10mS/cm. Since the 2x diluted simulation was less
concentrated in interferon (0.25g/L) than the 1x diluted run (0.32g/L), the salting-out of proteins
should have been less efficient (section 7.1.2). In order to understand this phenomenon fully, the
salting-out step during the protein recovery process needs to be characterized in more detail. For
example, the impact of salt concentration, pH and agitation time on the salting-out behaviour of
proteins. The results in chapters 4 and 5, showed that the salting-out had only a minor importance
in the optimization of IFN recovery and therefore the further characterization was not considered
to be a high priority.
The overall IFN recovery in both simulations is around 10%, without a significant difference be-
tween 0.04L and 0.5L scales. Hence, if the recovery process is performed with all 4 cycles, the
doubling of the volume during cycle 1 is not considered to be beneficial. However, one alternative
would be to perform only 3 cycles and leave out the salting-out step, which should improve the
IFN recovery of 15% when doubling the volume.
Figure 7.5 shows the total amount of protein throughout the recovery process simulation at 0.5L
scale for the original volume ratio (1x dilution) and the double volume ratio (2x dilution).
From figure 7.5 it can be seen that the amount of total protein and total interferon varried in a
similar way between the 2x diluted and 1x diluted runs. After the second centrifugation (cycle-2),
up to 50% of total protein was recovered in the 2x diluted simulation, which is a 20% increase
compared to the 1x dilution run. Hence, as a result of a two-fold dilution the recovery of total pro-
tein increased at this stage of the process. This finding is inconsistant with the previous findings
in the dilution study (7.3.1) or in the simulation at 0.04L scale (7.3.2). A reason for this may be
the low working volumes at 0.04L for the simulation at small scale and 0.005L for the dilution
experiments. As the results have shown (chapter 3), the accuracy and reproducibility of the recov-
ery process simulation increases with higher working volumes. Hence, the results obtained in this
section with the simulation at 0.5L working volume provide more reliable and reproducible results
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Fig. 7.5: Recovered total protein amount throughout the simulated recovery process in a small scale model
at 0.5L
for total protein.
During the salting-out step a similar observation was made for total protein and total interferon.
More protein salted-out in the less concentrated 2x diluted run, which is unexpected. The 2x di-
luted simulation run lost up 45% of total protein during the salting-out step and the 1x dilution
run lost up to 25% of total protein. As explained in the paragraph above this phenomenom needs
to be characterized in more detail in order to understand it completely. At the end of the recovery
process in the TCA-pellet the 2x and 1x diluted run recovered both around 5% of total protein
with no significant difference between them.
Looking at the ratio between host cell protein (HCP) and recombinant protein (IFN), there is no
significant difference detectable between the 2x and 1x dilution runs. The host cell protein behaves
in a similar way to the doubling of the volume as the recombinant protein, hence the same ratio of
HCP to IFN is generated throughout the simulation process.
Summarising the findings of the simulation of the recovery process, the duplication of the volume
during the resolubilization of precipitated protein (cycle-1) does improve the protein solubiliza-
tion. However, this enhancement in protein solubility is not protein specific and appears for the
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recombinant protein interferon-α-2b as well as for the host cell proteins of E.coli. The increased
loss of both IFN and HCP in the salting-out step due to increased volume, is unexpected. In order
to gain an increase in protein recovery throughout the recovery process, the process would need to
be shortened and performed without the salting-out step. This step should provide an improvement
of up to 15% in interferon recovery.
7.3.3.1 Recovery process simulation without the salting-out step
Section 7.3.3 showed an 15% increase in interferon solubility due to a two-fold dilution in cycle-1
of the recovery process. Unfortunately this increase got lost during the salting out step. Accord-
ingly it was suggested to perform the recovery process without the salting-out step. This section
discusses the results of the recovery process simulation without the salting-out step for a two-fold
dilution during cycle-1. Figure 7.6 showes the recovered protein fractions for the recovery process
simulation at 0.5l without the salting-out step for a two-fold and a one-fold dilution during cycle-1.
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Fig. 7.6: Recovery process simulation in a small scale model at 0.5L with a 2-fold dilution or 1x dilution
(control). Left side, shows the recovery of interferon throughout the simulation. Right side,
shows the recovery of total proteins.
Total proteins were quantified with Bradford assay as described in section 7.2.5 and total interferon-
α-2b was quantified with SDS-PAGE as described in section 7.2.6. As it can be seen in the left
image of figure 7.6, the recovery of interferon-α-2b gets improved from 40 to 60% recovery due
to a two-fold dilution in cycle-1. This observation confirms the findings of the previous section.
The improvement in interferon recovery persists until the end of the recovery process due to the
elimination of the salting-out step. Hence, the total interferon-α-2b recovery increased of 20% at
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the end of the recovery process in the presence of a 2-fold dilution in cycle-1 and in the absence
of the salting-out step.
The right image of figure 7.6 shows the total proteins recovered throughout the recovery process
simulation without the performance of the salting-out step for a two-fold and one-fold dilution in
cycle-1. Similar to the interferon results, total protein solubility is improved during cycle-1 from
30 to 50% due to a two-fold dilution in this cycle. These results confirm the findings from the
previouse section. The improvement in total protein recovery also persist until the end of the re-
covery process in the absence of the salting-out step. Hence, the TCA-pellet shows a 20% increase
in total protein recovery due to a two-fold dilution in cyle-1 and the elimination of the salting-out
step.
In summary, the total interferon-α-2b and total protein recovery can be improved up to 20% at the
end of the recovery process due to a two-fold dilution during cycle-1 and the elimination of the
salting-out step. With the absence of the salting-out step, the ratio between host cell proteins and
interferon in the final TCA-pellet did change. More host cell proteins are present in relation to
interferon-α-2b, which can have an impact on the down-stream process and it needs to be further
investigated.
7.3.4 Impact on Down-Stream Processing (DSP)
In section 7.3.3 the impact of a two-fold dilution in cycle-1 of the recovery process on the inter-
feron recovery was investigated. In the presence of the salting-out step no significant improvement
in IFN recovery was detectable. However, in the absence of the salting-out step a 20% improve-
ment in the interferon recovery at the end of the recovery process was detected. Due to the elim-
ination of the salting-out not only the interferon recovery was improved but also the recovery of
total protein and thus host cell proteins. The presence of higher fractions on host cell proteins can
interfer with the down-stream purification methods. Hence, this section focusses on the impact of
a two-fold dilution during cycle 1 of the recovery process and the absence of the salting-out step
on the first step of the down-stream process.
The first step of the down-stream process is an ion-exchange method with a SP sepharose column.
All experiments were performed as described in section 7.2.4. The TCA-pellets of the recovery
process simulation at 0.5l with a 2x and 1x dilution during cycle-1 and in the absence of the salt-
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ing out step, were used for the purifications with the ion-exchange method. The recovered total
interferon-α-2b and total proteins in the different fractions are shown in figure 7.7. Total inter-
feron was quantified by SDS-PAGE as described in section 7.2.6 and total protein was quantified
by Bradford assay as described in section 7.2.5.
Fig. 7.7: Recovered total interferon-α-2b throughout the simulation of the first down stream step, an IEC
method. TCA-pellet used for this purification derived from RP-simulation without the
performance of the salting-out step. Left side: RP-simulation with a 2-fold dilution factor; right
side: RP-simulation without dilution, control
The left image of figure 7.7 shows the total interferon and total protein recovered in the differ-
ent fractions of the purification run with the TCA-pellet of the recovery process simulation and a
two-fold dilution in cycle 1. It can be seen that over 50% of the initial interferon loaded onto the
column does not bind to the column and is detected in the flow through. Further 20% are detected
in the wash- and strip-sample and only 30% of the inital loaded interferon-α-2b is recovered in
the elution fractions 7-12.
Comparing these findings with the results obtained with the TCA-pellet of the recovery process
simulation with a one-fold dilution in cycle 1 and the absence of the salting-out step, no signifi-
cant differences can be observed (see right image of figure 7.7). This indicates that the addition
of a two-fold dilution during cycle-1 of the recovery process has no significant impact on the first
purification step of the down-stream process.
The TCA-pellets received from the recovery process simulation with a 2x and 1x dilution dur-
ing cycle-1 and in the presence of the salting-out step were also purified with the ion-exchange
method. Results of recovered interferon and total protein showed comparable results to the fin-
dings of figure 7.7. Hence, the absence of the salting-out step has no significant impact on the first
purification step of the down-stream process.
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In summary, the addition of a two-fold dilution during cycle 1 of the recovery process and the
absence of the salting-out step showed no significant impact on the interferon purification during
the first step of the down-stream process. In the elution fractions 7-12 over 30% of the initial
amount of interferon loaded onto the column is recovered, which is comparable to the findings
with the control sample (no dilution and salting-out step present).
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7.4 Conclusion and Outlook
In this chapter the optimization of the primary protein recovery process with a dilution step during
cycle 1 was discussed. The findings between the simulation runs of the recovery process at 0.04L
and 0.5L were inconsistant. Experiments operated at smaller scales (below 0.1L) show larger
variations in reproducibility and the results are therefore considered less reliable. Hence, the
simulation was performed at a larger scale of 0.5L which resulted in more reliable and reproducible
results with smaller variations.
An improvement of up to 15% in total interferon-α-2b and total protein solubility during cycle-1
was detected in the simulation run at 0.5L due to a two-fold dilution. However, the increased
protein recovery during cycle-1 is subsequently lost during the salting-out step. Hence, in order to
achieve an optimized process with increased interferon recovery, the process needs to be shortened
and the salting-out step discarded. As a result an increase in interferon and total protein recovery
should be achieved due to dilutions at cycle-1.
The addition of a two-fold dilution during cycle 1 in the absence of the salting-out step resulted
in a 20% increase in the interferon recovery at the end of the recovery process compared to a 1x
dilution during cycle-1. Hence, the elimination of the salting-out step and the addition of a two-
fold dilution in cycle-1 results in 60% recovery of the initial interferon-α-2b amount at the end of
the recovery process.
The impact on the first step of the down-stream process of a two-fold dilution during cycle-1
of the recovery process and in the presence or absence of the salting-out step was investigated.
None of the factors, neither the two-fold dilution nor the absence of the salting-out step, showed
a significant impact on the first purification step for interferon-α-2b. Thirty percent of the initial
interferon-α-2b loaded onto the column was recovered in the elution fractions for all samples.
The next step in the recovery process optimization with a two-fold dilution is the investigation
of an impact of the absence of the salting-out step on the interferon isoform distribution. Only
interferon-α-2b and isoform-4 can be used as the final drug substance at the end of the process.
Hence, the impact on the isoform distribution needs to be analysed. However, a more accurate
quantification method with higher resolution needs to be developed first (as discussed in chapter
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6).
Furthermore, a next step in the process optimization is the implementation at large/ manufacturing
scale. So far all experiments were performed at small scale of 0.500l. In a next step the two-fold
dilution during cycle-1 needs to be applied at pilot scale between 50 - 300 liters scale followed by
the implementation at manufacturing scale at 9000 liters. Due to the optimized recovery process,
the TCA-pellet should be more concentrated in interferon-α-2b. Hence, the impact of a more con-
centrated TCA-pellet on the down-stream process needs to be investigated. If the chromatographic
columns of the purification steps are overloaded due to higher concentrations of interferon-α-2b,
the TCA-pellet can be split in half and the down-stream process is performed twice. That way no
additional changes need to be implemented for the down-stream process.
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Chapter 8
Process Optimization - Solubility Study
with Detergents
8.1 Introduction
This chapter focuses on the application of different detergents to improve the protein solubility
throughout the primary protein recovery process of interferon-α-2b. Previous chapters (4 and
5) have shown that the low recovery yield of IFN at the end of the recovery process is mainly
due to low solubilisation levels of the protein during cycle-1 of the process. In order to improve
the protein solubility and hence the protein recovery, different detergents will be tested for their
potential to increase interferon-α-2b solubility.
8.1.1 Detergents
Detergents are water-soluble amphiphiles, containing hydrophilic and lipophilic parts, which have
the capacity to solubilize lipids, proteins and other hydrophobic molecules. In this section the dif-
ferent characteristics of detergents will be described, as well as their role in protein solubilisation
followed by the application of specific detergents such as Sarkosyl and Zwittergent 3-14.
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8.1.1.1 Detergent Characteristics
Detergents belong to the class of surfactants which decrease the surface-pressure at the air-water
interface when added to an aqueous medium. Detergents usually have a polar head group and
a hydrophobic chain (tail). This structure is the key for their function as solubilisation agent.
In aqueous solution they form spherical micelle structures, with the hydrophobic chains facing
away from the water [105]. The polar head is interacting with the water and the hydrophobic tails
aggregates, leaving a highly organized structure [106]. Detergents were originally developed as
cleaning agents as soap [8]. In the last century they also found their application in the biochem-
istry of proteins [8].
Detergents can be classified according to their chemical structure which are divided into four major
groups: ionic detergents, bile acid salts, non-ionic detergents and zwitterionic detergents. Ionic
detergents have a net charge on their head group which is either positive or negative. They are
generally used for the complete disruption of cellular structures and denaturation of proteins. Bile
acid salts are a type of ionic detergents but without a hydrophobic chain. Their backbone con-
sist of rigid steroidal groups. Instead of spherical micelles, they form kidney-shaped aggregates
[105][107].
Non-ionic detergents consist of an uncharged hydrophilic head and hydrophobic chain (tail). They
are considered to be mild and non-denaturing and used for breaking protein-lipid interactions
rather than protein-protein interactions. Non-ionic detergents with short hydrophobic chains can
lead to protein deactivation and some non-ionic detergents do precipitate in the presence of certain
salt-ions and are pH sensitive [105][107].
Zwitterionic detergents combine the characteristics of non-ionic and ionic detergents and are usu-
ally non-denaturing and not pH-sensitive. The synthetic zwittergents are known as sulfobetains
who differ in their hydrophobic tail length [105][106].
Each detergent, independent of chemical structure, has five important characteristics which help to
select the most suitable detergent. These are: critical micelle concentration (cmc), critical micelle
temperature (cmt), kraft point, cloud point and aggregation number [105]. The cmc is the minimal
detergent concentration required to form micellar structures. The critical micelle concentration is
dependent on the length of the hydrophobic alkyl chain. With an increase in the chain length, the
cmc decreases. The cmc of a detergent is needed to identify the correct amount of detergent to be
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added to a protein solution in order to achieve efficient protein solubilisation. Too low detergent
concentrations, below the cmc, result in insufficient solubilisation of proteins and too high deter-
gent concentrations can interfere during further purification steps [106].
The cmt gives the minimum required temperature for the detergent to form micelles. Most deter-
gents have a very low cmt, blow 0◦C, hence they do not precipitate in the cold. However, the cmt
increases with long hydrophobic alkyl chains [107].
The kraft point is also dependent on the temperature. This point defines the temperature at which
micelles are in equilibrium and the solubility becomes equal to the cmc. In most cases the kraft
point and cmt are identical or similar [105].
The cloud point defines the temperature at which non-ionic detergents separate as a pure phase
from an aqueous solution. A low cloud point can be an advantage in the separation of the detergent-
protein complex and other cell and media components [105].
The aggregation number of a detergent is known as the number of monomers contained in a mi-
celle and can be calculated by [106]:
AggregationNo. = micellarMWmonomericMW (8.1)
The aggregation number is not just dependent on the molecular weight of the detergent but also
on the ionic strength of the buffer. With an increase in ionic strength the aggregation number is
increasing as well [107]. Hence, with an increase of salt in the buffer more detergents monomers
are required to form micelles and the solubilisation property of the detergent is decreasing.
Certain different factors influence the characteristics of the detergents, especially the salt concen-
tration and pH-value of the detergent buffer. An increase in the ionic strength of the detergent
buffer leads to a decrease of the cmc while the micellar size increases. Ionic detergents are more
sensitive to variations in the salt concentration than non-ionic and zwitterionic detergents. The pH
value of the buffer affects the micelle size of the detergent and their stability. Especially ionic de-
tergents tend to protonate in acidic pH environment which can lead to precipitation of the detergent
[107].
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8.1.1.2 Detergents in protein solubilisation
For almost 40 years detergents and surfactants are used in solubilizing membrane proteins. The
detergent used most often in membrane studies is the non-ionic polyoxyethylene detergent Triton
X-100 [108].
Proteins with a high level of hydrophobic parts, such as membrane proteins, have a low solubility
level in water. They aggregate in order to protect their hydrophobic parts. In the presence of
detergents, the hydrophobic tail of the detergent interacts with the hydrophobic domain of the
protein and protects it from aggregation. A detergent-protein complex is formed [106].
Different detergents have different abilities to solubilize certain proteins. Some detergents are
known to be more harsh and even denature proteins (ionic detergents), whereas other detergents
are milder and preserve the biological activity of the protein [109]. Figure 8.1 shows the tendency
of detergents to denature proteins dependent on the detergent charge, size and length of the alkyl
chain.
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Fig. 8.1: The tendency of a detergent to denature membrane proteins can be qualitatively understood by
considering the size and charge of the polar head group, as well as the length of the alkyl tail [8].
Figure 8.1 shows that with a decrease in size of the head group and length of the alkyl tail and
an increase in charge the detergent becomes more harsh and lead to protein denaturation. With
an increase in the length of the alkyl tails (hydrophobic) the detergent is milder and the ability of
protein solubilisation is increasing. Alkyl tail length of C-8 to C-14 are commonly used for pro-
tein solubilisation [8]. With an increase in the alkyl tail length the critical micelle concentration is
decreasing. Detergents with smaller cmc have usually a larger average micellar molecular weight
which makes them more challenging for removal [110].
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Several hundreds of detergents are available nowadays for the solubilisation of proteins (mem-
brane proteins) and each of them shows different potential to solubilize different proteins. A few
characteristics should be considered by selecting the detergent to use. First, if the detergent needs
to be removed post-solubilisation step, detergents with high cmc and low molecular weight are
favourable. Those detergents are more easily to be removed by dialysis or ultrafiltration. How-
ever, if the cmc is too high, the required detergent concentration added to receive solubilisation is
increasing as well [107]. Another factor is the detergent property to absorb A-280. This might be
beneficial for detergent quantification but it can also interfere with the protein-analysis. Neverthe-
less, it should be considered during the selection for the right detergent [107].
If the solubilisation step follows an ion-exchange chromatographic or electrophoresis step, charged
detergents from the ionic-family should be avoided and non-ionic or zwitterionic detergents are
favourable [105]. The same applies for process steps requiring strong acidic environments with
low pH. In this case anionic detergents should be avoided since they form insoluble complexes
(precipitates) at low pH [105]. Other parameters that should be considered are temperature and
ionic strength of the buffer. Some detergents are unstable at low temperature and the solubility
potential of detergents is usually decreasing by the addition of large salt concentrations [105].
After selecting the best possible detergent, the detergent-protein ratio needs to be determined. In
general, to receive successful protein solubilisation, the detergent concentration is operated near
or at the critical micelle concentration of the detergent [105]. However, as a guide a concentration
of 1.0mg/ml of detergent is sufficient to solubilize 1.0mg/ml of protein [111].
Summarizing, the selection of the best detergent for the solubilisation of different proteins is de-
pendent on several factors. Sometimes more than one detergent fulfils the criteria and different
detergents need to be tested for their solubilisation potential in a small scale study.
8.1.1.3 Specific detergent for protein solubilisation
Five different detergents from all four groups were tested for their solubilisation potential of
interferon-α-2b during the primary protein recovery process. These are Triton X-100 (non-ionic),
Sodium-Deoxycholate (bile-acid salt), CHAPS (zwitterionic), Lauroylsarcosinate (anionic) and
Sulfobetains 3-08 - 3-16 (zwitterionic).
Triton X-100 is the detergent most widely used in protein membrane solubilisation. It has the
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advantage of a low critical micelle concentration, hence only small amount of Triton are required
to enhance protein solubility. On the other hand a low cmc results in high aggregations num-
bers and average micellar weight (MMW) which makes it more difficult to remove the detergent
from process samples. Sodium-deoxycholate is an ionic detergent and more precise a bile acid-
salt detergent. Its cmc is 4-8mM, more than 5 times higher than the cmc of Triton but conse-
quently the aggregation number and the MMW are reduced which makes them easier to remove
from process samples. CHAPS, chemical name 3-[(3-Cholamidopropyl)dimethylammonio]-1-
propanesulfonate, is a zwitterionic detergent, meaning it combines both characteristics of ionic
and non-ionic detergents. The physical properties, however, are similar to the detergent Deoxy-
cholate. The properties of Sarkosyl (Lauroylsarcosinate) and Zwittergent 3-14 will be discussed
in more details in the following two sections. Table 8.1 contains the physical properties of all five
detergents for the molar mass (MM), critical micelle concentration (cmc), aggregation number
(AGG) and the average micellar molecular weight (MMW). All values are given for room temper-
ature between 20 and 25◦C [16].
Tab. 8.1: Overview of physical properties of five different detergents. All values are given for room
temperature between 20 - 25◦C, [16]
Detergent MM [g/mol] cmc [mM] AGG MMW [Da]
Triton X-100 625.0 0.2 - 0.9 100 - 155 80’000
Deoxycholate 414.6 4 - 8 4 - 10 1’700 - 4’200
CHAPS 614.9 6 - 10 4 - 14 6’150
Sarkosyl 293.4 14.6 2.0 600
Zwittergent 3-14 363.6 0.1 - 0.4 83 30’000
Sarkosyl
N-laurylsarcosine (Sarkosyl) is an anionic detergent which is used for over 20 years in the solu-
bilisation of membrane proteins. Sarkosyl has a high critical micelle concentration of 14.6mM,
which has the consequence of high detergent concentrations in the process samples of up to 10%
Sarkosyl (340.8mM) [112]. However, due to the high cmc the average micellar molecular weight
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is very low (600Da) and thus the detergent is easily removed from process samples by dialysis or
ultrafiltration.
Leinwand et al (1991) [113] described the use of Sarkosyl in generating soluble proteins after
bacterial expression. Sarkosyl shows high potential to disrupt coaggregates between the target
recombinant protein and membrane proteins and to prevent those formations. However, Sarko-
syl has the disadvantage of having a carboxylic acid function. Hence it will protonate quickly at
relatively week acidic pH values [107].
Zwittergents
Zwittergent 3-14 belongs to the synthetic zwitterionic detergents, which are known as sulfobe-
taines [106]. Several different sulfobetaines exist with different length in their alkyl chain. Most
common ones are SB-3-08, SB-3-10, SB-3-12, SB-3-14 and SB-3-16. The potential for protein
solubilisation is increasing with the length of the alkyl chain, however, with an increase in the
alkyl chain the detergent stability is decreasing. Zwittergent 3-14 has a low critical micelle con-
centration with only 0.1 - 0.4mM, thus the average micellar molecular weight is quite high with
30’000Da and the detergent is difficult to remove from process samples [16].
Croze et al (1995) [114] used Zwittergent 3-14 throughout the purification of recombinant human
interferon-β. The author could show, that Zwittergent 3-14 is a nondenaturing and pH insensitive
detergent and the target protein remained its bioactivity at the end of the purification step. For
solubilisation purposes Zwittergent 3-14 was used at a concentration of 2.5% (68.76mM), which
is more than 150 times higher than the critical micelle concentration.
8.1.2 Design of Experiment
Design of Experiment was used for the optimization of protein solubility in the presence of deter-
gents. The software MODDE 10.0 from Umetrics supported the selection of the best design and
in the statistical analysis of the data. More information on the statistic background and different
experimental designs can be find in section 6.1.3.
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8.1.3 Aim and goals
The aim of this chapter is the optimization of the interferon-α-2b recovery throughout the primary
protein recovery process, by the addition of a detergent in cycle-1 to increase protein solubil-
ity. First, five different detergents will be tested for their potential to improve the solubility of
interferon-α-2b. Second, the optimal concentration of selected detergents, process volume and
agitation time will be determined using Design of Experiment and the software MODDE 10.0
from Umetrics. In a final step, the two selected detergents will be added to the primary recovery
process at the optimal determined concentration and the impact of the following recovery process
steps will be investigated in a small scale model. A discussion of the impact of the addition of
the detergents on interferon-α-2b and total protein recovery throughout the different steps of the
recovery process will be followed.
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8.2 Material and Methods
8.2.1 List of Materials
Tab. 8.2: Materials and suppliers
materials supplier
Recovery Process samples industrial partner
(EOF, and Sample-4)
interferon-α-2b drug substance industrial partner
NaOH Sigma Aldrich
Trizma Base Sigma Aldrich
EDTA tetrasodium salt VWR
Bovine serum albumin (BSA) Sigma Aldrich
Sarkosyl Sigma Aldrich
Zwittergent 3-14 Sigma Aldrich
Triton-X-100 Sigma Aldrich
CHAPS Sigma Aldrich
Na-Deoxycholate Sigma Aldrich
Zwittergent 3-08 - 3-16 Merck
Bradford Reagent Sigma Aldrich
Pierce R© BCA Protein Assay Kit Thermo Scientific
8.2.2 Protein solubilisation with detergents
The protein solubility experiments with detergents were performed using recovery process samples
from the manufacturing process. Sample time point 4 was selected for this purpose (compare
figure 2.3 in chapter 2.5). The sample 4 was thawed in a water bath at 37◦C and then centrifuged
in a bench top centrifuge (FL40R centrifuge, Thermo Scientific, Dublin, Ireland) at 7500rpm for
30 minutes and 4◦C. Supernatant was discharged and the pellet was dissolved in the detergent
solution according to the volume ratio of the manufacturing process (table 3.7). The detergent
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solution was prepared with water and the appropriate concentration of the different detergents.
After setting the pH to 7.0 with NaOH the sample was mixed for 4 hours constantly. To collect the
resuspended proteins, the sample was centrifuged again at 7500rpm for 30min and 4◦C and both
fractions, supernatant and pellet, were recovered and stored for protein analysis at 4◦C.
All experiments were performed in 50mL centrifuge tubes at a working volume of 5mL for the
resolubilization part.
8.2.3 Simulation of the Protein Recovery Process
The simulation of the recovery process (RP) is based on the primary protein recovery process
from the industrial partner as described in chapter 3.2.3. The original process is performed with a
working volume of 32’500L which was scaled down to 0.04L and 0.5L (table 3.7).
For the performance of the process simulation an end of fermentation (EOF) sample was used. The
EOF pellet originated from a small scale fermentation run performed from the industrial partner
and was shipped on dry ice to DCU. This pellet was resuspend in an EDTA-Tris-extraction buffer
(1mM EDTA, 20mM Tris, pH 8.0) in DCU to proceed with the simulation of the recovery process.
In order to implement the addition of a detergent into the original recovery process, the water
was replaced by the appropriate detergent solution in cycle-1 in order to resolubilize the protein
precipitates from the acid kill. The detergent solution was prepared with water and the required
concentration of detergent.
Throughout the simulation of the recovery process samples were taken at different time points as
it has been implemented on site with the industrial partner for the manufacturing process (chapter
2.5 and figure 2.3). Samples taken from the simulation process were stored at 4◦C until protein
analysis was performed.
8.2.4 Total protein quantification - BCA
Total protein was determined using the BCA assay as described in chapter 3.2.2 and table 3.5.
Sample pellets were dissolved in EDTA-Tris buffer prior to protein analysis. BSA dissolved in
water was used as a reference standard for all total protein quantifications. The blank was chosen
according to the sample to be analysed, which differs between water, EDTA-Tris buffer (1mM
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EDTA, 20mM Tris, pH 8.0), detergents or diluted fermentation media.
8.2.5 Total Interferon-α-2b quantification
Total interferon-α-2b was quantified using SDS-PAGE as described in chapter 5.2.3 and 5.2.4.
Sample pellets were dissolved in EDTA-Tris buffer (1mM EDTA, 20mM Tris, pH 8.0) prior to
analysis as described in section 8.2.4. No further sample treatment was required. The interferon-
α-2b drug substance was used as a reference standard for all quantifications.
8.2.6 Detergent quantification
Sarkosyl and Zwittergent 3-14 were quantified with RP-HPLC and UV-280 detection for Sarkosyl
and RI detection for Zwittergent 3-14. More details for the quantification procedure can be found
in section 9.2.5.
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8.3 Results and Discussion
8.3.1 Different detergents
In chapters 4 and 5, two critical process steps from the primary recovery process were identified.
CPS-1 was identified to have the biggest impact on the interferon loss throughout the process,
due to low protein solubility in water. In chapter 7, an increase of the volume during CPS-1 was
investigated in order to improve the protein solubility. Results showed an improvement from 32%
to 47% in interferon recovery after CPS-1 due to a two-fold dilution.
The enhancement in IFN solubility of about 15% due to dilution requires further improvement.
Detergents are well described in the literature to improve protein solubility, particularly for mem-
brane proteins or several recombinant proteins (section 8.1.1.1). As described in section 8.1.1.1,
detergents form micelles and interact with the protein to form a protein-detergent complex. There-
fore 5 different detergents, known from the literature to improve protein solubility, were investi-
gated and tested for their potential to improve interferon-α-2b solubility.
Figure 8.2 shows the amount of interferon resolubilized after the addition of the different deter-
gents.
water (neg.control) Triton-X-100 (3%) CHAPS (2.5%) Zwittergent 3-14 (1%)
Na-Deoxycholate (1.25%)
Sarkosyl (3%)
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Fig. 8.2: Interferon-α-2b solubility in different detergents: non-ionic (Triton X-100), zwitter ionic
(CHAPS and Zwittergent) and an-ionic (Na-Deoxycholate and Sarkosyl)
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The detergent solubility experiment was performed as described in section 8.2.2 and total interferon-
α-2b was quantified using SDS-PAGE as described in section 8.2.5. Different types of deter-
gents were tested: non-ionic detergents (Triton X-100), zwitter ionic detergents (CHAPS (3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate) and Zwittergent 3-14), and an-ionic de-
tergents (Na-Deoxycholate and Sarkosyl [Sodium lauroyl sarcosinate]). All selected detergents
were found in literature to improve protein solubility (section 8.1.1.3), at the concentrations used.
All detergent concentrations are well above their cmc (critical micelle concentration) to ensure mi-
celle formations (section 8.1.1.3, table 8.1). As can be seen from figure 8.2 some detergents have
a higher potential to improve interferon solubility than others. Triton X-100 and CHAPS have no
positive impact on IFN solubility. Indeed the results for 20% Triton and 25% CHAPS showed that
the IFN solubility was even below the solubility level of the negative control (32%; IFN solubil-
ity in water without detergent present). Sodium-Deoxycholate, on the other hand, does improve
the IFN solubility to a value of 60%, which is an enhancement of 28% compared to the negative
control. The highest potential to improve interferon solubility was demonstrated by Zwittergent
3-14 and Sarkosyl which showed more than 80% solubility of IFN, representing a 3-fold increase
compared to the negative control. Since Zwittergent 3-14 is a zwitter ionic detergent and Sarko-
syl an anionic detergent, the capability of detergents to improve the IFN solubility appears to be
independent of the net charge. Zwitter ionic detergents have no net charge and anionic detergents
have a negative net charge (section 8.1.1.1).
This leaves the question as to why do some detergents have a higher ability to improve the IFN
solubility than others? From literature studies (section 8.1.1.1), the chemical structure of the de-
tergents does appear to have an important role in their function and capability to improve protein
solubility. Figure 8.3 shows the different chemical structures of the 5 detergents tested in figure
8.2.
Looking at the chemical structures of the detergents in figure 8.3, some parallels can be seen
between the structure of Zwittergent 3-14 and Sarkosyl, the detergents showing the highest poten-
tial to improve IFN solubility. In the literature (section 8.1.1.1) it is suggested that the chemical
structure of the hydrophobic region of detergents, affects the structure of the micelles, which are
an important detergent characteristic in protein solubility. Compared to the other three detergents,
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Fig. 8.3: Chemical structure of different detergents: A) Triton X-100 - non-ionic; B) CHAPS -
zwitter-ionic; C) Zwittergent 3-14 - zwitter-ionic; D) Na-Deoxycholate - an-ionic; E) Sarkosyl -
an-ionic
Zwittergent 3-14 and Sarkosyl have a much longer hydrophobic carbon chain (tail). This tail seems
to be indispensable to improve interferon solubility. As discussed in section 8.1.1.1, an increase
in the length of the hydrocarbon chain results in an increase in the micelle size and a decrease of
the critical micelle concentration (cmc). This means that fewer detergent molecules are needed to
construct the micelle and increase protein solubility.
To investigate the dependency of the hydrocarbon length on interferon solubility, different Zwit-
tergents (all at 1%) which only differ in their hydrocarbon length were tested for protein solubility.
The results can be seen in figure 8.4.
Zwittergent 3-08 means that this Zwittergent has a hydrocarbon chain composed of 8 carbon-
atoms, Zwittergent 3-10 chain has 10 carbon atoms and so on. As seen in figure 8.4 the IFN
solubility increases with an increase in the hydrocarbon chain of the Zwittergent. This result con-
firms the suggestion, that the hydrocarbon chain has an important role in IFN solubility, which was
mentioned earlier in this section. A short hydrocarbon tail of only 8 or 10 carbon atoms appears
to have no positive impact on the IFN solubility. However, by increasing to 12 carbon atoms in
the hydrocarbon chain the IFN solubility was enhanced up to 70%. With 14 or 16 carbon atoms
the IFN solubility could be increased even further to 90%, representing a 3-fold increment in IFN
solubility compared to the negative control without detergent.
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Fig. 8.4: Interferon-α-2b solubility in Zwittergent-solutions dependent on the length of the detergent’s
carbon chain (tail)
The study with different detergents has shown that Zwittergent 3-14 (at 1% concentration) and
Sarkosyl (at 3% concentration) have the highest potential to improve interferon-α-2b solubility by
up to 90%. The ability of detergents to increase protein solubility was indeed shown to be depen-
dent on chemical structure and length of the hydrophobic hydrocarbon chain. It was demonstrated
that for Zwittergents, a minimum of 12 carbon atoms in the hydrocarbon chain are required to
achieve sufficient interferon solubility. Sarkosyl has 11 carbons in its hydrocarbon chain.
In conclusion, an addition of either Zwittergent 3-14 or Sarkosyl during cycle-1 (CPS-1) of the
protein recovery process was shown to increase the interferon solubility from 32% to 90%.
8.3.2 Optimization of Interferon solubility with Sarkosyl
8.3.2.1 Design of Experiment Study for Sarkosyl
The results from section 8.3.1 showed that Sarkosyl has a high capability to improve the interferon-
α-2b solubility during cycle-1 of the recovery process. The next step was to identify the optimal
process conditions during cycle-1 for successful IFN solubilisation. Three factors were selected
for investigation: detergent concentration, process volume and agitation time. The optimal de-
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tergent concentration should be as low as possible but high enough to achieve at least 75% IFN
solubility.
In order to investigate the impact of the detergent concentration, agitation time and process volume
on interferon solubility, a design of experiment (DoE) study was performed with Sarkosyl. With a
DoE investigation the influence of each factor onto the different responses as well as on each other
can be investigated (section 8.1.2). A central composite face-centred design with 2 levels and 3
factors was chosen for this investigation. The different parameters that were investigated for the
optimisation of the interferon solubility with design of experiment can be found in table 8.3 and
the full DoE worksheet, which lists all experiments performed for this design can be found in the
appendix A.
Tab. 8.3: Design of Experiment paramters for the optimisation of interferon solubility
detergent detergent concentration [%] process volume [ml] agitation time [h]
Sarkosyl 0.1 - 3.0 10 - 45 2 - 8
The experiments for DoE were performed as described in section 8.2.2, the amount of total
interferon-α-2b was quantified using SDS-PAGE as described in section 8.2.5 and total amount of
protein was analysed using the BCA assay as described in section 8.2.4.
Figure 8.5 shows a response surface plot of the interferon solubility as a function of Sarkosyl
concentration and process volume, generated with the statistic software MODDE 10.0. Factor 1
represents the Sarkosyl concentration in % shown on the x-axis, factor 2 illustrates the process
volume, plotted on the y-axis and the third factor describes the agitation time which is set to a
fixed value of 5 hours in figure 8.5. The value of 100% volume represents the working conditions
in the recovery process at manufacturing scale. Hence, 150% of the volume is equivalent to a
1.5-fold dilution factor as described in chapter 7. Two responses were measured during this DoE
investigation: solubilized amount of total interferon (z-axis) and the solubilized amount of total
protein (data not shown). The model used to generate figure 8.5 is dependent on the detergent
concentration, the process volume, the quadratic detergent concentration and the interaction be-
tween detergent concentration and process volume. The goodness of fit is 0.987, the goodness of
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prediction equals to 0.973 and the model validity is at 0.730. All these parameters indicate that
the model is robust and useful to provide reliable estimations of the interactions between detergent
concentration, process volume and interferon solubility (section 6.1.3.2). More details about the
statistics of this model can be found in the appendix A.
Fig. 8.5: Interferon-α-2b solubility as a function of Sarkosyl concentration [%] and process volume [%]
with a constant agitation time of 5.0h. Data generated with MODDE software 10.0
As seen in figure 8.5 the interferon solubility is highly dependent on the Sarkosyl concentration.
An increase in the detergent concentration results in an increase in the IFN solubility, with a max-
ima at 2.7% of Sarkosyl and 90% IFN solubility. The IFN solubility is also dependent on the
process volume. As discussed in chapter 7, an increase in process volume results in an enhance-
ment of the IFN-solubility. The impact of the volume increases with detergent concentration.
The impact of Sarkosyl concentration on IFN solubility is expected, since with higher detergent
concentrations more micelles can be formed which avoids or breaks-up protein aggregations to
enhance protein solubility.
The agitation time was shown to have no significant impact on the IFN solubility and even could
be removed from the model. This means that the agitation time during cycle 1 of the recovery
process (figure 2.2) can easily be shortened to 2 hours without a significant reduction in interferon
solubility.
All data were also analysed for total protein and the results show similar interactions of detergent
concentration, process volume and agitation time on total protein solubility as they show for total
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IFN (data not shown). The DoE results and statistics for the total protein model can be found in
the appendix A.
In summary, the optimal conditions for maximal interferon solubility are an increased process vol-
ume of 150% (dilution factor 1.5) and a Sarkosyl concentration of 2.7 - 3.0%. The next question is
what impact has the presence of Sarkosyl on the salting-out step of the recovery process? Hence,
a simulation of the recovery process at small scale was performed with the addition of Sarkosyl
during cycle-1. This will be discussed in the following section 8.3.2.2.
8.3.2.2 Process simulation with 3.0% Sarkosyl
In the previous section the optimal process conditions for cycle 1 were identified in order to im-
prove interferon-α-2b solubility to enhance the overall IFN recovery in the primary recovery pro-
cess. Agitation time and process volume were identified to be less important and therefore set to
their working conditions at the manufacturing process. The detergent concentration showed the
biggest impact on IFN solubility. The optimal Sarkosyl concentration was identified to be at 3.0%.
In this section the impact of the addition of Sarkosyl during cycle-1 on the recovery process will
be investigated.
The simulation of the recovery process was performed as described in section 8.2.3, total IFN was
quantified using SDS-PAGE as described in section 8.2.5 and total protein was quantified using
the BCA assay as explained in section 8.2.4. All results of different simulations of the recovery
process with Sarkosyl were performed at a small scale of 0.5L in triplicate.
Figure 8.6 shows the results for the amount of recovered interferon throughout the recovery pro-
cess simulation. The different cycles stand for the 4 centrifugation cycles performed throughout
the process (figure 2.2). The negative control was performed following the working conditions of
the manufacturing recovery process without any addition of detergent.
As can be seen from figure 8.6 the interferon recovery after centrifugation cycle 2 can be increased
3-fold, to 85% due to the addition of 3% Sarkosyl during cycle-1. Only 28% of IFN was recovered
at this point in the negative control. An interesting observation was made for CPS-2, the salting-out
step, in the presence of Sarkosyl. More than 50% of the recovered interferon from cycle-1 was lost
during the salting-out step and only 30% of IFN was recovered after the third centrifugation step.
Due to this enormous loss of interferon during the salting-out step, only 20% of overall interferon
PhD-Thesis from Tanja Buch 177
CHAPTER 8. PROCESS OPTIMIZATION - SOLUBILITY STUDY WITH DETERGENTS
Cycle 1 Cycle 2 Cycle 3 Cycle 4
0
20
40
60
80
100
Fig. 8.6: Interferon-α-2b amount throughout the recovery process simulation at 0.5L with and without the
addition of 3% Sarkosyl
was recovered at the end of the recovery process in which 3% Sarkosyl was present. However,
this is still 3 times higher than for the negative control with only 7% of total IFN recovery in the
TCA-pellet.
Since the major loss of IFN was detected during the salting-out step, the impact of CPS-2 on
interferon and Sarkosyl was analysed in more detail. Experiments and a literature survey (section
8.1.1.3) showed that Sarkosyl is highly unstable in the presence of chloride ions. They also showed
that the pI of Sarkosyl is at 5.0, consequently at a pH of 5.0 and below, Sarkosyl precipitates and
with it a lot of proteins. Changing the acid used during the salting-out step from HCl to acetic acid
to avoid the addition of chloride ions gave no improvement in the overall IFN recovery due to the
low pH set point of 4.5 (data not shown).
It was also tested whether a lower starting concentration of Sarkosyl may minimize the interference
during the salting-out step. Hence, instead of using 3% of Sarkosyl during cycle-1, only 1% of
Sarkosyl was added, however no improvement during the salting-out step was observed (data not
shown).
From the total protein behaviour throughout the simulation in the presence of 3% Sarkosyl, it can
be seen (figure 8.7) that they follow the same characteristics as for total interferon.
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Fig. 8.7: The amount of total protein throughout the recovery process simulation at 0.04L in the presence
and absence of 3% Sarkosyl
The results seen in figure 8.7 are as expected since, as discussed in section 8.3.1 and 8.3.2.1, the
addition of Sarkosyl does not improve the solubility of a specific type of protein but affects the
host cell protein solubility in the same way as it does for interferon. Therefore no difference in the
amount of total protein throughout the recovery process was expected compared to the amount of
IFN. Since total protein and interferon behave in a similar way throughout the recovery process in
the presence of Sarkosyl, the HCP/ IFN ratio remained the same at the end of the process.
The process characterizations in chapter 4 and 5 have shown that the salting-out step has a less
significant role in the protein recovery process, than the other three cycles. Since the salting-out
step results in the biggest loss in interferon and total protein in the presence of 3% Sarkosyl, a
simulation of the recovery process was performed in the absence of the salting-out step. Results
of this simulation for total interferon and total protein are shown in figure 8.8.
Both graphs in figure 8.8, for total interferon and for total protein, show that without performing
the salting-out step (centrifugation cycle 3), the protein recovery at the end of the process could
be increased 2- to 3-fold, by the addition of Sarkosyl. More than 75% of total interferon and up
to 90% of total protein was recovered at the end of the recovery process in the presence of 3%
Sarkosyl but in the absence of the salting-out step. In the absence of the salting-out the ratio of
host cell proteins to interferon also changed. Without the salting-out step and Sarkosyl present the
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Fig. 8.8: The amount of interferon-α-2b (left) and total protein (right) throughout the recovery process
simulation without salting-out step at 0.04L in the presence and absence of 3% Sarkosyl
ratio of host cell protein to IFN increased to approximately 25%, showing that a higher fraction of
host cell proteins are present. A shift of 25% in the protein distribution may have an impact on the
downstream purification and need to be considered later.
Summarizing, an increase in IFN recovery to 20% at the end of the recovery process can be
accomplished by the addition of 3% Sarkosyl during cycle-1 of the process. However, the addition
of Sarkosyl only improves the critical process step 1 and does not improve the CPS-2 (salting-out).
Due to the addition of Sarkosyl this critical process step is even impaired and more than 55% of
total IFN is lost. Total protein behaves in a similar way to IFN throughout the recovery process
with Sarkosyl. Performing the recovery process without the salting-out step but with addition of
Sarkosyl, gives an interferon recovery of more than 75% and up to 90% in total protein. The ratio
of HCP to IFN changes by up to 25%, which may have a significant impact on DSP.
Sarkosyl characteristics throughout the recovery process simulation
The Sarkosyl concentrations throughout the recovery process simulation after the addition in
cycle-1 were quantified using the RP-HPLC method with UV detector as described in section
8.2.6. During cycle-1 of the recovery process 3.0% Sarkosyl is added to improve the protein solu-
bility at this stage of the process.
Results of the recovery process simulation in the absence of the salting-out step showed a 95%
recovery of Sarkosyl in the TCA-pellet, the last sample of the recovery process (data not shown).
Only minor amounts of Sarkosyl were detected in the waste streams. These results indicate, that
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Sarkosyl has a strong interactions with the proteins present in the recovery process, since they
follow both the same characteristics throughout the recovery process. The final Sarkosyl concen-
tration in the TCA-pellet is dependent on the volume used for solubilizing the pellet.
8.3.3 Optimization of Interferon solubility with Zwittergent 3-14
8.3.3.1 Design of Experiment Study for Zwittergent 3-14
The DoE investigation with Sarkosyl in section 8.3.2.1 showed that the agitation time has no sig-
nificant impact on the IFN solubility and the impact of the process volume is very little compared
to the detergent concentration. Hence, the DoE-design for the Zwittergent 3-14 investigation was
reduced to only one factor. Only the Zwittergent 3-14 concentration itself was taken into account
and varied between 0.009% and 2%. Figure 8.9 shows that the amount of solubilized interferon is
dependent on the concentration of Zwittergent 3-14. Several different concentrations were tested
in order to find the optimum to reach an IFN solubility of at least 75%. The results were compared
to the negative control, IFN solubility in DI-water, which represents 0.0% of Zwittergent 3-14.
0.0 % 0.009 % 0.5 % 1.0 % 2.0 %
0
10
20
30
40
50
60
70
80
90
Fig. 8.9: Interferon-α-2b solubility as a function of Zwittergent 3-14 concentration [%]; cmc = 0.011%
As expected from previous results, the IFN solubility increases with increasing Zwittergent con-
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centration, with a maximum between 0.5 - 1.0%. These results show that a maximum IFN solu-
bility can be achieved with a lower Zwittergent 3-14 concentration than with Sarkosyl. This can
be explained by the critical micelle concentration (cmc) of both detergents. The cmc of Sarkosyl
is 0.42% (14.6mM) which is much higher than the cmc of Zwittergent 3-14 with 0.011% (0.4mM)
(section 8.1.1.3). A higher cmc means that higher detergent concentrations are required to achieve
the micelle formations which are important for protein solubilisation.
An unexpected result was the high IFN solubility at only 0.009% of Zwittergent 3-14 which is
below the cmc value. This result shows, that even without formation of micelles, Zwittergent
3-14 has a high capability to improve the IFN-solubility. Increasing the detergent concentration
above 1.0% did not result in any significant improvement in IFN solubility, leaving the optimal
conditions for Zwittergent 3-14 between 0.5 - 1.0% for maximal interferon solubility.
8.3.3.2 Recovery Process simulation with Zwittergent 3-14
Results from section 8.3.1 showed that Zwittergent 3-14 also showed a high potential to improve
interferon solubility. In section 8.3.3.1 the impact of the detergent concentration on IFN solubil-
ity was investigated to find the optimal conditions to improve CPS-1 from the recovery process
simulation. The high solubility values of IFN for very small Zwittergent concentrations was un-
expected. Therefore the recovery process simulation was performed with 5 different Zwittergent
concentrations (2.0%, 1.0%, 0.5%, 0.1% and 0.001%) in a small scale model at 0.04L, as described
in section 8.2.3. Total interferon (section 8.2.5) and total protein (section 8.2.4) were analysed for
all sample time points taken throughout the simulation. The total amount of interferon in each
sample taken after a centrifugation step of the simulation are shown in figure 8.10.
Each of the simulation runs at 0.04L scale, shown in figure 8.10, are performed at least twice
and the average values are presented, except for simulation with 2.0% Zwittergent which was per-
formed only once. The results show that all Zwittergent concentrations, even those below the cmc,
gave a significant improvement in interferon solubility and recovery after the second centrifuga-
tion step compared to the negative control without detergent. For 0.001% of Zwittergent 3-14 an
increase of more than 20% in IFN solubility was found compared to the negative control. These
results confirm the findings from section 8.3.3.1. However, the increased IFN recovery during
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Fig. 8.10: The amount of interferon-α-2b throughout the recovery process simulation at 0.04L scale with
the addition of Zwittergent 3-14 during cycle-1 at 5 different concentrations
cycle-1 (CPS-1) is lost during the salting-out step (CPS-2) for simulations with Zwittergent 3-14
concentrations less than 0.5%. Due to the addition of salt (NaCl) and reduction of the pH to 4.5,
the solubility of interferon (as well as all other proteins) decreases, since salt-ions interact with the
water molecules (section 7.1.2). Detergent molecules also interact with the salt-ions and their po-
tential for protein solubilisation is reduced (section 8.1.1.2). Zwittergent 3-14 concentrations less
than 0.5% are too low to compensate the interference of salt ions and to keep the proteins (IFN) in
solution (section 8.1.1.2). Hence, interferon precipitates during the salting-out step if the Zwitter-
gent 3-14 concentration present in solution is below 0.5%. For simulation runs with a Zwittergent
3-14 concentration above 0.5% the loss of interferon during the salting-out was only around 20%.
Hence, more than 70% of total IFN was recovered at the end of the process simulation with 1.0%
or 2.0% of Zwittergent 3-14 present.
The previous simulation runs were only performed in a small scale model at 0.04L scale. Results
have shown that this scale provides less accurate and less robust results for the simulation of the
recovery process. Hence, a simulation of the recovery process was also performed at 0.5L scale
which should provide more accurate results. Since the simulation at 0.04L scale showed that 1.0%
Zwittergent 3-14 is the lowest detergent concentration with a high interferon recovery of at least
60%, this concentration was selected for the simulation at larger scale.
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Both simulations, with 1.0% Zwittergent and negative control, were performed in triplicate and
samples were analysed at each sample time point for total interferon and total protein. Figure
8.11 shows the results of total IFN and total protein after each centrifugation cycle of the recovery
process simulation.
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Fig. 8.11: Interferon-α-2b (left) and total protein (right) throughout the recovery process simulation at
0.5L in the presence and absence of 1% Zwittergent 3-14
The recovery process simulation at 0.5L scale confirms the findings of the simulation at 0.04L
scale with 1.0% Zwittergent 3-14. Around 80% of total interferon was recovered after the 2nd
centrifugation step, which is consistent with the findings in section 8.3.3.1. Due to the addition of
the detergent Zwittergent 3-14 during cycle-1 the interferon solubility is increased which results
in twice as much IFN recovery at the end of CPS-1 due to the Zwittergent addition. The next step,
salting-out step, was identified as the CPS-2 during the process characterization in chapters 4 and
5. In the absence of detergent up to 25% of total interferon is lost during this step. In the presence
of 1.0% Zwittergent 3-14 the loss in IFN remains constant and does not increase, as observed du-
ring simulations with Sarkosyl (see section 8.3.2.2). At the end of the recovery process simulation
with 1.0% Zwittergent more than 50% of total interferon was recovered, and only 7 - 8% with no
detergent present. Hence, the addition of 1.0% Zwittergent during cycle-1 of the recovery process
improved the total interferon recovery at the end of the process by more than 6-fold.
Comparing the results of total interferon with total protein throughout the recovery process, it can
be seen (figure 8.11) that total protein follows the same characteristics throughout the recovery
process with and without 1.0% Zwittergent present. More than 80% of total protein was solu-
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bilized during cycle-1 due to the addition of detergent, however more than half of this was lost
during the salting-out step. Hence, less than 40% of total protein was recovered at the end of the
recovery process with 1.0% Zwittergent present. This corresponds to a 5-fold increase in total
protein recovery due to the addition of a detergent in cycle-1.
Since more total proteins are salted-out during the salting-out step than total interferon, the ratio
between HCP and IFN changes when Zwittergent is present at the end of the recovery process.
In the absence of a detergent, only 8.5% of total protein represents interferon. However, with the
Zwittergent 3-14 present interferon represents up to 22% of the total protein. This ratio between
host cell proteins and recombinant proteins can have an impact on the subsequent purification dur-
ing the down-stream processing and variations in this ratio need to be considered at that stage.
The simulation with the addition of 1.0% Zwittergent 3-14 was also performed with a shortened
recovery process, without performing the salting-out step. Results showed a recovery of up to
70% in total interferon at the end of the recovery process and a recovery of 65% in total protein
(data are not shown). In the absence of the detergent 25% of IFN and 22% of total protein were
recovered. Hence, eliminating the salting-out step results in an even higher recovery of total in-
terferon at the end of the recovery process, but also in an increased recovery in total protein, the
majority of which are host cell proteins. The presence of increased host cell proteins might inter-
fere with the down-stream processing. Therefore it must be investigated whether the exclusion of
the salting-out step is beneficial for the interferon purification and the overall process yield.
During the characterization of the recovery process in chapters 4 and 5 significant variations were
detected in the production of proteins (HCP and IFN) during the fermentation process. These
variations can reach up to ±20% in total protein and total interferon. Therefore it is important to
consider these variations during process optimization. The recovery process was simulated using
the twice the amount of total protein (and IFN) at the beginning of the recovery process simulation
(2x protein). The simulation (at 0.04L scale) was performed with the addition of 0.5% and 1.0%
of Zwittergent 3-14 during cycle-1 as well as with a negative control, and can be seen in figure
8.12.
The results for total interferon throughout the recovery process in figure 8.12 show that with the
addition of 1.0% Zwittergent 3-14 during cycle-1 up to 55 - 60% of IFN is recovered at the end of
the recovery process even with a double protein concentration (2x) at the end of the fermentation.
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Fig. 8.12: The amount of interferon-α-2b throughout the recovery process simulation at 0.04L scale with
double and single amounts of protein at the beginning of the process and the addition of
different concentrations of Zwittergent 3-14
It can also be seen that with only 0.5% Zwittergent 3-14 present, the recovery of IFN is reduced at
the end of the recovery process, if the protein concentration is twice as high. With a double protein
concentration and addition of 0.5% Zwittergent 3-14, only 15% of total interferon is recovered at
the end of the recovery process. This is 40% less compared to the single protein concentration.
These findings confirm those from the beginning of this section. Results from figure 8.10 showed,
that if the detergent concentration present during the salting-out step is too low to compensate
the interference from the salt-ions and to keep all interferon in solution, a large amount of IFN is
salted-out. If the protein concentration is doubled at the beginning of the recovery process, 0.5%
Zwittergent is insufficient to keep all interferon in solution and protect them from the interference
from the salt-ions. However, the addition of 1.0% Zwittergent provides a sufficient concentration
to recover a similar percentage of the total interferon irrespective of protein concentration at the
beginning of the recovery process.
In summary, this section has shown that with the addition of 1.0% Zwittergent 3-14 during cycle-1
of the recovery process, the interferon recovery increased from 8% up to 52% at the end of the
recovery process, after all 4 cycles of the manufacturing process. This enhancement is indepen-
dent of the protein concentration at the beginning of the recovery process, which can differ due to
variations in the protein production during fermentation. A reduction of the process cycles, hence,
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elimination of the salting-out step, results in an even higher interferon recovery of 70%.
Zwittergent 3-14 characteristics throughout the recovery process simulation
The Zwittergent 3-14 concentrations throughout the recovery process simulation after the addition
in cyle-1 were quantified using the RP-HPLC method with RI detector as described in section
8.2.6. During cycle-1 of the recovery process 1.0% Zwittergent 3-14 is added to improve the pro-
tein solubility at this stage of the process.
Figure 8.13 shows the recovered Zwittergent 3-14 fractions throughout the recovery process sim-
ulation at a scale of 0.5l.
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Fig. 8.13: Recovered Zwittergent 3-14 fractions throughout the recovery process simulation at a scale 0.5l.
Left: process simulation in the absence of the salting-out step. Right: process simulation in the
presence of the salting-out step
The left image of figure 8.13 shows the Zwittergent 3-14 characteristics throughout the recovery
process in the absence of the salting-out step. More than 90% of the initial Zwittergent 3-14 is
recovered after the centrifugation step post cycle-1. This is as expected, since the detergent was
added in order to keep the proteins in solution and to recover them in the supernatant after the
centrifugation. During the next centrifugation step only 60% of the Zwittergent 3-14 is recovered
in the TCA-pellet and 40% of the initial Zwittergent 3-14 remains in solution and is detected
in the supernatant. These findings indicate that the interaction between proteins and detergent
gets disturbed by the addition of TCA and only 60% of the present detergent concentration is
precipitating with the proteins. However, the results can also indicate that only 60% of the overall
present detergent molecules are in interactions with the proteins and only that detergent fraction
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gets precipitated.
Anyhow, only 60% of the Zwittergent 3-14 added during cycle-1 is found in the TCA-pellet at the
end of the recovery process in the absence of the salting-out step. The final detergent concentration
in the TCA-pellet is dependent on the volume used for solubilizing the pellet.
The right image of figure 8.13 shows the Zwittergent 3-14 characteristics throughout the recovery
process in the presence of the salting-out step. More than 90% of the Zwittergent 3-14 added
during cycle-1 is recovered after the centrifugation in cycle-2. This observation confirms the
findings of the Zwittergent 3-14 characteristics in the absence of the salting-out step. Further,
during the salting-out step in cycle-3 an additional 20% loss in Zwittergent 3-14 was observed.
This reduction in Zwittergent 3-14 corresponds to the loss in interferon and total protein detected
during the salting-out step in the presence of Zwittergent 3-14, as discussed in the previous section.
It is likely that the lost Zwittergent 3-14 molecules during the salting-out step precipitated due to
interactions with the proteins that were salted-out.
In the last step of the recovery process, an additional 30% loss of the initial Zwittergent 3-14
was detected due to the TCA addition. This observations corresponds again with the findings
of the Zwittergent characteristics in the absence of the salting-out step. Over 25% of the initial
Zwittergent 3-14 did not precipitate in the presence of TCA and was found in the waste stream of
cycle-4. However, only 40% of the Zwittergent 3-14 added during cycle-1 was recovered in the
final TCA-pellet. The final detergent concentration in the TCA-pellet is dependent on the volume
used for solubilizing the pellet.
In summary, 60% of the Zwittergent 3-14 added during cycle-1 of the recovery process is re-
covered in the absence of the salting-out step and only 40% is recovered in the presence of the
salting-out step. However, the final detergent concentration in the TCA-pellet is dependent on the
volume used for solubilizing the TCA-pellet. The possibility of having the Zwittergent 3-14 at
different concentrations in the TCA-pellet needs to be kept in mind for the investigation of the
impact of the optimized recovery process on the down-stream process.
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8.4 Conclusion
In this chapter process optimization using different detergents to improve protein solubility was
discussed. Two detergents were identified to have the highest potential for improving interferon-
α-2b solubility, Sarkosyl and Zwittergent 3-14. An investigation, using design of experiments was
used to determine the impact and significance of different factors on the critical process step 1
(CPS-1) of the recovery process. It was shown that the detergent concentration has the biggest
impact on the protein recovery during CPS-1. Sarkosyl at 3.0% resulted in a 90% recovery of IFN
during CPS-1 and addition of 1.0% Zwittergent 3-14 had a 80% recovery in interferon.
Recovery process simulations in a small scale model were performed to study the impact of de-
tergent addition during CPS-1 on the remaining steps of the recovery process. Simulations were
performed following all 4 cycles of the process and with the elimination of the salting-out step.
Results are gathered together in table 8.4.
Tab. 8.4: Summary of Recovery Process simulation results with the addition of detergents
full recovery process without salting-out
detergent present control detergent present control
Sarkosyl 3% interferon 20% 7% 75% 20%
tot. protein 20% 8% 90% 18%
Zwittergent 1% interferon 55% 7% 70% 25%
tot. protein 40% 8% 65% 22%
As can be seen in table 8.4, the highest interferon-α-2b recovery was achieved with 3% Sarkosyl
present and in the absence of the salting-out step. This condition results in a 10-fold increase
in interferon recovery at the end of the process compared to the original process conditions at
manufacturing scale. Due to the addition of Zwittergent 3-14 at 1%, the IFN recovery can be
enhanced 7-fold compared to the recovery in the original process. Excluding the salting-out step,
enhances the IFN recovery further and gives a 10-fold improvement, similar to the results with
Sarkosyl.
Both options, addition of 3% Sarkosyl or 1% Zwittergent 3-14, result in a large enhancement in
interferon recovery throughout the recovery process. Hence, there are four potential optimized
PhD-Thesis from Tanja Buch 189
CHAPTER 8. PROCESS OPTIMIZATION - SOLUBILITY STUDY WITH DETERGENTS
recovery processes available: addition of 3% Sarkosyl, or addition of 1% Zwittergent 3-14 to the
process, which is performed in the presence or absence of the salting-out step. In order to identify
which of these 4 processes is the most suitable and convenient one to be scaled-up and imple-
mented at manufacturing scale, the impact on the down-stream process needs to be considered.
The investigation of this chapter did not study the impact of the detergent on the interferon-isoform
distribution. It is possible that the different interferon-isoforms have different solubility levels,
hence, the isoform distribution at the end of the recovery process can be different in the presence
or absence of a detergent. In order to analyse the impact of a detergent on the interferon-isoform
distribution, complete mass balances of each isoform need to be set-up throughout the protein re-
covery process. As discussed in chapter 6 no analytical method is currently available that provides
the accuracy and robustness to quantify interferon-isoforms at all stages of the recovery process.
Hence, a more accurate and suitable method for interferon-isoform quantification needs to be
developed first, in order to give a statement about the impact of the detergents on the interferon-
isoform distribution.
The findings of this chapter also did not cover the impact of the addition of a detergent on the bio-
activity of interferon-α-2b. Before implementing the addition of a detergent to the protein recovery
process at manufacturing scale, the bio-activity of interferon-α-2b at the end of the recovery pro-
cess or down-stream process needs to be proven. However, findings in literature showed, that the
addition of Zwittergent 3-14 had no impact on the bio-activity of the analysed protein [114].
In a next step the impact of the proposed optimized recovery processes on the first step of the
down-stream process will be investigated. Four different aspects need to be considered: the im-
pact of the presence of a detergent, the impact of variations in the ratio between host cell proteins
and interferon, the impact of possible variations in total protein levels at the end of the recovery
process and the impact of a different interferon-isoform distribution on the binding affinity towards
the ion-exchange column. The removal of the detergents from the process needs to be investigated
as well. At the end of the production process, the pure drug substance interferon-α-2b should be
present without contamination by a detergent. Hence, the detergent needs to be removed, either
through existing down-stream methods or through an additional step between the recovery and
down-stream process. The removal of the detergents is discussed in the following chapter 9 and
the impact of the detergents on the down-stream process will be discussed in chapter 10.
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Chapter 9
Detergent Removal from the Recovery
Process
9.1 Introduction
This chapter will focus on different techniques in order to remove detergents from recovery process
samples. In chapter 8 two different detergents, Sarkosyl and Zwittergent 3-14, were added during
cycle-1 to the primary protein recovery process in order to increase the protein solubility and
protein recovery. These detergents need to be removed at the end of the primary protein recovery
process (TCA-pellet) prior to further steps of the down-stream process.
9.1.1 Quantification of detergent
The addition of a detergent to a bioprocess in order to improve protein solubility requires the
availability of a quantitative method for the detergent. Several different techniques for the quan-
tification of ionic, non-ionic and zwitterionic detergents have been described in the literature.
These techniques are spectrophotometric, potentiometric, titrimetric and labelling methods [115].
A colorimetric method is described by Haeuw et al. [116] which is based on the classical Lowry
method. Another method based on the titrimetric principle, detects zwitterionic detergents by titra-
tion with ammonium sulphate in the presence of Triton X-100 [116]. Rajasekharan et al. [117]
described a spectrophotometric methods for the quantification of non-ionic, ionic and zwitterionic
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detergents by the principle of binding oil (triolein) to the hydrophobic tail of the detergent and
measuring the turbidity changes. Unfortunately, all these methods are indirect methods and based
on the detection of reaction products, what makes them less precise and less sensitive [118].
A more accurate and faster method is the usage of high pressure liquid chromatography (HPLC).
Detergents are amphiphilic, hence contain hydrophobic parts which bind to reversed phase C-18
columns [116]. Some detergents containing chromaphores, such as Sarkosyl, absorb ultraviolet
light and can be detected with a UV-detector [119][120]. However, other detection method with
RP-HPLC are described in literature as well, which can be used for wider range of different deter-
gents (ionic, non-ionic and zwitterionic). These detection methods are: evaporative light scattering
(ELSD) [119], chemiluminescent nitrogen detection (CLND) [118] and charged aerosol detection
(CAD) [121]. A disadvantage of these three detection methods is that the detectors are no standard
lab equipment and often not available.
An alternative to UV, ELS, CLN and CA detection can be the refractive index detector (RID)[116].
The RI quantification is not limited to sugar containing detergents, neither does it require high
detergent concentrations [122]. Hence, it can be used for the detection of ionic, non-ionic and
zwitterionic detergents.
The refractive index describes how light propagates through a medium, or more specifically, it
measures how much light is deviated or refracted when entering a material. It than compares this
measurement to a reference medium [123]. The ratio between the speed of light of the reference
medium and the substance n is given by: [72]
n = cv (9.1)
With:
n = refractive index of substance ’n’
c = speed of light in vacuum [m/s]
v = speed of light in substance ’n’ [m/s]
A disadvantage of the RI detection is its incompatibility with gradient solutions which can be
problematic if several detergents need to be separated and analysed on the same time [116].
PhD-Thesis from Tanja Buch 192
CHAPTER 9. DETERGENT REMOVAL FROM THE RECOVERY PROCESS
9.1.2 Removal of detergents from process samples
The presence of detergents in process samples can unfortunately interfere with further purification
steps, such as ion-exchange chromatography steps or disrupt analytical work. Hence, in many
situations the detergent needs to be removed from the process samples at small scale for analytical
purposes or even at large scale for further purification steps [105]. Several different detergent re-
moval methods are described in literature which range from physical methods such as diafiltration,
resin adsorption, gel chromatography and dialysis to chemical methods such as co-precipitation
[124].
Some detergents are easier to remove than others. For example detergents with a high cmc value
are more easily removed than detergents with low cmc because they bind less tightly to the pro-
tein. Another detergent parameter affecting the removal process is the average micellar molecular
weight (MMW). Detergents with a large average MMW are more difficult to remove by dialysis or
ultrafiltration than detergent with a small MMW. Most non-ionic detergents have a large MMW,
however, these detergents can be removed by ion-exchange chromatography since they are not
known to interfere with the resin [107].
One of the most common methods for detergent removal is dialysis, especially for detergents with
a high cmc. Detergent-protein solutions are diluted below the critical micelle concentration in
order to break-up detergent micelles. The smaller detergent monomers can than easily be removed
from the solution by dialysis due to the diffusion of the detergent molecules to a lower concen-
trated area [105]. Unfortunately this technique is not suitable for large scale applications in which
case an ultrafiltration or UF/DF method would be used.
Other detergent removal techniques include hydrophobic adsorption, gel chromatography, ion-
exchange chromatography and nickel columns with His tags. Some of these techniques are ex-
plained in more detail in the following sections.
9.1.2.1 Ion-exchange chromatography
Section 8.1.1.1 described the different characteristics of detergents which could be divided in non-
ionic, ionic and zwitterionic subclasses. These characteristics of having positively or negatively
charged groups can be used for the removal of the detergent.
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Ion-exchange chromatography binds either anionic or cationic molecules, whereas non-ionic molecules
do not bind at all [105]. Hence, non-ionic or zwitterionic detergents can be removed by IEC be-
cause they do not bind to the resin and the detergent pool can be found in the flow through or wash
fraction of the column [125]. On the other hand, ionic detergents can be removed by IEC because
they do bind to some of the resins and the protein is either found in the flow-through or can be
washed off from the column by extensive washing [126].
In the following sections three different resins will be described in more detail for their potential to
remove detergents from process samples. These resins are: Dowex, hydroxyapatite and detergent
removal resin.
Dowex and Hydroxyapatite
Dowex ion-exchange resins are leaders in separation technology. Dowex resin find its application
in water treatment, power generation, food application, chemical process and bioprocess purifi-
cation. There are over 60 different Dowex resins available from Dow, which last from weak and
strong anion resins to weak and strong cation resins over mixed-bed resin and anion- and cation-
exchange resins [82]. Dowex meets the FDA food additive regulations as already discussed in
section 6.1.4.1.
Dowex R© 1x4 chloride form is an anion-exchange resin, hence it will bind negatively charged
molecules such as the anionic detergent Sarkosyl [127]. New data from Dow showed the suc-
cessful application of Dowex R© 1x4 chloride resins for the removal of the zwitterionic detergent
CHAPS while recovering over 80% of the protein contents [128].
Many detergents, especially zwitterionic detergents are stable over a wide pH range and their po-
sitive or negative charge is independent on the pH of the buffer. Hence, the binding of the detergent
to the resin is most likely independent on the pH. However, the net-charge of proteins is highly
dependent on the pH of the buffer. Thus, the pH may have an important role in the removal of
detergents from protein mixtures. The conductivity value is always an important factor in ion-
exchange chromatography and needs to be considered throughout all studies with IEC [129][130].
Hydroxyapatite is a mixed-mode resin which combines two modes of interactions simultaneously:
cation-exchanger and metal affinity chromatography [85]. More detailed information about the
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characteristics of hydroxyapatite can be find in section 6.1.4.2.
Most detergents, either non-ionic or ionic showed no binding affinity towards hydroxyapatite.
Hence, the detergent should be removed by hydroxyapatite chromatography and found in the flow
through of the column. Penin et al. [126] developed a detergent exchange assay for SDS (sodium
dodecyl sulphate) using hydroxyapatite chromatography, where the protein-detergent complex
bound to hydroxyapatite and the detergent was removed through extensive washing with the load-
ing buffer. Similar to the Dowex resin, pH and conductivity have an impact on the protein binding
to the hydroxyapatite resin and need to be considered in the investigation for detergent removal
using hydroxyapatite [131].
Detergent removal resin
Detergent removal resin is a commercial product from Thermo Scientific, specially developed
for the removal of detergents from protein-containing process samples. This resin combines the
separation techniques of size-exclusion and affinity chromatography. The porous resin matrix
allows only small molecules of less than 10kDa to enter and to get in contact with the detergent
affinity resin. Hence, large molecules such as proteins, do not get in contact with the affinity resin
and pass through the column [132].
The binding affinity of the detergents is independent of salt concentration and pH, however, it is
dependent on the micelle molecular weight (MMW). Detergents with a large MMW (>10kDa) will
not easily get in contact with the affinity resin due to the cut-off of the porous resin matrix. Studies
showed that the pH of a detergent solution can have an impact on the average micelle molecular
weight. Dependent on the detergent the MMW is either increasing or decreasing with a change in
the pH [133]. The presence of salt is as well affecting the MMW of detergents. With an increase
in the salt concentration the micelle molecular weight is increasing as well. Thus, it will be more
difficult for the detergent to pass through the porous resin matrix [107].
These facts show that even though the binding of detergents to the affinity resin is independent
of the pH and conductivity, these two parameters need to be considered throughout the detergent
removal assay due to their impact on the micelle molecular weight of the detergent.
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9.1.2.2 Ultrafiltration spin tubes
Ultrafiltration separates the detergent-protein mixture by size, thus this method is only effective
if the average micelle molecular weight differs from the molecular weight of the target protein.
Ionic detergents in particular, are known to have a small micelle molecular weights and there-
fore are suitable for removal with ultrafiltration. However, other studies showed potential to use
ultrafiltration for the removal of detergents with larger micelle molecular weights (MMW) [134].
Detergents with large MMW, larger than the cut-off pore size of the ultrafiltration membrane, form
a two-phase region on the membrane surface. In this dense micelle rich phase, the detergents are
present as surfactant monomers and slowly pass through the membrane. Studies showed a removal
yield of the detergent of 98%, but unfortunately also a protein loss of more than 50% [134].
Besides the micelle molecular weight of the detergent, the removal yield of detergent from process
samples by ultrafiltration is also highly dependent on three other parameter: membrane material,
temperature and salt concentration. Several studies showed that the best separation properties
were obtained with polysulfone or polyethersulfone membranes [134][135][136]. An increase in
temperature throughout the ultrafiltration has a positive impact on the permeate flux due to the de-
crease in solution viscosity and thermal expansion of the membrane material. On the other hand,
with an expansion of the membrane material and thus an increase of the pore-size, the protein loss
through ultrafiltration might increase as well [136]. During the removal of detergents with large
MMW, an increase in the temperature has a negative impact. With increasing temperature and
salt concentration the flux through the membrane is decreasing [134]. This can be explained by
the impact on the micelle molecular weight of the detergent. As described in section 8.1.1.1, the
MMW is increasing with an increase in temperature and ionic strength, especially for non-ionic
detergents. Hence, the removal of the detergent with ultrafiltration will be slowed down.
Franzreb et al. [134] also showed that eight exchange sample volumes are required in order to
receive an 98% removal of the detergent. Hence, a sample volume of 5ml in ultrafiltration spin
tubes, needs to be washed with 40ml of exchange buffer in order to remove 98% of the detergent.
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UF/DF system - scale up
A UF/DF system operates with a tangential flow system which is the major difference to the dead-
end filtration in ultrafiltration spin tubes. In order to scale up a UF/DF system certain different
parameters are important, which are: membrane type, protein concentration, process volume and
process time. In general the first decision has to be made for the membrane type and the TFF
(tangential flow filtration) module. Several different membrane materials are available, the most
common ones at large scale are: polysulfone, polyethtersulfone and cellulose. Cellulose has the
lowest protein adsorption whereas polyethersulfone is known to show the best separation tech-
niques for detergent removal. The TFF type needs to be selected dependent on the process volume
to be processed and on the available space. Spiral wound and flat plate are known to be more
efficient for larger process volumes, since they can be operated with increase turbulence compared
to hollow fibre [9].
The next key parameter to be selected in the membrane flux, which is highly dependent on the
trans-membrane pressure and the protein concentration of the solution to be filtered. Figure 9.1
shows a typical trend of flux versus trans-membrane pressure for low and high protein concentra-
tions.
Fig. 9.1: A typical trend of flux versus trans-membrane pressure for low and high protein concentrations
[9]
For a low protein concentration of around 5mg/ml a flux value of approximately 150 L/m2/h and
a trans-membrane pressure of 30psid is usually selected [137]. The next step is the calculation of
the required membrane area, which is dependent on the membrane flux and the process volume to
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be processed. The membrane area can be calculated following equation 9.2:
area
[
m2
]
= filtrate volume [L]÷ (Flux [L ∗m−2 ∗ h−1] ∗ process time [h])
(9.2)
With the membrane area and the membrane flux the required pump feed rate can be calculated as
follow:
Pump feed rate[L/min] = Flux
[
L ∗m−2 ∗ h−1] ∗Area [m2]
(9.3)
With these two equations the required membrane area, buffer volume, feed rate and process time
can be calculated dependent on the process volume and the present protein concentration.
9.1.3 Goals and Aims
The aim of this chapter is the successful removal of different detergents from the process samples
at the end of the primary protein recovery process prior to further down-stream processing. In a
first step, quantification methods for the two detergents, Sarkosyl and Zwittergent 3-14, are being
developed in order to quantify the reduced detergent levels during the removal steps. In a second
step different techniques such as ion-exchange chromatography and ultrafiltration are tested for
their potential to remove the two detergents from process samples.
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9.2 Material and Methods
9.2.1 List of Materials
Tab. 9.1: Materials and suppliers
materials supplier
Recovery Process samples industrial partner
(TCA-pellet)
Dowex R© 1x4 chloride form (20-50 mesh) Sigma Aldrich
Hydroxyapatite with < 200 nm particle size (BET) Sigma Aldrich
Sarkosyl Sigma Aldrich
Zwittergent 3-14 Sigma Aldrich
Detergent Removing Resin Thermo Scientific
Pierce R© Detergent Removal Spin Columns Thermo Scientific
Vivaspin 6 centrifugal concentrator Sartorius
Trizma Base Sigma Aldrich
EDTA tetrasodium salt VWR
Aeris WIDEPORE 3.6u XB-C18 column 150 x 4.6mm Phenomenex
Glycerol triolein Sigma Aldrich
Bovine serum albumin (BSA) Sigma Aldrich
interferon-α-2b drug substance industrial partner
Acetonitrile Fisher Scientific
Trifluoroacteic acid (TFA) Fisher Scientific
Triolein Sigma Aldrich
9.2.2 Detergent removal using Ion-exchange resins
To perform ion-exchange chromatography in order to remove detergents from process samples,
the chromatographic procedure was simulated in a small 2.0mL Eppendorf tube, instead of using
a column. Between 100 - 200mg of the specific resin was added to the Eppendorf tube, followed by
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the addition of 1.0mL of the process sample containing detergent (either Sarkosyl or Zwittergent 3-
14). After 2.0 hours of continuously mixing, the samples were centrifuged at 10’000rpm (12’200g)
for 15min at room temperature (Eppendorf centrifuge, Hamburg, Germany). The supernatant
(0.8mL) was recovered and stored at 4◦C for further analysis.
The resins to be investigated for this study were: Dowex R© 1x4 chloride form (20-50 mesh) and
hydroxyapatite with < 200 nm particle size (BET).
9.2.3 Detergent removal using Size exclusion and affinity chromatography
This method combines both, size exclusion and affinity chromatography, using a detergent remo-
ving resin (Thermo Scientific, Dublin, Ireland). This resin allows small molecules (< 10kDa), like
detergent molecules, to enter the affinity matrix and to bind to a specially developed ligand. Hence,
larger molecules (>10kDa), such as interferon-α-2b, pass through the column without interacting
with the affinity matrix, which avoids non-specific binding.
For the removal of the detergents, Pierce R© Detergent Removal Spin Columns were used, following
the manufacturer’s instruction manual [132].
Samples were taken from the recovered flow-through and stored at 4◦C for further analysis.
9.2.4 Detergent removal using Ultrafiltration/Diafiltration
Detergent removal with Ultrafiltration/Diafiltration was simulated at small scale with ultrafiltra-
tion spin tubes (Sartorius, Goettingen, Germany). These spin tubes contain a Polyethersulfone
membrane (PES) with a molecular weight cut off (MWCO) of 5kDa and 10kDa.
The process sample (5mL) containing detergent were filled in the upper chamber of the spin tube.
Tubes were centrifuged at 7000rpm (7122g) at room temperature for 40 minutes, until half of the
volume had passed through the membrane into the lower chamber. The upper chamber volume
was top up (to 5mL) with extraction buffer (20mM Tris, 1mM EDTA buffer, pH 8.0) and centrifu-
gation continued. This cycle was repeated a minimum of 5 times.
Samples were taken after every centrifugation cycle from the upper and lower chamber for mass
balances and stored at 4◦C for further analysis.
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9.2.5 Detergent quantification
Sarkosyl quantification - RP-HPLC
The amounts of Sarkosyl in process samples were quantified using RP-HPLC with a UV detector
(Agilent, Cork, Ireland) at 280nm and a C-18 column with a particle size of 3.6µm (Phenomenex,
Cheshire, UK). A gradient method was used for separation, with mobile phase A containing 0.1%
(v/v) trifluoroacetic acid (TFA) aqueous solution, and mobile phase B consistent of acetonitrile
(ACN) / 1.0% aqueous TFA (90:10, v/v). Column temperature was operated at 45◦C and the flow-
rate set constant to 1.0 mL/min. The gradient method is identical to the method for interferon-
isoform quantification with RP-HPLC described in chapter 6.
The retention time for Sarkosyl under the described conditions is between 5.2 and 5.4 minutes.
Zwittergent 3-14 quantification - spectrophotometric
Detection of small traces of Zwittergent 3-14 in process samples was performed with a spectropho-
tometric method with Triolein. Five µL of 1.015M Triolein was pipetted into a 1.5mL Eppendorf
tube and 1.0mL of process sample added on top. The solution was mixed for exactly 15 seconds
and the absorbance/ turbidity measured at 660nm immediately (compare [117]).
An absorbance reading above 0.0 indicates the presence of detergent traces.
Zwittergent 3-14 quantification - RP-HPLC-RID
Quantification of Zwittergent 3-14 was performed using a reverse-phase HPLC method (Agilent,
Cork, Ireland) with refractive index detector [122] and a C-18 column with a particle size of
3.6µm (Phenomenex, Cheshire, UK). An isocratic method was used with acetonitrile (ACN) /
1.0% aqueous TFA (45:55, v/v) for detergent detection, followed by a regeneration step of the
column with acetonitrile / water solvent (80:20, v/v). Column temperature was operated at 35◦C
and the flow-rate set to a constant volume of 1.0 ml/min for detection and column regeneration.
The retention time for Zwittergent under the described conditions is between 2.3 and 2.6 minutes.
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9.2.6 Total protein quantification - BCA
The total amounts of protein were quantified using the BCA assay as described in section 3.2.2
and table 3.5. Sample pellets were dissolved in EDTA-Tris buffer (1mM EDTA, 20mM Tris, pH
8.0) prior to protein analysis. BSA dissolved in water was used as a reference standard for all
total protein quantifications. The blank was chosen according to the sample to be analysed, and
included water, EDTA-Tris buffer, detergents or diluted fermentation media.
9.2.7 Total Interferon-α-2b quantification
The total amounts of interferon-α-2b were quantified using SDS-PAGE as described in section
5.2.3 and 5.2.4. Sample pellets were dissolved in EDTA-Tris buffer prior to analysis as men-
tioned in the section above. No further sample treatment was required. The interferon-α-2b drug
substance was used as a reference standard for all quantifications.
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9.3 Results and Discussion
This result and discussion section focuses on the removal of the detergent from recovery process
samples. If a detergent is added to the recovery process to improve protein solubility and total
interferon-α-2b yield, it needs to be ensured that this detergent can be removed from the process
during the DSP steps prior to the final filling of the drug substance is reached. The following
sections discuss the removal of two detergents, Sarkosyl and Zwittergent 3-14 from recovery pro-
cess samples. Four different techniques have been tested to remove both of the detergents and
the results are presented and discussed here. The first section focusses on the development of
quantification methods for both detergents in order to quantify the level of removal.
9.3.1 Development of quantification methods for Sarkosyl and Zwittergent 3-14
The first step in developing a method for detergent removal, is the development of quantification
methods for these detergents, otherwise it is impossible to determine to which level the detergent
has been removed. Hence, this section focuses on the development of quantification methods for
Sarkosyl and Zwittergent 3-14. First, the focus will be on Sarkosyl, followed by the results of
Zwittergent 3-14.
Figure 9.2 shows the linear regression between Sarkosyl concentration (%) and the peak area
(mAu*s). Results were obtained using the RP-HPLC method as described in section 9.2.5 under
Sarkosyl quantification. Detergents are amphipathic (section 8.1.1.1), thus their hydrophobic part
binds to C-18 columns. Sarkosyl, an an-ionic detergent, also has the characteristics to absorb UV
light at wavelengths between 250 - 280nm.
A linear relationship between Sarkosyl and peak area (as seen in figure 9.2), was observed for the
range 0.0 - 3.0% of Sarkosyl. Sarkosyl elutes with a retention time of 5.3min, thus it does not
interfere with the elution of interferon-α-2b or its isoforms. Standards of Sarkosyl were prepared
in DI-water, as well as in process media to investigate the impact of process samples on the quan-
tification method. Results show that the presence of process media had no significant impact on
the Sarkosyl quantification. The difference between the two slopes, one determined with Sarko-
syl in DI-water (74’244), the other with Sarkosyl in process media (77’385), is less than 4% and
therefore considered negligible. Hence, the RP-HPLC method with UV detector can be used to
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Fig. 9.2: Linear regression of Sarkosyl reference standards between 0.0 and 3.0%
quantify Sarkosyl in process samples at concentrations from 0.0 to 3.0%.
The quantification of Zwittergent 3-14 is more challenging. This detergent belongs to the category
of zwitter-ionic detergents which show no absorbance to UV light. In literature several different
indirect quantification methods are described for Zwittergents (section 9.1.1), one of which is
turbidity measurements at 660nm with Triolein. Figure 9.3 shows three linear regressions of
Zwittergent 3-14 reference standards between 0.0 - 0.10% concentration.
All three linear regressions shown in figure 9.3 were obtained following the procedure explained in
section 9.2.5 under spectrophotometric detection, using Zwittergent 3-14 dissolved in DI-water as
the reference standard. The variation between the different slopes is greater than 38%. These large
variations can be explained by the nature of this method. The added Triolein forms a complex with
Zwittergent 3-14 which shows a turbidity reading at 660nm. This complex is highly unstable, thus
the absorbance values are dependent on the measuring time point. Due to significant variations
in this method, it is not suitable for quantification but only for the detection of traces of Zwitter-
gent 3-14. Besides high variations, this method also showed interference with the process media
(results not shown), hence quantitative detection of Zwittergent 3-14 in process samples requires
process media as a blank to eliminate interference.
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Fig. 9.3: Linear regression of Zwittergent 3-14 reference standards between 0.0 and 0.10%
In order to quantify Zwittergent 3-14, a more accurate method is required. In the literature several
quantification methods are described using HPLC with a CAD detector (light scattering) [122].
Unfortunately such a device was not available for this study. An alternative was found using a RI
detector. The refractive index describes how light propagates through a medium, or more specifi-
cally, it measures how much light is deviated or refracted when entering a material, compare sec-
tion (section 9.1.1). In this way the refractive index detector also detects all non-sugar-containing
detergents, such as Zwittergent.
Figure 9.4 shows the linear regression model between the peak area of the refractive index signal
and the Zwittergent 3-14 concentration for three different injection volumes into the HPLC. All
measurements were performed following the method described in section 9.2.5 under Zwittergent
quantification with RP-HPLC and RID.
Figure 9.4 shows that a linear relation exists between the peak area and the Zwittergent 3-14
concentration for 0.05 - 1.0% of Zwittergent with a R2-value between 0.990 - 0.994. It also shows
that the slope is dependent on the injection volume of the Zwittergent. Hence, the injection volume
needs to be kept constant throughout different measurements. In order to increase the sensitivity
for small Zwittergent concentrations of around 0.05%, the injection volume was set to 60µL.
Process medium was shown to have a significant impact on the quantification of Zwittergent with
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Fig. 9.4: Linear regression of Zwittergent 3-14 reference standards in process media between 0.05 and
1.0% detected with RP-HPLC and RI detector
this RP-HPLC method, hence all reference standards were prepared in process media to have
similar conditions than the process samples to be analysed.
The variations in peak area between triplicates are less than±5.0% over the whole detection range.
Hence, this method is an accurate method to quantify Zwittergent 3-14 in process samples between
0.05 - 1.0% of Zwittergent.
9.3.2 Removal of Sarkosyl from process samples
Sarkosyl was added during cycle 1 of the recovery process in order to improve protein solubility
and increase the recovery of interferon-α-2b (chapter 8). The following sections focus on the
removal of Sarkosyl from this recovery process. Four different techniques will be discussed: an
ion-exchange method, a mixed-mode method, a combination of affinity and size exclusion and an
ultrafiltration spin-tube method.
9.3.2.1 Sarkosyl removal using ion-exchange resin
Ion-exchange resins can be used for removal from detergents of process samples due to the differ-
ent charged groups on detergents (section 9.1.2.1). Two different resins have been tested for the
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removal of Sarkosyl, an anionic (Dowex) and a mixed-mode resin (hydroxyapatite).
Dowex 1x4 chloride form
Dowex is one of the first manufactured ion-exchange resins and is still of high interest for applica-
tion at industrial scale (section 9.1.2.1). Dowex resin is available with certain different characte-
ristics: weak and strong acid cation exchanger, weak and strong basic anion exchanger, mixed bed
resin, fine mesh resin or resins with different polishing. For the removal of Sarkosyl an anionic
fine mesh resin was used (Dowex 1x4 chloride form, 20-50 mesh).
Figure 9.5 shows the obtained results for the unbound fraction of Sarkosyl, in green, and total
interferon, in blue. The aim of this experiment was to have all Sarkosyl molecules bound to the
resin while unbound total interferon-α-2b remained as high as possible in solution.
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Fig. 9.5: Recovery of unbound interferon and Sarkosyl after treatment with Dowex resin as a function of
conductivity of the process sample (pH constant at 7.0)
The experiment was performed as described in section 9.2.2. Total interferon was quantified with
SDS-PAGE, compare section 9.2.7 and Sarkosyl was quantified with RP-HPLC and UV detection
as described in section 9.2.5. Figure 9.5 shows the recovery of unbound Sarkosyl and interferon
after treatment with Dowex resin as a function of conductivity. It can be seen that at low conducti-
vity, 2.8mS/cm, the affinity of Sarkosyl and interferon to the Dowex resin was very high and more
than 98% of Sarkosyl and 95% of interferon of the initial concentration bound to the resin. As the
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conductivity increased the affinity of Sarkosyl and interferon for the Dowex resin decreased. This
observation is as expected. The affinity of proteins or detergents to resins is highly dependent on
conductivity, as explained in section (section 9.1.2.1).
The optimal condition was identified at 9.4mS/cm, where still more than 97% of Sarkosyl bound
to the resin, but only 50-55% of interferon. Hence, more than 45% of total interferon was reco-
vered, while removing 97% of Sarkosyl from the process sample. This result shows that Sarkosyl
has a higher affinity to bind to the Dowex-resin than interferon under these operating conditions.
The impact of pH on the binding affinity of Sarkosyl and interferon to Dowex resin was also stu-
died. The pH showed no significant impact on the binding affinity of either Sarkosyl or interferon
(data not shown). Hence, only the conductivity needs to be controlled for this method.
In summary, Sarkosyl can be removed from process samples using Dowex anionic exchange resin,
with a yield of more than 97% removal of Sarkosyl and over 40% recovery of interferon. However,
more than 60% of interferon was lost during this step, hence, other possibilities to remove Sarkosyl
from process samples will be investigated.
Hydroxyapatite
Hydroxyapatite is a mixed-mode resin, which involves non-specific interactions between posi-
tively charged calcium ions and negatively charged phosphate ions, thus it should bind positively
charged molecules as well as negatively charged molecules (section 9.1.2.1).
The aim of this experiment was to develop a method where Sarkosyl binds to the hydroxyapatite,
while the recombinant protein interferon-α-2b remained in solution. Figure 9.6 shows the recov-
ered Sarkosyl and interferon-α-2b fractions in process samples after exposing these samples to
hydroxyapatite as described in section 9.2.2. Different pH and conductivity values were chosen
to examine the impact of these parameters on the binding affinity of Sarkosyl or IFN towards
hydroxyapatite resin.
Sarkosyl and total interferon-α-2b concentrations in figure 9.6 were quantified using RP-HPLC
and SDS-PAGE as described in section 9.2.5 and 9.2.7. The results show that Sarkosyl (in green)
has a high affinity towards hydroxyapatite resin which is independent of pH or conductivity. The
result for Sarkosyl for pH 7.5 and conductivity of 2.8mS/cm is considered as an outlier, since no
explicable reason could verify this high recovery of Sarkosyl. Usually the affinity of molecules
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Fig. 9.6: Recovery of interferon-α-2b and Sarkosyl after treatment with hydroxyapatite resin dependent on
different pH and conductivity values
for the resin increases with lowering the conductivity and not the other way around. However,
ignoring the single outlier, Sarkosyl bound to hydroxyapatite independently of pH or conductivity
and 80 - 90% of the Sarkosyl could be removed.
On the other hand, the affinity of interferon-α-2b (in blue) towards hydroxyapatite resin shows
a high dependency on the pH and conductivity values. With low pH (5.5) and low conductivity
(2.8mS/cm) the affinity towards hydroxyapatite is increased and only 20% of the original IFN
amount was found in solution. With increasing pH and conductivity this affinity decreased and at
pH 7.5 and a conductivity greater than 10mS/cm only very little binding of IFN towards hydroxy-
apatite occurred.
Hence, the best conditions to remove Sarkosyl from process samples, while keeping interferon-α-
2b in solution using hydroxyapatite, is at neutral pH (7.5) and high conductivity (> 10.0mS/cm).
Under these optimal conditions 75% of Sarkosyl can be removed from the process samples while
recovering > 95% of interferon-α-2b in solution.
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9.3.2.2 Sarkosyl removal using size-exclusion and affinity resin in spin columns
Since pure ion-exchange resin binds both the detergent and protein of interest, interferon-α-2b,
a combined technique of size exclusion and affinity chromatography was tested to remove the
detergent from process samples. The ’Detergent Removing Resin’ from Thermo Scientific is a
resin only developed for the removal of unwanted detergents from process samples containing
proteins or other macromolecules (section 9.1.2.1). The resin matrix allows only small molecules,
less than 10kDa, to enter and come into contact with a specially developed detergent ligand. Larger
molecules pass through the column without entering the resin matrix and without coming into
contact with the detergent ligand. Hence, separation of detergent and proteins should be improved
and higher protein recovery should be achieved.
Experiments performed in this section were performed as described in section 9.2.3. Spin columns
were filled with the detergent removal resin as described in the kit manual [132]. Figure 9.7 shows
the recovered Sarkosyl concentration (in green) and total interferon fraction (in blue) in the flow
through of the spin columns as a function of pH and conductivity of the process sample.
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Fig. 9.7: Recovery of interferon and Sarkosyl in flow through of spin column packed with ’Detergent
Removal Resin’ at different pH and conductivity values
Total interferon-α-2b was quantified by SDS-PAGE as described in section 9.7 and Sarkosyl was
quantified with the RP-HPLC method as described in section 9.2.5. Figure 9.7 shows that Sarkosyl
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can be successfully removed from process samples while recovering more than 85% of interferon-
α-2b. Due to the limited size of the spin columns, a maximum of 1.0 - 1.5% of detergent could
be removed from process samples before the column reached saturation. Process samples used
for the experiments of figure 9.7 contained 1.0% of Sarkosyl at the beginning, hence a complete
removal Sarkosyl is possible with these small spin columns. However another experiment was
performed using process sample containing up to 2.0% of Sarkosyl. In this experiment only 80%
of the Sarkosyl was removed by the detergent removal resin due to overloading of the column
(data not shown). In order to remove more than 1.0 - 1.5% of Sarkosyl, larger columns would be
required or several cycles with fresh detergent removal resin need to be performed.
The data shown in figure 9.7 also show the impact of pH and conductivity on the binding affinity of
Sarkosyl and interferon-α-2b towards the resin. No significant impact of either pH or conductivity
can be observed for the binding of Sarkosyl towards the detergent removal resin. Under all 4
tested conditions, Sarkosyl bound to the resin successfully and more than 98% of Sarkosyl was
removed from the process sample. On the other hand some effects of the pH on the interferon-α-
2b interaction with the detergent removal resin were observed. The results in figure 9.7 show the
affinity of interferon towards the resin is stronger at acidic pH (5.5) than it is at neutral pH (7.5).
Theoretically interferon with a molecular weight of 19kDa, should not come into contact with the
detergent removal resin, since only small molecules of less than 10kDa should pass through the
pores to the resin (section 9.1.2.1). However, this suggest that there is a broad pore-size distribution
and it is possible that due to minor changes in the packing of the column some of these pores
are larger than others and also molecules with 19kDa get in contact with the detergent removal
resin. For this case a working pH of 7.5 is the optimum and results in more than 85% recovery of
interferon-α-2b. The conductivity shows no significant impact on the affinity of interferon towards
the detergent removal resin and can therefore be considered negligible.
In summary, using spin columns filled with detergent removal resin, successfully removes > 98%
of Sarkosyl from process samples while recovering > 75% of interferon-α-2b at a working pH of
7.5.
A negative aspect of this method is the scaling-up. So far the spin columns were loaded with
100µL of settled resin, which can remove 1.0% of Sarkosyl from 100µL sample (section 9.1.2.1).
In order to remove 3.0% of Sarkosyl from 9’000L at manufacturing scale, more than 27’000L of
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resin would be required. These large amounts are not available so far, thus this method is only
interesting at small scale of up to 100mL of resin.
9.3.2.3 Sarkosyl removal using Ultrafiltration/Diafiltration with spin tubes
As seen in previous sections no method tested so far for the removal of detergents from process
samples fulfilled all required criteria: detergent removal >95%, IFN recovery >60% and appli-
cation at large scale. Either the recovery of interferon was very low (see section 9.3.2.1) or the
application at large scale is impossible (see section 9.3.2.2). In this section the focus is on Ultra-
filtration/Diafiltration which separates the detergent from the process samples by size. In order
to simulate the UF/DF at small scale, spin tubes with different cut-offs were used as explained
in section 9.2.4. Since the protein of interest, interferon-α-2b, has a molecular weight of 19kDa,
membrane cut-offs of 10kDa and 5kDa were selected. This allows the protein to remain in the
retentate, whereas the detergent should be found in the flow-through of the spin tubes (permeate).
Figure 9.8 shows the recovered Sarkosyl (orange), total protein (green) and total interferon-α-2b
(blue) fractions after each cycle 1 - 6 with spin tubes having a 10kDa cut-off membrane.
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Fig. 9.8: Recovery of interferon and Sarkosyl in upper chamber (retentate) of spin tubes with 10kDa
cut-off (pH=7.0, C=10.0mS/cm): after each cycles the upper chamber was filled up with
extraction buffer and the centrifugation repeated as before
Sarkosyl concentrations of figure 9.8 were quantified using RP-HPLC as described in section 9.2.5
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and total protein and total interferon-α-2b were quantified using the BCA-assay and SDS-PAGE
as described in section 9.2.6 and 9.2.7. Figure 9.8 shows the recovered detergent and protein frac-
tions after 6 performed cycles with ultrafiltration spin-tubes. One cycle involves a centrifugation
run of the spin tube, filled with the process sample. After each cycle the volume in the upper
chamber (retentate) of the spin-tube was topped-up with EDTA-Tris buffer (1mM EDTA, 20mM
Tris, pH 8.0) and the contents of the lower chamber (permeate) was discharged (compare 9.2.4).
The results in figure 9.8 show a continuous, almost linear decrease in Sarkosyl concentration over
the 6 cycles, with a removal of more than 80% of the initial Sarkosyl concentration. Hence, with a
starting concentration of 3% Sarkosyl and 80% removal, only 0.6% of the Sarkosyl remains at the
end of cycle 6. Due to the addition of further cycles (10 instead of 6), the removal of Sarkosyl can
be further improved. In a new experiment 10 cycles were performed and Sarkosyl was removed
by more than 95% (data not shown).
Looking at the protein recovery throughout the cycles, it can be seen in figure 9.8 that total protein
and interferon-α-2b are recovered to 80% after 6 cycles, hence only 20% of the initial protein was
lost. This result is as expected, due to the molecular weight of interferon with 19kDa, it should
remain in the retentate. Analysing the different flow-through fractions of each cycle resulted in
no findings of interferon or any other proteins. It is therefore possible that the missing protein
fraction (20%) is trapped inside the membrane pores. The centrifugation of the spin-tubes is a
dead-end centrifugation system and not a continuous one, hence all molecules get drawn-down
into the membrane. However, if the g-force of the centrifuge is too high more proteins become
trapped within the membrane, thus reducing the g-force may improve the interferon recovery.
The addition of further cycles in order to improve the Sarkosyl removal will decrease the protein
recovery. Results after the performance of 10 cycles showed only 60% recovery of interferon (data
not shown). Consequently it is very important to choose the right g-force (pressure for UF/DF-
system) in order to minimize the loss of proteins which become trapped in the membrane pores
(due to high g-force or pressure).
In summary, using spin-tubes with a 10kDa cut-off for detergent removal results in 80 - 95% re-
moval of Sarkosyl and 80 - 60% recovery of interferon-α-2b dependent on the amount of cycles
performed and the rate of g-force selected for the centrifugation cycles.
It has to be kept in mind that the spin-tubes were only used to explore the potential of a UF/DF
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system to remove Sarkosyl (detergents) from process samples. Due to the limited available sample
volume, the spin-tubes were used as a simulation of a UF/DF system at small scale. At larger scale
(process scale) the UF/DF system would find its application.
Main differences between both techniques (spin-tubes and UF/DF) are the continuous flow in the
UF/DF system which is not possible with the spin-tubes. All molecules of all sizes are drawn to-
wards the membrane and some molecules become trapped inside, fouling the pores and hindering
smaller molecules passage through. This can be a big problem for the process samples used in
this study. It is known that the process samples contain a large fraction of host cell proteins which
have an average size of more than 100kDa. Hence, it is likely that these proteins will found the
membrane pores and interfere with the Sarkosyl removal. If a UF/DF system with a continuous
flow were used this phenomenon would be reduced. Larger molecules who do not pass through
the membrane would be carried on in the flow and do not found the membrane pores. Hence, using
a UF/DF system instead of spin-tube would be expected to improve Sarkosyl removal as well as
protein recovery.
In addition to spin-tubes with a 10kDa cut-off, spin-tubes with only 5kDa cut-off were also tested
for the removal of Sarkosyl from process sample. Due to the smaller pore size protein recovery
should be increased. Figure 9.9 shows the recovered fractions of Sarkosyl (orange), total protein
(green) and total interferon-α-2b (blue) after each cycle.
The explanation for the term cycles in this experiment have already been explained above, as well
as the quantification methods used for Sarkosyl, total protein and interferon. The results shown
in figure 9.9 are as expected. Sarkosyl was removed from the process samples at a much slower
rate compared to results with a 10kDa cut-off. After 6 cycles only 30% of the original Sarkosyl
concentration had been removed. On the other hand, the protein recovery was slightly improved
compared to the spin-tubes with 10kDa cut-off. Between 85-90% of protein was recovered after
6 cycles. The disadvantage of using only 5kDa cut-off instead of 10kDa, is the increased expen-
diture of time (i.e. lower productivity) that is required with the 5kDa cut-off to reach a detergent
removal yield of 95%. The 5kDa cut-off membrane takes more than 2.5 times longer in order to
remove the same amount of detergent of the samples. This can have a big impact on the process
cost especially at industrial scale. It therefore needs to be considered in the decision which situ-
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Fig. 9.9: Recovery of interferon and Sarkosyl in upper chamber of spin tubes with 5kDa cut-off (pH=7.0,
C=10.0mS/cm): after each cycles the upper chamber was filled up with extraction buffer and the
centrifugation repeated as before
ation is more beneficial, longer process time and more buffer consumption, or a slightly reduced
protein recovery but shorter process time.
In summary, the UF/DF system and membranes with 10kDa cut-off show the highest potential
to successfully remove Sarkosyl from process samples compared to all methods. It is the only
method that meets all three criteria: it removes Sarkosyl to a yield of 95 - 100%, it recovers
interferon-α-2b to a level of 60% or greater and it is straight forward to apply at large scale. At
large-scale the results are expected to improve further.
9.3.3 Removal of Zwittergent 3-14 from process samples
In addition to the detergent Sarkosyl the detergent Zwittergent 3-14 was also proposed to be added
to the primary protein recovery process in order to improve protein solubility (section 8.3.3.1).
Hence, a method needs to be developed in order to remove Zwittergent 3-14 from the process. In a
similar way to the method for Sarkosyl removal, the method for Zwittergent removal should fulfil
three criteria: first, to remove Zwittergent from process samples with a yield of 95% or higher.
Second, to recover interferon-α-2b to a level of at least 60% or higher and third, the method needs
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to be feasible for large scale.
Keeping these goals in mind, the same three techniques tested for Sarkosyl removal were inves-
tigated for their potential to remove Zwittergent 3-14: ion-exchange resin (Dowex and hydro-
xyapatite), size exclusion and affinity resin and ultrafiltration/diafiltration. Since Zwittergent is
an zwitter-ionic detergent and not an anionic detergent (as Sarkosyl), the characteristics and be-
haviour can be different. Therefore it is mandatory to investigate once again all three different
techniques for their potential to remove now Zwittergent 3-14 from process samples. All results
are shown and discussed in the following sections.
9.3.3.1 Zwittergent removal using Ion-exchange resin
Comparable to the experiments performed for Sarkosyl removal from process samples, two dif-
ferent resins were tested for the removal of Zwittergent 3-14. First an anionic resin (Dowex) and
second a mixed mode resin (hydroxyapatite).
Dowex
Dowex 1x4 chloride resin is an anion-exchanger which is used for purification of fine pharma-
ceuticals, as it meets requirements of the FDA Food Additive Regulation (section 9.1.2.1). As
described in section 9.2.2, Dowex resin was used to remove the detergent Zwittergent 3-14 from
process samples. The aim is to have all detergent molecules bound to the resin, while keeping the
protein of interest, interferon-α-2b, in solution.
Figure 9.10, shows the recovery of Zwittergent 3-14 and interferon-α-2b after treatment with
Dowex resin as a function of pH and conductivity.
Zwittergent 3-14 was quantified with RP-HPLC and RI detector as described in section 9.2.5 and
total interferon-α-2b was quantified by SDS-PAGE as described in section 9.2.7. Figure 9.10
shows that both Zwittergent 3-14 and interferon-α-2b bound to the Dowex resin with a similar
affinity. Between 80 to 20% of Zwittergent 3-14 and 80 to 50% of interferon bound to the Dowex
resin depending on conductivity and pH of the sample. Hence, the binding of Zwittergent-14 and
total interferon-α-2b towards the Dowex resin is dependent on the conductivity and pH. As the
conductivity and pH are lowered, the stronger is the binding of Zwittergent 3-14 and interferon
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Fig. 9.10: Recovery of interferon-α-2b and Zwittergent 3-14 after treatment with Dowex resin dependent
on different pH and conductivity values
to the resin. The impact of the conductivity is as expected. As explained in section 6.1.4.1, the
binding of molecules to resins is highly depending on the salt concentration (ionic strength) of the
sample. However, the impact of pH is unexpected. A pH of 5.5 is below the pI of interferon which
gives the protein a positively charge (compare section 6.1.4.1). Hence, the protein should not be
attracted to the negatively charged resin. It is possible that interferon binds through the detergent
to the resin and the interaction between detergent and protein increases with lower pH. This would
explain the reduces interferon recovery at lower pH values.
Unfortunately both protein and detergent bind with a similar affinity to the Dowex resin under all
conditions, which makes it impossible to separate one from the other with this technique. The best
separation was observed at pH 7.5 and a conductivity value of 9.8mS/cm. Under this condition
70% of Zwittergent 3-14 was removed with 50% recovery of interferon-α-2b. However, 70%
removal of Zwittergent 3-14 is not sufficient and does not meet the aim of at least 95% removal
yield.
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Hydroxyapatite
The anion-exchange resin Dowex showed no potential for a separation of the Zwittergent 3-14
and interferon-α-2b, for that reason the mixed-mode resin hydroxyapatite was also tested for its
potential to remove Zwittergent 3-14 from process samples. Mixed-mode resins have non-specific
interactions with positively and negatively charged molecules (compare section 9.1.2.1), which
may be beneficial in order to separate the detergent Zwittergent 3-14 from process samples con-
taining different kind of proteins.
Figure 9.11 describes the recovery of Zwittergent 3-14 and interferon-α-2b after treatment with
hydroxyapatite resin dependent on different pH and conductivity values.
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Fig. 9.11: Recovery of interferon-α-2b and Zwittergent 3-14 after treatment with hydroxyapatite resin as a
function of pH and conductivity
Zwittergent 3-14 was quantified using RP-HPLC and RI detector as described in section 9.2.5 and
total interferon-α-2b was quantified by SDS-PAGE as described in section 9.2.7. It can be seen
in figure 9.11 that Zwittergent 3-14 and total interferon bound both to hydroxyapatite resin with
different affinities at different pH and conductivity levels. However, the binding of Zwittergent
3-14 and interferon to hydroxyapatite, showed no direct correlation with conductivity or pH. This
observation is unexpected, especially in regards to the observations made during the Sarkosyl re-
moval from process samples discussed in section 9.3.2.1. In the presence of Sarkosyl, the binding
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of interferon-α-2b to hydroxyapatite showed a strong dependence on the conductivity and pH of
the process sample. This dependency of interferon cannot be seen with Zwittergent 3-14. This
leads to the conclusion that the affinity of interferon-α-2b towards hydroxyapatite is influence by
the detergent present in the sample. Accordingly, in the presence of Zwittergent 3-14 the recovery
of interferon is improved compared to the presence of Sarkosyl, with a yield of 55 to 90%.
The highest removal of Zwittergent 3-14 was achieved at a conductivity of 9.8mS/cm independent
on the pH with 70% removal. This yield is not sufficient and does not meet the target of at least
95% removal of Zwittergent 3-14. Accordingly this technique will not find application in the re-
moval of Zwittergent 3-14 from process samples.
In summary, both resins Dowex and hydroxyapatite do not have the potential to remove Zwitter-
gent 3-14 from process samples and reach the yield of 95% detergent removal, while recovering
at least 60% of interferon-α-2b. Hence, different techniques other than ion-exchange need to be
investigated.
9.3.3.2 Zwittergent removal using size-exclusion and affinity resin in spin columns
The ’Detergent Removal Resin’ from Thermo Fisher is, as described in section 9.3.2.2, a com-
bined technique of size-exclusion and affinity chromatography. The matrix allows only small
molecules to permeate and come in contact with a specially developed detergent ligand, whereas
larger molecules pass through the column without coming into contact with the ligand. The molec-
ular weight cut-off of the matrix is 10kDa. An expected difficulty for the removal of Zwittergent
3-14 from process samples, is the average micelle size of Zwittergent 3-14, of 30kDa which is
larger than the molecular weight cut-off of the ’Detergent Removal Resin’ matrix.
The experiments with the ’Detergent Removal Resin’ were performed with small spin columns
as described in section 9.2.3. Figure 9.12 shows the recovery of interferon-α-2b and Zwittergent
3-14 in the flow-through of the spin columns packed with ’Detergent Removal Resin’ as a function
of pH and conductivity.
Zwittergent 3-14 was quantified using RP-HPLC and RI detector as described in section 9.2.5 and
interferon-α-2b was quantified using SDS-PAGE as described in section 9.2.7. The results in fi-
gure 9.12 show that Zwittergent 3-14 could be removed from process samples with a yield of 80 -
20% depending on pH and conductivity. The initial concentration of Zwittergent 3-14 was 1.0%,
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Fig. 9.12: Recovery of interferon and Zwittergent 3-14 in flow through of spin column packed with
’Detergent Removal Resin’ at different pH and conductivity values
hence 0.8 - 0.2% of Zwittergent 3-14 concentration could be removed with the spin columns.
The results indicate that the binding of the detergent to the ’Detergent Removal Resin’ is dependent
on the pH and on conductivity of the process sample. With lower pH and lower conductivity the
affinity of the detergent towards the resin increased, hence the removal of the detergent improved.
This observation was unexpected, since the affinity of molecules to the resin is independent on the
pH and conductivity. However, the micelle molecular weight (MMW) of the detergent is affected
by the presence of salt-ions (section 8.1.1.1). With increasing ionic-strength, the MMW of the
detergent is increasing as well. Hence, with increasing conductivity less detergent micelles can
pass through the porose resin matrix and bind to the affinity resin.
The dependency on the pH and conductivity of the binding from the detergent to the resin was
not detectable during the Sarkosyl removal from process samples discussed in section 9.3.2.2. All
Sarkosyl bound completely to the ’Detergent Removal Resin’ independent of pH and conductiv-
ity. The difference in affinity towards the resin of both detergents could be due to their different
molecular weights and different detergent characteristics. The average micelle size of Sarkosyl is
only 0.l6kDa whereas the average micelle size for Zwittergent 3-14 is 30kDa. The formation of
micelles and their size is dependent on pH, conductivity and temperature (section 8.1.1.1). Hence
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it is possible, that the affinity of Zwittergent 3-14 towards the resin is independent of pH and con-
ductivity, but the micelle size of the detergent changes with different pH and conductivity values.
Smaller micelles can more readily pass through the matrix pores than larger one. Accordingly,
detergents with smaller micelles can be removed more efficiently with this ’Detergent Removal
Resin’ than detergents with larger micelles.
The recovery of interferon-α-2b is consistent and between 70 - 85% of the initial amount, inde-
pendent of pH and conductivity. During the removal of Sarkosyl a slight dependency on pH of
the resin affinity to interferon-α-2b was observed. This dependency cannot be seen throughout the
Zwittergent 3-14 removal. The difference between the affinity of interferon-α-2b to the resin in
the presence of Sarkosyl and Zwittergent 3-14 could be due to interactions between the detergent
and the protein. Detergents and proteins do interact with each other in solution and this interaction
is affected by pH (section 8.1.1.2), as well as the detergent characteristics. The interaction be-
tween Sarkosyl and interferon appears to be stronger and affected by pH more than the interaction
between Zwittergent 3-14 and interferon. Hence, the recovery of interferon-α-2b is dependent on
pH in the presence of Sarkosyl due to this interaction, but is not dependent on pH in the presence
of Zwittergent 3-14.
In summary, with the ’Detergent Removal Resin’ in spin columns more than 80% of the initial
Zwittergent 3-14 concentration could be removed at low pH (5.5) and low conductivity (<2.8mS/cm),
with a recovery of interferon-α-2b of 80%. The combination of size-exclusion and affinity resin
showed a higher potential for the removal of Zwittergent 3-14 than the usage of ion-exchange resin
on its own. However, removal of 80% of the initial detergent concentration is still not sufficient
to find application at industrial scale. As mentioned in section 9.3.2.2, the scale up of this method
for a large scale of 9’000L is impossible for the moment, since the ’Detergent Removal Resin’ is
only available in small amounts up to 100mL.
9.3.3.3 Zwittergent removal using Ultrafiltration/Diafiltration with spin tubes
The last technique tested for the removal of Zwittergent 3-14 from process samples is ultrafiltra-
tion/diafiltration which separates a mixture of molecules based on size depending on the molecu-
lar weight cut-off of the membrane. For the removal of Zwittergent 3-14 two different molecular
weight cut-offs were tested, 10kDa and 5kDa. The experiments were performed as described in
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section 9.2.4 using spin-tubes with different cut-offs to simulated the ultrafiltration/diafiltration
process at lab-scale.
Figure 9.13 shows the recovered fraction of interferon-α-2b, total protein and Zwittergent 3-14 in
the upper chamber (retentate) of the spin-tubes for a molecular weight cut-off of 10kDa.
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Fig. 9.13: Recovery of interferon, total protein and Zwittergent 3-14 in upper chamber (retentate) of
spin-tubes with 10kDa cut-off (pH=7.0, C=10.0mS/cm): after each cycle the upper chamber
was filled-up with extraction buffer and the centrifugation step repeated as before
Zwittergent 3-14 was quantified by RP-HPLC and RI detector as described in section 9.2.5 and
total protein and total interferon-α-2b were quantified using the BCA-assay and SDS-PAGE as
described in sections 9.2.6 and 9.2.7. The different cycles shown in figure 9.13 stand for the cen-
trifugation cycles performed. As mentioned in section 9.3.2.3 for Sarkosyl removal, the volume in
the upper chamber was topped-up with EDTA-Tris buffer (1mM EDTA, 20mM Tris, pH 8.0) after
each cycle.
The results in figure 9.13 show that Zwittergent 3-14 can be removed from process samples using
a spin column. After 6 cycles 80% of the initial Zwittergent 3-14 concentration had been removed.
Unfortunately, the removal rate of the detergent was reduced in the last cycles (4 - 6) and almost
stagnates, consequential it is unlikely that the addition of more cycles would improve Zwittergent
3-14 removal. The reason for this slow removal of Zwittergent 3-14 in the last cycles, is probably
due to the large average micelle size (30kDa) of the detergent. During each centrifugation cycle
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the volume in the upper chamber of the spin-tube decreases, hence, the concentration of detergent
and/or proteins increases. At higher concentrations the formation of micelles of the detergent in-
creased and the risk of these micelles fouling the membrane and blocking pores is enhanced. The
fouling of the membrane by detergent micelles or other large molecules should be reduced in a
UF/DF system, particularly using a TFF system. In a TFF ultrafiltration/diafiltration system a con-
tinuous flow is applied across the membrane which reduces membrane polarisation and fouling.
Hence, the removal of Zwittergent 3-14 would be expected to improve in a TFF operated UF/DF
system compared to a dead-end centrifugation system using spin-tubes.
The recovery of total protein and total interferon-α-2b decreases constantly throughout the differ-
ent centrifugation cycles, with a recovery of 50% of the initial total protein and total interferon.
The addition of more cycles would most likely lead to further loss in interferon-α-2b. Compared
to the UF/DF results for Sarkosyl removal (section 9.3.2.3), where no interferon was found in the
flow-through of the spin-tubes, all lost interferon could be detected in the flow-through for the
removal of Zwittergent 3-14. This result is unexpected. Interferon-α-2b has a molecular weight
of 19kDa, hence little should pass through the membrane pores with a cut-off of 10kDa. A reason
for this unexpected observation could be that the g-force of the centrifugation cycles was too high
creating a high transmembrane pressure and possible membrane distortion, consequently larger
molecules were pulled through the pores. A reduction of the g-force would decrease this loss of
interferon throughout the cycles, but would also reduce the removal of Zwittergent 3-14.
Another option to reduce the loss of interferon is the reduction of the pore size of the membrane.
Thus same experiment was performed with spin-tubes with a cut-off of only 5kDa. Figure 9.14
shows the recovered fractions of Zwittergent 3-14, total protein and total interferon in the retentate
of the spin-tubes with 5kDa cut-off.
It can be seen in figure 9.14 that the recovery of total protein and total interferon-α-2b throughout
the 6 cycles increased compared to the spin-tubes with 10kDa cut-off. After 6 cycles more than
80% of total protein and total interferon was recovered, hence only 20% of the initial interferon
was lost. However, it can also be seen that the removal of Zwittergent 3-14 is reduced and stagnates
at 50% removal for the last 4 cycles. Thus, no improvement in the Zwittergent removal is expected
due to addition of further cycles.
In summary, membranes with a cut-off of 10kDa show potential for the removal of Zwittergent
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Fig. 9.14: Recovery of interferon, total protein and Zwittergent 3-14 in upper chamber (retentate) of
spin-tubes with 5kDa cut-off (pH; 7.0, C; 10.0mS/cm): after each cycle the upper chamber was
filled with extraction buffer and the centrifugation step repeated as before
with a yield of 80% while recovering 50% of interferon-α-2b. The removal of detergent and the
recovery of interferon is likely to be improved using an ultrafiltration/diafiltration system and a
selection of a suitable value for g-force or pressure. On the other hand membranes with only 5kDa
cut-off did not show significant potential for the removal of Zwittergent 3-14 since only 50% of
the initial Zwittergent concentration could be removed.
9.3.4 Theoretical scale-up of detergent removal methods
Of the studied methods the most promising one for detergent removal was ultrafiltration/diafiltration
using spin-tubes. At large-scale a continuous TFF operated UF/DF system would be used. As de-
scribed in section 9.1.2.2 several parameters are important to scale-up an ultrafiltration method.
The most important parameters for the selection of the correct membrane-size are: filtrate volume
[L], flux or flow rate [L∗m−2∗h−1], process time [h], protein concentration [g/L] and membrane
type. With this information the required membrane area can be calculated using equation 9.2.
For the application of a UF/DF system for the removal of detergents from the protein recovery
process, the following parameters were assumed:
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filtrate volume: 9’000 L
protein concentration: 5.0 g/L
membrane type: regenerated cellulose
flux: 150 L/m2/h
process time: 4 hours
With a low protein concentration of 5 g/L higher filtration flux rates are required. The flux de-
creases with an increase in protein concentration. Using the above parameters the required mem-
brane area can be calculated as follows using equation 9.4:
area
[
m2
]
= filtrate volume [L]÷ (Flux [L ∗m−2 ∗ h−1] ∗ process time [h])
= 9′000 [L]÷ (150 [L ∗m−2 ∗ h−1] ∗ 4 [h])
= 15
[
m2
] (9.4)
In order to have a safety margin for process time and filtrate volume an extra 20% is included for
the membrane area calculation. With the 20% safety margin a 18 m2 membrane area is required to
process 9’000L in 4 hours with an initial protein concentration of 5.0g/L. The regenerated cellulose
membrane has been chosen due to its very low protein binding characteristics (section 9.1.2.2).
The next step is the calculation of required feeding buffer and the trans-membrane pressure (TMP).
The TMP is dependent on the protein concentration and on the flux. With low protein concentra-
tion and high flux rates, a high trans-membrane pressure is required of around 30 psi. The required
feeding buffer volume is dependent on the necessary diafiltration volume (DV). One DV is pro-
cessed when the filtrate volume collected equals the starting retentate volume. Results from the
experiments with the spin-tubes showed that 6-10 cycles were required to remove the detergents
up to 95%. One cycle corresponds to 12 DV, meaning 3-5 diafiltration volumes are required. With
one DV corresponding to 9’000L a feeding buffer volume between 27’000 and 45’000L will be
required to remove the detergents from process samples.
Since the continuous UF/DF is expected to be much more efficient than a dead-end filtration sys-
tem with spin tubes, these calculations should represent the worst-case scenario.
PhD-Thesis from Tanja Buch 225
CHAPTER 9. DETERGENT REMOVAL FROM THE RECOVERY PROCESS
9.4 Conclusion
In this chapter 3 different techniques were investigated for the removal of two different detergents,
Sarkosyl and Zwittergent 3-14, from process samples. The techniques were: ion-exchange resin,
size exclusion with affinity resin in combination and ultrafiltration/diafiltration.
The first two sections of this chapter focused on the quantification of the detergent Sarkosyl and
Zwittergent 3-14. Results have shown that RP-HPLC with UV detector can be used to quantify
Sarkosyl in process samples in the presence of different proteins. Since Zwittergent 3-14 does
not absorb UV light, a different method was required for its quantification. RP-HPLC with RI
detector showed good and accurate results for the quantification of Zwittergent 3-14. With these
two methods it was possible to quantify Sarkosyl and Zwittergent 3-14 in the process samples.
The next sections focused strictly on the removal of the different detergents. All results are sum-
marized and conclusion are drawn in the following two sections for the removal of Sarkosyl and
the removal of Zwittergent 3-14.
9.4.1 Removal of Sarkosyl
Five different techniques were tested for their potential to remove Sarkosyl from process samples
while recovering most of the interferon-α-2b. The first method was an ion-exchange method with
a Dowex resin, which successfully binds Sarkosyl but also interferon-α-2b. The conductivity of
the process sample has a significant impact on the binding affinity of Sarkosyl and interferon to-
wards the resin. A conductivity of 10mS/cm was shown to represent a reasonable compromise in
order to remove more than 97% of the initial Sarkosyl concentration while recovering 40% of the
interferon.
The next method tested was again an ion-exchange method with a mixed mode resin, hydroxyapa-
tite. Data showed that Sarkosyl and interferon-α-2b bind to this resin depending on the conduc-
tivity and pH of the process sample. The best working conditions were found at a pH of 7.5 with a
conductivity of 10mS/cm. Under these conditions 75% of the initial Sarkosyl concentration could
be removed while keeping more than 95% of interferon-α-2b in solution.
The third method tested was a combination of size exclusion with affinity resin in spin columns.
Results show that Sarkosyl can be removed successfully by more than 98% of the initial concen-
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tration while recovering over 75% of interferon-α-2b. No significant impact of the conductivity
was observed and only a minor impact of the pH could be detected. Hence, performing the method
at a neutral pH is beneficial for the interferon recovery.
The fourth and fifth techniques were ultrafiltration/diafiltration methods performed with spin-tubes
and two different cut-offs. A membrane with 10kDa pore size showed high potential for the suc-
cessful removal of Sarkosyl from process samples. Up to 80 - 95% of the initial Sarkosyl concen-
tration was removed from process samples, while recovering between 80 - 60% of interferon-α-2b.
The use of membranes with smaller pore size (5kDa) resulted in a slight improve in protein reco-
very but only 60% removal of Sarkosyl.
9.4.2 Removal of Zwittergent 3-14
The same five techniques tested for Sarkosyl removal were also tested for Zwittergent 3-14 re-
moval from process samples. The ion-exchange method with Dowex-resin showed a dependency
of pH and conductivity on the binding of Zwittergent and interferon to the resin. The best com-
promise was found to be at a pH of 7.5 with a conductivity of 10.0mS/cm which resulted in 70%
removal of the initial Zwittergent 3-14 concentration while recovering 50% of interferon-α-2b.
The second ion-exchange method was performed with the mixed-mode resin hydroxyapatite. Nei-
ther the Zwittergent 3-14 nor interferon binding to hydroxyapatite showed an obvious impact on
the pH or conductivity values. However, the optimum working conditions were observed at a con-
ductivity of 10.0mS/cm, independent on the pH. At these conditions 70% of the initial Zwittergent
3-14 concentration was removed while keeping 75% of interferon-α-2b in solution.
The combination of size exclusion and affinity resin was studied for Zwittergent 3-14 removal
as the third method. No effect of pH or conductivity was observed on the binding affinity of in-
terferon. However, the binding affinity of Zwittergent towards the resin was dependent on the
pH and the conductivity. Hence, optimal working conditions were observed at a pH of 5.5 and
a conductivity value of 2.8mS/cm. Under these conditions 80% of the initial Zwittergent 3-14
concentration was removed while recovering 80% of interferon-α-2b.
The last two techniques tested for Zwittergent 3-14 removal were ultrafiltration/diafiltration meth-
ods performed with spin-tubes and two different cut-off sizes. With a 10kDa cut-off 80% of the
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initial Zwittergent 3-14 concentration was removed while 50% of interferon-α-2b was recovered.
The addition of further cycles might improve the removal of Zwittergent even further but also
reduce the recovery of interferon. The use of a smaller cut-off membranes (5kDa) did not show
any beneficial results. The recovery of interferon was improved to 80% but only 50% of the initial
Zwittergent concentration could be removed.
9.4.3 Overall conclusion and outlook
Comparing all five methods with each other, the most promising method for successful removal
of the detergent while recovering as much interferon as possible is the combined technique of size
exclusion with affinity resin. Unfortunately this method finds its application only at small-scale up
to 100mL and is not suitable for large scale application up to 9’000L. Hence, an alternative method
is the ultrafiltration/diafiltration method using spin-tubes with a cut-off of 10kDa. Up to 80 - 95%
of the initial Sarkosyl concentration could be removed while recovering between 80 - 60% of in-
terferon. Also for Zwittergent 3-14 more than 80% of the initial concentration was successfully
removed while recovering 50% of interferon-α-2b. The application of this technique with a TFF
operated UF/DF system at large-scale should even improve the yield for both detergents removal
as well as the recovery of interferon-α-2b.
In summary the different studies showed that the removal of Zwittergent 3-14 from process sam-
ples is more challenging than the removal of Sarkosyl. The reason is the average micelle size of
the two detergents, which is much smaller for Sarkosyl than for Zwittergent 3-14.
A next step will be to look at the scale-up of the ultrafiltration/diafiltration method with a TFF
operated UF/DF system to test the theoretical estimated parameters of membrane size, pressure
and flow-rate for accuracy and functionality. It also needs to be tested what impact the new protein
recovery process samples, containing small amounts of detergents, have on the down-stream pro-
cess. The impact of different concentrations of both detergents on the first step of the down-stream
process will be investigated and discussed in chapter 10.
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Chapter 10
Impact of Optimized Recovery Process
on Down-Stream Process
10.1 Introduction
Chapter 8 focused on the application of two detergents, Sarkosyl and Zwittergent 3-14, throughout
the primary protein recovery process to improve the interferon-α-2b solubility and overall reco-
very. In chapter 9 several different techniques were tested to remove the detergents from process
samples to a yield of 95%. This chapter will now focus on the impact of these two detergents on
the down-stream process. Therefore the first step of the down-stream process of interferon-α-2b, a
cation-exchange chromatography method, will be characterized for its ability to purify interferon
from host cell proteins. In a second step different concentrations of the two detergents will be
investigated for interference with IFN purification using the IEC method. The different detergent
concentrations derived from addition during the primary recovery process in chapter 8 and the
remaining concentration after the detergent removal study from chapter 9.
10.1.1 Down-stream process for interferon-α-2b
The down-stream process for the production of the drug substance interferon-α-2b follows the
primary protein recovery process and consists of several purification steps, involving extraction,
conversion, three chromatographic steps, crystallization and ultrafiltration techniques. The last
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sample of the primary protein recovery process (compare figure 2.2 in chapter 2), the TCA-
pellet, is extracted and injected onto an ion-exchange column for purification and concentration of
interferon-α-2b. The first down-stream step is followed by a conversion of the IFN isoforms and
an ultrafiltration step for further concentration of the protein.
The remaining steps of the down-stream process are of less interest, since the focus in this chapter
is mainly on the first down-stream process, ion-exchange chromatography which is explained in
more detail in the following section.
10.1.1.1 Ion-exchange chromatography with SP Sepharose column
The first step in the down-stream process of interferon-α-2b is an ion-exchange chromatography.
In order to process the last sample of the primary protein recovery process, the TCA-pellet, IFN
and all related isoforms are extracted from the pellet by resolubilizing the pellet in an extraction
buffer (375mM Tris, 19mM EDTA at pH 8.0). After solubilisation for 120 minutes the pH is
adjusted to 5.45 with acetic acid and the solution is filtered through a 0.5µm filter. The extraction
of the TCA-pellet results in approximately 3’100 l which is the feed volume for the ion-exchange
method.
The ion-exchange chromatography step is a cation-exchanger with a 75l SP Sepharose fast flow
(FF) column, which objective is to separate interferon and its isoforms form host cell proteins
(HCP). The column is equilibrated with the equilibration and wash buffer, 10mM sodium acetate
at pH 5.5 followed by feed injection of the extracted TCA-pellet (3’100l) at a constant flow rate of
4500ml/min and a controlled temperature between 2-8◦C. After a wash step the interferon is eluted
from the column with a gradient from 0.0M NaCl to 0.42M NaCl over 4 hours at 4500ml/min flow
rate and a pH of 5.5. Only 20% of the elution volume is pooled together for further purification
steps (≈ 220l) which is dependent on the highest UV-280 reading. After elution the column is
regenerated in 0.5M NaOH and 1M NaCl for further purifications.
The 3’100l feed volume containing interferon-α-2b and its isoforms from the TCA-pellet are
eluted into 1’080l elution volume of which only 220l contain interferon and its isoforms. This
means that through the cation-exchange method the process volume is reduced 14 fold from 3’100l
down to 220l for further purification.
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10.1.2 Cation-exchange chromatography
The purification of recombinant proteins from multicomponent protein mixtures throughout the
down-stream process involves usually a series of different types of liquid chromatography which
includes size exclusion, ion-exchange, adsorption and affinity chromatographic processes [138].
Ion-exchange chromatography (IEC) is the most common and widely used liquid chromatography
technique in industrial purification due to its large sample-handling capacity, broad applicability
and ease of scale-up and automation abilities [78].
IEC separates multicomponent protein mixtures primarily through electrostatic interactions be-
tween the charged amino acid side chains and the surface charge on the ion-exchange resin [139].
Proteins have ionisable chemical fragments which positive or negative charge enhancement is a
function of the proteins pI and the surrounding pH [140]. As described in section 6.1.4.1 the pI
(isoelectric point) of the protein is the pH at which the net charge on the protein is zero. If the pH
of a solution is below the pI of the target protein, the net charge on the protein becomes positively
charged and the protein will bind to a cation-exchange resin and vice versa [138].
The cation- or anion-resins exist with several different chemical properties such as matrix com-
position, pH and pressure stability, density of charged groups and ligand chemistry [141]. An
important aspect for a successful separation of protein mixtures by ion-exchange chromatogra-
phy is the selection of an optimal ion-exchange resin which is mainly based on the desired resin
charge and strength and the sample properties. Various resins are available with positive and
negative functional groups as strong and weak ion-exchangers. Strong ion-exchangers are fully
ionized over a broad pH range, whereas weak ion-exchanger are partially ionized over a narrow pH
range and thus their charge can vary significantly with the pH. Weak ion-exchange resins are com-
monly more flexible in selectivity and require milder elution conditions than strong ion-exchange
resins [78][142]. Sulfopropyl (SP) functional groups are strong cation-exchangers (exchange ca-
pacity: -0.22mmol/ml)[143] and are conventional resins in the use of protein purification [141].
SP-Sepharose cation-exchange resins are widely used in combination with sodium acetate buffers
at pH levels between 5.5 to 6.0, due to the pKa value of sodium acetate of 4.75 (calculated with
the Henderson Hasselbalch equation [144]). The buffer strength should be minimal at a concen-
tration of 10mM, in order to provide sufficient buffer capacity (10mM sodium acetate with 8.6mM
Na-acetate and 1.4mM acetic acid results in a pH of 5.53). However, buffers with a high buffering
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strength (50 - 100mM) can also interfere with the binding of proteins to the resin and reduce the
binding capacity [78].
The binding affinity of proteins towards the resin is mainly dependent on the chemical and phys-
ical properties of the protein itself. However, other factors can affect the protein binding as well,
which are conductivity, temperature, flow-rate and the dynamic binding capacity of the column.
If the ionic strength of the protein sample or the loading buffer is too high, salt ions bind to the
binding sites of the column resin and decrease the binding capacity of the column [78]. The impact
of temperature on the protein binding affinity is less significant and hence, ion-exchange chroma-
tography is often carried out at room temperature. However, temperature can have an impact on
the protein structure and thus on the protein binding to the resin. Some studies have shown that
the protein binding to the column resin is improved at lower temperature (10◦C) [145].
The flow-rate is directly correlated to the contact or residence time between protein and resin.
With an increase in the flow-rate the residence time is decreasing. In general, the protein binding
is decreased with an increase in the flow-rate. However, low flow-rates lead to an increase in the
elution volume and thus to protein dilution [146]. The binding capacity of a column has also a sig-
nificant impact on the protein binding. If the column is overloaded no additional protein binding
can occur. The dynamic binding capacity of a column can be characterized by the performance of
breakthrough curves and calculated using the following equation:
dynamic binding capacity = C0 ∗ (VL − V0) (10.1)
With:
VL = volume loaded up to the breakthrough point
V0 = void volume of the column
C0 = concentration of protein in the feedstock
The shape of the breakthrough curve provides information about the column efficiency, as the
sharper the curve is the higher is the column efficiency [146].
The elution condition and format varies from protein to protein and is dependent on protein stabil-
ity. More detailed information is described in the following section.
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10.1.2.1 Gradient versus isocratic elution
The final step during chromatography is the elution of the protein from the column. In ion-
exchange chromatography the protein elution can be achieved by varying either the pH or the
ionic strength of the elution buffer. Most commonly used is elution by changing the ionic strength.
Ion-exchange columns are highly dependent on salt concentration. Hence, a small change in the
ionic strength will have a large effect on the retention of the protein [147]. Zhang et al. [148] have
shown that the pH elution can provide better resolution than the salt elution. However, using a
pH elution provides higher risks of protein precipitation at the proteins pI. On the other hand, an
increased salt concentration in the elution fraction can interfere with further down-stream steps.
Hence, it is dependent on the protein properties and the down-stream process itself which of the
two elution conditions is more favourable.
Besides the elution conditions, the elution format needs to be selected as well. Two main different
elution formats are commonly used: isocratic elution and gradient elution. Isocratic elution uses
only one elution buffer at a constant ionic strength and pH value. This method is less complex,
easy to develop and easy to transfer from one system to another. However, the isocratic elution is
usually not useful to separate multi-component samples. In this case a gradient method is much
more beneficial, which provides a higher peak capacity [149]. Throughout the gradient elution
either the pH or the ionic strength is varied in a continuous or discontinuous (stepwise) approach
[78].
10.1.2.2 Interference of host cell proteins
A challenge in recombinant protein production with microbial cells, especially in hosts such as
E.coli, is the purification of the recombinant protein from host cell proteins. Cation-exchange
chromatography is a common technique widely used to remove host cell proteins from the fermen-
tation broth [150]. However, host cell proteins are also known to interfere with the purification
of recombinant proteins due to interaction with the stationary phase or protein-protein interac-
tions. Especially the purification of small recombinant proteins with a low molecular weight can
be affected by the presence of host cell proteins.
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10.1.2.3 Interferences of detergents
Detergents are amphiphilic molecules as described in section 8.1.1.1 and they contain a hydrophilic
head and a hydrophobic tail. They are widely used to increase protein solubility (8.1.1.2) and can
be divided into four major groups: ionic detergents, bile salts, non-ionic detergents and zwitteri-
onic detergents. Detergents of categorizes a and b are known to interfere with purifications with
ion-exchange chromatography. For example anionic detergents, such as Sarkosyl, will bind to
anion-exchange columns and thus interfering with the protein binding to the column. In cation-
exchange chromatography, anionic detergents inhibit the binding of proteins to the resin by mask-
ing their negative charges [151]. Non-ionic and zwitterionic detergents have no net charge, thus
they should not interfere with the purification by ion-exchange chromatography. Some studies
show, that also non-ionic and zwitterionic detergents can partially mask the native charges of the
proteins, which results in a decreased binding affinity of the protein towards the ion-exchange resin
[151]. However, studies from Dencher et al. [152] showed an increased binding of the protein to
the column in the presence of zwitterionic detergents.
The impact of detergents on ion-exchange chromatography can be dependent on several charac-
teristics of the detergent, for example: cmc, micellar molecular weight, cloud point and UV-
transparency. It was shown that detergents with high cmc are less suitable for the application in
ion-exchange chromatography than detergents with lower critical micelles concentrations [153].
10.1.3 Goals and Aims
The aim of this chapter is the investigation of the impact of two detergents, Sarkosyl and Zwit-
tergent 3-14, on the first down-stream step for interferon-α-2b, an ion-exchange chromatography
method. This investigation is carried out in three main steps. First, the ion-exchange chromatog-
raphy method is characterized for its interferon-α-2b recovery and certain parameters such as
flow-rate, protein load and the presence of host cell proteins are investigated for their level of in-
terferences throughout the purification. Second, the presence of the anionic detergent, Sarkosyl,
during the purification is studied at different concentrations of the detergent to find the minimal ac-
ceptable detergent concentration at which interferences on the IEC method are negligible. In a last
step the impact of the zwitter-ionic detergent, Zwittergent 3-14, is investigated on the ion-exchange
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method and the recovery of interferon-α-2b. The IEC method is also studied for its potential to
remove the detergent from process samples throughout the purification step for interferon-α-2b,
in order to avoid interferences with further purification methods during the down-stream process.
PhD-Thesis from Tanja Buch 235
CHAPTER 10. IMPACT OF OPTIMIZED RECOVERY PROCESS ON DOWN-STREAM
PROCESS
10.2 Material and Methods
10.2.1 List of Materials
Tab. 10.1: Materials and suppliers
materials supplier
Recovery process samples industrial partner
Trizma Base Sigma Aldrich
interferon-α-2b drug substance industrial partner
EDTA tetrasodium salt VWR
Sarkosyl Sigma Aldrich
Zwittergent 3-14 Sigma Aldrich
Acetic Acid (glacial) 100% VWR
Sodium Acetate Merck
HiTrap SP HP or FF 5ml column GE Healthcare
Sodium chloride Merck
Pierce R© BCA Protein Assay Kit Thermo Scientific
Bovine serum albumin (BSA) Sigma Aldrich
10.2.2 Ion-Exchange Chromatography - HiTrap cation exchanger
This method was developed by the industrial partner and protocols were applied to the systems
available in the labs in DCU. Only minor changes had to be made, which are discussed in the
result section.
Sample preparation
Samples used for the ion-exchange chromatography are called the TCA-pellet, which is the last
sample of the protein recovery process. Ten gram of this pellet were dissolved in 100mL of 10mM
acetic acid solution and homogenized for 10 minutes for an acid wash. After homogenization
the solution was centrifuged at 4000rpm for 45min at 4◦C with a FL40R centrifuge (Thermo
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Scientific, Dublin, Ireland). The supernatant was discharged and the pellet was solubilized in
500mL of extraction buffer (20mM Tris, 1mM EDTA, pH 8.0) and homogenized for 20 minutes.
pH was set to 8.0 with either 4M acetic acid or 1M Tris and agitated gently for 2 hours until all
precipitants were solubilized. Next, conductivity was reduced below 2mS/cm with 5mM sodium
acetate (pH 5.5) and pH was adjusted to 5.5 with 4M acetic acid. In a last step, the solution was
re-centrifuged at 4000rpm for 15min at 4◦C using a FL40R centrifuge (Thermo Scientific, Dublin,
Ireland). The pellet was discharged and the supernatant was filtered through a 0.45µm PVDF filter
(Millipore, USA).
Purification with IEC
Ion-exchange chromatography was performed with a cation exchange column (GE Healthcare,
Buckinghamshire, UK), HiTrap SP HP or FF, with a 5mL column volume. The column is con-
nected to a chromatography system AKTA Explorer (GE Healthcare, Buckinghamshire, UK)
which controlled the salt gradient and solvent flow-rate. Two mobile phases were used for the
separation: mobile phase A was 10mM sodium acetate at pH 5.5 and mobile phase B was 10mM
sodium acetate, 0.7M sodium chloride at pH 5.5. The separation was performed at room temper-
ature (no temperature control) and with a continuous flow rate of 5.0mL/min. During elution 3
parameters were monitored: UV at 280nm, conductivity and the gradient between mobile phase
A and B.
Before sample injection, the HiTrap column was equilibrated with mobile phase A for 20 min
at 5mL/min, followed by flushing the system (by-passing the column) with the sample solution
for 6.0min. One hundred millilitre of the sample were injected onto the column at a flow-rate of
5.0mL/min and the flow through collected for further analysis. After sample injection the column
was washed with 8 column volumes (40mL) of mobile phase A to remove all non-bound pro-
teins from the column. The waste from this step was collected for further analysis and labelled as
’wash’ sample. After the wash step the elution of the sample followed, which was done using two
different operations:
First, a gradient method, mobile phase B was increased continuously from 0% to 60% in 18
minutes at a flow rate of 5.0mL/min. The eluent was collected using a fraction collector which
collected a new fraction every minute. Alternative a second operation was used based on an iso-
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cratic method. The ratio between mobile phase A and B was set to a fixed value and elution was
performed at this ratio for a defined time with a flow-rate of 5mL/min. The specific ratio and
duration of the elution was defined for each experiment individually.
Following elution the column was cleaned by stripping the column with 100% mobile phase B for
5min at 5ml/min. These fractions were collected for further analysis and labelled as ’strip’ sample.
In a last step the column was regenerated with 50mL of mobile phase B at 5.0ml/min before equi-
libration in preparation for the next sample. Each column could be used at least 5 times without
losing resolution in the purification.
The complete methods for equilibration, sample load, column wash, elution and column regener-
ation can be found in the appendix B.
10.2.3 Detergent quantification
Sarkosyl and Zwittergent 3-14 were quantified following the methods described in section 9.2.5.
10.2.4 Total protein quantification
Total protein was quantified using the BCA assay as described in section 3.2.2 and table 3.5 or the
Bradford assay as described in section 3.2.2 and table 3.6. Samples without a detergent present
were analysed using the Bradford assay, whereas samples with a detergent present were analysed
using the BCA-assay. Sample pellets were dissolved in EDTA-Tris buffer (20mM Tris, 1mM
EDTA, pH 8.0) prior to protein analysis. BSA dissolved in water was used as a reference standard
for all total protein determinations. The reagent blank was chosen according to the sample to be
analysed, and included water, EDTA-Tris buffer or detergents.
10.2.5 Total Interferon-α-2b quantification
Total interferon-α-2b was quantified using SDS-PAGE as described in chapter 5.2.3 and 5.2.4.
Sample pellets were dissolved in EDTA-Tris buffer (20mM Tris, 1mM EDTA, pH 8.0) prior
to analysis as mentioned in the section above. No further sample treatment was required. The
interferon-α-2b drug substance was used as a reference standard for all quantifications.
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10.2.6 Interferon-Isoform quantification
Interferon-isoforms were quantified using the RP-HPLC method as described in section 6.2. Ref-
erence standards of interferon-α-2b were prepared in phosphate buffer as well as in phosphate
buffer containing 3% Sarkosyl and 1% Zwittergent 3-14.
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10.3 Results and Discussion
This result and discussion section is divided into three main parts: the first focuses on the charac-
terization of the ion-exchange chromatographic method and the investigation of the interference of
host cell proteins on the interferon-α-2b purification. The second and third parts concentrate on the
impact of the two detergents, Sarkosyl and Zwittergent 3-14, on the purification of interferon-α-2b
using the ion-exchange method.
10.3.1 Characterization of Ion-Exchange Chromatography with HiTrap column
The first step of the down-stream process for the industrial manufacture of interferon-α-2b is an
ion-exchange-chromatographic step. As described in section 10.1.1.1, this cation exchanger binds
the positive charged interferon-α-2b in order to purify it from host cell proteins. The TCA-pellet,
derived from the primary protein recovery process, was therefore re-dissolved in an extraction
buffer (375mM Tris, 19mM EDTA, pH 8.0), pH adjusted to 5.45, conductivity set below 2mS/cm
and filtered through 0.45µm pore size. Four x 800L were loaded onto a 75L column (SP Sepharose
Fast Flow) and 240L (7.5%) were collected for further purifications. Figure 10.1 shows a flow-
chart of the cation-exchange chromatography method.
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Fig. 10.1: Flow-chart of the ion-exchange chromatography method
This first DSP step was simulated at small scale using a 5mL HiTrap SP Sepharose HP or FF col-
umn. Sample preparations and chromatography were performed in a similar way to the manufac-
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turing process as described in section 10.2.2. Figure 10.2 shows the chromatogram of a TCA-pellet
derived from the manufacturing process and extracted at small scale in the labs in DCU.
 HiTrap IFN Purification wash001:10_P960_Flow
   0
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Fig. 10.2: AKTA chromatogram of purification of TCA-pellet: negative control
Figure 10.2 shows the UV reading at 280nm (blue), the conductivity reading (brown) and the gra-
dient of mobile phase B (green) from the sample load, the wash step, the elution in 18 fractions
and the stripping of the column. The loading of the sample corresponds to the first 100mL in the
chromatogram with a UV-280 reading of around 4000mAU, followed by the wash step for 40mL
with the UV-280 reading dropping to 200mAU. The third part, shown in the chromatogram in
figure 10.2 is the elution of interferon-α-2b collected in 18 fractions each with 5mL volume. The
UV-280 reading usually reaches its maximum at 1300 - 1500mAU in fraction 9 and drops back
down to 300mAU in fraction 13 or 14. The last step is the stripping of the column with 25mL,
which usually shows a small peak in the UV-280 reading with a maximum of 500mAU.
The selection criteria for the fractions to be pooled for further purification is the highest UV-280
reading±2 fractions on each side, which would mean fraction 7-11 with the maximum UV reading
being in fraction 9. Some purification chromatograms showed a remote tailing in the elution peak
which lead to the decision to take fractions 7-12 for further purification as a default setting. Be-
side this selection criteria all fractions, sample load, wash-step, elution-fractions and strip-sample,
PhD-Thesis from Tanja Buch 241
CHAPTER 10. IMPACT OF OPTIMIZED RECOVERY PROCESS ON DOWN-STREAM
PROCESS
were analysed for total protein using the Bradford assay and for total interferon-α-2b using SDS-
PAGE. Fractions 7-12 from the elution were also analysed for interferon-α-2b and its isoforms
with RP-HPLC.
The chromatogram in figure 10.2 and the quantified amounts of protein in each fraction are clas-
sified as the negative control sample for all further runs performed with this method.
Figure 10.3 shows total protein and total interferon-α-2b in the different collected fractions of the
TCA-pellet purification using the ion-exchange method and HiTrap column. The results corres-
pond to the chromatogram shown in figure 10.2.
protein load flow though wash sample
Fr-7 Fr-8 Fr-9 Fr-10 Fr-11 Fr-12
strip sample
0
20
40
60
80
100
Fig. 10.3: Interferon-α-2b and total protein fractions quantified in samples of the purification of a
TCA-pellet (negative control) with the HiTrap column
Total protein (in green) was quantified by the Bradford assay as described in section 10.2.4 and
total interferon-α-2b (in blue) was quantified by SDS-PAGE as described in section 10.2.5. Figure
10.3 shows that 50% of the loaded interferon-α-2b was found in the flow through and does not
bind to the column and around 10% were found in the wash- and strip-sample. This means that
only 40% of the loaded interferon-α2b was found in the eluted fractions. Nearly all of these
40% are found in fractions 7-12, with a maximum of 20% in fraction 10. This low yield in IFN
recovery is unexpected and leads to the conclusion that the column was overloaded. Roughly 40mg
of interferon-α-2b was loaded onto the 5mL HiTrap column. The theoretical dynamic binding
capacity of this column is 55mg ribonuclease/ml medium at 5ml/min, which would mean 275mg
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ribonuclease for the 5ml column. Hence, it is very unlikely that the column is overloaded with
40mg interferon. Other reasons for low protein binding to the column are: high flow-rate, column
temperature, binding-buffer or low binding affinity of the protein to the column. Each of these
reasons was investigated and discussed in more detail later in this section.
Looking at the total protein in the different fractions of the TCA-pellet purification it can be seen
that almost 70% of the loaded total protein was found in the flow-through, 10% in the wash- and
strip-sample and only 20% in the eluted fractions. These findings are as expected, as the aim of
this purification method was, to purify interferon from host cell proteins. Figure 10.3 also shows
that the maximum of eluted total protein is in fraction 9 and not fraction 10 as for interferon-α-
2b. The maximum in fraction 9 corresponds to the observed maximum in the UV-280 reading
seen in figure 10.2. This indicates that the UV-280 in the chromatogram is mainly dictated by the
elution of total protein and does not correspond to the interferon-α-2b elution. The shift between
the elution of total protein and interferon also indicates that total protein is eluting earlier from
the column at a lower salt concentration than interferon. Hence, the binding affinity towards the
column should be less than the binding affinity of interferon.
Figure 10.3 shows only the recovered fractions of total protein and interferon, expressed as a
percentage of the protein loaded. However, looking at the actual amount of total protein and
interferon (shown in the first row of table 10.5) it can be seen that interferon represents only a
very small fraction of the total proteins. Interferon-α-2b is less than 9% of the protein in the
loaded sample and only 20% of the protein eluted from the column. This means that each eluted
fraction (7-12) contains around 4-5 times more total protein (in mg) than interferon-α-2b. This
also explains why the UV-280 reading of figure 10.2 corresponds more to the quantified total
protein and less to interferon-α-2b.
Interferon-α-2b was also quantified using RP-HPLC as described in section 10.2.6. Fractions
7-12 were injected directly onto the RP-HPLC column and quantified over the peak-area from
the UV-280 readings. The start sample of the TCA-pellet was first filtered through a 0.22µm
filter and then directly injected on the RP-HPLC column without any pre-treatment. Due to the
presence of several different host cell proteins in the TCA-pellet, the HPLC chromatogram shows
over 60 small peaks in less than 20 minutes. This makes the quantification and selection of the
correct peak very challenging and results have to be treated with caution. The quantification of
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the TCA-pellet resulted in 17.16mg total interferon-α2b, meaning all isoforms were measured
together. This is only half the amount determined by SDS-PAGE (35.86mg). The total interferon-
α-2b in fraction 7-12 quantified by RP-HPLC resulted in 4.8mg, compared to 14.5mg quantified
by SDS-PAGE. The comparison between results obtained by SDS-PAGE and RP-HPLC indicates
an overestimation of interferon quantification using SDS-PAGE, a result similar to that seen and
discussed in chapter 5 and 6. However, the proportion between interferon load and recovery is
comparable. Results from the RP-HPLC show a 30% recovery of interferon, and SDS-PAGE
results show a 40% interferon recovery. It is likely that the amount of interferon in the TCA-
pellet was overestimated by RP-HPLC due to interference by host cell proteins. Thus, with less
interferon load the recovered portion in fractions 7-12 would be higher than 30%. Hence both
quantification methods give similar results for the proportion between interferon load and recovery,
consequently all further analysis for IFN will be done by SDS-PAGE quantification.
Both interferon quantification methods indicated a loss of 60% of interferon-α-2b during the pu-
rification step with the ion-exchange Sepharose column. Most of the lost interferon was found in
the flow through, thus it did not bind to the column. In order to investigate the low IFN recovery
during this step, several factors were examined. First, two factors to be investigated were over-
loading of the column and the flow-rate. Is the flow rate too high during protein loading, some
proteins may flushed through the column without giving them enough time to bind to the column.
Hence, protein load and flow-rate during protein load were reduced by 50% for a purification run.
The third factor is the column temperature. At manufacturing scale this ion-exchange method is
performed at 4◦C. During small scale performance the column temperature was uncontrolled and
therefore at room temperature. As described in section 10.1.2, lower temperatures can be benefi-
cial for protein binding to the column. Due to difficulties in the implementation of setting-up the
whole AKTA system in a cold room, only the column was put on ice during the purification and
both mobile phases were kept refrigerated until use. The fourth factor investigated was the salt
concentration of the binding buffer (mobile phase A). If the salt concentration is too high it can
interfere with the binding of proteins to the column. Hence, the sodium acetate concentration was
reduced from 10mM to 5mM for one purification run. The last factor investigated was a low bind-
ing affinity of interferon-α-2b towards the Sepharose column. Thus, the same sample was loaded
twice onto the same column. The flow-through of the first sample load was recovered and directly
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loaded onto the column a second time without performing the elution or wash-step in between.
All results on the impact of the five described factors on the interferon recovery during the ion-
exchange method are gathered together in table 10.2. The table shows measured amounts for total
protein and total interferon for sample load, flow through, wash- and strip-sample and the elution
fractions 7-12 in mg and in percentage in relation to the sample load. It also shows the proportion
factor between total protein and interferon in the starting sample.
All experiments were performed with the TCA-pellet from the manufacturing process and sample
preparation was performed as described in section 10.2.2. Total protein was quantified using the
Bradford assay as described in section 10.2.4 and total interferon was quantified using the SDS-
PAGE as described in section 10.2.5.
The first row in table 10.2 shows the results of the negative control from the TCA-pellet purifica-
tion following SOP instructions from the industrial partner as described in section 10.2.2. These
are also the same results shown in figure 10.2 and 10.3. All other results will be compared and
assessed in relation to this negative control.
The second row shows the results after reducing the protein load onto the column. Instead of 35mg
of interferon-α-2b only 12mg were loaded onto the column at the same flow rate to investigate a
potential overload of the column. As can be seen in the last column of table 10.2, the reduction of
the protein load showed no significant impact on the interferon recovery in fractions 7-12 of the
column-elution. The recovery was even slightly lower with 34.33% of the loaded interferon com-
pared to 40% recovery in the negative control. The reduced IFN recovery indicates a low binding
affinity of interferon towards the column or an increased interference of other molecules. With a
reduced protein load, less interferon molecules are available to interact with the binding sites of
the column.
The next row lists the results for a reduced flow-rate of 2.5ml/min during the protein load. Fifty
percent of the loaded interferon were recovered in elution fractions 7-12 which is slightly higher
than the control run. Hence, it can be assumed that the reduction of the flow-rate during protein
load results in improvement of the recovery of interferon from 40 to 50%. However, more than 35
- 40% of interferon was still detected in the flow-through and did not bind to the column. Hence,
other factors must interfere with the binding between interferon and Sepharose column.
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In row 4 of table 10.2 the impact of a reduced column temperature is shown. Results show no
significant difference compared to the control sample. However, it has to be kept in mind that the
temperature was not controlled nor monitored, meaning the actual column temperature during the
purification is unknown. It is possible that controlling the column and buffer temperature at 4◦C
has a more significant positive impact on the IFN recovery. However, a 80% IFN recovery simply
through controlling the column temperature at 4◦C is unlikely, since the cooling of the column and
mobile phases showed no positive impact at all.
The next factor investigated was a reduced salt concentration in the binding buffer, as seen in row
5. No significant impact on the interferon-α-2b recovery was detected compared to the control
run (36% to 40%). The original salt concentration of the binding buffer, 10mM sodium acetate,
was already at the lower levels. If the salt concentration is too low the buffer loses its potential to
control the pH and can have a negative effect on protein binding.
Row 6 of table 10.2 shows the results to investigate a potential low binding affinity of interferon to
the column. The flow through was collected and directly re-loaded onto the column without any
wash- or elution-step. Results show that due to re-loading of the flow-through no improvement
in IFN recovery was achieved. Hence, no further IFN bound to the column after the first loading
run. If interferon-α-2b has only a low binding affinity towards the column, more IFN should have
bound to the column in the second loading run. Since the observation showed no additional IFN
binding in the second loading run, it is very likely that other molecules present in the sample
interfere with the binding of interferon to the column. Most likely these molecules are host cell
proteins, which represent a high fraction of the total protein amount of the TCA-sample.
In order to investigate a potential interference of host cell proteins with the binding of interferon to
the column, a purified sample was tested for its binding affinity to the column. The purified sample
derived from collected elution fractions 7-12 from different runs of the TCA-pellet. Row 7 of table
10.2 shows the recovered interferon at the different stages during the ion-exchange method. More
than 90% of the loaded interferon was recovered in the elution fractions 7-12. This result shows,
if less host cell proteins are present in the sample (only 60% compared to 90% in control sample),
the purification is more efficient and the recovery yield of interferon is over 90%. In a next step
the purified sample was mixed 50:50 with the unpurified control sample to increase the amount
of host cell protein in the starting sample. Row 8 of table 10.2 shows the results. The increase in
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host cell proteins decreased the recovered interferon in elution fractions 7-12 from 90 to 55%. The
interferon loss in the flow through did increase from 0.4 to 32% due to the increase in host cell
proteins. These results confirm the assumption that host cell proteins interfere with the binding of
interferon to the column and therefore reduce the recovery yield of IFN in the elution fractions. A
next step will be to investigate how the host cell proteins interfere with the interferon-α-2b binding
to the column. This will be discussed in more detail in the following section.
In summary the results of the first DSP step, an ion-exchange method, showed that interferon-
α-2b was purified from host cell proteins from 8.5% purity to 19%. Unfortunately only 40% of
the loaded interferon was recovered in the purified fractions and over 50% was found in the flow
through of the column. Several different factors were investigated for their potential to improve the
interferon recovery. Only a reduced flow-rate during protein load showed a small positive impact
on the IFN recovery. The largest impact was shown to be the absence or a reduction in host cell
protein in the starting sample. This led to the conclusion that host cell proteins interfere with the
binding of interferon to the column, which will be investigated and discussed in more detail in the
following section.
10.3.1.1 Interferences of host cell proteins with the interferon purification
The previous section showed that host cell proteins have a major impact on the binding of inter-
feron to the ion-exchange column. In order to investigate how the host cell proteins interfere with
the IFN binding, different potential scenarios of the interaction were gathered together. Figure
10.4 gives a schematic overview of 4 potential cases of how host cell proteins can interfere with
interferon binding to the column. In all 4 cases, the black vertical line represents the ion-exchange
column, the red v-shapes illustrate the binding sites on the column, the small blue figures represent
interferon-α-2b and the large green figures are host cell proteins. In case one, some of the inter-
feron binds to the column, whereas other interferon bind to host cell proteins which prevent them
from binding to the column. In scenario two, host cell proteins interact with interferon molecules
which are bound to the column. Hence, larger host cell proteins block potential binding sites for
other interferon molecules. Case three describes the case where, due to the high levels of HCP, the
host cell proteins bind directly to the column such that only some interferon attaches to the column
through interactions with the host cell proteins. The last scenario 4, assumes that interferon and
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host cell proteins both bind to the column, but larger host cell proteins block potential binding
sites for other interferon, thereby reducing the capacity.
Fig. 10.4: Possible interferences of host cell proteins with the binding of interferon-α-2b to the
ion-exchange column - 4 scenarios: 1.) some IFN bind to HCP and prevent binding of IFN to
the column. 2.) HCP interacts with IFN bound to the column and blocks potential binding sites
for other IFN molecules. 3.) HCP binds directly to the column and only some interferon can
attach to the column through HCP. 4.) IFN and HCP bind both to the column, but larger HCP
blocks potential binding sites for further interferon to bind, i.e. HCP reduces the column
capacity.
In order to investigate which of the described scenarios occurs during the binding of interferon to
the column, two different experiments were performed. The first experiment investigated whether
scenario 2, 3 or both occur during HCP interactions. In both cases either host cell proteins or
interferon bind to another protein through protein-protein interactions at the surface of the column.
Detergents break-up protein-protein interactions, hence, a second wash-step was implemented
following the original wash-step with binding buffer (10mM sodium acetate). The additional
wash-step was performed with 1.0% Zwittergent 3-14 in 10mM sodium acetate. If protein-protein
interactions occurred in the column, the unbound protein should be eluted with the detergent wash-
step.
Figure 10.5 shows the AKTA chromatogram of the purification of a TCA-pellet with an additional
wash step containing 1.0% Zwittergent 3-14 following the original wash step with 10mM sodium
acetate.
The red circle in figure 10.5 shows a clear peak in the additional wash step, indicating that either
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Fig. 10.5: AKTA chromatogram of sample purification with an additional wash step with detergent: red
circle
host cell proteins or interferon were indeed attached to the column by protein-protein interactions.
Analysing the additional wash step using the BCA assay for total protein and SDS-PAGE for total
interferon-α-2b showed only host cell proteins were present in this sample and no interferon was
detectable. This clearly shows that scenario 3 of figure 10.4 is negligible and case 2 is likely to be
the prominent interference mechanism.
In order to examine if case 1 and 4 are existent or negligible one further experiment was per-
formed. The recovered flow-through of a TCA-pellet purification was injected onto a fresh, re-
generated column. If interferon molecules were not attached to any host cell proteins (case 4),
these interferon molecules should bind to the fresh regenerated column. However, if interferon is
attached to host cell proteins no further binding of interferon to the fresh column should occur.
Figure 10.6 shows the results for total protein and total interferon of the different steps throughout
the ion-exchange purification. The graph on the left shows the results of purification run 1 and the
graph on the right shows the results of purification run 2 using the flow through of run 1 as starting
sample. Total protein was quantified using the Bradford assay as described in section 10.2.4 and
total interferon-α-2b was quantified using the SDS-PAGE as described in section 10.2.5.
The left graph of figure 10.6 shows the TCA-pellet purification with standard operating conditions
as described in section 10.2.2. The obtained results for total protein and total interferon are com-
parable to the negative control sample, with 50% of loaded interferon found in the flow-through
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of the column and 38 - 40% of interferon recovered in the elution fractions 7-12. These results
are as expected, if scenario one in figure 10.4 is the predominant mechanism for IFN binding
interference.
Fig. 10.6: Interferon-α-2b and total protein fractions quantified in samples of the purification of a
TCA-pellet with the HiTrap column: left, purification of TCA-pellet; right, purification of flow
through from previous purification
The graph on the right of figure 10.6 also shows a purification with standard operating conditions
except that the starting sample is not TCA-pellet but the flow-through of the purification run 1
(graph to the left). It can be seen that the recovery of interferon decreased to less than 10%, and
more than 80% of the loaded interferon was found in the flow-through, not binding to the column.
These results lead to the conclusion that it is more likely that scenario 1 (from figure 10.4) occurs
within the column and interferon and host cell proteins interact with each other. Depending on
how the proteins interact, interferon can either still bind to the column (case 2) or the binding
site of interferon to the column is blocked by host cell proteins and no binding occurs (case 1).
Scenario 4 cannot be eliminated completely. Some host cell proteins will also bind directly to the
column, since host cell proteins are also found in the purified elution fractions.
In summary, results have shown that the main interferences of host cell proteins with the binding
of interferon to the column are due to interactions between interferon and host cell proteins as
described in scenarios one and two in figure 10.4. Some interference will also result from host
cell proteins blocking potential binding sites of interferon as described in case four. To avoid
these interferences, protein-protein interactions need to be eliminated. This can be achieved by
the addition of a detergent in the starting sample. On the other hand, the detergent itself can have
a major impact on protein binding to the column itself.
However, it was not the primary focus of this study to optimize the ion-exchange purification step
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but more to characterize it and to apply it to samples obtained from the recovery process simulation
from chapter 8. These results can be found in the following section 10.3.2.
For all results obtained for the investigation of host cell protein interferences it needs to be kept
in mind that interferon was always quantified by SDS-PAGE which separates proteins only by
molecular weight. Hence, it is possible that some interferon detected in the starting or flow through
samples are not interferon-α-2b but only host cell proteins with the same molecular weight or
some isoforms of interferon with different characteristics. Even though RP-HPLC confirmed the
findings of the SDS-PAGE results in the negative control sample at the beginning of this section,
this fact cannot be completely neglected and has to be considered for further optimization steps of
the purification method.
10.3.1.2 Isocratic elution of interferon-α-2b
The original SOP for the ion-exchange purification follows a gradient elution from 0 - 60% mobile
phase B (elution buffer) in 18 minutes with a flow rate of 5ml/min (compare section 10.2.2). This
corresponds to a salt concentration of 0 - 0.42M NaCl. It was shown in figure 10.2, that most
proteins and interferon-α-2b elute after 9 - 10 minutes which corresponds to a salt concentration
of 0.21M NaCl (30% mobile phase B). To simplify the method and to reduce the salt concentration
in the recovered fraction, an isocratic approach was tested for the elution of interferon-α-2b from
the column.
The TCA-pellet was prepared and the ion-exchange purification was performed as described in
section 10.2.2, except for the elution-phase. After the wash-step with the binding buffer, the
method was stopped and isocratic elution was conducted manually, by increasing the salt concen-
tration step wise, starting at 0.147M NaCl (21% mobile phase B), which corresponds to elution
fraction 6. The aim of this experiment was to find the lowest possible salt concentration for
interferon-α-2b elution.
Figure 10.7 shows interferon-α-2b and total protein fractions throughout different steps of the ion-
exchange purification with a step-wise isocratic elution at 21%, 25%, 28% and 31% of mobile
phase B.
Total protein was quantified using the Bradford assay as described in section 10.2.4 and total
interferon-α-2b was quantified using the SDS-PAGE as described in section 10.2.5. Figure 10.7
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Fig. 10.7: Interferon-α-2b and total protein fractions quantified in samples of the purification of a
TCA-pellet with the HiTrap column and isocratic elution: 25% of B represents 0.175M NaCl
which corresponds to fraction 7 during the gradient elution
shows that the majority (>95%) of interferon-α-2b bound to the column elutes at a salt concen-
tration of 0.175M NaCl (25% mobile phase B), which corresponds to elution fraction 7. The
elution conditions for 25% mobile phase B were 5ml/min for 3.3min giving a collection volume
of 16.5mL. No interferon was detected after the elution condition of 21% mobile phase B (0.147M
NaCl - elution fraction 6) at 5ml/min for 5 minutes. And only a minor percentage of interferon
was detected after the elution conditions of 28% mobile phase B (0.196M NaCl - elution fraction
8). These results indicate that all proteins elute at a similar salt concentration of 0.175M NaCl and
no gradient elution is required for elution of interferon from the column. Hence, with isocratic
elution at 25% mobile phase B (0.175M NaCl), all column bound interferon can be recovered in
less than 20mL. Compared to the results obtained with gradient elution the recovered volume is
reduced from 25mL to 20ml, meaning interferon is more concentrated, and the salt concentration
in the recovered fraction is also reduced from 0.21M to 0.175M NaCl.
Looking at the recovery of interferon-α-2b under isocratic elution, no significant difference can
be observed compared to the gradient elution. In the negative control, with gradient elution, 40%
of the loaded interferon was recovered in elution fractions 7-12, 50% IFN was found in the flow
through and 10% was detected in the wash- and strip-sample. Under isocratic elution 33% of
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the loaded interferon-α-2b was recovered in the elution at 25% of mobile phase B, 50% IFN was
found in the flow through and 11% was detected in the wash- and strip-sample. The slightly
reduced amount of interferon recovered in the elution between gradient and isocratic is not signifi-
cant. Given that the flow-through and wash/strip sample resulted in similar results, the difference
between the recovered interferon in the elution fractions was almost certainly due to variations in
the quantification method, namely SDS-PAGE.
In summary the isocratic elution of interferon-α-2b at 25% mobile phase B (0.175M NaCl) is an
efficient and simplified alternative to the gradient elution method. Interferon-α-2b will be more
concentrated due to a smaller elution volume and the salt concentration in the recovered elution
fraction will also be reduced compared to the gradient elution fraction. In the event of further
optimization studies of this ion-exchange purification method, the implementation of an isocratic
elution should be considered.
10.3.2 Impact of detergents on Ion-Exchange Chromatography step
This section discusses the impact of the two different detergents, Sarkosyl and Zwittergent 3-14, on
the ion-exchange purification, which is the first DSP-step following the primary protein recovery
process. Both detergents were used during the recovery process to improve protein solubility
(chapter 8), hence the impact of their presence in the final TCA-pellet on the purification needs to
be examined.
First, the impact of Sarkosyl on the ion-exchange method will be discussed followed by the results
of the impact of Zwittergent 3-14.
10.3.2.1 Impact of Sarkosyl on IEC
The impact of Sarkosyl on the ion-exchange purification was tested for different concentrations of
the detergent. First the impact of Sarkosyl concentration present throughout the recovery process
was examined, followed by smaller detergent concentrations, which would be present after the
performance of a detergent removal step.
In order to improve protein solubility during the primary protein recovery process, Sarkosyl was
added at a concentration of 3.0% during cycle-1. Results of chapter 8 showed that at the end of
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the optimized recovery process with Sarkosyl, the detergent was still present at a concentration of
2.4 - 2.6%. Hence, the impact of the presence of 3.0% Sarkosyl in the TCA-pellet on the first step
of the down-stream process needs to be investigated.
At first, a TCA-pellet of the manufacturing process containing 3% Sarkosyl was used for interferon-
α-2b purification with the ion-exchange method, as described in section 10.2.2. It was not possible
to bring this purification to an end, since loading a TCA-pellet containing 3% Sarkosyl onto the
Sepharose column, was impossible. Sarkosyl is an anionic detergent, which is known to interfere
with some ion-exchange resins. In the literature most described interactions are between Sarkosyl
and anion exchangers (section 10.1.2.3) but apparently Sarkosyl also interacts with the cation-
exchanger Sepharose. This observations lead to the conclusion that Sarkosyl needs to be removed
from the recovery process sample prior to the down-stream process.
In chapter 9 different techniques were proposed for the removal of Sarkosyl from process samples.
Over 95% - 98% of the initial 3% Sarkosyl could be removed with some of the techniques. Hence,
the next experiment was performed with a Sarkosyl concentration of 0.15% which corresponds to
95% removal. The sample preparation was the same as in the previous test, a TCA-pellet from
the manufacturing process was spiked with 0.15% of Sarkosyl and interferon purification was per-
formed with the ion-exchange method as described in section 10.2.2. First observations made
during the performance was the successful loading of the sample. However, after quantifying total
interferon-α-2b in the collected samples, no interferon was detectable in the elution fractions 7-12
(data not shown). On the contrary, 90% of the loaded interferon was detected in the flow-through
and 10% in the wash- and strip-sample. This leads to the conclusion that the presence of a Sarkosyl
concentration of 0.15% prevents the binding of interferon to the column completely. The binding
of total protein to the column was less affected than interferon. Over 10% of the original loaded
total protein was detected in the elution fractions 7-12 (data not shown), 80% in the flow through
and 10% in the wash- and strip-sample. These results lead to the conclusion that the presence
of 0.15% Sarkosyl in the TCA-pellet has a significant negative impact on the purification steps.
Hence, the Sarkosyl concentration in the TCA-pellet needs to be reduced further.
The next experiment was performed with a TCA-pellet containing a Sarkosyl concentration of
0.06%, which corresponds to 98% removal. The IFN purification was performed under standard
conditions as described in section 10.2.2. Figure 10.8 shows the AKTA chromatogram of the
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TCA-pellet purification containing a Sarkosyl concentration of 0.06% (on the left side) and the
control sample without detergent present (on the right side).
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Fig. 10.8: AKTA chromatogram from TCA-pellet purifications containing a Sarkosyl concentration of
0.06% (left) or without Sarkosyl (right)
The chromatograms of both purifications, with and without Sarkosyl at 0.06%, look very similar.
However, analysing the collected samples for the TCA-pellet containing 0.06% Sarkosyl, resulted
in only 6% recovery of the loaded interferon in the elution fractions 7-12, 80% in the flow through
and 15% in the wash- and strip-sample. The interferon recovery of the control sample without
Sarkosyl present was as expected: 38% recovery of the loaded IFN in the elution fractions 7-12,
50% in the flow through and 12% in the wash- and strip-sample. These big differences between
control and Sarkosyl-containing sample were unexpected since the elution chromatograms were
very similar in their UV-280 profile. Having a closer look at the chromatograms in figure 10.8, one
major different can be seen. The elution peak of the control sample has a small shoulder on the
right side. This shoulder indicates the presence of the majority of interferon in the elution fractions
10 and 11 of the control sample. The other small difference between both chromatograms is the
height of both peaks. The control sample reaches a slightly higher UV-280 value of 1750mAU,
compared to 1600mAU for the TCA-sample with a Sarkosyl concentration of 0.06% present. The
difference in the peak height can be explained by the reduced recovery of total protein in the
elution fractions. The TCA-pellet containing 0.06% of Sarkosyl resulted in 12% recovery of the
loaded total protein in the elution fractions 7-12, whereas the negative control without Sarkosyl
showed 17% recovery in total protein.
However, with only 6% recovery in interferon-α-2b, the impact of Sarkosyl at a concentration of
0.06% is still significant. Hence, the Sarkosyl concentration was reduced once more to 0.03%
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which corresponds to 99.0% removal.
In a last experiment a TCA-pellet derived from the manufacturing process was spiked with Sarko-
syl to a concentration of 0.03% and used for interferon purification with the ion-exchange method
as described in section 10.2.2. Results of the quantified interferon-α-2b and total protein in the
different collected samples throughout the purification, are shown in figure 10.9.
protein load flow through wash-sample fractions: 7-12 strip-sample
0
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40
60
80
100
Fig. 10.9: Interferon-α-2b and total protein fractions quantified in samples after the purification of a
TCA-pellet containing 0.03% Sarkosyl
The interferon recovery in the elution fractions 7-12 is 23% of the initial loaded IFN, which is a
significant improvement compared to the IFN recovery with 0.06% Sarkosyl present. However,
the IFN recovery is still 1.6 times less than in the negative control without any Sarkosyl present.
The total protein recovery with 0.03% Sarkosyl present, is also lower than in the control sample,
13% recovery in the elution fractions 7-12 with 0.03% Sarkosyl compared to 18% in the control
sample. These results show, that even with a low concentration of 0.03%, Sarkosyl has a significant
impact on interferon purification. However, achieving a Sarkosyl removal of more than 99% is
very challenging, as shown in chapter 9. Hence, the presence of Sarkosyl in the primary recovery
process results in maximal 20-25% recovery in interferon-α-2b throughout the first down-stream
step, if 99% of Sarkosyl has been removed prior to the purification method.
In summary, the results showed that the presence of Sarkosyl in primary recovery process samples
has a major impact on the first purification step. Even after 99% detergent removal, the impact
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on interferon-α-2b recovery throughout the DSP-step was still significant. However, looking on
the following steps throughout the down-stream process, it is important to know how the Sarkosyl
concentration behaves through the first DSP-step and how much of the Sarkosyl concentration gets
carried onto the next DSP-step. Figure 10.10 shows the Sarkosyl concentration in all fractions of
the ion-exchange purification with the TCA-pellet containing Sarkosyl at 0.06%.
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Fig. 10.10: Sarkosyl concentration quantified in each sample of the TCA-pellet purification containing
0.06% Sarkosyl
The amount of Sarkosyl was quantified by RP-HPLC and UV detection as described in section
10.2.3. The Sarkosyl concentrations shown in figure 10.10 are the absolute values quantified in
each fraction independent on their fraction-volume. It can be seen in figure 10.10 that the majority
of the Sarkosyl is found in the flow-through and wash sample, both of which go to the waste
stream. The concentration of Sarkosyl detected in the elution fractions is very low between 0-
0.015%. However, the Sarkosyl concentration elutes in a similar profile to interferon, with the
maximum in fractions 10 and 11. This leads to the conclusion that some detergent molecules
and proteins still interact with each other throughout the ion-exchange method. For the following
DSP steps, elution fractions 7-12 will be collected together and the Sarkosyl concentration of all
6 fractions gives an average concentration of 0.007%, which should have no significant impact on
the second DSP-step, a UF/DF-method.
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10.3.2.2 Impact of Zwittergent on IEC
The impact of the presence of Zwittergent 3-14 on the first down-stream process step, an ion-
exchange method, was examined. Zwittergent 3-14 was utilized to improve protein solubility
during the primary protein recovery process (chapter 8). The first part of this section focuses on
the impact of Zwittergent 3-14 at 1.0%, which is the detergent concentration added during the
recovery process, on the ion-exchange purification followed by the impact of reduced Zwittergent
concentrations, which would be present after a detergent removal step.
To investigate the impact of Zwittergent 3-14 being present at the end of the recovery process
on the ion-exchange purification, a TCA-pellet of the manufacturing process was prepared as
described in section 10.2.2. The TCA-pellet solution was than spiked with Zwittergent 3-14 at a
concentration of 1.0% and the ion-exchange purification was performed as usual.
Figure 10.11 shows the AKTA chromatogram of the whole purification method for the TCA-pellet
containing 1.0% Zwittergent.
Fig. 10.11: AKTA chromatogram of sample purification with 1.0% Zwittergent 3-14 present
The chromatogram looks very similar to the chromatogram of the control sample without detergent
(see figure 10.2). Only in the elution fraction after fraction 11 or 12 some minor differences are
visible (red arrow). The UV-280 peak is wider and prolate compared to the negative control
and the UV-280 reading does not return to the start value (200mAU) but stagnates between 600
and 400mAU. These results indicate that the presence of Zwittergent at 1.0% has an impact on
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interferon-α-2b purification.
In order to gain more information as to how Zwittergent 3-14 affects IFN purification, all samples
collected during the purification run were analysed for total interferon and total protein. The
results of these quantifications are shown in figure 10.12.
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Fig. 10.12: Total interferon and total protein recovery after sample purification with 1.0% Zwittergent
3-14 present
Total protein was analysed using the BCA-assay as described in section 10.2.4 and total interferon-
α-2b was quantified using the SDS-PAGE as described in section 10.2.5. The results in figure
10.12 indicate that the presence of 1.0% Zwittergent 3-14 in the TCA-pellet has no impact on the
binding of interferon-α-2b to the ion-exchange column. Only 25-30% of the loaded interferon
was found in the flow-through, which is 15-20% less than observed in the control sample without
detergent (45% of IFN in flow through). This improvement of the interferon binding to the column
correlates with the observation made throughout the study of host cell protein interference on IFN
binding to the column (section 10.3.1.1). The results indicated that host cell proteins interact with
interferon and thus prevent interferon from binding to the column (scenario 1 in figure 10.4). To
avoid or reduce this interference, the suggestion was made to add a detergent to the process sample
prior to purification. The observations in this section confirm this suggestion. With the addition
of Zwittergent 3-14 prior to the purification the binding of interferon to the column improved to
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15-20%.
Looking at the recovered interferon detected in the elution fractions it can be seen that the elution
is protracted, which corresponds to the observation made in figure 10.11. The elution fractions
7-12 contained 33.5% of the loaded interferon, but an additional 11% was found in the last elution
fractions 13-18 and 7% in the strip-sample. These results indicate that the binding of interferon-α-
2b to the column is stronger in the presence of 1.0% Zwittergent 3-14 and a stronger salt gradient is
required to elute all IFN from the column. With the original salt gradient only 33% of the loaded
interferon is recovered for further down-stream steps. However, a stronger salt gradient might
increase the interferon recovery to 45 - 50%, which is higher than the recovery of the control
sample without Zwittergent (38%). Instead of changing the salt gradient, an isocratic elution
mode might be even more beneficial in order to improve the interferon recovery. This option will
be discussed in one of the following section 10.3.2.3.
The impact on the interferon elution profile of Zwittergent 3-14 also indicates that some detergent
is still present during the elution. Hence, Zwittergent 3-14 was quantified in all collected fractions
of this purification experiment and results are discussed in the following section.
The binding and elution of total protein towards the column in the presence of 1.0% Zwittergent
3-14 was less affected. 62% of the loaded total protein was found in the flow through, 9% in
the wash-sample, 20% in the elution fractions and 7% in the strip-sample. This proportion is
comparable to the findings of the control sample without detergent present, except for the 7% in
the strip-sample. The increased amount in the strip sample is the only indication that the binding
of total protein to the column is slightly stronger in the presence of Zwittergent 3-14 than without
it.
In summary, the presence of 1.0% Zwittergent 3-14 in the process sample showed a positive impact
on the binding of interferon-α-2b to the column. However, besides the impact on the binding, an
impact on the elution of IFN from the column was also observed. In the presence of Zwittergent
3-14 the interferon affinity is increased and stronger salt gradients would be required to remove
all bound interferon, otherwise only 33.5% of the loaded interferon-α-2b is recovered for further
purification steps.
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Zwittergent 3-14 removal during DSP
In order to investigate the behaviour of the Zwittergent 3-14 itself during the interferon purification
with the ion-exchange method, all purification fractions were analysed for their Zwittergent 3-14
concentration. Figure 10.13 shows the Zwittergent 3-14 recovery after purification of the TCA-
pellet containing 1.0% Zwittergent 3-14.
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Fig. 10.13: Zwittergent 3-14 recovery after purification of TCA-pellet containing 1.0% Zwittergent 3-14
Zwittergent 3-14 was quantified with RP-HPLC and RI detector as described in section 10.2.3.
Similar to the presentation of the Sarkosyl results, the Zwittergent 3-14 concentrations shown
in figure 10.13 are the absolute values quantified in each fraction independent on their fraction-
volume. It can be see that the majority of Zwittergent 3-14 is found in the flow through of the
column and does not interact with the column. However, it is also observed that the Zwittergent
3-14 concentration in the elution fractions proceeding proportional to the interferon results. No
interferon nor Zwittergent 3-14 is detected in elution fractions 1-6. From elution fractions 7-10
both amounts increase and from elution fractions 11-18 they decrease with a higher concentration
in the last fraction compared to the first fraction. These results indicate that Zwittergent 3-14 is
interacting in some way with the column, either directly or through interactions with the proteins.
Injecting 1.0% Zwittergent 3-14 on the column without any proteins being present resulted in a
100% recovery of the injected detergent in the flow through and no binding or interactions were
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observed between Zwittergent 3-14 and the column itself (data not shown). This leads to the
conclusion that Zwittergent 3-14 does not bind directly to the column but through interactions
with proteins, interferon and or host cell proteins.
Calculating the average Zwittergent 3-14 concentration between elution fractions 7-12 results in a
detergent concentration of 0.226% in 30mL purified sample. This shows, that Zwittergent 3-14 is
removed through the ion-exchange purification by 90% of its initial starting concentration referring
to the recovered average detergent concentration of the starting volume. However, due to reduction
of the volume, the detergent is concentrated to the final concentration of 0.226% Zwittergent 3-
14, which will be present and needs to be taken into account for the next purification step of the
down-stream process.
10.3.2.3 Isocratic elution of interferon-α-2b containing 1% Zwittergent 3-14
Results in the last section showed, that interferon-α-2b binds stronger to the ion-exchange column
in the presence of 1.0% Zwittergent 3-14. In order to remove all interferon from the column the
suggestion was made to increase the salt concentration during the elution. In this experiment an
isocratic elution mode at different salt concentrations starting from 0.147M (21% mobile phase B)
to 0.35M (50% mobile phase) was investigated. During the elution the alterations in the UV-280
reading was observed. As soon as the UV-280 reading showed no further significant increase or
decrease, the next salt concentration was adjusted.
A TCA-pellet from the manufacturing process was prepared as described in section 10.2.2 and
spiked with 1.0% Zwittergent 3-14 followed by the ion-exchange purification. The method was
performed as described in section 10.2.2 except the elution phase. This part was performed man-
ually with isocratic elution at different salt concentration as explained above.
Figure 10.15 shows total interferon-α-2b and total protein in collected samples after purification
with isocratic elution at different salt concentrations of the TCA-pellet containing 1.0% Zwitter-
gent 3-14.
Total protein was quantified using the BCA-assay as described in section 10.2.4 and total interferon-
α-2b was quantified using SDS-PAGE as described in section 10.2.5. Results in figure 10.15
confirm the findings of the previous section of an increased interferon binding to the column in
the presence of 1.0% Zwittergent in the TCA-pellet. Only 33% of interferon-α-2b was found in
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Fig. 10.14: Total interferon-α-2b and total protein recovery after sample purification with 1.0%
Zwittergent 3-14 present and isocratic elution at different salt concentrations
the flow-through, which is less than in the control sample without detergent. Following the re-
sults of the flow-through and the wash-sample, are the results for the different isocratic elution
fractions with increasing salt concentrations, starting at 0.147M NaCl corresponding to 21% of
mobile phase B (elution fraction 6). Less than 5% of the loaded interferon was detected in this
fraction after 5 minutes of constant elution at 5ml/min and no significant increase in the UV-280
reading was observed. The next fraction was collected at an isocratic elution at 0.175M NaCl
(25% of mobile phase B, elution fraction 7) for 3 minutes at 5ml/min. Over 15% of the loaded
IFN was detected in this fraction with a UV-280 maximum at 1000mAU. In the third fraction, at
0.196M NaCl (28% mobile phase B, elution fraction 8), 18% of the loaded interferon was detected
which was unexpected. The UV-280 reading showed no increment but only continuous decreasing
from 500mAU down to 100mAU over the whole 4 minutes at 5ml/min. The last two fractions at
0.217M NaCl (31% mobile phase B) and 0.35M NaCl (50% mobile phase B) showed only very
little interferon recovery and constant UV-280 reading below 100mAU for 5 and 4 minutes at
5ml/min. These findings suggest that more than 38% of the loaded interferon-α-2b can be recov-
ered with an isocratic elution at 0.196M NaCl (28% mobile phase B). Without detergent present
all interferon eluted at 0.175M NaCl (25% mobile phase B) as results showed in section 10.3.1.2.
This is another confirmation of the observation that interferon-α-2b has a higher affinity for the
PhD-Thesis from Tanja Buch 264
CHAPTER 10. IMPACT OF OPTIMIZED RECOVERY PROCESS ON DOWN-STREAM
PROCESS
ion-exchange column in the presence of 1.0% Zwittergent 3-14.
However, looking at the last fraction in figure 10.15 it can be seen that 15% of the loaded interferon
was still recovered in the strip-sample, which goes to the waste stream. In order to recover this IFN
portion in the elution fraction, the salt concentration would need to be increased to 0.4M NaCl or
higher. However, a high salt concentration can have a negative impact on other purification meth-
ods or on the protein itself (section 10.1.2), hence the interferon elution should be operated at the
lowest salt concentration as possible.
In order to confirm the findings of isocratic interferon elution at 0.196M NaCl the experiment was
repeated with only one isocratic elution step at 0.196M NaCl (28% mobile phase B). The UV-280
reading and quantified interferon results indicated a very slow elution of IFN from the column
(data not shown). This leads to a big dilution of the interferon in the recovered fraction. Hence,
a higher salt concentration (0.217M NaCl) was selected for a faster elution of interferon from the
column and a more concentrated IFN in the recovered fraction.
Figure 10.15 shows an AKTA chromatogram of the isocratic elution profile at 0.217M NaCl
corresponding to 31% mobile phase B (elution fraction 9) for a TCA-pellet containing 1.0% Zwit-
tergent 3-14.
Fig. 10.15: AKTA chromatogram of an isocratic elution at 31% mobile phase B of TCA-pellet containing
1.0% Zwittergent 3-14 (31% mobile phase B equals to 0.217M NaCl which corresponds to
fraction 9 of a gradient elution)
The isocratic elution chromatogram of interferon-α-2b at 0.217M NaCl shows two maxima in the
UV-280 reading. The first maximum was reached after 0.6min elution at 5ml/min with a UV-280
reading of 1100mAU. The second maximum reached a UV-280 reading of 1400mAU after 3.9
minutes of 5ml/min elution. This observation of two maxima was unexpected and needs to be fur-
ther investigated. Each maximum was collected as a separate fraction and analysed for interferon
and total protein.
The results of the analysed fractions as well as the other collected samples of the purification of
PhD-Thesis from Tanja Buch 265
CHAPTER 10. IMPACT OF OPTIMIZED RECOVERY PROCESS ON DOWN-STREAM
PROCESS
a TCA-pellet containing 1.0% Zwittergent 3-14 are shown in figure 10.16. The ion-exchange pu-
rification was performed as described in section 10.2.2 except the elution, which was performed
manually with isocratic conditions at 0.217M NaCl. During the isocratic elution 4 different frac-
tions were collected. Fraction zero is called 31%-prime during which the AKTA system and the
column were flushed with 31% mobile phase B (0.217M NaCl) at 5ml/min until the conductivity
reading was constant. Fraction 1 was operated under similar conditions to fraction zero and all
following fractions. Eluent was collected for 2 minutes until UV-280 reading reached its first min-
imum. Fraction 2 was collected for 4 minutes at 5ml/min and fraction 3 for 2.5 minutes.
Figure 10.16 shows the recovery of total interferon-α-2b, total protein and Zwittergent 3-14 in the
collected samples throughout the purification of a TCA-pellet containing 1.0% Zwittergent 3-14
with isocratic elution at 0.217M NaCl.
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Fig. 10.16: Total interferon-α-2b, total protein and Zwittergent 3-14 recovery after purification of
TCA-pellet with 1.0% Zwittergent 3-14 present. Isocratic elution at 31% of mobile phase B
(31% mobile phase B equals to 0.217M NaCl which corresponds to fraction 9 of a gradient
elution)
Total protein was quantified using the BCA-assay as described in section 10.2.4, total interferon-
α-2b was quantified using SDS-PAGE as described in section 10.2.5 and Zwittergent 3-14 was
quantified by RP-HPLC and RI detector as described in section 10.2.3. It can be seen in figure
10.16 that only 35% of loaded interferon-α-2b was detected in the flow through. This finding is as
expected and was already seen in previous purifications of TCA-pellets containing 1.0% Zwitter-
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gent 3-14. No interferon was detected in the 31%-prime fraction which was as expected. Flushing
the system and column with elution conditions has the only purpose to adapt the column envi-
ronment to the elution conditions. That way the elution of interferon starts without delay when
collecting the elution fractions and big dilutions can be prohibited.
Only a small portion of less than 5% of the loaded interferon was detected in the elution fraction
1. This was unexpected. Due to the high UV-280 reading with a maximum at 1100mAU a higher
IFN proportion was expected. However, the UV-280 reading is not protein specific and also rep-
resents all host cell proteins eluted at that time. The majority of interferon-α-2b was recovered
in the second elution fraction. More than 40% of the loaded IFN was recovered during these 4
minutes. Elution fraction 3 shows only a small portion of interferon of less than 5% which was
as expected. The UV-280 reading was constantly decreasing during this fraction from 400mAU
down to 200mAU.
The strip sample still contains 10% of the loaded interferon which is higher than the control sam-
ple. However, as mentioned previously, in order to reduce this portion it would require a much
higher salt concentration during the elution which can have an negative impact on further purifi-
cation steps.
The host cell proteins showed no significant changes compared to the negative control without any
detergent present except the slightly higher protein portion in the strip sample. This phenomenon
was already discussed before in the previous section.
In summary, using an isocratic elution at 0.217M NaCl for TCA-pellet purification containing
1.0% Zwittergent 3-14 results in an interferon-α-2b recovery of 50% in 30ml fraction volume.
The gradient elution of the TCA-pellet containing 1.0% Zwittergent 3-14 resulted in 33.5% recov-
ery of the loaded interferon in the elution fractions 7-12. Hence, due to isocratic elution the IFN
recovery could be improved from 33.5 to 50% in the same fraction volume. And the interferon
recovery of TCA-pellet with 1.0% Zwittergent 3-14 present is even improved compared to the
negative control without a detergent which results only in 40% recovery of the loaded interferon.
Besides interferon and total protein recovery, figure 10.16 also shows the recovery of Zwittergent
3-14 in the collected samples after purification with isocratic elution of the TCA-pellet containing
1.0% Zwittergent. In contrast to previous Zwittergent results, these data are not the absolute con-
centrations of Zwittergent but the proportion of detergent per volume recovered in each fraction
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in relation to the starting concentration of 1.0%. The results show that the majority of Zwitter-
gent 3-14 (>90%) does not interact with the column and is collected in the flow through and the
wash-sample. Only small levels of less than 10% were found in elution fractions one, two and
three. Under consideration of the volume of elution fraction 1 and 2, the absolute concentration of
Zwittergent 3-14 in both fractions together would be around 0.3%. These results illustrate that in
fact 90% of the Zwittergent 3-14 was removed by the ion-exchange purification but the recovered
10% became 3 times concentrated in the elution fraction. This results in 0.3% Zwittergent 3-14
in the recovered fractions for further down-stream process steps. These findings confirm the pre-
vious observations from section 10.3.2.2, which showed 0.23% Zwittergent 3-14 in the recovered
fraction for further purification steps.
Impact of the Recovery Process simulation samples on DSP
Throughout the primary protein recovery process optimization with Zwittergent 3-14 (chapter 8)
two different optimized processes with Zwittergent 3-14 were proposed. The first includes the
addition of Zwittergent during cycle 1 but otherwise following the steps of the original process,
including the salting-out step. The second optimized recovery process involves the addition of
Zwittergent 3-14 during cycle 1 but in the absence of the salting-out step. Due to the removal
of the salting-out step the proportion between host cell proteins and interferon increased. Results
of section 10.3.1.1 showed that host cell proteins do interfere with the interferon purification by
ion-exchange chromatography. Hence it is important to investigate the impact of the different pro-
portions between HCP and IFN on the ion-exchange purification.
The TCA-pellets recovered after the large scale simulation at 0.5L of the protein recovery process
with 1.0% Zwittergent in the presence and absence of the salting-out step were prepared for the
ion-exchange purification as described in section 10.2.2. The purification was performed under
standard conditions and an isocratic elution at 31% mobile phase B (0.217M NaCl). Obtained
results for interferon-α-2b and total protein showed for both pellets that only a small portion of
the loaded interferon bound to the column (15%) and the majority was found in the flow through
(75%). The reduced interferon recovery of both pellets can be explained by the reduced Zwit-
tergent 3-14 concentration in the TCA-pellets after the recovery process simulations. Results in
chapter 8 showed that the Zwittergent 3-14 concentration is decreasing throughout the recovery
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process simulation below 0.5%. It is possible that below a certain concentration, Zwittergent 3-
14 loses its ability to prohibit interactions of host cell proteins with the interferon binding to the
column and start to interfere with the IFN-affinity itself. For that reason, the Zwittergent 3-14
concentration in both TCA-pellets derived from the recovery process simulation in absence and
presence of the salting-out step was adjusted to 1.0% prior to the ion-exchange purification.
Repeating the purification with the TCA-pellets and adjusted Zwittergent 3-14 concentrations to
1.0%, resulted in comparable results for both TCA-pellets than previously obtained with the TCA-
pellet from the manufacturing process. One third (35%) of loaded interferon-α-2b was found in
the flow through, 40-45% of interferon was recovered in the isocratic elution fraction and 15-20%
of IFN was detected in the wash- and strip-sample (date not shown). These results indicate that
the changes in the proportion between host cell protein and interferon due to the presence or ab-
sence of the salting-out step has no significant impact on the recovery of interferon during the
ion-exchange purification. The results also showed that a decrease in the Zwittergent 3-14 con-
centration from 1.0% to 0.5% has a negative impact on interferon purification and the detergent
concentration needs to be adjusted to 1.0% prior to purification. Another option besides adjusting
the Zwittergent 3-14 concentration would be the removal of the detergent from the process sam-
ple prior to purification. The impact of process samples on the purification post Zwittergent 3-14
removal is discussed in the following section 10.3.2.4.
10.3.2.4 Impact on DSP post Zwittergent 3-14 removal
One possibility to reduce the impact of Zwittergent 3-14 on the down-stream process is the removal
of the detergent prior to the DSP. Chapter 9 discussed different techniques for the removal of
Zwittergent 3-14. This section discusses the impact on the ion-exchange purification of small
remaining traces of Zwittergent 3-14 after the detergent removal step. It is assumed that 95% of the
initial Zwittergent 3-14 concentration could be removed, which leaves only 0.05% of Zwittergent
left in the process sample.
A TCA-pellet from the manufacturing process was spiked with 0.05% Zwittergent 3-14 and ion-
exchange purification was performed as described in section 10.2.2 with the standard gradient
elution method. Figure 10.17 shows recovered interferon-α-2b and total protein after purification
of the TCA-pellet containing 0.05% Zwittergent 3-14.
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Fig. 10.17: Total interferon-α-2b and total protein recovery after purification of TCA-pellet with 0.05%
Zwittergent 3-14 present. Gradient elution from 0 - 60% mobile phase B
Total protein was quantified using BCA assay as described in section 10.2.4 and total interferon-α-
2b was quantified using SDS-PAGE as described in section 10.2.5. Results show a similar recovery
of interferon than analysed in the negative control sample without detergent present, with a slightly
higher interferon portion in the flow-through. More than half (55%) of the loaded IFN was detected
in the flow through which is 5-10% higher than the control sample. 35% of loaded interferon was
analysed in the elution fractions 7-12, which is slightly lower than the control sample with 38-40%
IFN recovery. Previous results with 1.0% showed an improved interferon binding to the column
but also a delayed and declined IFN recovery after column elution. With 0.05% Zwittergent 3-14
no impact on the column elution was observed, however, a minor negative impact on the interferon
binding to the column was detected. These findings confirm the observation from the previous
section where a reduced Zwittergent 3-14 concentration showed interference with the interferon
binding to the column. The results indicate that the presence of 0.05% Zwittergent 3-14 has
a minor negative impact on the interferon purification but results for the IFN recovery yield in
elution fractions are still satisfying.
The amount of total protein showed a very similar trend compared to interferon. A minor increase
of total protein in the flow-through and a small decrease in the elution fractions 7-12.
Zwittergent 3-14 was quantified as well in all fractions with the RP-HPLC method and RI detector.
However, no detergent could be detected in any of the elution fractions. This shows that the
PhD-Thesis from Tanja Buch 270
CHAPTER 10. IMPACT OF OPTIMIZED RECOVERY PROCESS ON DOWN-STREAM
PROCESS
majority of the 0.05% Zwittergent 3-14 was detected in the flow-through and wash-sample and
the concentration in the elution fractions is below 0.005%.
In summary, the presence of 0.05% Zwittergent 3-14 in process samples showed only a minor
impact on the interferon purification with the ion-exchange method. Only 32% of the loaded
interferon-α-2b was recovered in the elution fractions 7-12 for further purification steps which
is slightly slower compared to the control sample without detergent present with 38-40% IFN
recovery. However, the IFN recovery yield was still sufficient (35%), hence, the impact was
negligible.
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10.4 Conclusion
This chapter focused on the impact of the presence of two different detergents in recovery process
samples on the first purification step of the down-stream process. At first the purification step, an
ion-exchange method, was characterized, followed by the study of the impact of Sarkosyl on the
DSP step and finally the impact of Zwittergent 3-14.
In order to summarize results and draw conclusions this section is divided into four parts: first
the characterization of the IEC, second the impact of Sarkosyl and third the impact of Zwittergent
3-14 followed by the final overall conclusion and outlook.
10.4.1 Characterization of IEC
The purification with the ion-exchange method of a TCA-pellet from the manufacturing process
results in only 38-40% recovery of the loaded interferon-α-2b and 45-50% were detected in the
flow through. Difference parameters, such as flow-rate, IFN load, column temperature or loading
buffer were analysed for their impact on the low interferon recovery during this purification. None
of them showed a significant impact. The main impact on the poor interferon recovery yield is due
to the presence of host cell proteins. Investigation of host cell protein interference indicated that
HCP interact with interferon and hence, interfere with the IFN binding to the column. To reduce
this interference the suggestion was made to add a detergent to the process samples which avoids
protein-protein interactions.
In conclusion, host cell proteins interfere with the interferon binding to the column due to protein-
protein interactions for which reason the recovery yield of interferon-α-2b of the ion-exchange
purification is only 38-40%.
10.4.2 Impact of Sarkosyl
Investigating the impact of Sarkosyl on the ion-exchange purification showed, that Sarkosyl has
a major impact on this first down-stream step. Without removal, at 3% Sarkosyl, no loading of
the sample onto the column was possible, which leads to the conclusion that Sarkosyl interacts
with the column and blocks the pores and/or binding sites. Even after 99% removal of detergent,
the remaining 0.03% Sarkosyl still had a significant impact on the purification and only 20-25%
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of the loaded interferon was recovered in the elution fraction for further down-stream steps. The
recovery of interferon during the first down-stream step in the present of small traces of Sarko-
syl could be improved by equilibrating the ion-exchange column with the Sarkosyl concentration
being present in the process sample. This needs to be further investigated before applying the
Sarkosyl addition at manufacturing scale.
Results also showed, that with the ion-exchange method leftover traces of Sarkosyl from the de-
tergent removal step do further decrease with a removal yield of 90%.
This leads to the conclusion that even after successful removal of Sarkosyl (yield 99%) the maxi-
mal interferon recovered from the purification is only 20-25% of the initially loaded IFN.
10.4.3 Impact of Zwittergent 3-14
The investigation of the impact on the ion-exchange purification of 1.0% Zwittergent 3-14 in
process samples showed a distinct effect on the interferon binding to the column. Due to the
presence of Zwittergent 3-14 more interferon bound to the column and only 30-35% of loaded
IFN was found in the flow-through. However, the elution of interferon was delayed and resulted
only in a recovery yield of 33%. In order to improve the IFN elution, higher salt concentrations
were required. An isocratic elution mode was applied at constant 0.217M NaCl, which resulted in
40-45% recovery of interferon-α-2b. Zwittergent 3-14 was also removed from the process sample
through the ion exchange method. Over 90% of the initial Zwittergent 3-14 concentration were
removed from 1.0% in 100mL down to 0.3% in 30mL fraction volume.
Smaller concentrations of Zwittergent 3-14, less than 1.0%, were shown to have a negative impact
on interferon recovery during the purification. This led to the conclusion to either adjust the
detergent concentration back to 1.0% prior to purification or remove the Zwittergent further with
detergent removal steps. At least 95% of the 1.0% Zwittergent 3-14 needs to be removed to be
below 0.05% in the process sample prior to the purification. Zwittergent 3-14 at 0.05% showed a
small but negligible impact on the IFN purification with a IFN recovery yield of 32%.
It can be concluded that Zwittergent 3-14 at 1.0% has a positive impact on the purification and
interferon recovery can be improved to 40-45% with the implementation of an isocratic elution.
The ion-exchange method can also be used to remove the Zwittergent from process samples with
a yield of 90%.
PhD-Thesis from Tanja Buch 273
CHAPTER 10. IMPACT OF OPTIMIZED RECOVERY PROCESS ON DOWN-STREAM
PROCESS
It still needs to be investigated if the implementation of the isocratic elution has an impact on the
IFN isoform distribution. It is possible that some isoforms have a higher binding affinity to the
column than others and elute only at salt concentrations higher than 0.22M NaCl. These isoforms
would elute in the strip sample with the isocratic elution at 0.217M NaCl.
10.4.4 Overall Conclusion and outlook
It was shown that the first step of the down-stream process, an ion-exchange method, has only an
interferon-α-2b recovery yield of 38-40% which is unsatisfying. In order to improve the IFN re-
covery two possibilities are available. First, addition of a detergent prior to the purification which
improves the binding of interferon to the column or second addition of another purification step to
remove host cell proteins from the process sample.
The presence of a detergent at the end of the recovery process, showed to have significant im-
pact on the interferon purification with the ion-exchange method. Sarkosyl needs to be removed
completely from the process sample prior to purification to avoid any interference with the IFN
binding to the column. Even at a removal yield of 99% (0.03% Sarkosyl) only 20-25% of the
loaded interferon is recovered during the purification which is 13-20% less than the recovery of
the negative control without any detergent.
The presence of Zwittergent 3-14 on the other hand showed a positive influence on the IFN pu-
rification. With the implementation of an isocratic elution, 40-45% of the loaded interferon-α-2b
was recovered during the ion-exchange purification while removing 90% of the 1.0% Zwittergent
concentration from the process sample.
A next step would be the application at large-scale for the two detergents present during the ion-
exchange purification. In particular the implementation of the isocratic elution conditions with
1.0% Zwittergent 3-14 needs to be tested at larger scale.
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Chapter 11
Summary Chapter - Optimized Protein
Recovery Process
11.1 Introduction
This chapter will summarize the results obtained throughout the optimization of the primary pro-
tein recovery process in chapters 7, 8, 9 and 10 and propose three new optimized recovery pro-
cesses for interferon-α-2b with an increased recovery yield.
The primary protein recovery process for interferon-α-2b was characterized setting-up mass bal-
ances for total protein, total interferon-α-2b and interferon-isoforms throughout the whole reco-
very process. Two critical process steps (CPS) were identified in chapters 4, 5 and 6, with CPS-1
during cycle 1 and CPS-2 during cycle-2 with an overall loss in total interferon-α-2b of 80%. The
majority of this loss (60%) was found to be during cycle-1 (CPS-1) due to insufficient protein
solubilisation. Further results led to the conclusion of a protein saturation problem during this step
of the process. With CPS-1 being responsible for over 60% loss of interferon-α-2b, this step was
the primary focus throughout the process optimization study.
The following sections in this chapter will propose three optimized recovery processes for interferon-
α-2b by discussing the protein recovery and economic factors such as cost and time reduction.
Possible advantages and disadvantages of each optimized process compared to the original pro-
cess will be discussed in order to select the optimal protein recovery process for interferon-α-2b.
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11.2 Optimized Recovery Processes
This section will focus on the illustration of three optimized recovery processes for interferon-α-
2b including the first down-stream step. The critical process step 1, characterized in chapters 4,
5 and 6 showed a 60% loss in interferon due to insufficient protein solubilisation and saturation
problems. Hence, a dilution study was performed around the CPS-1 in order to improve the inter-
feron solubility, as discussed in chapter 7. Section 11.2.1 will summarize these results including
the impact on the down-stream process and propose an optimized protein recovery process.
A different approach to increase protein solubility was the addition of detergents throughout cycle
1 of the protein recovery process. Sarkosyl and Zwittergent 3-14 showed the highest potential to
solubilize interferon-α-2b as discussed in chapter 8. After the successful implementation of the
addition of a detergent in a small scale study of the recovery process, the removal of those deter-
gents needed to be investigated. Two different approaches were available for the removal of the
detergents: first, developing a new method for the removal and second, using the first down-stream
step for the detergent removal. Chapter 9 discussed the potential of several different techniques
to remove the detergents, Sarkosyl and Zwittergent 3-14, at the end of the recovery process prior
to purification steps. Chapter 10 shows the impact of the two different detergents on the first
down-stream step at different concentrations and discussed the potential of the ion-exchange step
to remove the detergents from the process. The following two sections 11.2.2 and 11.2.3 summa-
rize the results for Sarkosyl and Zwittergent 3-14 and propose the optimal recovery process for
interferon-α-2b considering additional detergent removal steps and the impact on the down-stream
process.
Current primary protein recovery process
The current primary protein recovery process, as described in section 2.3 and displayed in figure
2.2, exist out of 4 centrifugation steps with a total process time between 16 and 20 hours. The
interferon-α-2b recovery at the end of the process in the TCA-pellet is 20% with the major loss of
60% during cycle-1. Throughout the first down-stream step, an ion-exchange method, only 40%
of the interferon is recovered in the elution fraction for further purification steps. Hence, only 8%
of the initial produced interferon-α-2b is remaining after the recovery process and the first down-
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stream step. Assuming, 7’000g of total interferon-α-2b are produced throughout the fermentation
process, only 560g of IFN are recovered during the recovery process and first down-stream step,
with the majority loss of 5’600g throughout the primary protein recovery process.
End of protein recovery process ion-exchange step overall recovery
Fermentation cycles IFN recovery runs IFN recovery of IFN
100% → 4 cycles 20% → 1 run 40% → 8%
7’000g → 1’400g → 560g → 560g
11.2.1 Optimized Recovery Process with two-fold dilution
The two-fold dilution during cycle-1 was performed in the presence or absence of the salting-
out step (cycle 3), as discussed in chapter 7. In order to achieve a significant improvement in
interferon recovery at the end of the protein recovery process, the salting-out step needs to be
eliminated from the process. Hence, the new optimized recovery process would exist only out
of 3 cycles (process time 15 hours), with a double process volume during cycle-1 and an overall
interferon-α-2b recovery of 60%. Results of chapter 7 showed that the two-fold dilution has no
significant impact on the first down-stream step, hence, the ion-exchange step can be performed
following the standard protocol. However, with a three-fold increase in interferon-α-2b recovery
at the end of the primary protein recovery process, the ion-exchange column would be overloaded
with only one purification run. Thus, the TCA-pellet needs to be divided into two parts and each
fraction is purified separately by the down-stream process. With a 40% recovery of interferon in
each elution fraction of the ion-exchange runs, 24% of the initial produced interferon-α-2b is re-
covered after the first down-stream step. Assuming, 7’000g of total interferon-α-2b are produced
throughout the fermentation process, 1’680g of IFN are recovered during the recovery process
and first down-stream step. Compared to the current protein recovery process, this is a three-fold
improvement in the interferon-α-2b recovery. However, at least the first down-stream step needs
to be performed twice due to the increased interferon-α-2b amount in the TCA-pellet.
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End of protein recovery process ion-exchange step overall recovery
Fermentation cycles IFN recovery runs IFN recovery of IFN
100% → 3 cycles 60% → 2 runs 40% each → 24%
7’000g → 4’200g → 840g each → 1’680g
11.2.2 Optimized Recovery Process with 3% Sarkosyl
The addition of 3% Sarkosyl to the primary protein recovery process to improve protein solubil-
ity was discussed in chapter 8. Results showed that the presence of Sarkosyl interferes with the
salting-out step due to instability of the detergent below a pH of 5.0. Hence, the protein recovery
process would need to be performed in the absence of the salting-out step. Results from chapter
10 showed a significant impact of Sarkosyl-containing process samples on the first down-stream
step, an ion-exchange method. Hence, it was concluded that Sarkosyl needs to be removed from
the process prior to the down-stream process. Chapter 9 discussed several different techniques
for the removal of Sarkosyl from the process and the UF/DF-method showed the most efficient
removal rate while recovering interferon-α-2b. The implementation of the UF/DF step is most
beneficial after the solubilisation step of the protein recovery process (cycle-1). This results in the
elimination of the TCA-precipitation step at the end of the recovery process and replacing it with
the UF/DF step.
Accordingly, the optimized protein recovery process exists out of two cycles (process time 5
hours) with the addition of 3% Sarkosyl during cycle 1 and an interferon-α-2b recovery of 80%.
The UF/DF method removes more than 95% of Sarkosyl while recovering more than 60% of
interferon-α-2b with a process time of 4-5 hours. After the removal of the detergent from the
process the first down-stream step is performed following the standard protocol. Results showed
(chapter 10) that even traces of Sarkosyl (<0.03%) have a significant impact on the purification
with the ion-exchange method and only 25% of interferon-α-2b is recovered in the elution frac-
tion for further purifications. With 60% recovery during the UF/DF step and only 25% interferon
recovery throughout the ion-exchange step, the overall recovery in interferon-α-2b from the ini-
tial produced amount is only 12%. Assuming, 7’000g of interferon-α-2b are produced during
the fermentation process, only 840g will be recovered after the first down-stream step, which is
only 1.5-fold higher compared to the current recovery. Due to the addition of 3% Sarkosyl the
interferon solubility increased four-fold, however, due to detergent removal steps and the reduced
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recovery throughout the purification in the presence of detergent traces, the overall improvement
in interferon-α-2b recovery is only 1.5-fold.
End of recovery process UF/DF ion-exchange step overall
Ferment. cycles IFN-yield IFN-yield runs IFN-yield IFN-yield
100% → 2 80% → 60% → 1 25% → 12%
7’000g → 5’600g → 3’360g → 840g → 840g
11.2.3 Optimized Recovery Process with 1% Zwittergent 3-14
The addition of 1.0% Zwittergent 3-14 during cycle-1 of the protein recovery process improved
the protein solubility as discussed in chapter 8. Results showed, that Zwittergent 3-14 is less
pH-sensitive than Sarkosyl, thus the protein recovery process can be performed in the absence or
presence of the salting-out step. In the presence of the salting-out step the interferon-α-2b re-
covery at the end of the recovery process was 55%. Results during the characterization showed
no significant impact of the salting-out step on the interferon-α-2b recovery and neither on the
interferon-isoform distribution. Hence, the salting-out step can be eliminated from the re-
covery process which results in a 70% recovery of interferon-α-2b due to the addition of
Zwittergent 3-14.
Results of the first down-stream step in chapter 10 showed that due to the presence of Zwitter-
gent 3-14 the binding of interferon towards the ion-exchange column is stronger and an isocratic
elution mode is more beneficial. Hence, with 1% Zwittergent 3-14 present in the process sample
and an isocratic elution mode, more than 50% of interferon-α-2b is recovered throughout the first
down-stream step. However, a reduced Zwittergent 3-14 concentration in the process samples
indicated a negative impact on the purification by ion-exchange. Thus, the Zwittergent 3-14 (SB
3-14) concentration needs to be adjusted to 1.0% at the end of the protein recovery process prior to
the down-stream process. The ion-exchange method also showed potential to remove Zwittergent
3-14 successfully from process samples with 75% removal, leaving Zwittergent 3-14 at a concen-
tration of 0.25% in the elution fraction. Since the 70% of interferon-α-2b recovery, rather than the
8% of the standard recovery process, would almost certain exceed the capacity of the ion-exchange
column, the final material from the primary recovery process would need to be divided into two
fractions and the ion-exchange cycle operated twice.
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Performing the protein recovery process in the absence of the salting-out step, but in the pres-
ence of 1.0% Zwittergent 3-14, followed by the ion-exchange step with an isocratic elution mode,
results in 35% recovery of interferon-α-2b for the further purification steps. Assuming, 7’000g
interferon-α-2b are produced during the fermentation, 2’450g are recovered throughout the pro-
tein recovery process and the first down-stream step. This is more than a 4-fold improvement in
the interferon recovery compared to the current recovery process.
End of recovery process SB 3-14 ion-exchange step overall
Ferment. cycles IFN-yield adjustment runs IFN-yield IFN-yield
100% → 3 70% → 100% → 2 50% → 35%
7’000g → 4’900g → 4’900g → 1’225g → 2’450g
11.3 Advantages and disadvantages of the optimized process
The previous sections proposed three different optimized recovery processes for interferon-α-2b.
This section will discuss some advantages and disadvantages of each of the proposed processes to
finally select the optimal recovery process.
The first optimized recovery process, using a two-fold dilution during cycle-1 of the recovery pro-
cess in order to improve the protein solubility was proposed in section 11.2.1. A three-fold increase
in total interferon-α-2b recovery was achieved after the first down-stream step, from 8% recovery
to a 24% overall recovery. However, a negative aspect and challenging problem is the increase in
process volume in cycle-1 due to the dilution step. In order to implement this process change, the
availability of a larger reactor needs to be assured. Another problem for the implementation of this
optimized process at manufacturing scale can be the capacity of the final centrifugation step of the
primary recovery, which will need to process twice as much volume than before. This separator
run needs to be performed twice in order to process the entire process volume, which increases
process time and cost.
In summary, the optimized recovery process using a two-fold dilution gives a three-fold increase in
interferon-α-2b recovery, however the implementation at large scale can be challenging, although
productivity and yield would increase significantly compared to the standard recovery process.
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The optimized recovery process using an addition of 3% Sarkosyl during cycle-1 of the protein
recovery process resulted in only a 1.5-fold increase in interferon-α-2b recovery after the first
down-stream step. However, these calculations are worst case scenarios and it is very likely that
the recovery, especially during the UF/DF step, will be improved. Using 3% Sarkosyl during the
recovery process resulted in the highest interferon-α-2b solubility of all three processes. However,
due to the characteristics of the detergent, the implementation of a new detergent-removal method
would be indispensable. The removal of the detergent, followed by the first down-stream step
result in an increased loss of interferon-α-2b and only 12% overall recovery. Another negative
aspect of this optimized recovery process is the three-fold increase in process volume after the
UF/DF step which needs to be processed by the ion-exchange method. Unfortunately a reduction
of volume is not possible as it would increase the detergent concentration.
In summary, the addition of Sarkosyl did result in the highest interferon-α-2b solubility but due
to unavoidable implementation of a detergent removal method, the overall interferon-α-2b is only
1.5-fold increased compared to the current recovery. Hence, it is not worth to continue with the
implementation of this optimized recovery process at pilot scale or manufacturing scale.
The last proposed optimized recovery process was the addition of 1.0% Zwittergent 3-14 dur-
ing cycle-1 of the recovery process to increase protein solubility. This optimized process results in
more than four-fold increment in the overall interferon-α-2b recovery. The application of this opti-
mized process at larger scale is the less challenging one without any significant volume increments
or implementation of new methods. Only small changes, such as the addition of the detergent and
the elimination of the salting-out step, need to be adjusted for the optimized process. Also the per-
formance of the ion-exchange method was simplified by using an isocratic elution mode instead
of a gradient elution. However, due to the increase in interferon recovery throughout the protein
recovery process, the first step of the down-stream process needs to be performed twice, which
results in an increase in process time and cost.
In summary, the addition of 1.0% Zwittergent 3-14 during cycle-1 of the recovery process and the
elimination of the salting-out step results in the optimal protein recovery process with a four-fold
increase in the interferon-α-2b recovery.
Another point which needs to be considered with the optimized protein recovery process is the
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variation in protein production throughout the fermentation. As shown in chapter 4 the amount of
protein at the end of the fermentation can vary ±20%. So far these variations in total interferon-
α-2b could not be observed in the final TCA-pellet at the end of the recovery process (due to
protein saturation problems in cycle-1) and thus had no impact on the down-stream process. How-
ever, with the enhanced protein solubility in cycle-1 due to the addition of Zwittergent 3-14 these
variations in interferon-α-2b will be detectable in the final TCA-pellet and need to be consid-
ered during the down-stream process. In order to ensure and maintain reproducibility throughout
the entire down-stream process, the interferon-α-2b concentration in the feed-volume of the first
ion-exchange method should be kept constant with a tolerance level of ±5% and if necessary the
down-stream process needs to be performed twice or three times.
A schematic illustration of the most efficient optimized protein recovery process can be seen in
figure 11.1.
The optimized protein recovery process for interferon-α-2b in figure 11.1 shows the addition of
1.0% Zwittergent 3-14 during cycle 1 and the elimination of the salting-out step resulting in a
four-fold increase in interferon recovery after the first down-stream step.
Throughout this study the impact of Zwittergent 3-14 on the protein activity of interferon-α-2b
was not investigated. However, Croze et al. [114] have shown that interferon-β retained its full
bio-activity in the presence of 2.5% Zwittergent 3-14. These results suggest that interferon-α-2b
would almost certain retain its bio-activity in the presence of Zwittergent 3-14.
Besides the bio-activity of interferon-α-2b, the impact of Zwittergent 3-14 on the interferon-
isoform distribution was not completely investigated. Results with the currently available method
indicated no significant difference in the isoform distribution due to solubilisation in the presence
of Zwittergent 3-14, however further studies with complete mass balances need to be performed
using a more accurate analytical method than currently available.
In summary, the optimized protein recovery process for interferon-α-2b with the addition of 1.0%
Zwittergent 3-14 resulted in a four-fold increase in the interferon-α-2b recovery. The process
time of the of the recovery process itself was reduced from 16 to 14 hours. However, the down-
stream process time was increased due to the performance of two or three purification runs of the
same TCA-pellet. Since the majority of the process costs and process time is during the fermen-
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Fig. 11.1: The optimized primary protein recovery process for interferon-α-2b with 1.0% Zwittergent
3-14 addition during cycle-1 and in the absence of the salting-out step. First down-stream step,
an ion-exchange method, is performed with isocratic elution. Overall IFN recovery is 35%
which is a four-fold increase to the current recovery.
tation process, it is beneficial to perform the fermentation once, recover an increased amount of
interferon-α-2b and perform the down-stream process two or three times as necessary.
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11.4 Conclusion
This chapter summarized all findings of the previous chapters 7, 8, 9 and 10 and proposed three
optimized protein recovery processes using a two-fold dilution, addition of 3% Sarkosyl and ad-
dition of 1% Zwittergent 3-14 in cycle-1 of the recovery process. The interferon-α-2b recovery
throughout the recovery process and until the first down-stream step was analysed and compared
to the current process performance. A two-fold dilution resulted in a three-fold increase in IFN
recovery, the addition of 3% Sarkosyl resulted only in 1.5-fold increment in IFN and the addition
of 1% Zwittergent 3-14 resulted in more than four-fold increase in the interferon recovery after
the first down-stream step.
Following the proposed optimized recovery processes, advantages and disadvantages were dis-
cussed for each of the optimized recovery processes in order to find the most efficient and ap-
plicable protein recovery process. The addition of 1.0% Zwittergent 3-14 during cycle-1 of the
recovery process turned out to be the most applicable and efficient optimized process for an in-
creased interferon-α-2b recovery. The optimized recovery process is very similar to the current
process which makes it easier for the implementation of the new process at larger scale. On the
other hand, this optimized process resulted in the highest interferon-α-2b recovery throughout the
recovery process and the first down-stream step.
The next step is the implementation of the optimized recovery process and the first down-stream
step at manufacturing or pilot scale. However, prior to this step three other aspects of the optimized
process need to be verified first. The impact of Zwittergent 3-14 addition on the bio-activity on
interferon-α-2b and on the interferon-isoform distribution. And the impact of possible variations
in the protein production on the optimized recovery process as well on the down-stream process.
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Summary, Conclusion and Perspective
12.1 Introduction
The results obtained in chapters 3 to 11 will first be summarized before comparing them to the
different objectives of this thesis. Following the gathering of the results, conclusion will be drawn
and an outlook will be given for the next steps. Table 12.1 summarizes the objectives of this thesis,
as they were already listed in table 2.1 in section 2.4.
Tab. 12.1: Thesis objectives
Work package Objectives
1.) Analytical Toolkit • total protein (Bradford, BCA-assay)
• total interferon-α-2b (SDS-PAGE, Western Blot, Biacore)
• isoforms (RP-HPLC & purification, concentration)
2.) Process Characterization • total protein (mass balances & CPS)
• total interferon-α-2b (mass balances & CPS)
• isoforms (mass balances)
3.) Process Optimization • solubility study (dilution experiment, detergents)
• detergent removal
• impact on DSP
.
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12.2 Summary
Chapter 3 showed the successful set-up of a small scale model of the industrial primary protein re-
covery process. The performance of simulation runs varying different parameters such as volume,
protein concentrations and type of protein, provided first information about the characteristics of
this process and the small scale model. The simulations were also used for the selection and set-up
of analytical methods.
The Bradford assay was identified as the most accurate method in order to detect the amount of
total protein in recovery process samples using BSA as the reference standard. The simulations
also showed that the model provides more reliable results as the working volume increases i.e.
with higher scales. A last result was the finding of the recovery process non-specificity to different
types of proteins.
In chapter 4 the primary recovery process was characterized and protein mass balances have been
set-up throughout the entire recovery process. An overall loss of up to 90% in total protein was
identified throughout the recovery process. This loss occurred mainly in two identified critical
process steps (CPS). Cycle 1 was selected as the critical process step 1 with a loss of more than
80% of total protein. The main problem of CPS-1 is the poor solubility of proteins and low
saturation levels of proteins in water. The second critical process step was identified during cycle
2, with a total protein loss of 40% due to salting-out by the addition of NaCl and HCl.
Chapter 5 contained the setting-up of mass balances for total interferon-α-2b throughout the pri-
mary recovery process. An overall loss of 80% in interferon-α-2b was detected. The same critical
process steps as identified for total protein were identified for interferon-α-2b. CPS-1, during
cycle 1, showed a loss of 60% interferon, and CPS-2, during cycle 2, a loss of up to 30%.
The first part of chapter 6 focused on the development and optimization of quantification methods
for interferon-isoforms. Three RP-HPLC were successfully optimized with design of experiment
for their accuracy and resolution. However, accuracy and resolution were not sufficient to quantify
interferon-isoforms in all recovery process samples. Host cell proteins and low interferon-isoform
concentration were interfering with the analytical methods. Hence, purification and concentration
methods for interferon-isoforms were investigated to purify interferon prior to the quantification.
However, no technique met the required criteria to purify interferon-isoforms successfully.
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Selected samples of the recovery process were analysed anyway for the interferon-isoform distri-
bution with the optimized RP-HPLC methods. Results were less accurate and robust but confirmed
the findings of chapters 4 and 5 of two critical process steps and a total interferon loss of 75%. The
main reduction was identified in isoform-2 and isoform-3, whereas isoform-4 and interferon-α-2b
showed only a 50% loss throughout the recovery process.
Chapter 7 discussed the dilution study around the critical process step 1 in order to increase protein
solubility and to prevent protein saturation. A two-fold dilution during cycle 1 of the protein re-
covery process resulted in 15% increase of interferon-α-2b solubility. However, this improvement
was not detectable at the of the recovery process due to increased losses throughout the critical
process step 2 (salting-out step). An elimination of the salting-out step resulted in 15-20% im-
provement in interferon-α-2b recovery at the end of the process compared to a one-fold dilution.
At the end of this chapter the impact of a two-fold dilution during cycle 1 of the recovery process
on the first down-stream step was investigated. No significant impact of an increase in interferon-
α-2b recovery on the ion-exchange method was detected.
In chapter 8 different detergents were tested to increase interferon-α-2b solubility throughout the
critical process step 1. Two detergents, Sarkosyl and Zwittergent 3-14 were identified as having
the highest potential for improving IFN solubility. Sarkosyl at a concentration of 3% resulted in
90% solubility of interferon-α-2b during CPS-1. However, this increment was not detectable at
the end of the recovery process due to an increased loss of interferon throughout the salting-out
step. In the absence of the salting-out step more than 75% of interferon-α-2b was recovered at
the end of the recovery process. Zwittergent 3-14 at a concentration of 1.0% resulted in 80% IFN
solubility during the critical process step one and an overall IFN recovery of 55% at the end of
the recovery process. However, in the absence of the salting-out step this IFN recovery could be
improved to 70%, which is a 3.5-fold improvement compared to the original recovery process.
Chapter 9 focused on the removal of the two detergents, Sarkosyl and Zwittergent 3-14, from
process samples. In a first step two RP-HPLC methods were developed to quantify Sarkosyl
and Zwittergent 3-14 in recovery process samples. In a second step five different techniques
were tested for their potential to remove Sarkosyl and/ or Zwittergent 3-14 from process samples.
Under consideration of the application at large-scale, the detergent removal yield and interferon-
α-2b recovery, an ultrafiltration/ diafiltration technique showed the most promising results. Using
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a membrane with a 10kDa cut-off, more than 80-95% of Sarkosyl could be removed from the
samples while recovering between 80-60% of interferon-α-2b and 80% of Zwittergent 3-14 was
removed while recovering 50% of the interferon.
In chapter 10 the impact of the presence of the two detergents, Sarkosyl and Zwittergent 3-14
on the first down-stream step was investigated. In a first step the ion-exchange chromatography
method was characterized and results showed that only 38-40% of the initial interferon-α-2b was
recovered in the elution fractions of the column. After the investigation of several different factors,
the presence of host cell proteins was identified as the biggest impact on poor interferon-α-2b
recovery throughout this purification step.
In a second step the impact of the presence of Sarkosyl and Zwittergent 3-14 on the interferon
purification with the ion-exchange method was investigated. The presence of 3% Sarkosyl resulted
in a blockage of the column which led to the conclusion that Sarkosyl needs to be removed from
the process prior to the down-stream step. However, even a 99% removal of Sarkosyl, leaving the
detergent at a concentration of 0.03%, resulted in a significant impact on the interferon purification
and only 20-25% of the initial loaded interferon-α-2b was recovered in the elution fractions.
The presence of Zwittergent 3-14 in the process samples had less impact on the down-stream step.
In the presence of 1.0% Zwittergent 3-14 the binding affinity between interferon and the column
was increased and the elution of IFN was delayed. Changing the elution mode to an isocratic
elution at 0.217M NaCl resulted in 40-45% recovery of the initial loaded interferon-α-2b in the
elution fraction. In parallel more than 90% of the detergent concentration was removed throughout
this ion-exchange method which resulted in a Zwittergent 3-14 concentration of 0.25% prior to
the next purification step. However, reduced Zwittergent 3-14 concentrations of less than 1.0%
resulted in a negative impact of the interferon-α-2b purification unless the detergent concentration
was below 0.05%.
Chapter 11 summarized all findings from chapters 7, 8, 9 and 10 and proposed three new optimized
recovery processes including the first down-stream step. After discussion of advantages and dis-
advantages of each optimized process the addition of 1.0% Zwittergent 3-14 in the absence of the
salting-out step and the implementation of an isocratic elution during the ion-exchange method re-
sulted in the most applicable and efficient optimized recovery processes with a four-fold increase
in interferon-α-2b recovery.
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The following table 12.2 summarizes the results achieved in the optimization of the primary pro-
tein recovery process (chapters 7 and 8) and shows the losses in interferon-α-2b and total protein
throughout the primary protein recovery process in its current version and from the optimized pro-
cesses.
Tab. 12.2: Summary of the recovery of total protein, total interferon-α-2b and interferon-isoforms
throughout the primary protein recovery process of the manufacturing process, 2-fold dilution
process, with 3% Sarkosyl and with 1.0% Zwittergent 3-14
process description protein losses in [%] recovery in [%]
process salting-out protein Acid Cycle-1 Cycle-2 Cycle-3 overall
pres/ abs analysed Kill solubility salting-out TCA-pellet recovery
m
an
uf
ac
tu
ri
ng
pr
oc
es
s
pr
es
en
t total prot. 20% 75% 40% <1% 10%
total IFN 20% 65% 30% <1% 20%
isoforms - 58% 40% - 25%
2x
di
lu
tio
n
pr
oc
es
s
pr
es
en
t total prot. - 50% 80% <1% 5%
total IFN - 40% 80% <1% 8%
ab
se
nt total prot. - 50% - <1% 50%
total IFN - 40% - <1% 60%
3.
0%
Sa
rk
os
yl
pr
oc
es
s
pr
es
en
t total prot. - 10% 70% <5% 20%
total IFN - 20% 65% <5% 20%
ab
se
nt total prot. - 10% - <5% 90%
total IFN - 20% - <5% 75%
1.
0%
Z
w
itt
er
-
ge
nt
3-
14
pr
oc
es
s
pr
es
en
t total prot. - 22% 50% <1% 40%
total IFN - 20% 30% <1% 55%
ab
se
nt total prot. - 22% - <5% 65%
total IFN - 20% - <5% 70%
Table 12.2 shows that almost all modified recovery processes show an increase in interferon-α-2b
recovery. However, as discussed in chapter 11 the implementation of a two-fold dilution during
the recovery process can be challenging in its implementation at large scale and the presence of
Sarkosyl had a negative impact on the interferon-α-2b purification. Hence, the most applicable
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and efficient optimized recovery process is the addition of 1.0% Zwittergent 3-14 in the absence
of the salting-out step and implementation of an isocratic elution mode during the ion-exchange
purification step.
12.3 Conclusion
In this PhD-thesis the primary protein recovery process was characterized for total protein, total
interferon-α-2b and interferon-isoforms and two critical process steps were identified during cycle
1 and 2 for all types of proteins. Since total protein and interferon-α-2b both followed similar
characteristics throughout the recovery process, these results confirmed the findings of chapter
3, where no protein specificity of the recovery process could have been seen in the small-scale
study of the primary protein recovery process. CPS-1 was identified with the majority of protein
loss, which makes this step as the number one priority for optimization studies. Interferon-α-2b
was detected in the waste stream of the centrifugation step post cycle 1 due to insufficient IFN
solubility and low saturation levels in water.
Table 12.1 shows the objectives of this project divided into three work packages and the majority
of work package one and two have been successfully completed and discussed during chapter 3, 4,
5 and 6. The methods of the analytical toolkit have been set up and were used in order to achieve
the aims of work package 2, characterization of the primary protein recovery process. During the
characterization, mass balances have been set-up and critical process steps could be identified for
total protein as well as total interferon-α-2b.
The results for work package three were discussed in chapter 7, 8, 9 and 10. A protein solubility
study was performed, with the application of a dilution and the addition of two different detergents
in order to improve interferon-α-2b solubility and to increase the IFN recovery at the end of the
process. Furthermore, methods for the removal of those detergents have been developed and the
impact on the first down-stream step of the optimized recovery processes was investigated.
With the findings of this thesis it can be concluded that the primary protein recovery process for
interferon-α-2b was successfully optimized and the interferon recovery four-fold increased due to
the addition of Zwittergent 3-14 during cycle 1 of the recovery process. This optimized primary
protein recovery process, as discussed in chapter 11 can be seen in figure 12.1.
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Fig. 12.1: The optimized primary protein recovery process for interferon-α-2b with 1.0% Zwittergent
3-14 addition during cycle-1 and in the absence of the salting-out step. First down-stream step,
an ion-exchange method, is performed with isocratic elution. Overall IFN recovery is 35%
which is a four-fold increase to the current recovery.
12.4 Perspective
As discussed in the previous section, all objectives of the three work packages were successfully
achieved throughout this project. However, further tasks need to be carried out for the success-
ful application of the optimized recovery process. An obvious step is the implementation of the
optimized recovery process at a pilot scale using continuous centrifugation systems to simulate
similar process conditions at manufacturing scale. Furthermore, the application of the isocratic
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elution mode of the ion-exchange method needs to be tested in a pilot scale or manufacturing
scale to verify the findings of the small scale process. To improve the overall process yield further
the interferon-α-2b recovery of the first down-stream step can be enhanced by optimizing IFN
purification using ion-exchange method.
Besides the implementation of the optimized recovery process at large scale, the impact of the ad-
dition of Zwittergent 3-14 on the protein bio-activity and the interferon-isoform distribution needs
to be investigated. Hence, an analytic method for interferon-α-2b bio-activity is required and the
protein activity needs to be tested in the presence and absence of the detergent and at the end of the
down-stream process. In order to study the impact of Zwittergent 3-14 on the interferon-isoform
distribution a more accurate analytical method is required to quantify all different isoforms in re-
covery process samples. This could be achieved by the implementation of a UPLC method or a
LC-MS method or the development of efficient purification methods to purify interferon from host
cell proteins prior to quantification.
Another step to increase the overall interferon-α-2b yield is the optimization of the fermentation
process to increase the protein productivity. So far a simple batch process is used with two uncon-
trolled temperature shifts. To optimize the interferon productivity the temperature shifts can be
controlled throughout the process with the application of calorimetric technology and the imple-
mentation of a feeding strategy throughout the bio-process, using a fed-batch process can improve
the interferon-α-2b productivity even further.
Besides the improvement in protein productivity, the optimization of the fermentation process can
also resolve the problem with variations in the protein production throughout the fermentation.
Having a more stable and robust protein production would reduce the variations throughout the
primary protein recovery process and the down-stream process.
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12.5 Final Conclusion
This project collaboration between the industrial partner and NIBRT/ DCU has shown that with
strategic planning, process optimization can be achieved which results in an increase of the overall
process yield. First, the setting-up of an analytical toolkit provides robust and reliable methods
in order to carry out process characterizations and to identify critical process steps by setting-up
mass balances. In a second step, these critical process steps can be optimized with the help of
design of experiments in order to increase the overall process yield. In a last step, the impact of
the optimized process on following process steps needs to be investigated and considered for the
selection of the most efficient and applicable optimized process.
In this project this strategic planning resulted in an optimized primary protein recovery process
with a four-fold increase in interferon-α-2b recovery due to the addition of a detergent and the
elimination of a process step.
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Appendix A
Statistics for design of experiment
A.1 Statistics for RP-HPLC optimization
Bakerbond-method
Exp No Exp Name Run Order Incl/Excl Injection Volume IFN Load Flow Rate Temperature Retention time Area Peak width
1 A 3 Incl 10 2 1 35 13.528 2019.1 0.7336
2 A 16 Excl 40 2 1 35 9.855 482.22 0.6682
3 A 14 Incl 10 20 1 35 12.513 23015.6 0.6056
4 B 27 Incl 40 20 1 35 12.385 22808.5 0.4442
5 B 28 Incl 10 2 3.2 35 8.791 720.803 0.5243
6 A 26 Incl 40 2 3.2 35 9.855 482.22 0.6682
7 A 19 Incl 10 20 3.2 35 8.794 7071.06 0.5807
8 A 20 Incl 40 20 3.2 35 8.83 6530.6 0.6053
9 A 9 Incl 10 2 1 55 13.363 2268.39 0.5962
10 B 13 Incl 40 2 1 55 12.599 1973.71 0.3864
11 A 11 Incl 10 20 1 55 12.435 25285.7 0.5688
12 A 2 Incl 40 20 1 55 12.532 22761.5 0.5785
13 A 18 Incl 10 2 3.2 55 9.515 605.265 0.617
14 A 1 Incl 40 2 3.2 55 9.592 546.666 0.6216
15 B 29 Incl 10 20 3.2 55 8.315 6855.89 0.4561
16 A 4 Incl 40 20 3.2 55 8.875 6329.14 0.6227
17 C 6 Incl 10 11 2.1 45 9.674 5322.93 0.423
18 C 8 Incl 40 11 2.1 45 9.668 6353.13 0.42
19 C 21 Incl 25 2 2.1 45 9.99 962.059 0.3969
20 C 7 Incl 25 20 2.1 45 9.536 10042.6 0.4363
21 C 12 Incl 25 11 1 45 12.732 11723.6 0.4108
22 C 5 Incl 25 11 3.2 45 8.569 3572.96 0.4384
23 C 23 Incl 25 11 2.1 35 9.525 5507.69 0.4321
24 C 22 Incl 25 11 2.1 55 9.133 5563.78 0.4242
25 A 15 Incl 25 11 2.1 45 9.685 5908.6 0.3787
26 A 25 Incl 25 11 2.1 45 9.655 5836.8 0.3798
27 A 10 Incl 25 11 2.1 45 9.618 5809 0.3778
28 B 24 Incl 25 11 2.1 45 9.727 5514.77 0.4274
29 C 17 Incl 25 11 2.1 45 9.777 5522.26 0.4207
Fig. A.1: The full list of experiments, factor levels and results for all three responses for the design of
experiment of the bakerbond column: Experiments in the categories A and B were performed
first. In order to improve the developed model experiments from category C were added.
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Retention time Coeff. SC Std. Err. P Conf. int(±)
Constant 9.63527 0.0752218 7.16906e-032 0.156433
Injection Volume 0.0227579 0.0612295 0.713853 0.127334
IFN Load -0.334424 0.0612295 2.03156e-005 0.127334
Flow Rate -1.88626 0.0612295 5.78162e-019 0.127334
Temperature -0.0479801 0.0612295 0.442018 0.127334
F*F 1.2661 0.0969916 1.51897e-011 0.201706
Inj*F 0.191147 0.0652582 0.00801781 0.135712
N = 28 Q2 = 0.964 Cond. no. = 2.975
DF = 21 R2 = 0.982 RSD = 0.2495
R2 adj. = 0.977
Conf. lev. = 0.95
Peak width Coeff. SC Std. Err. P Conf. int(±)
Constant 0.386163 0.0179513 2.72818e-014 0.0377143
Injection Volume -0.014469 0.0134772 0.297188 0.0283145
IFN Load -0.00799768 0.0134772 0.560281 0.0283145
Flow Rate 0.0173468 0.0134772 0.214358 0.0283145
Temperature -0.0122476 0.0134772 0.37548 0.0283145
Inj*Inj 0.0442669 0.0341588 0.211376 0.0717649
Load*Load 0.0393669 0.0341588 0.264206 0.0717649
F*F 0.0473669 0.0341588 0.182479 0.0717649
T*T 0.0509169 0.0341588 0.153384 0.0717649
Inj*F 0.0585526 0.0143645 0.000708786 0.0301787
N = 28 Q2 = 0.534 Cond. no. = 6.456
DF = 18 R2 = 0.818 RSD = 0.05489
R2 adj. = 0.728
Conf. lev. = 0.95
Fig. A.2: The full list of coefficients for the models retention time and peak width of the bakerbond
column, including the p-values of ANOVA. The list also provides the numbers of experiments
included (N), the degress of freedom (DF), the R2 and Q2 values of each model and the
condition number (cond.no)
Fig. A.3: Response Surface Plot of the DoE investigation for the bakerbond-method. The retention time
(left) and peak width (right) dependent on the flow rate and column temperature. Injection
volume is set to constant at 20µL and interferon load is set constant to 11µg.
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Fig. A.4: Sweet-Spot-Plot of the DoE investigation for the bakerbond-method. The retention time and
peak width in dependency on the IFN load and injection volume with column temperature and
flow-rate set constant at 35◦C and 2.05ml/min. The sweet spot (green area) indicates where both
criteria are fullfilled: retention time between 9.5 - 12min and peak width <0.64min.
Zorbax-method
Exp No Exp Name Run Order Incl/Excl Injection vol. IFN load Flow rate Temp. Retention time Area Peak width
1 N1 20 Incl 10 2 0.5 25 20.375 4875.1 0.3192
2 N2 2 Incl 40 2 0.5 25 20.329 3800.8 0.3003
3 N3 9 Excl 10 20 0.5 25
4 N4 16 Incl 40 20 0.5 25 20.177 39998.6 0.4145
5 N5 14 Incl 10 2 2 25 14.116 1131.11 0.2363
6 N6 23 Incl 40 2 2 25 14.07 1005.79 0.2342
7 N7 5 Incl 10 20 2 25 13.787 13178.2 0.294
8 N8 25 Incl 40 20 2 25 13.757 20472.6 0.3299
9 N9 13 Incl 10 2 0.5 55 22.072 4520.14 0.2863
10 N10 19 Incl 40 2 0.5 55 22.117 3063.72 0.2712
11 N11 6 Incl 10 20 0.5 55 21.811 45358.1 0.4155
12 N12 7 Incl 40 20 0.5 55 21.871 38788.1 0.3934
13 N13 27 Incl 10 2 2 55 13.757 1079.67 0.1871
14 N14 8 Incl 40 2 2 55 13.684 889.658 0.1811
15 N15 15 Incl 10 20 2 55 13.495 12583.9 0.2959
16 N16 21 Incl 40 20 2 55 13.445 10231.9 0.2753
17 N17 26 Incl 10 11 1.25 40 15.608 10351.4 0.2558
18 N18 3 Incl 40 11 1.25 40 15.651 11085 0.2686
19 N19 1 Incl 25 2 1.25 40 15.714 1681.83 0.2324
20 N20 11 Incl 25 20 1.25 40 15.54 19833.7 0.3356
21 N21 10 Incl 25 11 0.5 40 21.986 25565.9 0.3536
22 N22 4 Incl 25 11 2 40 14.463 6418.98 0.2387
23 N23 17 Incl 25 11 1.25 25 14.53 10395 0.2437
24 N24 12 Incl 25 11 1.25 55 14.963 10666.8 0.2621
25 N25 24 Incl 25 11 1.25 40 15.662 10086.1 0.2565
26 N26 22 Incl 25 11 1.25 40 15.607 10080.2 0.2586
27 N27 18 Incl 25 11 1.25 40 15.646 10312.1 0.2656
Fig. A.5: The full list of experiments, factor levels and results for all three responses for the design of
experiment of the zorbax column: Experiment number 3 was excluded from the model, since no
results were generated for this HPLC-run.
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Retention time Coeff. SC Std. Err. P Conf. int(±)
Constant 15.6206 0.0227405 0 0.047776
Injection vol. -0.00456105 0.0157258 0.775104 0.0330388
IFN load -0.121605 0.0157258 3.96181e-007 0.0330388
Flow rate -3.68478 0.0157258 8.09361e-033 0.0330388
Temp. 0.32844 0.0157258 4.55421e-014 0.0330388
F*F 2.6456 0.0351869 6.07208e-024 0.0739249
T*T -0.8324 0.0351869 5.2126e-015 0.0739249
F*T -0.511057 0.016761 6.018e-017 0.0352135
N = 26 Q2 = 0.999 Cond. no. = 5.176
DF = 18 R2 = 1.000 RSD = 0.06406
R2 adj. = 1.000
Conf. lev. = 0.95
Peak width Coeff. SC Std. Err. P Conf. int(±)
Constant 0.260946 0.00466316 7.84574e-019 0.00993924
Injection vol. -0.00152032 0.00327429 0.649087 0.00697895
IFN load 0.0506537 0.00327429 1.25472e-010 0.00697895
Flow rate -0.0492925 0.00327429 1.84452e-010 0.00697896
Temp. -0.0116648 0.00327429 0.00283533 0.00697895
Load*Load 0.0151922 0.00722256 0.0527128 0.0153944
F*F 0.0273422 0.00722256 0.00179509 0.0153944
Inj*T -0.00546464 0.00349584 0.138858 0.00745118
Load*F -0.00598536 0.00349585 0.107462 0.00745118
Load*T 0.00626463 0.00349585 0.09332 0.00745118
F*T -0.00510216 0.00349584 0.165054 0.00745118
N = 26 Q2 = 0.913 Cond. no. = 5.185
DF = 15 R2 = 0.972 RSD = 0.01313
R2 adj. = 0.953
Conf. lev. = 0.95
Fig. A.6: The full list of coefficients for the models retention time and peak width of the zorbax column,
including the p-values of ANOVA. The list also provides the numbers of experiments included
(N), the degress of freedom (DF), the R2 and Q2 values of each model and the condition number
(cond.no)
Fig. A.7: Response Surface Plot of the DoE investigation for the zorbax-method. The retention time (left)
and peak width (right) dependent on the flow rate and column temperature. Injection volume is
set to constant at 20µL and interferon load is set constant to 15µg.
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Fig. A.8: Sweet-Spot-Plot of the DoE investigation for the zorbax-method. The retention time and peak
width in dependency on the IFN load and injection volume with column temperature and
flow-rate set constant at 40◦C and 1.25ml/min. The sweet spot (green area) indicates where both
criteria are fullfilled: retention time between 15 - 19min and peak width <0.25min.
Aeris-method
Exp No Exp Name Run Order Incl/Excl Injection volume IFN load Flow rate Temp. Rt Area Width
1 N1 24 Incl 10 2 0.5 25 15.708 2501.39 0.4374
2 N2 20 Incl 40 2 0.5 25 14.627 2551 0.4211
3 N3 2 Incl 10 20 0.5 25 14.19 32987.2 0.8899
4 N4 12 Incl 40 20 0.5 25 14.386 33054.7 1.0103
5 N5 11 Incl 10 2 2.5 25 8.81 796.99 0.6185
6 N6 19 Incl 40 2 2.5 25 8.383 681.832 0.4016
7 N7 3 Incl 10 20 2.5 25 8.137 10641.8 0.8087
8 N8 5 Incl 40 20 2.5 25 8.109 10508.7 0.7637
9 N9 26 Incl 10 2 0.5 55 16.471 2500.95 0.4215
10 N10 17 Incl 40 2 0.5 55 16.49 2660.28 0.4044
11 N11 15 Incl 10 20 0.5 55 15.985 32644.3 0.8371
12 N12 27 Incl 40 20 0.5 55 17.241 31741.5 0.8114
13 N13 10 Incl 10 2 2.5 55 8.702 622.378 0.3958
14 N14 9 Incl 40 2 2.5 55 8.612 612.236 0.3924
15 N15 8 Incl 10 20 2.5 55 8.616 9764.85 0.7205
16 N16 23 Incl 40 20 2.5 55 8.288 8096.84 0.6842
17 N17 25 Incl 10 11 1.5 40 9.622 6246.05 0.6534
18 N18 1 Incl 40 11 1.5 40 9.676 6664.97 0.6035
19 N19 14 Incl 25 2 1.5 40 9.784 1040.63 0.4008
20 N20 6 Incl 25 20 1.5 40 9.371 11486.4 0.6966
21 N21 22 Incl 25 11 0.5 40 15.738 16748.8 0.7354
22 N22 7 Incl 25 11 2.5 40 9.01 3999.22 0.6039
23 N23 21 Incl 25 11 1.5 25 8.803 7212.59 0.6647
24 N24 13 Incl 25 11 1.5 55 9.136 6296.23 0.591
25 N25 18 Incl 25 11 1.5 40 9.658 6487.52 0.6237
26 N26 16 Incl 25 11 1.5 40 9.503 6482.59 0.6216
27 N27 4 Incl 25 11 1.5 40 9.697 6563.85 0.6682
Fig. A.9: The full list of experiments, factor levels and results for all three responses for the design of
experiment of the aeris column.
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Rt Coeff. SC Std. Err. P Conf. int(±)
Constant 9.57798 0.102257 2.37017e-023 0.216775
Injection volume -0.0238339 0.0679202 0.730234 0.143984
IFN load -0.181333 0.0679202 0.0167772 0.143984
Flow rate -3.56494 0.0679202 2.43332e-019 0.143984
Temp. 0.466 0.0679202 3.82779e-006 0.143984
F*F 2.92857 0.157832 3.03135e-012 0.334589
T*T -0.475934 0.157832 0.00821068 0.334589
Inj*Load 0.167187 0.0720403 0.033835 0.152718
Inj*T 0.137313 0.0720403 0.0747682 0.152718
Load*T 0.160063 0.0720403 0.041066 0.152718
F*T -0.406063 0.0720403 3.71367e-005 0.152718
N = 27 Q2 = 0.981 Cond. no. = 5.301
DF = 16 R2 = 0.995 RSD = 0.2882
R2 adj. = 0.992
Conf. lev. = 0.95
Width Coeff. SC Std. Err. P Conf. int(±)
Constant 0.625233 0.00981248 1.41469e-024 0.0204685
Injection volume -0.0161222 0.0120178 0.194784 0.0250687
IFN load 0.184939 0.0120178 1.49991e-012 0.0250687
Flow rate -0.0321778 0.0120178 0.014472 0.0250687
Temp. -0.0420889 0.0120178 0.0022436 0.0250687
Inj*F -0.0226812 0.0127468 0.0903819 0.0265894
Load*F -0.0434688 0.0127468 0.00277547 0.0265894
N = 27 Q2 = 0.863 Cond. no. = 1.299
DF = 20 R2 = 0.932 RSD = 0.05099
R2 adj. = 0.911
Conf. lev. = 0.95
Fig. A.10: The full list of coefficients for the models retention time and peak width of the aeris column,
including the p-values of ANOVA. The list also provides the numbers of experiments included
(N), the degress of freedom (DF), the R2 and Q2 values of each model and the condition
number (cond.no)
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A.2 Statistics for Sarkosyl optimization
Exp No Exp Name Run Order Incl/Excl Detergent conc Volume Agitation time IFN conc Total Protein conc
1 N1 5 Incl 0.1 33.33 2 0 10.87
2 N2 15 Incl 3 33.33 2 55.02 46.48
3 N3 9 Incl 0.1 150 2 0 16.66
4 N4 16 Incl 3 150 2 78.8 67.57
5 N5 2 Incl 0.1 33.33 8 0 11.7
6 N6 13 Incl 3 33.33 8 45.9 48.1
7 N7 8 Incl 0.1 150 8 2.55 18.44
8 N8 12 Incl 3 150 8 82.88 68.71
9 N9 11 Incl 0.1 91.665 5 0 15.39
10 N10 3 Incl 3 91.665 5 68.52 82.71
11 N11 17 Excl 1.55 33.33 5 17.47 36.17
12 N12 6 Incl 1.55 150 5 86.52 68.88
13 N13 14 Incl 1.55 91.665 2 61.4 51.05
14 N14 1 Incl 1.55 91.665 8 66.34 58.17
15 N15 7 Incl 1.55 91.665 5 67.2 51.7
16 N16 10 Incl 1.55 91.665 5 70.4 55.37
17 N17 4 Incl 1.55 91.665 5 73.6 59
Fig. A.11: The full list of experiments, factor levels and results for all three responses for the design of
experiment of the interferon-α-2b solubility study with Sarkosyl. Experiment number 11 was
excluded from the model, since it was identified as an outlier in the normal distribution of the
residuals,
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IFN conc Coeff. SC Std. Err. P Conf. int(±)
Constant 69.4209 1.89352 7.49285e-013 4.16756
Detergent conc 32.857 1.45307 1.42677e-010 3.19814
Volume 8.93434 1.54605 0.000123052 3.4028
Det*Det -36.0539 2.3868 1.05855e-008 5.25325
Det*Vol 7.27625 1.62458 0.000933174 3.57564
N = 16 Q2 = 0.973 Cond. no. = 3.062
DF = 11 R2 = 0.987 RSD = 4.595
R2 adj. = 0.982
Conf. lev. = 0.95
Total Protein conc Coeff. SC Std. Err. P Conf. int(±)
Constant 56.1211 3.02957 1.21412e-009 6.66795
Detergent conc 24.051 2.32486 5.26165e-007 5.11692
Volume 7.44321 2.47363 0.0118867 5.44436
Det*Det -17.4581 3.8188 0.000801249 8.40503
Det*Vol 3.64625 2.59928 0.188267 5.7209
N = 16 Q2 = 0.867 Cond. no. = 3.062
DF = 11 R2 = 0.928 RSD = 7.352
R2 adj. = 0.902
Conf. lev. = 0.95
Fig. A.12: The full list of coefficients for the models interferon-α-2b solubility and total protein solubility,
including the p-values of ANOVA. The list also provides the numbers of experiments included
(N), the degress of freedom (DF), the R2 and Q2 values of each model and the condition
number (cond.no)
Fig. A.13: Response Surface Plot of the DoE investigation for the protein solubility study. The
interferon-α-2b solubility(left) and total protein solubility (right) dependent on the process
volume and Sarkosyl concentration.
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Ion-exchange purification - HiTrap
method
UNICORN V3.10
User: MSD     27.04.2012 15:52:10
Method file: c:\...\MSDmethod\HiTrap Equilibrate Wash and Equilibrate
Method Information
Method name: HiTrap Equilibrate Wash and Equilibrate
Method created by: MSD
Date of creation: 03.11.2011 17:09:58
Target system: System 1
Method last modified by: MSD
Date of last modification: 03.11.2011 17:09:58
Strategy name: E100_110
Strategy date: 19.06.1999 13:57:16
Strategy size: 1012080 bytes 
Variables
Main method:
  Main
  0.00  Base Volume 5.03 {ml} HiTrap_SP_1x5_ml 
  0.00  Flow 5.00 {ml/min} 
  0.00  PumpBInlet B1 
  0.00  ColumnPosition Position2 
  0.00  OutletValve WasteF1 
  0.00  BufferValveA1 A11 
  0.00  Block  Remove_Storage_Solution
    Remove_Storage_Solution
    0.00  Base SameAsMain 
    0.00  BufferValveA1 A11 
    25  End_block 
  0.00  Block  Regenerate
    Regenerate
    0.00  Base SameAsMain 
    0.00  Gradient 100 {%B} 0.00 {base} 
    50  End_block 
  0.00  Block  Equilibrate
    Equilibrate
    0.00  Base SameAsMain 
    0.00  Gradient 0 {%B} 0.00 {base} 
    90  AutoZeroUV 
    100.00  End_block 
Fig. B.1: AKTA-Explorer method for the equilibration of the cation-exchange column HiTrap SP HP with
5ml column volume (GE Healthcare)
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UNICORN V3.10
User: MSD     27.04.2012 15:53:22
Method file: c:\...\MSDmethod\HiTrap IFN Purification
Method Information
Method name: HiTrap IFN Purification
Method created by: Sean
Date of creation: 29.08.1982 17:34:04
Target system: System 1
Method last modified by: MSD
Date of last modification: 01.11.2011 10:16:20
Strategy name: E100_110
Strategy date: 19.06.1999 13:57:16
Strategy size: 1012080 bytes 
Variables
Main method:
  Main
  0.00  Base CV 5.03 {ml} HiTrap_SP_1x5_ml 
  0.00  Flow 5.00 {ml/min} 
  0.00  ColumnPosition Position2 
  0.00  Wavelength 280 {nm} 254 {nm} 260 {nm} 
  0.00  Block  Sample_Load
    Sample_Load
    0.00  Base Volume 
    0.00  ColumnPosition Position2 
    0.00  BufferValveA1 A18 
    0.00  OutletValve F3 
    100.00  End_block 
  0.00  Block  Wash
    Wash
    0.00  Base SameAsMain 
    0.00  PumpWash A11 OFF OFF OFF 
    0.00  BufferValveA1 A11 
    0.00  OutletValve WasteF1 
    5.00  End_block 
  0.00  Block  Elution
    Elution
    0.00  Base SameAsMain 
    0.00  Gradient 60 {%B} 18.00 {base} 
    0.00  OutletValve FracF2 
    0.00  FractionCollector 5.00 {ml} 
    18.00  FractionationStop 
    18.00  End_block 
  0.00  Block  Strip
    Strip
    0.00  Base SameAsMain 
    0.00  OutletValve F3 
    0.00  Gradient 100.00 {%B} 0.00 {base} 
    5.00  End_block 
Fig. B.2: AKTA-Explorer method for the purification of interferon-α-2b using cation-exchange column
HiTrap SP HP with 5ml column volume (GE Healthcare)
PhD-Thesis from Tanja Buch X
Appendix C
Oral presentations/ poster
At the following conferences, oral presentations/ posters have been given:
• 16th European Congress on Biotechnology (ECB) Conference, Edinburgh; Optimization of
an industrial primary protein recovery process by Design of Experiment; poster, July (2014)
• 3rd Annual Limerick Postgraduate Research Conference, Limerick; Application of Design
of Experiment for Optimization of a protein recovery process; oral presentation, May (2014)
• Research Day of School of Biotechnology, Dublin City University, Dublin; Optimization
of an industrial primary recovery process using Design of Experiments; oral presentation,
February (2014)
• 33rd International Symposium on the Separation of Proteins, Peptides & Polynucleotides
Group (ISPPP), Boston; Purifying and concentrating recovery process samples for recom-
binant protein purification; oral presentation, July (2013)
• Research Day of School of Biotechnology, Dublin City University, Dublin; Characteriza-
tion and optimization of an industrial primary recovery process to enhance the protein yield;
poster, January (2013)
• 9th European Society of Biochemical Engineering Sciences (ESBES) Conference, Istanbul;
Characterization and optimization of an industrial primary recovery process to enhance the
protein yield; poster, September (2012)
• Research Day of School of Biotechnology, Dublin City University, Dublin; Optimization of
a protein recovery of Interferon by analyzing and controlling the protein recovery process;
oral presentation, January (2012)
